,project_id,fiscal_year,report_title,principal_investigator,supervisor,research_org,lab_staff_within_org,extramural_collab,collab_other_NCI,collab_other_NIH,publications,url
0,BC000155-10,"October 01, 1999 -  September 30, 2000",The Effect of Phytochemicals on the Carcinogen Activation Pathway Mediated by th,Grace  Yeh; PhD,NULL,"Basic Research Laboratory, NCI",NULL,NULL,Henry  Ciolino; PhD  (Cellular Defense and Carcinogenesis Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=12334
1,BC000157-10,"October 01, 1999 -  September 30, 2000",Imidodipeptides and Amino Acid Metabolites in Cell Regulation and Carcinogenesis,James Ming Phang; MD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,NULL,Steven  Donald  (Metabolism and Cancer Susceptibility Section)|Jay M Mei  (Metabolism and Cancer Susceptibility Section)|Ying  Peng  (Metabolism and Cancer Susceptibility Section)|Xiao Ya J Sun  (Metabolism and Cancer Susceptibility Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11195
2,BC000162-10,"October 01, 1999 -  September 30, 2000",Systems-based modelling of retinoid - drug interactions.,Kevin C Lewis,NULL,"Basic Research Laboratory, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11190
3,BC000163-10,"October 01, 1999 -  September 30, 2000",Mechanisms for modulating the Androgen Response in Prostate Cancer Cells,James Ming Phang; MD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,NULL,Steven  Donald  (Metabolism and Cancer Susceptibility Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11191
4,BC000189-07,"October 01, 1999 -  September 30, 2000",Dietary Regulation of Biochemical/Molecular Changes in Carcinogen Resistant Cell,Grace  Yeh; PhD,NULL,"Basic Research Laboratory, NCI",NULL,NULL,Henry  Ciolino; PhD  (Cellular Defense and Carcinogenesis Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11188
5,BC003229-30,"October 01, 1999 -  September 30, 2000",T-Cell Antigen Recognition and Tumor Antigens,Ettore  Appella; MD|IRP Faculty Profile,NULL,"Chemical Immunology Section, NCI",NULL,NULL,NULL,NULL,"1. Appella E, Arnott D, Sakaguchi K, Wirth PJ   (2000) Proteome mapping by two-dimensional polyacrylamide gel electrophoresis in combination with mass spectrometric protein sequence analysis.  EXS 88:1-27.|2. Bergman AC, Benjamin T, Alaiya A, Waltham M, Sakaguchi K, Franzen B, Linder S, Bergman T, Auer G, Appella E, Wirth PJ, Jornvall H   (2000) Identification of gel-separated tumor marker proteins by mass spectrometry.  Electrophoresis 21:679-86.|3. Doolan DL, Southwood S, Chesnut R, Appella E, Gomez E, Richards A, Higashimoto YI, Maewal A, Sidney J, Gramzinski RA, Mason C, Koech D, Hoffman SL, Sette A   (2000) HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles.  J Immunol 165:1123-37.|4. Dzuris JL, Sidney J, Appella E, Chesnut RW, Watkins DI, Sette A   (2000) Conserved MHC class I peptide binding motif between humans and rhesus macaques.  J Immunol 164:283-91.|5. Emmert-Buck MR, Gillespie JW, Paweletz CP, Ornstein DK, Basrur V, Appella E, Wang QH, Huang J, Hu N, Taylor P, Petricoin EF   (2000) An approach to proteomic analysis of human tumors.  Mol Carcinog 27:158-65.|6. Eura M, Chikamatsu K, Katsura F, Obata A, Sobao Y, Takiguchi M, Song Y, Appella E, Whiteside TL, DeLeo AB   (2000) A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck.  Clin Cancer Res 6:979-86.|7. Hoffmann TK, Nakano K, Elder EM, Dworacki G, Finkelstein SD, Appella E, Whiteside TL, DeLeo AB   (2000) Generation of T cells specific for the wild-type sequence p53(264-272) peptide in cancer patients: implications for immunoselection of epitope loss variants.  J Immunol 165:5938-44.|8. Kobayashi H, Wood M, Song Y, Appella E, Celis E   (2000) Defining promiscuous MHC class II helper T-cell epitopes for the HER2/neu tumor antigen.  Cancer Res 60:5228-36.|9. Sakaguchi K, Saito S, Higashimoto Y, Roy S, Anderson CW, Appella E   (2000) Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase Effect on Mdm2 binding.  J Biol Chem 275:9278-83.|10. Sidney J, Dzuris JL, Newman MJ, Johnson RP, Amitinder K, Walker CM, Appella E, Mothe B, Watkins DI, Sette A   (2000) Definition of the mamu A*01 peptide binding specificity: application to the identification of wild-type and optimized ligands from simian immunodeficiency virus regulatory proteins.  J Immunol 165:6387-99.",https://intramural.nih.gov/search/searchview.taf?ipid=11187
6,BC003581-31,"October 01, 1999 -  September 30, 2000",The Analytical Chemistry of New Anticancer Drugs,Harry  Ford,NULL,"ANALYTICAL CHEMSTRY SECT, NCI",James A Kelley; PhD|Nancy M Malinowski,NULL,Kahsay  Habte  (Laboratory of Medicinal Chemistry),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11185
7,BC003663-24,"October 01, 1999 -  September 30, 2000",Role of protein kinases in modulating cell growth and malignant transformation,Wayne  Anderson; PhD,NULL,"Laboratory of Cellular Oncology, NCI",Michael  Lee|Conrad  Mallia; PhD|Wei  Wang; PhD,NULL,Terry H Bird  (National Cancer Institute),NULL,"1. Dimon-Gadal S, Gerbaud P, Therond P, Guibourdenche J, Anderson WB, Evain-Brion D, Raynaud F   (2000) Increased oxidative damage to fibroblasts in skin with and without lesions in psoriasis.  J Invest Dermatol 114:984-9.",https://intramural.nih.gov/search/searchview.taf?ipid=11186
8,BC004496-23,"October 01, 1999 -  September 30, 2000",Chromosomal Proteins and Chromosomal Functions,Michael  Bustin; PhD|IRP Faculty Profile,NULL,"PROTEIN SECT, NCI","Yuri  Postnikov; MD, PhD",NULL,Yehudit  Birger  (National Cancer Institute)|Jae  Lim; BS  (National Cancer Institute)|Marta  Prymakowska-Bosak  (National Cancer Institute),NULL,"1. Herrera JE, Schiltz RL, Bustin M   (2000) The accessibility of histone H3 tails in chromatin modulates their acetylation by P300/CBP-associated factor.  J Biol Chem 275:12994-9.",https://intramural.nih.gov/search/searchview.taf?ipid=11182
9,BC004504-28,"October 01, 1999 -  September 30, 2000",Alterations in Interacting Signaling Pathways that Initiate Squamous Carcinogene,Stuart H Yuspa; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular Carcinogenesis and Tumor Promotion, NCI",NULL,NULL,Christina K Cheng  (In Vitro Pathogenesis Section)|Laura  Hansen  (In Vitro Pathogenesis Section)|Luowei  Li  (In Vitro Pathogenesis Section)|Andre M Rocha  (National Cancer Institute)|Tyrone C Spady; PhD  (National Cancer Institute)|Kwang Sun Suh  (National Cancer Institute),NULL,"1. Denning MF, Dlugosz AA, Cheng C, Dempsey PJ, Coffey RJ, Threadgill DW, Magnuson T, Yuspa SH   (2000) Cross-talk between epidermal growth factor receptor and protein kinase C during calcium-induced differentiation of keratinocytes.  Exp Dermatol 9:192-9.|2. Hansen LA, Woodson RL, Holbus S, Strain K, Lo YC, Yuspa SH   (2000) The epidermal growth factor receptor is required to maintain the proliferative population in the basal compartment of epidermal tumors.  Cancer Res 60:3328-32.|3. Yuspa SH, Hansen L, Li L, Joseloff E, Weinberg W, Fernandez-Salas E   (2000) Interacting signaling pathways in the pathogenesis of squamous cell carcinoma.  Medicina (B Aires) 60:689-92.",https://intramural.nih.gov/search/searchview.taf?ipid=11183
10,BC004517-24,"October 01, 1999 -  September 30, 2000",DNA Repair in Human Cancer-Prone Genetic Diseases,Kenneth H Kraemer; MD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,NULL,Steffen  Emmert  (National Cancer Institute)|Sikandar  Khan  (LAB MOLECULAR CARCINOGENESIS)|Hanoch  Slor  (LAB MOLECULAR CARCINOGENESIS),NULL,"1. Emmert S, Kobayashi N, Khan SG, Kraemer KH   (2000) The xeroderma pigmentosum group C gene leads to selective repair of cyclobutane pyrimidine dimers rather than 6-4 photoproducts.  Proc Natl Acad Sci U S A 97:2151-6.|2. Kraemer KH   (2000) Predisposition, susceptibility and DNA repair in radiation-induced skin cancer.  Radiat Res 154:724;discussion 726-7.|3. Metter EJ, Tarone RE, Bohr VA, Grossman L, Hedayati M, Bale SJ, Emmert S, Kraemer KH   (2000) A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism.  Carcinogenesis 21:1821-5.|4. Rapin I, Lindenbaum Y, Dickson DW, Kraemer KH, Robbins JH   (2000) Cockayne syndrome and xeroderma pigmentosum.  Neurology 55:1442-9.|5. Slor H, Batko S, Khan SG, Sobe T, Emmert S, Khadavi A, Frumkin A, Busch DB, Albert RB, Kraemer KH   (2000) Clinical, cellular, and molecular features of an Israeli xeroderma pigmentosum family with a frameshift mutation in the XPC gene: sun protection prolongs life.  J Invest Dermatol 115:974-80.",https://intramural.nih.gov/search/searchview.taf?ipid=11184
11,BC004582-25,"October 01, 1999 -  September 30, 2000",Mechanisms of Transition Metal-Induced Carcinogenesis,"Kazimierz S Kasprzak; PhD, DSc",NULL,"Metals Section, NCI",Robert M Bare|Aldona Aleksandra Karaczyn|Renata  Kowara|Susan L North,NULL,NULL,NULL,"1. (2000) Micro-PIXE analysis of the testes and sperm of CrCl3-treated mice, in Metal Ions in Biology and Medicine. Centeno J, Collery P, Vernet G, Finkelman R, Gibb H, Etienne JC, eds., Libbey Eurotext (Paris) Volume 6,  pp. 339-41.|2. Bench G, Grant P, Anderson LM, Kasprzak KS   (2000) Micro-pixe analysis of the testes and sperm of CrCl3-treated mice, in Metal Ions in Biology and Medicine. Cenleno JA, Collery Ph, Vernet G, Finkelman RB, Gibb H, Etienne JC, eds., John Libbey Eurotext (Paris), pp. 339-341.|3. Kasprzak KS, Buzard GS   (2000) The role of metals in oxidative damage and redox cell signaling derangement, in Molecular Biology and Toxicology of Metals. Koropatnick J, Zalups R, eds., Taylor and Francis (London), pp. 477-527.|4. Bal W, Kozlowski H, Kasprzak KS   (2000) Molecular models in nickel carcinogenesis.  J Inorg Biochem 79:213-8.|5. Bal W, Liang R, Lukszo J, Lee SH, Dizdaroglu M, Kasprzak KS   (2000) Ni(II) specifically cleaves the C-terminal tail of the major variant of histone H2A and forms an oxidative damage-mediating complex with the cleaved-off octapeptide.  Chem Res Toxicol 13:616-24.|6. Bal W, Wojcik J, Maciejczyk M, Grochowski P, Kasprzak KS   (2000) Induction of a secondary structure in the N-terminal pentadecapeptide of human protamine HP2 through Ni(II) coordination An NMR study.  Chem Res Toxicol 13:823-30.|7. Bialkowska A, Bialkowski K, Gerschenson M, Diwan BA, Jones AB, Olivero OA, Poirier MC, Anderson LM, Kasprzak KS, Sipowicz MA   (2000) Oxidative DNA damage in fetal tissues after transplacental exposure to 3'-azido-3'-deoxythymidine (AZT).  Carcinogenesis 21:1059-62.|8. Bialkowski K, Kasprzak KS   (2000) Activity of the antimutagenic enzyme 8-oxo-2'-deoxyguanosine 5'-triphosphate pyrophosphohydrolase (8-oxo-dGTPase) in cultured chinese hamster ovary cells: effects of cell cycle, proliferation rate, and population density.  Free Radic Biol Med 28:337-44.|9. Buzard GS, Kasprzak KS   (2000) Possible roles of nitric oxide and redox cell signaling in metal-induced toxicity and carcinogenesis: a review.  J Environ Pathol Toxicol Oncol 19:179-99.|10. Kasprzak KS, Bialkowski K   (2000) Inhibition of antimutagenic enzymes, 8-oxo-dGTPases, by carcinogenic metals Recent developments.  J Inorg Biochem 79:231-6.|11. Sipowicz M, Anderson LM, Kasprzak KS   (2000) Oxidative DNA damage in liver of mice with different susceptibility to hepatocarcinogenesis.  Ann. Med. Acad. Bialystok 45:116-21.",https://intramural.nih.gov/search/searchview.taf?ipid=11181
12,BC004798-30,"October 01, 1999 -  September 30, 2000",Retinoids in Differentiation and Neoplasia,Luigi M De Luca; PhD,NULL,"Differentiation Control Section, NCI",NULL,NULL,Fausto  Andreola  (Laboratory of Cellular Carcinogenesis and Tumor Promotion)|Yoshiko  Honda  (National Cancer Institute)|Yasushi  Shimizu  (National Cancer Institute)|Takemi  Tanaka  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11180
13,BC004829-26,"October 01, 1999 -  September 30, 2000",The Identification and Characterization of Human Genes Associated with Neoplasia,Robert  Callahan; PhD,NULL,"ONCOGENETICS SECT, NCI",Sharon A Bargo|Laura  De marchis,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13648
14,BC005051-22,"October 01, 1999 -  September 30, 2000",Signal Transduction Pathways of Transforming Growth Factor-beta,Anita B Roberts; PhD,NULL,"Laboratory of Cell Regulation and Carcinogenesis, NCI",Stacey A Davis|Kathleen C Flanders; PhD|Richard  Kim|William  Parks; MD|Ester  Piek|Catherine D Sullivan|Show all 7,NULL,NULL,NULL,"1. Huang S, Flanders KC, Roberts AB   (2000) Characterization of the mouse Smad1 gene and its expression pattern in adult mouse tissues.  Gene 258:43-53.",https://intramural.nih.gov/search/searchview.taf?ipid=11178
15,BC005093-22,"October 01, 1999 -  September 30, 2000",Growth/Differentiation Factors in Organogenesis,Alan O Perantoni; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI",Lee F Dove|Zoia  Levashova|Serguei Y Plissov,NULL,NULL,NULL,"1. Plisov SY, Ivanov SV, Yoshino K, Dove LF, Plisova TM, Higinbotham KG, Karavanova I, Lerman M, Perantoni AO   (2000) Mesenchymal-epithelial transition in the developing metanephric kidney: gene expression study by differential display.  Genesis 27:22-31.",https://intramural.nih.gov/search/searchview.taf?ipid=11179
16,BC005148-21,"October 01, 1999 -  September 30, 2000",Mammary Tumorigenesis in Inbred and Feral Mice,Robert  Callahan; PhD,NULL,"ONCOGENETICS SECT, NCI",Sharon A Bargo|William J Lowther|David M Mccurdy|Ahmed M Raafat|June L Traicoff,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11175
17,BC005177-20,"October 01, 1999 -  September 30, 2000",Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,Miriam Christine Poirier; PhD,NULL,"Carcinogen-DNA Interactions Section, NCI",Ofelia  Olivero; PhD,NULL,Rao L Divi  (National Cancer Institute)|Vi T Nguyen  (National Cancer Institute),Mariana J Gerschenson (NHLBI),"1. Diwan BA, Olivero OA, Poirier MC   (2000) Absence of structural or functional alterations in male and female reproductive organs of F1 and F2 generations derived from female mice exposed to 3'-azido-3'-deoxythymidine during pregnancy.  Toxicol Lett 115:9-15.|2. Ewings EL, Gerschenson M, St Claire MC, Nagashima K, Skopets B, Harbaugh SW, Harbaugh JW, Poirier MC   (2000) Genotoxic and functional consequences of transplacental zidovudine exposure in fetal monkey brain mitochondria.  J Acquir Immune Defic Syndr 24:100-5.|3. Gerschenson M, Erhart SW, Paik CY, St Claire MC, Nagashima K, Skopets B, Harbaugh SW, Harbaugh JW, Quan W, Poirier MC   (2000) Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3'-azido-3'-deoxythymidine.  AIDS Res Hum Retroviruses 16:635-44.|4. Gerschenson M, Poirier MC   (2000) Fetal patas monkeys sustain mitochondrial toxicity as a result of in utero zidovudine exposure.  Ann N Y Acad Sci 918:269-81.|5. Meng Q, Su T, Olivero OA, Poirier MC, Shi X, Ding X, Walker VE   (2000) Relationships between DNA incorporation, mutant frequency, and loss of heterozygosity at the TK locus in human lymphoblastoid cells exposed to 3'-azido-3'-deoxythymidine.  Toxicol Sci 54:322-9.|6. Meng Q, Walker DM, Olivero OA, Shi X, Antiochos BB, Poirier MC, Walker VE   (2000) Zidovudine-didanosine coexposure potentiates DNA incorporation of zidovudine and mutagenesis in human cells.  Proc Natl Acad Sci U S A 97:12667-71.|7. Olivero OA, Shearer GM, Chougnet CA, Kovacs AA, Baker R, Stek AM, Khoury MM, Poirier MC   (2000) Incorporation of zidovudine into cord blood DNA of infants and peripheral blood DNA of their HIV-1-positive mothers.  Ann N Y Acad Sci 918:262-8.|8. Phillips DH, Farmer PB, Beland FA, Nath RG, Poirier MC, Reddy MV, Turteltaub KW   (2000) Methods of DNA adduct determination and their application to testing compounds for genotoxicity.  Environ Mol Mutagen 35:222-33.|9. Poirier MC, Santella RM, Weston A   (2000) Carcinogen macromolecular adducts and their measurement.  Carcinogenesis 21:353-9.|10. Slikker W, Olivero OA, Patterson TA, Poirier MC   (2000) Potential toxicities of HIV therapeutics in the developing infant.  Teratology 61:397-8.",https://intramural.nih.gov/search/searchview.taf?ipid=11174
18,BC005190-20,"October 01, 1999 -  September 30, 2000",Design and Development of Novel Immunotherapies for Human Cancer,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",NULL,NULL,"Philip M Arlen; MD  (Experimental Oncology Section)|Kwong Yok Tsang  (Experimental Oncology Section)|Mingzhu  Zhu; MD, PhD  (Experimental Oncology Section)",NULL,"1. Kaufman H, Schlom J   (2000) Vaccines for colon cancer, in Cancer vaccines and immunotherapy. Stern PL, Beverly PCL, Carroll MW, eds., Cambridge University Press (Cambridge, U.K.), pp. 107-134.|2. Schlom J, Tsang K, Hodge J, Greiner J   (2000) Carcinoembryonic antigen as a vaccine target, in Cancer Immunology: Immunology in Medicine Series. Rees RC, Robins A, eds., Kluwer Academic Publishers (Norwell, MA, USA), pp. 73-100.|3. Arlen P, Tsang KY, Marshall JL, Chen A, Steinberg SM, Poole D, Hand PH, Schlom J, Hamilton JM   (2000) The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs recombinant poxvirus vaccines.  Cancer Immunol Immunother 49:517-29.|4. Eder JP, Kantoff PW, Roper K, Xu GX, Bubley GJ, Boyden J, Gritz L, Mazzara G, Oh WK, Arlen P, Tsang KY, Panicali D, Schlom J, Kufe DW   (2000) A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer.  Clin Cancer Res 6:1632-8.|5. Freund YR, Mirsalis JC, Fairchild DG, Brune J, Hokama LA, Schindler-Horvat J, Tomaszewski JE, Hodge JW, Schlom J, Kantor JA, Tyson CA, Donohue SJ   (2000) Vaccination with a recombinant vaccinia vaccine containing the B7-1 co-stimulatory molecule causes no significant toxicity and enhances T cell-mediated cytotoxicity.  Int J Cancer 85:508-17.|6. Hodge JW, Rad AN, Grosenbach DW, Sabzevari H, Yafal AG, Gritz L, Schlom J   (2000) Enhanced activation of T cells by dendritic cells engineered to hyperexpress a triad of costimulatory molecules.  J Natl Cancer Inst 92:1228-39.|7. Hodge JW, Schlom J   (2000) Costimulatory molecules in vaccine design.  Ernst Schering Res Found Workshop  23-52 pp.|8. Horig H, Lee DS, Conkright W, Divito J, Hasson H, LaMare M, Rivera A, Park D, Tine J, Guito K, Tsang KW, Schlom J, Kaufman HL   (2000) Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B71 co-stimulatory molecule.  Cancer Immunol Immunother 49:504-14.|9. Kass E, Parker J, Schlom J, Greiner JW   (2000) Comparative studies of the effects of recombinant GM-CSF and GM-CSF administered via a poxvirus to enhance the concentration of antigen- presenting cells in regional lymph nodes.  Cytokine 12:960-71.|10. Marshall JL, Hoyer RJ, Toomey MA, Faraguna K, Chang P, Richmond E, Pedicano JE, Gehan E, Peck RA, Arlen P, Tsang KY, Schlom J   (2000) Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses.  J Clin Oncol 18:3964-73.|11. Patel SD, Moskalenko M, Tian T, Smith D, McGuinness R, Chen L, Winslow GA, Kashmiri S, Schlom J, Stanners CP, Finer MH, McArthur JG   (2000) T-cell killing of heterogenous tumor or viral targets with bispecific chimeric immune receptors.  Cancer Gene Ther 7:1127-34.|12. Reisfeld RA, Schlom J   (2000) Report of the second annual walker's cay colloqium on cancer vaccines and immunotherapy, March 8-11, 2000.  Int J Immunopharmacol 22:1009-14.|13. Salazar E, Zaremba S, Arlen PM, Tsang KY, Schlom J   (2000) Agonist peptide from a cytotoxic t-lymphocyte epitope of human carcinoembryonic antigen stimulates production of tc1-type cytokines and increases tyrosine phosphorylation more efficiently than cognate peptide.  Int J Cancer 85:829-38.|14. Tamura M, Milenic DE, Iwahashi M, Padlan E, Schlom J, Kashmiri SV   (2000) Structural correlates of an anticarcinoma antibody: identification of specificity-determining residues (SDRs) and development of a minimally immunogenic antibody variant by retention of SDRs only.  J Immunol 164:1432-41.|15. Tempero M, Leichner P, Baranowska-Kortylewicz J, Harrison K, Augustine S, Schlom J, Anderson J, Wisecarver J, Colcher D   (2000) High-dose therapy with 90Yttrium-labeled monoclonal antibody CC49: a phase I trial.  Clin Cancer Res 6:3095-102.|16. von Mehren M, Arlen P, Tsang KY, Rogatko A, Meropol N, Cooper HS, Davey M, McLaughlin S, Schlom J, Weiner LM   (2000) Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B71 transgenes in patients with recurrent CEA-expressing adenocarcinomas.  Clin Cancer Res 6:2219-28.|17. Zhu MZ, Marshall J, Cole D, Schlom J, Tsang KY   (2000) Specific cytolytic T-cell responses to human CEA from patients immunized with recombinant avipox-CEA vaccine.  Clin Cancer Res 6:24-33.|18. Schlom J, Greiner J, Kass E, Panicali D (submitted in 2000) A Recombinant Non-replicating Virus Expressing Gm-csf And Uses Thereof To Enhance Immune Responses. Patent issued: 2412050 (CA in 2011). Patents pending: 01946395.9 (EP application); 03105975.5 (HK application); 2002-510097 (JP application); PCT/US01/19201 (PC application); 60/211,717 (US application); 10/297,168 (US application); 2001268452 (AU application).",https://intramural.nih.gov/search/searchview.taf?ipid=11171
19,BC005216-29,"October 01, 1999 -  September 30, 2000",The role of cAMP-dependent protein kinase in growth control,"Yoon S Cho-Chung; MD, PhD",NULL,"CELLULAR BIOCHEMSTRY SECT, NCI",Catherine  Neary,NULL,Langzhu  Tan  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11170
20,BC005231-26,"October 01, 1999 -  September 30, 2000",Role of Subunit Interactions in Enzyme Chemistry and Cellular Regulation,Claude  Klee; PhD,NULL,"Laboratory of Biochemistry, NCI",NULL,NULL,Shipeng  Li; PhD  (Protein Biochemistry Section)|Sergei B. Ruvinov; PhD  (Protein Biochemistry Section)|Seun Ah Yang  (National Cancer Institute),Amy Xiaoyun Yang (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13820
21,BC005254-19,"October 01, 1999 -  September 30, 2000",Regulation of HTLV-I Transcription,John N Brady; PhD,NULL,"National Cancer Institute, NCI",Hanxin  Lu,NULL,NULL,NULL,"1. Mahieux R, Pise-Masison CA, Lambert PF, Nicot C, De Marchis L A, Gessain P, Green W, Hall JN, Brady   (2000) Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function.  J Virol 74:6866-74.|2. Nicot C, Mahieux R, Opavsky R, Cereseto A, Wolff L, Brady JN, Franchini G   (2000) HTLV-I Tax transrepresses the human c-Myb promoter independently of its interaction with CBP or p300.  Oncogene 19:2155-64.|3. Pise-Masison CA, Mahieux R, Radonovich M, Jiang H, Duvall J, Guillerm C, Brady JN   (2000) Insights into the molecular mechanism of p53 inhibition by HTLV type 1 Tax.  AIDS Res Hum Retroviruses 16:1669-75.|4. Pise-Masison CA, Mahieux R, Radonovich MF, Jiang H, Brady JN   (2000) Human T-lymphotropic virus type-I-tax protein Utilizes distinct pathways for p53 Inhibition which are cell-type dependent.  J Biol Chem, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=11168
22,BC005258-21,"October 01, 1999 -  September 30, 2000",Molecular Studies of Eukaryotic Gene Regulation,Bruce  Paterson; PhD|IRP Faculty Profile,NULL,"Biochemistry of Gene Expression Section, NCI",Qin  Wei,NULL,Hye Jung Baek  (Laboratory of Biochemistry)|Concetta  Lipardi  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13821
23,BC005263-19,"October 01, 1999 -  September 30, 2000",Eukaryotic Chromatin Structure and Gene Regulation,Carl  Wu; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Monica  La|Ryan  Ranallo|Wei-Hua  Wu,NULL,Noriko  Aita  (National Cancer Institute)|Paul  Badenhorst; PhD  (Chromosome Structure and Gene Regulation Section)|Dragony  Fu  (National Cancer Institute)|Ali  Hamiche; PhD  (National Cancer Institute)|Ju-Gyeong  Kang; PhD  (National Cancer Institute)|Gabriele Helga Marchler; PhD  (National Cancer Institute)|Show all 10.,Deborah A Hursh (OD),"1. Wu C, Becker P, Tsukiyama T   (2000) ATP-Dependent Chromatin Remodeling by the ISWI Complexes, in Chromatin Structure and Gene Expression. Elgin SCR, Workman JL, eds., Oxford University Press, Inc. (New York, USA) Volume 35,  pp. 114-35.|2. Hoang A, Huang J, Rudra-Ganguly N, Zheng J, Powell W, Rabindran S, Wu C, Roy-Burman P   (2000) A novel association between the human heat shock transcription factor 1 (HSF1) and prostate adenocarcinoma.  Am J Pathol 156:857-64.",https://intramural.nih.gov/search/searchview.taf?ipid=11169
24,BC005265-18,"October 01, 1999 -  September 30, 2000",Kinase Activities of Nm23 Proteins,Paul  Wagner; PhD,NULL,"Protein Biochemistry Section, NCI",Ngoc Diep T Vu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11167
25,BC005267-16,"October 01, 1999 -  September 30, 2000",Mechanisms of Plasmid Maintenance: Partitioning,Michael  Yarmolinsky; PhD,NULL,"Microbial Genetics and Biochemistry Section, NCI",Jerome F Clark|Oleg  Rodionov; PhD,NULL,Rotem  Edgar  (National Cancer Institute)|Jian-Jiang  Hao  (National Cancer Institute),NULL,"1. Kalnin K, Stegalkina S, Yarmolinsky M   (2000) pTAR-encoded proteins in plasmid partitioning.  J Bacteriol 182:1889-94.|2. Yarmolinsky M   (2000) Transcriptional silencing in bacteria.  Curr Opin Microbiol 3:138-43.|3. Yarmolinsky MB   (2000) MicroReview: A pot-pourri of plasmid paradoxes: effects of a second copy.  Mol Microbiol 38:1-7.",https://intramural.nih.gov/search/searchview.taf?ipid=11164
26,BC005268-13,"October 01, 1999 -  September 30, 2000",Mechanism of Meiotic Recombination,Michael Joseph Lichten; PhD|IRP Faculty Profile,NULL,"Microbial Genetics and Biochemistry Section, NCI",Thorsten  Allers|Robert A Shroff|Tzuchen A Wu,NULL,Valerie  Borde  (National Cancer Institute)|Karin M Werner  (National Cancer Institute),NULL,"1. Allers T, Lichten M   (2000) A method for preparing genomic DNA that restrains branch migration of Holliday junctions.  Nucleic Acids Res 28:e6.|2. Borde V, Goldman A, Lichten M   (2000) Direct coupling between meiotic DNA replication and recombination initiation.  Science 290:806-9.|3. Gerton JL, DeRisi J, Shroff R, Lichten M, Brown PO, Petes TD   (2000) Global mapping of meiotic recombination hotspots and coldspots in the yeast Saccharomyces cerevisiae.  Proc Natl Acad Sci U S A 97:11383-90.|4. Goldman A, Lichten M   (2000) Restriction of ectopic recombination by interhomolog interactions during Saccharomyces cerevisiae meiosis.  Proc Natl Acad Sci U S A 97:9537-42.",https://intramural.nih.gov/search/searchview.taf?ipid=11165
27,BC005270-19,"October 01, 1999 -  September 30, 2000",Molecular Mechanism of Action of Phorbol Ester,Peter  Blumberg; PhD|IRP Faculty Profile,NULL,"Molecular Mechanisms of Tumor Promotion Section, NCI",Nancy E Lewin|Patricia S. Lorenzo; PhD,NULL,Noemi  Kedei  (National Cancer Institute)|Z  Szabo; MD  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11162
28,BC005271-09,"October 01, 1999 -  September 30, 2000",Gene Regulation and Function: The B-ZIP Proteins,Charles  Vinson; PhD|IRP Faculty Profile,NULL,"Microbial Genetics and Biochemistry Section, NCI",NULL,NULL,Asha Acharya Acharya Srirama  (Nucleic Acids Section)|Maria  Bonovich  (Nucleic Acids Section)|Tarek  Deeb  (Nucleic Acids Section)|Alain  Mir  (Nucleic Acids Section)|Jaideep  Moitra  (Nucleic Acids Section)|Jonathan R Moll  (Nucleic Acids Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11163
29,BC005272-09,"October 01, 1999 -  September 30, 2000",Transcriptional regulation of development,Mark  Mortin; PhD,NULL,"Biochemistry of Gene Expression Section, NCI",Tamara L Jones,NULL,Xiaolin  Bi  (National Cancer Institute)|Zoya N Demidenko  (National Cancer Institute)|Xiang  Yang  (National Cancer Institute),NULL,"1. Avedisov SN, Krasnoselskaya I, Mortin M, Thomas BJ   (2000) Roughex mediates G(1) arrest through a physical association with cyclin A.  Mol Cell Biol 20:8220-9.|2. Dekel I, Russek N, Jones T, Mortin MA, Katzav S   (2000) Identification of the Drosophila melanogaster homologue of the mammalian signal transducer protein, Vav.  FEBS Lett 472:99-104.|3. Yang X, van Beest M, Clevers H, Jones T, Hursh DA, Mortin MA   (2000) decapentaplegic is a direct target of dTcf repression in the Drosophila visceral mesoderm.  Development 127:3695-702.",https://intramural.nih.gov/search/searchview.taf?ipid=11161
30,BC005273-09,"October 01, 1999 -  September 30, 2000",Genetics of Cancer Risk-Related Behaviors and Complex Traits,Dean H. Hamer; PhD|IRP Faculty Profile,NULL,"Gene Structure and Regulation Section, NCI",Stella t  Hu|Kira K Lueders; PhD|Leo  Sirota,NULL,Sven Roger Bocklandt  (Laboratory of Biochemistry)|Michael G Dupree  (National Cancer Institute)|Edward  Kuff  (Laboratory of Biochemistry)|Maxine F Singer  (National Cancer Institute)|Rachel  Wernicke  (Laboratory of Biochemistry),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13822
31,BC005275-05,"October 01, 1999 -  September 30, 2000",Cell cycle regulation during Drosophila eye development.,Barbara J. Thomas; PhD,NULL,"Gene Structure and Regulation Section, NCI",NULL,NULL,Sergei N Avedisov  (National Cancer Institute)|Miho  Matakatsu  (National Cancer Institute),NULL,"1. Avedisov SN, Krasnoselskaya I, Mortin M, Thomas BJ   (2000) Roughex mediates G(1) arrest through a physical association with cyclin A.  Mol Cell Biol 20:8220-9.",https://intramural.nih.gov/search/searchview.taf?ipid=11159
32,BC005295-19,"October 01, 1999 -  September 30, 2000",Mechanisms of Induction and Suppression of Viral and Tumor-derived Oncogene-depe,Donald G Blair; PhD,NULL,"Oncogene Mechanisms Section, NCI",Bo  Chen|Qiuping  Gu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11156
33,BC005317-17,"October 01, 1999 -  September 30, 2000","Role of Selenium in Cancer, HIV Infection and Human Health",Dolph Lee Hatfield; PhD|IRP Faculty Profile,NULL,"Molecular Biology of Selenium Section, NCI",Ilanchezhian  Shanmugam,NULL,Soo-Ung  Lee  (National Cancer Institute)|Huijun  Zhi  (Developmental Genetics Section),NULL,"1. Copeland PR, Fletcher JE, Carlson BA, Hatfield DL, Driscoll DM   (2000) A novel RNA binding protein, SBP2, is required for the translation of mammalian selenoprotein mRNAs.  EMBO J 19:306-14.|2. Kim LK, Matsufuji T, Matsufuji S, Carlson BA, Kim SS, Hatfield DL, Lee BJ   (2000) Methylation of the ribosyl moiety at position 34 of selenocysteine tRNA.  RNA 6:1306-15.|3. Kumaraswamy E, Malykh A, Korotkov KV, Kozyavkin S, Hu Y, Kwon SY, Moustafa ME, Carlson BA, Berry MJ, Lee BJ, Hatfield DL, Diamond AM, Gladyshev VN   (2000) Structure-expression relationships of the 15-kDa selenoprotein gene Possible role of the protein in cancer etiology.  J Biol Chem 275:35540-7.|4. Mansur DB, Hao H, Gladyshev VN, Korotkov KV, Hu Y, Moustafa ME, El-Saadani MA, Carlson BA, Hatfield DL, Diamond AM   (2000) Multiple levels of regulation of selenoprotein biosynthesis revealed from the analysis of human glioma cell lines.  Biochem Pharmacol 60:489-97.|5. Tujebajeva RM, Copeland PR, Xu XM, Carlson BA, Harney JW, Driscoll DM, Hatfield DL, Berry MJ   (2000) Decoding apparatus for eukaryotic selenocysteine insertion.  EMBO Rep 1:158-63.|6. Warner GJ, Berry MJ, Moustafa ME, Carlson BA, Hatfield DL, Faust JR   (2000) Inhibition of selenoprotein synthesis by selenocysteine tRNA[Ser]Sec lacking isopentenyladenosine.  J Biol Chem 275:28110-9.",https://intramural.nih.gov/search/searchview.taf?ipid=11154
34,BC005318-18,"October 01, 1999 -  September 30, 2000",Structure-Function of Cytochrome P450,Fred  Friedman; PhD,NULL,"METABOLIC CONTL SECT, NCI",NULL,NULL,Richard C Robinson  (Laboratory of Metabolism)|Stanley  Smith  (Laboratory of Metabolism),NULL,"1. Dai R, Pincus MR, Friedman FK   (2000) Molecular modeling of mammalian cytochrome P450s.  Cell Mol Life Sci 57:487-99.|2. Omata Y, Dai R, Smith SV, Robinson RC, Friedman FK   (2000) Synthetic peptide mimics of a predicted topographical interaction surface: the cytochrome P450 2B1 recognition domain for NADPH-cytochrome P450 reductase.  J Protein Chem 19:23-32.|3. Smith SV, Koley AP, Dai R, Robinson RC, Leong H, Markowitz A, Friedman FK   (2000) Conformational modulation of human cytochrome P450 2E1 by ethanol and other substrates: a CO flash photolysis study.  Biochemistry 39:5731-7.",https://intramural.nih.gov/search/searchview.taf?ipid=11155
35,BC005352-18,"October 01, 1999 -  September 30, 2000",Mechanisms in Perinatal Carcinogenesis,Lucy M Anderson; PhD,NULL,"Cellular Pathogenesis Section, NCI",Yuk Sing Robert Cheng,NULL,NULL,NULL,"1. Bench G, Grant P, Anderson LM, Kasprzak KS   (2000) Micro-pixe analysis of the testes and sperm of CrCl3-treated mice, in Metal Ions in Biology and Medicine. Cenleno JA, Collery Ph, Vernet G, Finkelman RB, Gibb H, Etienne JC, eds., John Libbey Eurotext (Paris), pp. 339-341.|2. Anderson LM, Diwan BA, Fear NT, Roman E   (2000) Critical windows of exposure for Children's health: cancer in human epidemiological studies and neoplasms in experimental animal models.  Environ Health Perspect 108 Suppl 3:573-94.|3. Bialkowska A, Bialkowski K, Gerschenson M, Diwan BA, Jones AB, Olivero OA, Poirier MC, Anderson LM, Kasprzak KS, Sipowicz MA   (2000) Oxidative DNA damage in fetal tissues after transplacental exposure to 3'-azido-3'-deoxythymidine (AZT).  Carcinogenesis 21:1059-62.|4. Chhabra SK, Anderson LM, Perella C, Desai D, Kyrtopoulos SA, Souliotis VL   (2000) Co-exposure to ethanol with N-nitrosodimethylamine or 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone during lactation of rats: marked increase in O6-methylguanine-DNA adducts in maternal mammary gland and in suckling lung kidneys.  Toxicol Appl Pharmacol 169:191-200.|5. Diwan BA, Ramakrishna G, Anderson LM, Ramljak D   (2000) Overexpression of Grb2 in inflammatory lesions and preneoplastic foci and tumors induced by N-nitrosodimethylamine in Helicobacter hepaticus-infected and -noninfected A/J mice.  Toxicol Pathol 28:548-54.|6. Hecht SS, Trushin N, Chhabra S, Anderson LM, Nerurkar PV   (2000) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured monkey lung explants.  Drug Metab Dispos 28:5-9.|7. Josyula S, Lu LJ, Salazar JJ, Nerurkar PV, Jones AB, Grady JJ, Snyderwine EG, Anderson LM   (2000) DNA adducts of 2-amino-3-methylamidazo[4,5-f]quinoline (IQ) in fetal tissues of patas monkeys after transplacental exposure.  Toxicol Appl Pharmacol 166:151-60.|8. Josyula S, Schut HA, Diwan BA, Anver MA, Anderson LM   (2000) Age-related alterations in 32P-postlabeled DNA adducts in livers of mice infected with the tumorigenic bacterial pathogen, Helicobacter hepaticus.  Int J Oncol 17:811-8.|9. Olshan AF, Anderson L, Roman E, Fear N, Wolff M, Whyatt R, Vu V, Diwan BA, Potischman N   (2000) Workshop to identify critical windows of exposure for children's health: Cancer work group summary.  Environ Health Perspect 108:595-97.|10. Ramakrishna G, Bialkowska A, Perella C, Birely L, Fornwald LW, Diwan BA, Shiao YH, Anderson LM   (2000) Ki-ras and the characteristics of mouse lung tumors.  Mol Carcinog 28:156-67.|11. Ramakrishna G, Sithanandam G, Cheng RY, Fornwald LW, Smith GT, Diwan BA, Anderson LM   (2000) K-ras p21 expression and activity in lung and lung tumors.  Exp Lung Res 26:659-71.|12. Ramljak D, Calvert RJ, Wiesenfeld PW, Diwan BA, Catipovic B, Marasas WF, Victor TC, Anderson LM, Gelderblom WC   (2000) A potential mechanism for fumonisin B(1)-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3beta activity.  Carcinogenesis 21:1537-46.|13. Shiao YH, Resau JH, Nagashima K, Anderson LM, Ramakrishna G   (2000) The von Hippel-Lindau tumor suppressor targets to mitochondria.  Cancer Res 60:2816-9.|14. Sipowicz M, Anderson LM, Kasprzak KS   (2000) Oxidative DNA damage in liver of mice with different susceptibility to hepatocarcinogenesis.  Ann. Med. Acad. Bialystok 45:116-21.",https://intramural.nih.gov/search/searchview.taf?ipid=11151
36,BC005367-17,"October 01, 1999 -  September 30, 2000",The Genetic Structure of Natural Populations of Past and Present,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",NULL,NULL,Valerie A Beason  (National Cancer Institute)|Victor A David  (Genetics Section)|Warren  Johnson  (Genetics Section)|Janice S Martenson  (Genetics Section)|Jill  Slattery  (Genetics Section)|Mary A Thompson  (Genetics Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11152
37,BC005384-17,"October 01, 1999 -  September 30, 2000",Allelic Variation in the Eotaxin Chemokine Gene Influences HIV-1 Infection and A,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",James  Lautenberger; PhD,NULL,Janice S Martenson  (Genetics Section)|Michael E Sanford  (National Cancer Institute)|Mary A Thompson  (Genetics Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11153
38,BC005385-17,"October 01, 1999 -  September 30, 2000","The Development of the Domestic cat, Felis catus, as an Animal Model",Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",NULL,NULL,Victor A David  (Genetics Section)|William J. Murphy  (Genetics Section)|Naoya  Yuhki; MD  (Genetics Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11149
39,BC005389-17,"October 01, 1999 -  September 30, 2000",Reproductive Strategies in Animal Species Emphasizing Developmental Biology,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",NULL,NULL,Janice S Martenson  (Genetics Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11150
40,BC005399-17,"October 01, 1999 -  September 30, 2000",Oncogenesis in Animal Models of Human Cancers,Lucy M Anderson; PhD,NULL,"Cellular Pathogenesis Section, NCI",Qasim A Khan; PhD|Yih-horng  Shiao|George T Smith,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11146
41,BC005414-17,"October 01, 1999 -  September 30, 2000",Characterization of Primate Retroviruses,Raoul  Benveniste; PhD,NULL,"IMMUNOGENETICS SECT, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11147
42,BC005436-17,"October 01, 1999 -  September 30, 2000",Inhibitory monoclonal antibodies to human cytochrome P450 enzymes: a new avenue,Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Nucleic Acids Section, NCI",Kristopher W Krausz,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11144
43,BC005445-16,"October 01, 1999 -  September 30, 2000",Analysis of Pathways that Suppress or Accelerate Premalignant Progression and Ma,Stuart H Yuspa; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular Carcinogenesis and Tumor Promotion, NCI",Ulrike F Lichti; PhD,NULL,Wendy  Bowers  (National Cancer Institute)|Christina K Cheng  (In Vitro Pathogenesis Section)|Michael  Gerdes  (National Cancer Institute)|Luowei  Li  (In Vitro Pathogenesis Section)|Tyrone C Spady; PhD  (National Cancer Institute),NULL,"1. Rehman I, Lowry DT, Adams C, Abdel-Fattah R, Holly A, Yuspa SH, Hennings H   (2000) Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein.  Mol Carcinog 27:298-307.|2. Yuspa SH   (2000) Overview of carcinogenesis: past, present and future.  Carcinogenesis 21:341-4.",https://intramural.nih.gov/search/searchview.taf?ipid=11145
44,BC005450-17,"October 01, 1999 -  September 30, 2000",Chromatin Structure and Gene Expression,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,NULL,Gisele  Mautino; PhD  (National Cancer Institute)|Mary  Winters  (Hormone Action and Oncogenesis Section)|Ronald G Wolford  (Hormone Action and Oncogenesis Section)|Nianqing  Xiao  (National Cancer Institute),NULL,"1. Fletcher TM, Ryu BW, Baumann CT, Warren BS, Fragoso G, John S, Hager GL   (2000) Structure and dynamic properties of a glucocorticoid receptor-induced chromatin transition.  Mol Cell Biol 20:6466-75.|2. Hager GL   (2000) Understanding nuclear receptor function: from DNA to chromatin to the interphase nucleus.  Prog Nucleic Acid Res Mol Biol 66:279-305.",https://intramural.nih.gov/search/searchview.taf?ipid=11142
45,BC005453-16,"October 01, 1999 -  September 30, 2000",Cellular and Molecular Biology of the Hepatic Stem Cell Compartment,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI",NULL,NULL,"Tanya N Hoang  (Cellular and Molecular Biology Section)|Shuji  Terai  (National Cancer Institute)|Tadahisa  Teramoto; MD, PhD  (Cellular and Molecular Biology Section)",NULL,"1. Feng SL, Guo Y, Factor VM, Thorgeirsson SS, Bell DW, Testa JR, Peifley KA, Winkles JA   (2000) The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas.  Am J Pathol 156:1253-61.|2. Nagy P, Bisgaard HC, Schnur J, Thorgeirsson SS   (2000) Studies on hepatic gene expression in different liver regenerative models.  Biochem Biophys Res Commun 272:591-5.|3. Terai S, Aoki H, Ashida K, Thorgeirsson SS   (2000) Human homologue of maid: A dominant inhibitory helix-loop-helix protein associated with liver-specific gene expression.  Hepatology 32:357-66.",https://intramural.nih.gov/search/searchview.taf?ipid=11143
46,BC005480-15,"October 01, 1999 -  September 30, 2000",Molecular Epidemiology of Human Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Haress  Rahim|Glennwood E Trivers,NULL,Helen M Cawley  (Molecular Genetics and Carcinogenesis Section)|Mohammed A. Khan; PhD  (Molecular Genetics and Carcinogenesis Section)|Aizen  Marrogi  (Special Review and Logistics Branch)|Koh  Miura  (National Cancer Institute)|Siobhan A Nicholson  (National Cancer Institute)|Judith A Welsh  (Molecular Genetics and Carcinogenesis Section)|Show all 7.,NULL,"1. Hussain SP, Harris CC   (2000) p53 mutation load: A molecular linkage to carcinogen exposure and cancer, in Biomonitors and Biomarkers as indicators of environmental change. Butterworth FM, Gunatilaka A, Gonsebatt ME, eds., Plenum Publishing Corp (New York) Volume 2,  pp. 333-346.|2. Balmain A, Harris CC   (2000) Carcinogenesis in mouse and human cells: parallels and paradoxes.  Carcinogenesis 21:371-7.|3. Barrett JC, Bishop M, DeGeorge J, DuBois R, Harris C, Varmus H, Wood A, Yispa S, Tennant R   (2000) Fourteenth Aspen Cancer Conference: Mechanisms of toxicity, carcinogenesis and cancer prevention.  Mol Carcinog 27:259-267.|4. Bennett WP, Alavanja MC, Harris CC   (2000) RESPONSE: re: environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women.  J Natl Cancer Inst 92:760-1.|5. Butkiewicz D, Rusin M, Harris CC, Chorazy M   (2000) Identification of four single nucleotide polymorphisms in DNA repair genes: XPA and XPB (ERCC3) in Polish population.  Hum Mutat 15:577-8.|6. Hussain SP, Harris CC   (2000) Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens.  Mutat Res 462:311-22.|7. Hussain SP, Hollstein MH, Harris CC   (2000) p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment.  Ann N Y Acad Sci 919:79-85.|8. Shields PG, Harris CC   (2000) Cancer risk and low-penetrance susceptibility genes in gene-environment interactions.  J Clin Oncol 18:2309-15.",https://intramural.nih.gov/search/searchview.taf?ipid=13823
47,BC005482-15,"October 01, 1999 -  September 30, 2000",Regulation of papillomavirus gene expression,"Carl C Baker; MD, PhD",NULL,"Cellular Regulation and Transformation Section, NCI",Janet M Dipasquale|Jesse F Quintero,NULL,"Jennifer  Sprague  (National Cancer Institute)|Fang  Yuan  (National Cancer Institute)|Zhi Ming  Zheng; MD, PhD  (HIV and AIDS Malignancy Br)",NULL,"1. McBride AA, Dlugosz A, Baker CC   (2000) Production of infectious bovine papillomavirus from cloned viral DNA by using an organotypic raft/xenograft technique.  Proc Natl Acad Sci U S A 97:5534-9.|2. Zheng ZM, Baker CC   (2000) Parameters that affect in vitro splicing of bovine papillomavirus type 1 late pre-mRNAs.  J Virol Methods 85:203-14.|3. Zheng ZM, Quintero J, Reid ES, Gocke C, Baker CC   (2000) Optimization of a weak 3 splice site counteracts the function of a bovine papillomavirus type 1 exonic splicing suppressor in vitro and in vivo.  J Virol 74:5902-10.|4. Zheng ZM, Reid ES, Baker CC   (2000) Utilization of the bovine papillomavirus type 1 late-stage-specific nucleotide 3605 3 splice site is modulated by a novel exonic bipartite regulator but not by an intronic purine-rich element.  J Virol 74:10612-22.",https://intramural.nih.gov/search/searchview.taf?ipid=13824
48,BC005488-15,"October 01, 1999 -  September 30, 2000",Mechanisms of Inorganic Carcinogenesis,Michael  Waalkes; PhD,NULL,"Inorganic Carcinogenesis Section, NCI",Eduardo  Brambila-Columbres|Hua  Chen|Wei  Qu; PhD,NULL,William E Achanzar  (National Cancer Institute),"Jie  Liu; MD, PhD (NIAAA)","1. Chen H, Liu J, Merrick B, Waalkes M   (2000) Genetic events associated with arsenite-induced malignant transformation: application of cDNA microarray technology, in Proceedings of the Sixth International Symposium on Metal Ions in Biology and Medicine. Vernet PG, ed., John LIbby Eurotext, Ltd. (France), pp. 104-106.|2. Achanzar WE, Achanzar KB, Lewis JG, Webber MM, Waalkes MP   (2000) Cadmium induces c-myc, p53, and c-jun expression in normal human prostate epithelial cells as a prelude to apoptosis.  Toxicol Appl Pharmacol 164:291-300.|3. Coogan TP, Achanzar WE, Waalkes MP   (2000) Spontaneous transformation of cultured rat liver (TRL 1215) cells is associated with down-regulation of metallothionein: implications for sensitivity to cadmium cytotoxicity and genotoxicity.  J Environ Pathol Toxicol Oncol 19:261-73.|4. Quintanilla-Vega B, Hoover D, Bal W, Silbergeld EK, Waalkes MP, Anderson LD   (2000) Lead effects on protamine-DNA binding.  Am J Ind Med 38:324-9.|5. Quintanilla-Vega B, Hoover DJ, Bal W, Silbergeld EK, Waalkes MP, Anderson LD   (2000) Lead interaction with human protamine (HP2) as a mechanism of male reproductive toxicity.  Chem Res Toxicol 13:594-600.|6. Romach EH, Zhao CQ, Del Razo LM ME, Cebrian MP, Waalkes   (2000) Studies on the mechanisms of arsenic-induced self tolerance developed in liver epithelial cells through continuous low-level arsenite exposure.  Toxicol Sci 54:500-8.|7. Waalkes MP   (2000) Cadmium carcinogenesis in review.  J Inorg Biochem 79:241-4.|8. Waalkes MP, Fox DA, States JC, Patierno SR, McCabe MJ   (2000) Metals and disorders of cell accumulation: modulation of apoptosis and cell proliferation.  Toxicol Sci 56:255-61.|9. Waalkes MP, Keefer LK, Diwan BA   (2000) Induction of proliferative lesions of the uterus, testes, and liver in swiss mice given repeated injections of sodium arsenate: possible estrogenic mode of action.  Toxicol Appl Pharmacol 166:24-35.|10. Waalkes MP, Rehm S, Cherian MG   (2000) Repeated cadmium exposures enhance the malignant progression of ensuing tumors in rats.  Toxicol Sci 54:110-20.|11. Yuan C, Kadiiska M, Achanzar WE, Mason RP, Waalkes MP   (2000) Possible role of caspase-3 inhibition in cadmium-induced blockage of apoptosis.  Toxicol Appl Pharmacol 164:321-9.",https://intramural.nih.gov/search/searchview.taf?ipid=11140
49,BC005522-13,"October 01, 1999 -  September 30, 2000",Role of Thyroid-Specific Enhancer-Binding Protein in Development,Shioko  Kimura; PhD|IRP Faculty Profile,NULL,"Endocrinology Section, NCI",Yuki  Ota,NULL,NULL,NULL,"1. Yuan B, Li C, Kimura S, Engelhardt RT, Smith BR, Minoo P   (2000) Inhibition of distal lung morphogenesis in Nkx21(-/-) embryos.  Dev Dyn 217:180-90.",https://intramural.nih.gov/search/searchview.taf?ipid=11138
50,BC005529-14,"October 01, 1999 -  September 30, 2000",Genomic and Molecular Organization of the Mammalian Major Histocompatibility Com,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",NULL,NULL,Naoya  Yuhki; MD  (Genetics Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11139
51,BC005536-14,"October 01, 1999 -  September 30, 2000",Basic and Applied Studies in Development of an AIDS Vaccine,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"IMMUNE BIOLOGY OF RETROVIRAL INFECTION SECT, NCI",Mary K Aldrich|Yvette Y Edghill-Smith|Michel R Leno|Melissa E Leonard|Lois Jean Patterson|Bo  Peng|Show all 9,NULL,Lulu  Lim  (National Cancer Institute)|Yuanmei  Lou  (National Cancer Institute),"Ge  Li; MD, PhD (NHLBI)","1. Leno MR, Buge S, Patterson LJ, Guroff MR   (2000) Development of prophylactic vaccines against HIV, in Pharmacology of HIV Infection and AIDS. Fuchs D, Aruoma OI, eds., OICA International (Saint Lucia, London), pp. 71-104.|2. Leno M, Kowalski M, Robert-Guroff M   (2000) CD8 T cell anti-HIV activity as a complementary protective mechanism in vaccinated chimpanzees.  AIDS 14:893-4.|3. Margolis L, Glushakova S, Chougnet C, Shearer G, Markham P, Robert-Guroff M, Benveniste R, Miller CJ, Cranage M, Hirsch V, Franchini G   (2000) Replication of simian immunodeficiency virus (SIV) in ex vivo lymph nodes as a means to assess susceptibility of macaques in vivo.  Virology 275:391-397.|4. Patterson LJ, Peng B, Abimiku AG, Aldrich K, Murty L, Markham PD, Kalyanaraman VS, Alvord WG, Tartaglia J, Franchini G, Robert-Guroff M   (2000) Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques.  AIDS 14:2445-55.|5. Robert-Guroff M   (2000) IgG surfaces as an important component in mucosal protection.  Nat Med 6:129-30.",https://intramural.nih.gov/search/searchview.taf?ipid=11134
52,BC005539-14,"October 01, 1999 -  September 30, 2000",Vector Mediated Gene Transfer in Cancer and AIDS,Suresh  Arya; PhD,NULL,"Gene Expression and Molecular Pathogenesis Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11132
53,BC005548-13,"October 01, 1999 -  September 30, 2000",Biological Functions of the Oncogenes Encoding Rho-Specific Exchange Factors,Toru  Miki; PhD,NULL,"MOLECULAR BIOLOGY SECT, NCI",NULL,NULL,Xiaozhen  Xie  (Molecular Tumor Biology Section)|Yunbo  Yu  (Molecular Tumor Biology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11130
54,BC005553-31,"October 01, 1999 -  September 30, 2000",Biology of plasma cell tumor development,Stuart  Rudikoff; PhD,NULL,"MOLECULAR IMMUNOLOGY SECT, NCI",NULL,NULL,Chun Wu Crowder; PhD  (Molecular Immunology Section)|Ya-Wei  Qiang  (Molecular Immunology Section),NULL,"1. Ge NL, Rudikoff S   (2000) Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo.  Oncogene 19:4091-5.|2. Ge NL, Rudikoff S   (2000) Insulin-like growth factor I is a dual effector of multiple myeloma cell growth.  Blood 96:2856-61.",https://intramural.nih.gov/search/searchview.taf?ipid=11128
55,BC005561-13,"October 01, 1999 -  September 30, 2000",Function of Hepatocyte-enriched Transcription Factors,Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Nucleic Acids Section, NCI",Graham P Hayhurst|Yusuke  Inoue,NULL,Christopher  Sinal  (National Cancer Institute),NULL,"1. Akiyama TE, Ward JM, Gonzalez FJ   (2000) Regulation of the liver fatty acid-binding protein gene by hepatocyte nuclear factor 1alpha (HNF1alpha) Alterations in fatty acid homeostasis in HNF1alpha-deficient mice.  J Biol Chem 275:27117-22.",https://intramural.nih.gov/search/searchview.taf?ipid=11129
56,BC005562-13,"October 01, 1999 -  September 30, 2000",Role of Xenobiotic Metabolism in Cancer Susceptibility,Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Nucleic Acids Section, NCI",NULL,NULL,Christopher  Sinal  (National Cancer Institute),NULL,"1. Aitchison KJ, Gonzalez FJ, Quattrochi LC, Sapone A, Zhao JH, Zaher H, Elizondo G, Bryant C, Munro J, Collier DA, Makoffa AI, Kerwin RW   (2000) Identification of novel polymorphisms in the 5' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significance.  Pharmacogenetics 10:695-704.|2. Aitchison KJ, Jann MW, Zhao JH, Sakai T, Zaher H, Wolff K, Collier DA, Kerwin RW, Gonzalez FJ   (2000) Clozapine pharmacokinetics and pharmacodynamics studied with Cyp1A2-null mice.  J Psychopharmacol 14:353-9.|3. Corchero J, Pimprale S, Kimura S, Gonzalez F   (2001) Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation.  Pharmacogenetics 11:1-6.|4. Echizen H, Tanizaki M, Tatsuno J, Chiba K, Berwick T, Tani M, Gonzalez FJ, Ishizaki T   (2000) Identification of CYP3A4 as the enzyme involved in the mono-N-dealkylation of disopyramide enantiomers in humans.  Drug Metab Dispos 28:937-44.|5. Heidel SM, MacWilliams PS, Baird WM, Dashwood WM, Buters JT, Gonzalez FJ, Larsen MC, Czuprynski CJ, Jefcoate CR   (2000) Cytochrome P4501B1 mediates induction of bone marrow cytotoxicity and preleukemia cells in mice treated with 7,12-dimethylbenz[a]anthracene.  Cancer Res 60:3454-60.|6. Kimura S, Gonzalez FJ   (2000) Applications of genetically manipulated mice in pharmacogenetics and pharmacogenomics.  Pharmacology 61:147-53.|7. Krausz KW, Goldfarb I, Yang TJ, Gonzalez FJ, Gelboin HV   (2000) An inhibitory monoclonal antibody to human cytochrome P450 that specifically binds and inhibits P4502C9II, an allelic variant of P4502C9 having a single amino acid change Arg144 Cys.  Xenobiotica 30:619-25.|8. Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR   (2000) CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.  J Clin Invest 105:1067-75.|9. Narimatsu S, Kobayashi N, Masubuchi Y, Horie T, Kakegawa T, Kobayashi H, Hardwick JP, Gonzalez FJ, Shimada N, Ohmori S, Kitada M, Asaoka K, Kataoka H, Yamamoto S, Satoh T   (2000) Species difference in enantioselectivity for the oxidation of propranolol by cytochrome P450 2D enzymes.  Chem Biol Interact 127:73-90.|10. Peterson TC, Hodgson P, Fernandez-Salguero P, Neumeister M, Gonzalez FJ   (2000) Hepatic fibrosis and cytochrome P450: experimental models of fibrosis compared to AHR knockout mice.  Hepatol Res 17:112-125.|11. Sai Y, Dai R, Yang TJ, Krausz KW, Gonzalez FJ, Gelboin HV, Shou M   (2000) Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450.  Xenobiotica 30:327-43.|12. Sata F, Sapone A, Elizondo G, Stocker P, Miller VP, Zheng W, Raunio H, Crespi CL, Gonzalez FJ   (2000) CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activity.  Clin Pharmacol Ther 67:48-56.|13. Shou M, Lu T, Krausz KW, Sai Y, Yang T, Korzekwa KR, Gonzalez FJ, Gelboin HV   (2000) Use of inhibitory monoclonal antibodies to assess the contribution of cytochromes P450 to human drug metabolism.  Eur J Pharmacol 394:199-209.|14. Sinal CJ, Miyata M, Tohkin M, Nagata K, Bend JR, Gonzalez FJ   (2000) Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation.  J Biol Chem 275:40504-10.|15. Sinclair JF, Szakacs JG, Wood SG, Walton HS, Bement JL, Gonzalez FJ, Jeffery EH, Wrighton SA, Bement WJ, Sinclair PR   (2000) Short-term treatment with alcohols causes hepatic steatosis and enhances acetaminophen hepatotoxicity in Cyp2e1(-/-) mice.  Toxicol Appl Pharmacol 168:114-22.|16. Ueno T, Tamura S, Frels WI, Shou M, Gonzalez FJ, Kimura S   (2000) A transgenic mouse expressing human CYP1A2 in the pancreas.  Biochem Pharmacol 60:857-63.",https://intramural.nih.gov/search/searchview.taf?ipid=11125
57,BC005596-31,"October 01, 1999 -  September 30, 2000",Pathogenesis of plasma cell tumors in mice,Michael  Potter; MD,NULL,"Laboratory of Genetics, NCI",Wendy Dianne Du Bois De Vroylande|Gary M Jones|Elizabeth B Mushinski|Kimberly R Williams,NULL,NULL,NULL,"1. Potter M, Jones G, Dubois W, Williams K, Mushinski E   (2000) Myeloma proteins that bind Hsp65 (GroEL) are polyreactive and are found in high incidence in pristine induced plasmacytomas.  Curr Top Microbiol Immunol 252:265-71.|2. Potter M, Melchers F   (2000) Opinions on the nature of B-1 cells and their relationship to B cell neoplasia.  Curr Top Microbiol Immunol 252:307-24.",https://intramural.nih.gov/search/searchview.taf?ipid=11127
58,BC005597-11,"October 01, 1999 -  September 30, 2000",Biochemistry of Energy-Dependent (Intracellular) Protein Degradation,Michael  Maurizi; PhD|IRP Faculty Profile,NULL,"Biochemistry of Proteins Section, NCI",Fusheng  Guo; PhD|Sung Gyun Kang; PhD|Fatima  Rasulova,NULL,Satyendra K Singh  (Protease Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11123
59,BC005598-11,"October 01, 1999 -  September 30, 2000",Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",NULL,NULL,Ding wu  Shen; PhD (Multidrug Resistence Section)|Carol O Cardarelli  (Multidrug Resistence Section)|Shyam S Chauham  (Multidrug Resistence Section)|Wilfred D Vieira  (Multidrug Resistence Section),NULL,"1. Ambudkar SV, Rosen BP, Gottesman MM   (2000) Workshop on ABC Transporters and Human Diseases.  Drug Resist Updat 3:51-54.|2. Aran JM, Pastan I, Gottesman MM   (1999) Therapeutic strategies involving the multidrug resistance phenotype: the MDR1 gene as target, chemoprotectant, and selectable marker in gene therapy.  Adv Pharmacol 46:1-42.|3. Booth CL, Pulaski L, Gottesman MM, Pastan I   (2000) Analysis of the properties of the N-terminal nucleotide-binding domain of human P-glycoprotein.  Biochemistry 39:5518-26.|4. Hafkemeyer P, Licht T, Pastan I, Gottesman MM   (2000) Chemoprotection of hematopoietic cells by a mutant P-glycoprotein resistant to a potent chemosensitizer of multidrug-resistant cancers.  Hum Gene Ther 11:555-65.|5. Lee CG, Ramachandra M, Jeang KT, Martin MA, Pastan I, Gottesman MM   (2000) Effect of ABC transporters on HIV-1 infection: inhibition of virus production by the MDR1 transporter.  FASEB J 14:516-522.|6. Licht T, Goldenberg SK, Vieira WD, Gottesman MM, Pastan I   (2000) Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in mice.  Gene Ther 7:348-58.|7. Sedelnikova OA, Panyutin IG, Luu AN, Reed MW, Licht T, Gottesman MM, Neumann RD   (2000) Targeting the human mdr1 gene by 125I-labeled triplex-forming oligonucleotides.  Antisense Nucleic Acid Drug Dev 10:443-52.|8. Shen DW, Goldenberg S, Pastan I, Gottesman MM   (2000) Decreased accumulation of 14Ccarboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake.  J Cell Physiol 183:108-16.",https://intramural.nih.gov/search/searchview.taf?ipid=11124
60,BC005599-10,"October 01, 1999 -  September 30, 2000","Tumor Suppressor Protein, p53",Ettore  Appella; MD|IRP Faculty Profile,NULL,"Chemical Immunology Section, NCI",Oleg  Demidov|Sharlyn  Mazur; PhD|Shinichi  Saito,NULL,NULL,NULL,"1. Appella E, Anderson CW   (2000) Signaling to p53: breaking the posttranslational modification code.  Pathol Biol (Paris) 48:227-45.|2. Chao C, Saito S, Anderson CW, Appella E, Xu Y   (2000) Phosphorylation of murine p53 at ser-18 regulates the p53 responses to DNA damage.  Proc Natl Acad Sci U S A 97:11936-41.|3. Chao C, Saito S, Kang J, Anderson CW, Appella E, Xu Y   (2000) p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage.  EMBO J 19:4967-75.|4. Choi J, Appella E, Donehower LA   (2000) The structure and expression of the murine wildtype p53-induced phosphatase 1 (Wip1) gene.  Genomics 64:298-306.|5. Higashimoto Y, Saito S, Tong XH, Hong A, Sakaguchi K, Appella E, Anderson CW   (2000) Human p53 is phosphorylated on serines 6 and 9 in response to DNA damage-inducing agents.  J Biol Chem 275:23199-203.|6. Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S, Pandolfi PP, Pelicci PG   (2000) PML regulates p53 acetylation and premature senescence induced by oncogenic Ras.  nature 406:207-10.|7. Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW, Seth P, Appella E, Srivastava S   (2000) p53 regulates the expression of the tumor suppressor gene maspin.  J Biol Chem 275:6051-4.",https://intramural.nih.gov/search/searchview.taf?ipid=11122
61,BC005617-12,"October 01, 1999 -  September 30, 2000",Regulation of the TGF-beta type II receptor gene expression by ets family of tra,Seong-Jin  Kim; PhD,NULL,"Laboratory of Cell Regulation and Carcinogenesis, NCI",Youngsuk  Yi; PhD,NULL,Young-Hyuck  Im  (National Cancer Institute)|Hueng Tae Kim  (National Cancer Institute)|Danielle L Poulin  (National Cancer Institute),NULL,"1. Chang J, Lee C, Hahm K, Yi Y, Choi S, Kim S   (2000) Over-expression of ERT(ESX/ESE-1/ELF3), an ets-related transcription factor, induces endogenous TGF-beta type II receptor expression and restores the TGF-beta signaling pathway in Hs578t human breast cancer cells.  Oncogene 19:151-154.|2. Im Y, Kim H, Lee C, Poulin D, Welford S, Sorensen P, Denny C, Kim S   (2000) EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of TGF-beta type II receptor gene.  Cancer Res 60:1536-1540.|3. Kim S   (2000) Molecular mechanism of inactivation of TGF-eta receptors during carcinogenesis.  Protein, Nucleic Acid, and Enzyme 46:111-116.|4. Kim S, Im Y, Markowitz S, Bang Y   (2000) Molecular Mechanisms of Inactivation of TGF-beta Receptors during Carcinogenesis.  Cytokine Growth Factor Rev 11:159-168.|5. Kunda S, Kim I, Yang T, Doglio L, Lang S, Zhang X, Buttyan R, Kim S, Chang J, Cai X, Wang Z, Lee C   (2000) Absence of rpoximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-beta type II dominant negative receptor.  Prostate 43:118-124.|6. Lee BI, Park SH, Kim JW, Sausville EA, Kim HT, Nakanishi O, Trepel JB, Kim SJ   (2001) MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells.  Cancer Res 61:931-4.|7. Lucas P, Kim S, Melby S, Ward J, Gress R   (2000) Disruption of T cell homeostasis in mice expressing a T cell specific dominant negative TGF-beta type II receptor.  J Exp Med 191:1187-1196.|8. Park S, Birchenall-Roberts M, Yi Y, Lee B, Lee D, Bertolette D, Fu T, Ruscetti F, Kim S   (2000) Mechanism of Induction of TGF-beta Type II Receptor Gene Expression by v-Src in Murine Myeloid Cells.  Cell Growth Differ 12:9-18.|9. park S, Kim Y, Park B, Hargaad S, Kim S   (2000) Inactivation of a Sequence-Specific Enhancer Binding Protein Is Responsible for the Loss of Expression of ERT/ELF-3/ESX/ESE-1/jen in Human Gastric Cancer Cell Lines.  Oncogene 20:1235-1245.",https://intramural.nih.gov/search/searchview.taf?ipid=11121
62,BC005620-12,"October 01, 1999 -  September 30, 2000",Development of Vaccines Against Retrovirus Infection in Primates,Raoul  Benveniste; PhD,NULL,"IMMUNOGENETICS SECT, NCI",NULL,NULL,"Mary  Carrington; MS, PhD  (Laboratory of Genomic Diversity)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11117
63,BC005643-10,"October 01, 1999 -  September 30, 2000",Yeast as a Model Organism to Study nucleocytoplasmic trafficking,Ravi  Dhar; PhD,NULL,"Basic Research Laboratory, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11116
64,BC005645-11,"October 01, 1999 -  September 30, 2000",T-cell Transformation by Oncoviruses,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"ANIMAL MODELS and RETROVIRAL VACCINES SECT, NCI",NULL,NULL,NULL,NULL,"1. D'Agostino DM, Zotti L, Ferro T, Franchini G, Chieco-Bianchi L, Ciminale V   (2000) The p13II protein of HTLV type 1: comparison with mitochondrial proteins coded by other human viruses.  AIDS Res Hum Retroviruses 16:1765-70.|2. Dekaban GA, Peters AA, Mulloy JC, Johnson JM, Trovato R, Rivadeneira E, Franchini G   (2000) The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits.  Virology 274:86-93.|3. Johnson JM, Mulloy JC, Ciminale V, Fullen J, Nicot C, Franchini G   (2000) The MHC class I heavy chain is a common target of the small proteins encoded by the 3' end of HTLV type 1 and HTLV type 2.  AIDS Res Hum Retroviruses 16:1777-81.|4. Nicot C, Mahieux R, Opavsky R, Cereseto A, Wolff L, Brady JN, Franchini G   (2000) HTLV-I Tax transrepresses the human c-Myb promoter independently of its interaction with CBP or p300.  Oncogene 19:2155-64.|5. Nicot C, Mahieux R, Takemoto S, Franchini G   (2000) Bcl-X(L) is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples.  Blood 96:275-81.|6. Nicot C, Opavsky R, Mahieux R, Johnson JM, Brady JN, Wolff L, Franchini G   (2000) Tax oncoprotein trans-represses endogenous B-myb promoter activity in human T cells.  AIDS Res Hum Retroviruses 16:1629-32.|7. Takemoto S, Trovato R, Cereseto A, Nicot C, Kislyakova T, Casareto L, Waldmann T, Torelli G, Franchini G   (2000) p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(ARF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells.  Blood 95:3939-44.|8. Trovato R, Cereseto A, Takemoto S, Gessain A, Watanabe T, Waldmann T, Franchini G   (2000) Deletion of the p16INK4A gene in ex vivo acute adult T cell lymphoma/leukemia cells and methylation of the p16INK4A promoter in HTLV type I-infected T cell lines.  AIDS Res Hum Retroviruses 16:709-13.",https://intramural.nih.gov/search/searchview.taf?ipid=11113
65,BC005652-11,"October 01, 1999 -  September 30, 2000",Identification of Single Nucleotide Polymorphisms in Cancer-Related Genes,Michael  Dean; PhD|IRP Faculty Profile,NULL,"Human Genetics Section, NCI",NULL,NULL,Vicente  Baca-Ruiz  (National Cancer Institute)|Vanessa  Clark  (National Cancer Institute),NULL,"1. Schriml LM, Peterson RJ, Gerrard B, Dean M   (2000) Use of denaturing HPLC to map human and murine genes and to validate single-nucleotide polymorphisms.  Biotechniques 28:740-5.|2. Tucker M, Goldstein A, Dean M, Knudson A   (2000) National Cancer Institute Workshop Report: the phakomatoses revisited.  J Natl Cancer Inst 92:530-3.",https://intramural.nih.gov/search/searchview.taf?ipid=11114
66,BC005657-11,"October 01, 1999 -  September 30, 2000",Molecular Basis for the Pathogenesis of Murine Retroviruses,Sandra  Ruscetti; PhD,NULL,"Retroviral Molecular Pathogenesis Section, NCI",Atsushi  Oue|Angelo  Spadaccini|Delores M Thompson|Takashi  Yugawa,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13825
67,BC005673-10,"October 01, 1999 -  September 30, 2000",Chemistry and Biology of Nitric Oxide,Larry K Keefer; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI",Carlos A Valdez,NULL,Ernst  Arnold  (Chemistry Section)|Paul J Donovan  (Chemistry Section)|Anthony  Fitzhugh  (Chemistry Section)|Joseph  Saavedra  (Chemistry Section),NULL,"1. Saavedra J, Fitzhugh A, Keefer LK   (2000) Diazeniumdiolates (formerly NONOates) in cardiovascular research and potential clinical applications, in Contemporary Cardiology, Vol. 4, Nitric Oxide and the Cardiovascular System. Loscalzo J, Vita JA, eds., Humana Press (Totowa, NJ), pp. 431-446.|2. Saavedra J, Hrabie J, Keefer LK   (2000) Nitric oxide-releasing derivatives of biomedically important substrates, in The Biology of Nitric Oxide, Part 7. Wiklund P, Gustafsson L, Moncada S, eds., Portland Press (London), pp. 9.|3. Arnold EV, Keefer LK, Hrabie JA   (2000) Reaction of nitric oxide with benzyl cyanide to yield a bis-diazeniumdiolated imidate.  Tetrahedron Lett 41:8421-8424.|4. Fitzhugh AL, Keefer LK   (2000) Diazeniumdiolates: pro- and antioxidant applications of the NONOates.  Free Radic Biol Med 28:1463-9.|5. Hrabie JA, Arnold EV, Citro ML, George C, Keefer LK   (2000) Reaction of nitric oxide at the beta-carbon of enamines A new method of preparing compounds containing the diazeniumdiolate functional group.  J Org Chem 65:5745-51.|6. Keefer LK   (2000) Design of ntiric oxide-releasing drugs.  Pharm. News 7:27-32.|7. Mowery K, Schoenfisch M, Saavedra J, Keefer LK, Meyerhoff M   (2000) Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release.  Biomaterials 21:9-21.|8. Saavedra J, Keefer LK   (2000) NO better pharmaceuticals.  Chem Br 36:30-33.|9. Saavedra J, Mooradian D, Mowery K, Schoenfisch M, Citro M, Davies K, Meyerhoff M, Keefer LK   (2000) Conversion of a polysaccharide to nitric oxide-releasing form Dual mechanism anticoagulant activity of diazeniumdiolated heparin.  Bioorg Med Chem Lett 10:751-753.|10. Saavedra JE, Shami PJ, Wang LY, Davies KM, Booth MN, Citro ML, Keefer LK   (2000) Esterase-sensitive nitric oxide donors of the diazeniumdiolate family: in vitro antileukemic activity.  J Med Chem 43:261-9.|11. Souici A, Mirkovitch J, Hausel P, Keefer LK, Felley-Bosco E   (2000) Transition mutation in codon 248 of the p53 tumor suppressor gene induced by reactive oxygen species and a nitric oxide releasing compound.  Carcinogenesis 21:281-287.|12. Waalkes MP, Keefer LK, Diwan BA   (2000) Induction of proliferative lesions of the uterus, testes, and liver in swiss mice given repeated injections of sodium arsenate: possible estrogenic mode of action.  Toxicol Appl Pharmacol 166:24-35.|13. Fitzhugh AL, Cafferata RL, Cheng PL, Hendriks ML, Keefer LL, Saavedra JL, Tedeschi EL, Verhoeven ML (submitted in 2000) Nitric Oxide Releasing Metallic Medical Devices. Patent issued: 6,270,779 (US in 2001). Patents pending: 05022005.2 (EP application); 01932992.9 (FR application); 01932992.9 (GB application); 01932992.9 (IE application); 2001-581880 (JP application); PCT/US01/14407 (PC application); 09/865,242 (US application); 01932992.9 (DE application); 01932992.9 (EP application).",https://intramural.nih.gov/search/searchview.taf?ipid=11112
68,BC005681-10,"October 01, 1999 -  September 30, 2000",Approaches to Gene Mapping Development and Applications,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",NULL,NULL,"Michael J Smith; PhD, BS  (Office of Management)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11110
69,BC005688-10,"October 01, 1999 -  September 30, 2000",Combination of Vaccine Modalities to Prevent HIV-I Infection and Modeling of Ear,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"ANIMAL MODELS and RETROVIRAL VACCINES SECT, NCI",Liljana  Stevceva|Elzbieta A Tryniszewska,NULL,NULL,NULL,"1. Beer BE, Bailes E, Dapolito G, Campbell BJ, Goeken RM, Axthelm MK, Markham PD, Bernard J, Zagury D, Franchini G, Sharp PM, Hirsch VM   (2000) Patterns of genomic sequence diversity among their simian immunodeficiency viruses suggest that LHoest monkeys (Cercopithecus lhoesti) are a natural lentivirus reservoir.  J Virol 74:3892-3898.|2. Hel Z, Venzon D, Poudyal M, Tsai WP, Giuliani L, Woodward R, Chougnet C, Shearer G, Altman JD, Watkins D, Bischofberger N, Abimiku A, Markham P, Tartaglia J, Franchini G   (2000) Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques.  Nat Med 6:1140-6.|3. Kuroda MJ, Schmitz JE, Lekutis C, Nickerson CE, Lifton MA, Franchini G, Harouse JM, Cheng-Mayer C, Letvin NL   (2000) Human immunodeficiency virus type 1 envelope epitope-specific CD4(+) T lymphocytes in simian/human immunodeficiency virus-infected and vaccinated rhesus monkeys detected using a peptide-major histocompatibility complex class II tetramer.  J Virol 74:8751-6.|4. Stevceva L, Abimiku AG, Franchini G   (2000) Targeting the mucosa: genetically engineered vaccines and mucosal immune responses.  Genes Immun 1:308-15.|5. Franchini G, Hel Z, Pavlakis G, Tartaglia J (submitted in 2000) Immunogenicity Using A Combination Of Dna And Vaccinia Virus Vector Vaccines. Patent issued: 7,771,729 (US in 2010). Patents pending: 01932792.3 (EP application); 2001-579837 (JP application); 60/200,444 (US application); 10/258,570 (US application); 12/845,350 (US application); 2001259291 (AU application); 2407303 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=11108
70,BC005691-09,"October 01, 1999 -  September 30, 2000",Inhibition of p53 Tumor Suppressor Function by HTLV-I,John N Brady; PhD,NULL,"National Cancer Institute, NCI",NULL,NULL,Janet  Duvall  (Virus Tumor Biology Section)|Claire  Guillerm; PhD  (Virus Tumor Biology Section)|Michael  Radonovich  (Virus Tumor Biology Section)|Craig C Whiteford  (Virus Tumor Biology Section),NULL,"1. Mahieux R, Pise-Masison CA, Lambert PF, Nicot C, De Marchis L A, Gessain P, Green W, Hall JN, Brady   (2000) Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function.  J Virol 74:6866-74.|2. Pise-Masison CA, Mahieux R, Jiang H, Ashcroft M, Radonovich M, Duvall J, Guillerm C, Brady JN   (2000) Inactivation of p53 by human T-cell lymphotropic virus type 1 Tax requires activation of the NF-kappaB pathway and is dependent on p53 phosphorylation.  Mol Cell Biol 20:3377-86.|3. Pise-Masison CA, Mahieux R, Radonovich M, Jiang H, Duvall J, Guillerm C, Brady JN   (2000) Insights into the molecular mechanism of p53 inhibition by HTLV type 1 Tax.  AIDS Res Hum Retroviruses 16:1669-75.|4. Pise-Masison CA, Mahieux R, Radonovich MF, Jiang H, Brady JN   (2000) Human T-lymphotropic virus type-I-tax protein Utilizes distinct pathways for p53 Inhibition which are cell-type dependent.  J Biol Chem, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=11106
71,BC005703-09,"October 01, 1999 -  September 30, 2000","BOG, a Novel pRb Binding Protein Affecting Cell-cycle Control and Transformation","Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI",NULL,NULL,Roberto  Loi  (Cellular and Molecular Biology Section)|Chien-Hua  Niu  (Cellular and Molecular Biology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11107
72,BC005708-09,"October 01, 1999 -  September 30, 2000",Function of Xenobiotic Receptors,Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Nucleic Acids Section, NCI",Graham P Hayhurst|Yusuke  Inoue|Christopher James Nicol|Sun Hee Yim,NULL,NULL,NULL,"1. Corton JC, Lapinskas PJ, Gonzalez FJ   (2000) Central role of PPARalpha in the mechanism of action of hepatocarcinogenic peroxisome proliferators.  Mutat Res 448:139-51.|2. DeLuca JG, Doebber TW, Kelly LJ, Kemp RK, Molon-Noblot S, Sahoo SP, Ventre J, Wu MS, Peters JM, Gonzalez FJ, Moller DE   (2000) Evidence for peroxisome proliferator-activated receptor (PPAR)alpha-independent peroxisome proliferation: effects of PPARgamma/delta-specific agonists in PPARalpha-null mice.  Mol Pharmacol 58:470-6.|3. Elizondo G, Corchero J, Sterneck E, Gonzalez FJ   (2000) Feedback inhibition of the retinaldehyde dehydrogenase gene ALDH1 by retinoic acid through retinoic acid receptor alpha and CCAAT/enhancer-binding protein beta.  J Biol Chem 275:39747-53.|4. Elizondo G, Fernandez-Salguero P, Sheikh MS, Kim GY, Fornace AJ, Lee KS, Gonzalez FJ   (2000) Altered cell cycle control at the G(2)/M phases in aryl hydrocarbon receptor-null embryo fibroblast.  Mol Pharmacol 57:1056-63.|5. Hasmall SC, James NH, Macdonald N, Gonzalez FJ, Peters JM, Roberts RA   (2000) Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha and TNFalpha.  Mutat Res 448:193-200.|6. Holden PR, Hasmall SC, James NH, West DR, Brindle RD, Gonzalez FJ, Peters JM, Roberts RA   (2000) Tumour necrosis factor alpha (TNFalpha): role in suppression of apoptosis by the peroxisome proliferator nafenopin.  Cell Mol Biol (Noisy-le-grand) 46:29-39.|7. Hunt MC, Lindquist PJ, Peters JM, Gonzalez FJ, Diczfalusy U, Alexson SE   (2000) Involvement of the peroxisome proliferator-activated receptor alpha in regulating long-chain acyl-CoA thioesterases.  J Lipid Res 41:814-23.|8. Idle JR, Corchero J, Gonzalez FJ   (2000) Medical implications of HGP's sequence of chromosome 22.  Lancet 355:319.|9. Kersten S, Mandard S, Tan NS, Escher P, Metzger D, Chambon P, Gonzalez FJ, Desvergne B, Wahli W   (2000) Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene.  J Biol Chem 275:28488-93.|10. Nakajima T, Kamijo Y, Usuda N, Liang Y, Fukushima Y, Kametani K, Gonzalez FJ, Aoyama T   (2000) Sex-dependent regulation of hepatic peroxisome proliferation in mice by trichloroethylene via peroxisome proliferator-activated receptor alpha (PPARalpha).  Carcinogenesis 21:677-82.|11. Pan DA, Mater MK, Thelen AP, Peters JM, Gonzalez FJ, Jump DB   (2000) Evidence against the peroxisome proliferator-activated receptor alpha (PPARalpha) as the mediator for polyunsaturated fatty acid suppression of hepatic L-pyruvate kinase gene transcription.  J Lipid Res 41:742-51.|12. Peters JM, Lee SS, Li W, Ward JM, Gavrilova O, Everett C, Reitman ML, Hudson LD, Gonzalez FJ   (2000) Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta).  Mol Cell Biol 20:5119-28.|13. Peters JM, Rusyn I, Rose ML, Gonzalez FJ, Thurman RG   (2000) Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis.  Carcinogenesis 21:823-6.|14. Portilla D, Dai G, Peters JM, Gonzalez FJ, Crew MD, Proia AD   (2000) Etomoxir-induced PPARalpha-modulated enzymes protect during acute renal failure.  Am J Physiol Renal Physiol 278:F667-75.|15. Sapone A, Peters JM, Sakai S, Tomita S, Papiha SS, Dai R, Friedman FK, Gonzalez FJ   (2000) The human peroxisome proliferator-activated receptor alpha gene: identification and functional characterization of two natural allelic variants.  Pharmacogenetics 10:321-33.|16. Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ   (2000) Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.  Cell 102:731-44.|17. Tohkin M, Fukuhara M, Elizondo G, Tomita S, Gonzalez FJ   (2000) Aryl hydrocarbon receptor is required for p300-mediated induction of DNA synthesis by adenovirus E1A.  Mol Pharmacol 58:845-51.|18. Tomita S, Sinal CJ, Yim SH, Gonzalez FJ   (2000) Conditional disruption of the aryl hydrocarbon receptor nuclear translocator (Arnt) gene leads to loss of target gene induction by the aryl hydrocarbon receptor and hypoxia-inducible factor 1alpha.  Mol Endocrinol 14:1674-81.|19. Turunen M, Peters JM, Gonzalez FJ, Schedin S, Dallner G   (2000) Influence of peroxisome proliferator-activated receptor alpha on ubiquinone biosynthesis.  J Mol Biol 297:607-14.|20. Watanabe K, Fujii H, Takahashi T, Kodama M, Aizawa Y, Ohta Y, Ono T, Hasegawa G, Naito M, Nakajima T, Kamijo Y, Gonzalez FJ, Aoyama T   (2000) Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity.  J Biol Chem 275:22293-9.|21. Wu X, Peters JM, Gonzalez FJ, Prasad HS, Rohrer MD, Gimble JM   (2000) Frequency of stromal lineage colony forming units in bone marrow of peroxisome proliferator-activated receptor-alpha-null mice.  Bone 26:21-6.",https://intramural.nih.gov/search/searchview.taf?ipid=13826
73,BC005725-09,"October 01, 1999 -  September 30, 2000",ABC Transporters in Human Disease and Multidrug Resistance,Michael  Dean; PhD|IRP Faculty Profile,NULL,"Human Genetics Section, NCI",NULL,NULL,Tarmo  Annilo  (National Cancer Institute),NULL,"1. Schriml LM, Dean M   (2000) Identification of 18 mouse ABC genes and characterization of the ABC superfamily in Mus musculus.  Genomics 64:24-31.",https://intramural.nih.gov/search/searchview.taf?ipid=11103
74,BC005740-08,"October 01, 1999 -  September 30, 2000",Transgenic Models for Prostate and Breast Cancer,Jeffrey E Green; MD,NULL,"Laboratory of Cell Regulation and Carcinogenesis, NCI",Kartiki Vasant Desai|Jason  Kang|Ziyao M Liu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11102
75,BC005742-08,"October 01, 1999 -  September 30, 2000",Biology of Vascular Endothelial Growth Factors in the Mammary Gland,Unnur P Thorgeirsson; MD,NULL,"Tumor Biology and Carcinogenesis Section, NCI",Makoto  Takehama,NULL,Shannon  Matheny  (National Cancer Institute)|Katrin  Neubauer  (Laboratory of Cellular Carcinogenesis and Tumor Promotion)|Daniel J Schoeffner  (National Cancer Institute),NULL,"1. Buck TB, Hall AL, Sinha CC, Bunce OR, Thorgeirsson UP   (2000) cis-hydroxyproline stimulates the growth of rat mammary carcinoma cells.  In Vivo 14:7-11.|2. Harris SR, Panaro NJ, Thorgeirsson UP   (2000) Oxidative stress contributes to the anti-proliferative effects of flavone acetic acid on endothelial cells.  Anticancer Res 20:2249-54.|3. Schoeffner DJ, Thorgeirsson UP   (2000) Susceptibility of nonhuman primates to carcinogens of human relevance.  In Vivo 14:149-56.",https://intramural.nih.gov/search/searchview.taf?ipid=11100
76,BC005744-08,"October 01, 1999 -  September 30, 2000",Biological Effects of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1),Unnur P Thorgeirsson; MD,NULL,"Tumor Biology and Carcinogenesis Section, NCI",Christine M Connor,NULL,Katrin  Neubauer  (Laboratory of Cellular Carcinogenesis and Tumor Promotion),NULL,"1. Yoshiji H, Kuriyama S, Miyamoto Y, Thorgeirsson UP, Gomez DE, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Thorgeirsson SS, Fukui H   (2000) Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model.  Hepatology 32:1248-54.",https://intramural.nih.gov/search/searchview.taf?ipid=13827
77,BC005748-08,"October 01, 1999 -  September 30, 2000",Aquisition of Genomic Alterations During Mammary Gland Cancer Induction in Rats,Elizabeth  Snyderwine; PhD,NULL,"Chemical Carcinogenesis Section, NCI",Liang  Shan|Minshu R Yu,NULL,NULL,NULL,"1. Snyderwine E   (2000) Carcinogenicity in Animals and Specific Organs Mammary Gland, in Food BOrne Carcinogens Heterocyclic Amines. Nagao M, Sugimura T, eds., John Wiley & Sons, LTD (New York), pp. 241-256.|2. Roberts-thomson S, Snyderwine E   (2000) Characterization of peroxisome proliferator-activated receptor alpha in normal rat mammary gland and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mammary gland tumore from rats fed high and low fat diets.  Toxicol Lett 118:79-86.|3. Yu M, Ryu DY, Snyderwine EG   (2000) Genomic imbalance in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine.  Mol Carcinog 27:76-83.",https://intramural.nih.gov/search/searchview.taf?ipid=11101
78,BC005750-08,"October 01, 1999 -  September 30, 2000",Transgenic Models for Cooperation of c-myc and Growth Factors in Tumorigenesis,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI",Elizabeth A Conner,NULL,Valentina  Factor  (Cellular and Molecular Biology Section)|Tanya N Hoang  (Cellular and Molecular Biology Section)|Chang Goo Huh  (Cellular and Molecular Biology Section)|Eric R Lemmer  (Cellular and Molecular Biology Section),NULL,"1. Thorgeirsson SS   (2000) Growth factors and cell cycle regulation in hepatocarcinogenesis, in Chronic hepatitis: New concepts of pathogenesis, diagnosis and treatment. Dienes HP, Schirmacher P, Brechot C, Okuda K, eds., Kluwer Academic Publishers BV (Dordrecht, The Netherlands), pp. 208-213.|2. Arsura M, Mercurio F, Oliver AL, Thorgeirsson SS, Sonenshein GE   (2000) Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells.  Mol Cell Biol 20:5381-91.|3. Bouzahzah B, Fu M, Iavarone A, Factor VM, Thorgeirsson SS, Pestell RG   (2000) Transforming growth factor-beta1 recruits histone deacetylase 1 to a p130 repressor complex in transgenic mice in vivo.  Cancer Res 60:4531-7.|4. Conner EA, Lemmer ER, Omori M, Wirth PJ, Factor VM, Thorgeirsson SS   (2000) Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.  Oncogene 19:5054-62.|5. Hsia CC, Nakashima Y, Thorgeirsson SS, Harris CC, Minemura M, Momosaki S, Wang NJ, Tabor E   (2000) Correlation of immunohistochemical staining and mutations of p53 in human hepatocellular carcinoma.  Oncol Rep 7:353-6.|6. Jensen MR, Audolfsson T, Factor VM, Thorgeirsson SS   (2000) In vivo expression and genomic organization of the mouse cyclin I gene (Ccni).  Gene 256:59-67.|7. Lemmer ER, Welch JL, Tsai T, Keck-Waggoner CL, Huh C, Zimonjic DB, Popescu NC, Thorgeirsson SS   (2000) Genomic structure and chromosome location of the mouse RelA p65 gene (Rela).  Cytogenet Cell Genet 89:129-32.|8. Sanders S, Keck-Waggoner CL, Zimonjic DB, Popescu NC, Thorgeirsson SS   (2000) Assignment of WDR7 (alias TRAG, TGF-beta resistance associated gene) to orthologous regions of human chromosome 18q211-->q22 and mouse chromosome 18D1-E3 by fluorescence in situ hybridization.  Cytogenet Cell Genet 88:324-5.|9. Sanders S, Thorgeirsson SS   (2000) Promotion of hepatocarcinogenesis by phenobarbital in c-myc/TGF-alpha transgenic mice.  Mol Carcinog 28:168-73.|10. Thorgeirsson SS, Factor VM, Snyderwine EG   (2000) Transgenic mouse models in carcinogenesis research and testing.  Toxicol Lett 112-113:553-5.|11. Yoshiji H, Kuriyama S, Miyamoto Y, Thorgeirsson UP, Gomez DE, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Thorgeirsson SS, Fukui H   (2000) Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model.  Hepatology 32:1248-54.|12. Yuan BZ, Keck-Waggoner C, Zimonjic DB, Thorgeirsson SS, Popescu NC   (2000) Alterations of the FHIT gene in human hepatocellular carcinoma.  Cancer Res 60:1049-53.",https://intramural.nih.gov/search/searchview.taf?ipid=11097
79,BC005753-08,"October 01, 1999 -  September 30, 2000",HIV Tat Transcriptional Activation,John N Brady; PhD,NULL,"National Cancer Institute, NCI",NULL,NULL,Emmanuel  Agbottah  (Virus Tumor Biology Section)|Michael  Radonovich  (Virus Tumor Biology Section),NULL,"1. Kashanchi F, Agbottah ET, Pise-Masison CA, Mahieux R, Duvall J, Kumar A, Brady JN   (2000) Cell cycle-regulated transcription by the human immunodeficiency virus type 1 Tat transactivator.  J Virol 74:652-60.|2. Wortman MJ, Krachmarov CP, Kim JH, Gordon RG, Chepenik LG, Brady JN, Gallia GL, Khalili K, Johnson EM   (2000) Interaction of HIV-1 Tat with Puralpha in nuclei of human glial cells: characterization of RNA-mediated protein-protein binding.  J Cell Biochem 77:65-74.|3. Zhou M, Halanski MA, Radonovich MF, Kashanchi F, Peng J, Price DH, Brady JN   (2000) Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription.  Mol Cell Biol 20:5077-86.|4. Zhou M, Kashanchi F, Jiang H, Ge H, Brady JN   (2000) Phosphorylation of the RAP74 subunit of TFIIF correlates with Tat-activated transcription of the HIV-1 long terminal repeat.  Virology 268:452-60.",https://intramural.nih.gov/search/searchview.taf?ipid=11098
80,BC005785-06,"October 01, 1999 -  September 30, 2000",Epithelial Homeostasis and Tumorigenesis in TGF-betas,Lalage  Wakefield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Regulation and Carcinogenesis, NCI",Binwu  Tang|Yu-an  Yang,NULL,Jennifer L MacGregor  (National Cancer Institute),NULL,"1. Wakefield LM, Yang YA, Dukhanina O   (2000) Transforming growth factor-beta and breast cancer: Lessons learned from genetically altered mouse models.  Breast Cancer Res 2:100-6.",https://intramural.nih.gov/search/searchview.taf?ipid=11093
81,BC005789-06,"October 01, 1999 -  September 30, 2000",In Vivo Mutagenicity and Carcinogenicity of Heterocyclic Amines in Transgenic Ro,Elizabeth  Snyderwine; PhD,NULL,"Chemical Carcinogenesis Section, NCI",NULL,NULL,Marion L Jones  (National Cancer Institute)|Mau T Tran  (National Cancer Institute),NULL,"1. Thorgeirsson SS, Ryu D, Weidner V, Snyderwine E   (1999) Carcinogenicity and mutagenicity of heterocyclic amines in transgenic mouse models.  Cancer Lett 143:245-7.",https://intramural.nih.gov/search/searchview.taf?ipid=11094
82,BC005793-06,"October 01, 1999 -  September 30, 2000",Mechanism of viral hepatitis-mediated liver carcinogenesis,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Chuan-Ging  Wu,NULL,NULL,NULL,"1. Wang XW   (2000) Abrogation of p53-induced apoptosis by the hepatitis B virus X gene, in Methods in Molecular Medicine: Hepatocellular Carcinoma Methods and Protocols. Habib N, ed., Humana Press Inc. (Totowa, NJ) Volume 45,  pp. 57-70.",https://intramural.nih.gov/search/searchview.taf?ipid=11091
83,BC005794-06,"October 01, 1999 -  September 30, 2000",Mutational and Functional Analysis of the p53 Tumor Suppressor Gene,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Marek  Rusin,NULL,Amy B Foraker  (National Cancer Institute)|Teh-Ia  Huo  (National Cancer Institute)|Beth A Jeffries  (National Cancer Institute)|Steven P Linke  (Molecular Genetics and Carcinogenesis Section)|Koh  Miura  (National Cancer Institute)|Ana  Robles  (Molecular Genetics and Carcinogenesis Section)|Show all 9.,NULL,"1. Hsia CC, Nakashima Y, Thorgeirsson SS, Harris CC, Minemura M, Momosaki S, Wang NJ, Tabor E   (2000) Correlation of immunohistochemical staining and mutations of p53 in human hepatocellular carcinoma.  Oncol Rep 7:353-6.|2. Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP, Shields PG, Ham AJ, Swenberg JA, Marrogi AJ, Harris CC   (2000) Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease.  Cancer Res 60:3333-7.|3. Hussain SP, Raja K, Amstad PA, Sawyer M, Trudel LJ, Wogan GN, Hofseth LJ, Shields PG, Billiar TR, Trautwein C, Hohler T, Galle PR, Phillips DH, Markin R, Marrogi AJ, Harris CC   (2000) Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases.  Proc Natl Acad Sci U S A 97:12770-5.",https://intramural.nih.gov/search/searchview.taf?ipid=11092
84,BC005795-06,"October 01, 1999 -  September 30, 2000",Cell Cycle Control and Tumor Suppressors,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",NULL,NULL,Remy Marie Pedeux  (Molecular Genetics and Carcinogenesis Section),NULL,"1. Marrogi A, Pass HI, Khan M, Metheny-Barlow LJ, Harris CC, Gerwin BI   (2000) Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in vitro antiproliferative effects of a COX-2 inhibitor.  Cancer Res 60:3696-700.",https://intramural.nih.gov/search/searchview.taf?ipid=11089
85,BC005800-06,"October 01, 1999 -  September 30, 2000",Prostate and Breast Cancer Susceptibility Genes in African Americans and Hispani,"Michael J Smith; PhD, BS",NULL,"Office of Management, NCI",NULL,NULL,Stephen J O'Brien; PhD  (Laboratory of Genomic Diversity)|Cheryl Ann Winkler  (Laboratory of Genomic Diversity),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11090
86,BC006140-24,"October 01, 1999 -  September 30, 2000",Studies of Histone Functions in Chromatin,William M Bonner; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",NULL,NULL,Christophe  Redon  (National Cancer Institute),NULL,"1. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM   (2000) A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage.  Curr Biol 10:886-95.|2. Rogakou EP, Nieves-Neira W, Boon C, Pommier Y, Bonner WM   (2000) Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139.  J Biol Chem 275:9390-5.|3. Rogakou EP, Redon C, Boon C, Johnson K, Bonner WM   (2000) Rapid histone extraction for electrophoretic analysis.  Biotechniques 28:38-40, 42, 46.",https://intramural.nih.gov/search/searchview.taf?ipid=11087
87,BC006150-19,"October 01, 1999 -  September 30, 2000",Protein-Associated DNA Breaks as Indicator of Topoisomerase Inhibition,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Glenda B Kohlhagen|Kurt  Kohn; PhD,NULL,"Juana  Barcelo  (National Cancer Institute)|Jihyun  Larose  (National Cancer Institute)|Philippe  Pourquier  (National Cancer Institute)|Annemarie H Van Hattum  (National Cancer Institute)|Qiang  Yu; MD, PhD  (National Cancer Institute)|Hongliang  Zhang  (CHEMSTRY SECT)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11088
88,BC006161-17,"October 01, 1999 -  September 30, 2000",DNA Topoisomerases as Target of Action of Anticancer Drugs,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Glenda B Kohlhagen,NULL,Gary S Laco  (National Cancer Institute)|Philippe  Pourquier  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11085
89,BC006173-15,"October 01, 1999 -  September 30, 2000",Dideoxynucleosides as Potential Anti-AIDS Drugs,Victor  Marquez; PhD,NULL,"ORGANIC CHEMSTRY SECT, NCI",M A Siddiqui,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11086
90,BC006174-15,"October 01, 1999 -  September 30, 2000",Carbocyclic Nucleoside Isosteres as Potential Antitumor and Antiviral Agents,Victor  Marquez; PhD,NULL,"ORGANIC CHEMSTRY SECT, NCI",Pamela L Russ,NULL,"David G Johns; MD, PhD  (Laboratory of Medicinal Chemistry)|Peiyuan  Wang  (National Cancer Institute)",NULL,"1. Marquez V, Russ P (submitted in 2000) 5-substituted Derivatives Of Conformationally Locked Nucleoside Analogues. Patent issued: 2417251 (CA in 2013). Patents pending: 01957228.8 (BE application); 01957228.8 (CH application); 01957228.8 (CY application); 01957228.8 (DE application); 01957228.8 (DK application); 01957228.8 (EP application); 01957228.8 (ES application); 01957228.8 (FI application); 01957228.8 (FR application); 01957228.8 (GB application); 01957228.8 (GR application); 01957228.8 (IE application); 01957228.8 (IT application); 01957228.8 (LI application); 01957228.8 (LU application); 01957228.8 (MC application); 01957228.8 (NL application); 01957228.8 (PT application); 01957228.8 (SE application); 01957228.8 (TR application); 60/220,934 (US application); 10/346,762 (US application); 01957228.8 (AT application); 2001278993 (AU application). Tracking number: E-249-2000-0-EP-07 (EP application).",https://intramural.nih.gov/search/searchview.taf?ipid=11083
91,BC006176-15,"October 01, 1999 -  September 30, 2000",Enzyme Inhibitors as Potential Anticancer and Antiviral Drugs,Victor  Marquez; PhD,NULL,"ORGANIC CHEMSTRY SECT, NCI",Kassoum  Nacro,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11084
92,BC006177-15,"October 01, 1999 -  September 30, 2000",The Analytical Chemistry of Anti-AIDS Agents,James A Kelley; PhD,NULL,"ANALYTICAL CHEMSTRY SECT, NCI",Jeri S. Roth; MS|Harry  Ford|Nancy M Malinowski|Manohar  Sethi,NULL,NULL,NULL,"1. Chen IJ, Neamati N, Nicklaus MC, Orr A, Anderson L, Barchi JJ, Kelley JA, Pommier Y, MacKerell AD   (2000) Identification of HIV-1 integrase inhibitors via three-dimensional database searching using ASV and HIV-1 integrases as targets.  Bioorg Med Chem 8:2385-98.|2. Zhang X, Lee YK, Kelley JA, Burke TR   (2000) Preparation of aryl isothiocyanates via protected phenylthiocarbamates and application to the synthesis of caffeic acid (4-Isothiocyanato)phenyl ester.  J Org Chem 65:6237-40.",https://intramural.nih.gov/search/searchview.taf?ipid=11081
93,BC006178-15,"October 01, 1999 -  September 30, 2000",Applications of New Mass Spectral Techniques,James A Kelley; PhD,NULL,"ANALYTICAL CHEMSTRY SECT, NCI",Jeri S. Roth; MS,NULL,NULL,NULL,"1. Gao Y, Luo J, Yao ZJ, Guo R, Zou H, Kelley J, Voigt JH, Yang D, Burke TR   (2000) Inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands 2 4-(2-Malonyl)phenylalanine as a potent phosphotyrosyl mimetic.  J Med Chem 43:911-20.|2. Roth JS, Wang J, Kelley JA   (2000) Determination of lodenosine and its major metabolite in human plasma by liquid chromatography/electrospray ionization tandem mass spectrometry.  J Mass Spectrom 35:1313-9.|3. Siddiqui MA, Driscoll JS, Abushanab E, Kelley JA, Barchi JJ, Marquez VE   (2000) The beta-fluorine effect in the non-metal hydride radical deoxygenation of fluorine-containing nucleoside xanthates.  Nucleosides Nucleotides Nucleic Acids 19:1-12.",https://intramural.nih.gov/search/searchview.taf?ipid=11082
94,BC006192-12,"October 01, 1999 -  September 30, 2000",Investigations on the integrated behavior of molecular regulatory networks that,Kurt  Kohn; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11079
95,BC006198-11,"October 01, 1999 -  September 30, 2000",Inhibitors of Tyrosine Kinase-Dependent Signalling asAnticancer Agents,Terrence R Burke; PhD|IRP Faculty Profile,NULL,"ORGANIC CHEMSTRY SECT, NCI",NULL,NULL,James A Kelley; PhD (ANALYTICAL CHEMSTRY SECT)|Yang  Gao  (National Cancer Institute)|Ding-Guo  Liu  (Laboratory of Medicinal Chemistry),NULL,"1. Burke TR, Liu DG, Gao Y   (2000) Use of a heck reaction for the synthesis of a new alpha-azido phosphotyrosyl mimetic suitably protected for peptide synthesis.  J Org Chem 65:6288-91.|2. Gao Y, Luo J, Yao ZJ, Guo R, Zou H, Kelley J, Voigt JH, Yang D, Burke TR   (2000) Inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands 2 4-(2-Malonyl)phenylalanine as a potent phosphotyrosyl mimetic.  J Med Chem 43:911-20.|3. Gao Y, Wu L, Luo JH, Guo R, Yang D, Zhang ZY, Burke TR   (2000) Examination of novel non-phosphorus-containing phosphotyrosyl mimetics against protein-tyrosine phosphatase-1B and demonstration of differential affinities toward Grb2 SH2 domains.  Bioorg Med Chem Lett 10:923-7.",https://intramural.nih.gov/search/searchview.taf?ipid=11080
96,BC007184-11,"October 01, 1999 -  September 30, 2000",Molecular Biology of Cellular Injury,Albert J Fornace; MD,NULL,"Gene Response Section, NCI",Dmitry  Bulavin|Jeffery  Hildesheim|Mary  Hollander|Oleg  Kovalsky|Jesus M Salvador-Sanchez|Jeffery Xiwu Zhou,NULL,Laura  Henmueller; PhD  (National Cancer Institute),NULL,"1. Bittner M, Chen Y, Amundson S, Dougherty E, Fornace AJ, Meltzer P, Trent J   (2000) Obtaining and evaluating gene expression profiles with cDNA microarrays, in Genomics and Proteomics. Suhai S, ed., Kluwer Academic / Plenum Publishers (New York, NY), pp. 5-25.|2. Amundson SA, Do KT, Shahab S, Bittner M, Meltzer P, Trent J, Fornace AJ   (2000) Identification of potential mRNA biomarkers in peripheral blood lymphocytes for human exposure to ionizing radiation.  Radiat Res 154:342-6.|3. Amundson SA, Myers TG, Scudiero D, Kitada S, Reed JC, Fornace AJ   (2000) An informatics approach identifying markers of chemosensitivity in human cancer cell lines.  Cancer Res 60:6101-10.|4. Elizondo G, Fernandez-Salguero P, Sheikh MS, Kim GY, Fornace AJ, Lee KS, Gonzalez FJ   (2000) Altered cell cycle control at the G(2)/M phases in aryl hydrocarbon receptor-null embryo fibroblast.  Mol Pharmacol 57:1056-63.|5. Jin S, Antinore MJ, Lung FD, Dong X, Zhao H, Fan F, Colchagie AB, Blanck P, Roller PP, Fornace AJ, Zhan Q   (2000) The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression.  J Biol Chem 275:16602-8.|6. Jin S, Zhao H, Fan F, Blanck P, Fan W, Colchagie AB, Fornace AJ, Zhan Q   (2000) BRCA1 activation of the GADD45 promoter.  Oncogene 19:4050-7.|7. Koch-Paiz CA, Momenan R, Amundson SA, Lamoreaux E, Fornace AJ   (2000) Estimation of relative mRNA content by filter hybridization to a polyuridylic probe.  Biotechniques 29:706, 708, 712, 714.|8. Meng RD, McDonald ER, Sheikh MS, Fornace AJ, El-Deiry WS   (2000) The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis.  Mol Ther 1:130-44.|9. Sheikh MS, Fornace AJ   (2000) Death and decoy receptors and p53-mediated apoptosis.  Leukemia 14:1509-13.|10. Sheikh MS, Fornace AJ   (2000) Role of p53 family members in apoptosis.  J Cell Physiol 182:171-81.|11. Sheikh MS, Hollander MC, Fornance AJ   (2000) Role of Gadd45 in apoptosis.  Biochem Pharmacol 59:43-5.|12. Smith ML, Ford JM, Hollander MC, Bortnick RA, Amundson SA, Seo YR, Deng CX, Hanawalt PC, Fornace AJ   (2000) p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes.  Mol Cell Biol 20:3705-14.|13. Zhao H, Jin S, Antinore MJ, Lung FD, Fan F, Blanck P, Roller P, Fornace AJ, Zhan Q   (2000) The central region of Gadd45 is required for its interaction with p21/WAF1.  Exp Cell Res 258:92-100.",https://intramural.nih.gov/search/searchview.taf?ipid=11077
97,BC007333-09,"October 01, 1999 -  September 30, 2000",Pharmacology of HIV Viral DNA and Retroviral Integrases,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Glenda B Kohlhagen|Ann  Orr,NULL,Christophe R Marchand  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11078
98,BC007349-08,"October 01, 1999 -  September 30, 2000",New strategies for drug discovery: Gene expression profiling and bioinformatics,"John N Weinstein; MD, PhD",NULL,"Developmental Therapeutics Branch, NCI",Yves  Pommier; PhD|Kurt  Kohn; PhD|William Curtis Reinhold|Lawrence H Smith,NULL,Fuad  Gwadry  (National Cancer Institute),Jae  Lee (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11076
99,BC007354-07,"October 01, 1999 -  September 30, 2000",Polypeptide Inhibitors of Cell Cycle Proliferation,Peter P Roller; PhD,NULL,"ORGANIC CHEMSTRY SECT, NCI",Xiaodong  Zheng,NULL,Ya-Qiu  Long  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13828
100,BC007363-06,"October 01, 1999 -  September 30, 2000",Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs,Terrence R Burke; PhD|IRP Faculty Profile,NULL,"ORGANIC CHEMSTRY SECT, NCI",Godwin C G Pais|Xue-Chun  Zhang,NULL,NULL,NULL,"1. Orban Z, Mitsiades N, Burke TR, Tsokos M, Chrousos GP   (2000) Caffeic acid phenethyl ester induces leukocyte apoptosis, modulates nuclear factor-kappa B and suppresses acute inflammation.  Neuroimmunomodulation 7:99-105.|2. Zhang X, Lee YK, Kelley JA, Burke TR   (2000) Preparation of aryl isothiocyanates via protected phenylthiocarbamates and application to the synthesis of caffeic acid (4-Isothiocyanato)phenyl ester.  J Org Chem 65:6237-40.",https://intramural.nih.gov/search/searchview.taf?ipid=11074
101,BC007365-06,"October 01, 1999 -  September 30, 2000",Regulation of ADP-ribosylation factor,"Paul A Randazzo; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI",Zhongzhen  Nie|Stacey S Stauffer,NULL,Koichi  Miura  (National Cancer Institute),NULL,"1. Jackson TR, Brown FD, Nie Z, Miura K, Foroni L, Sun J, Hsu VW, Donaldson JG, Randazzo PA   (2000) ACAPs are arf6 GTPase-activating proteins that function in the cell periphery.  J Cell Biol 151:627-38.|2. Kam JL, Miura K, Jackson TR, Gruschus J, Roller P, Stauffer S, Clark J, Aneja R, Randazzo PA   (2000) Phosphoinositide-dependent activation of the ADP-ribosylation factor GTPase-activating protein ASAP1 Evidence for the pleckstrin homology domain functioning as an allosteric site.  J Biol Chem 275:9653-63.|3. Puertollano R, Randazzo P, Presley J, Hartnell L, Bonifacino JS   (2000) The GGAs promote ARF-dependent recruitment of clathrin to the TGN.  Cell 105:93-102.|4. Randazzo PA, Andrade J, Miura K, Brown MT, Long YQ, Stauffer S, Roller P, Cooper JA   (2000) The Arf GTPase-activating protein ASAP1 regulates the actin cytoskeleton.  Proc Natl Acad Sci U S A 97:4011-6.",https://intramural.nih.gov/search/searchview.taf?ipid=13829
102,BC008000-30,"October 01, 1999 -  September 30, 2000",Regulation of Gene Activity,Alfred Charles Johnson; PhD,NULL,"Laboratory of Molecular Biology, NCI",NULL,NULL,Barbara  Murphy  (Molecular Biology Section)|Katsura  Nishi  (Molecular Biology Section)|Toshiki  Rikiyama  (Molecular Biology Section),NULL,"1. Johnson AC, Murphy BA, Matelis CM, Rubinstein Y, Piebenga EC, Akers LM, Neta G, Vinson C, Birrer M   (2000) Activator protein-1 mediates induced but not basal epidermal growth factor receptor gene expression.  Mol Med 6:17-27.|2. Liu XW, Katagiri Y, Jiang H, Gong LJ, Guo LY, Shibutani M, Johnson AC, Guroff G   (2000) Cloning and characterization of the promoter region of the rat epidermal growth factor receptor gene and its transcriptional regulation by nerve growth factor in PC12 cells.  J Biol Chem 275:7280-8.",https://intramural.nih.gov/search/searchview.taf?ipid=11075
103,BC008226-24,"October 01, 1999 -  September 30, 2000","Hormones, Antihormones and Growth Factors in Mammary Development and Tumorigenes",Barbara V Vonderhaar; PhD,NULL,"CELLULAR and MOLECULAR PHYSIOLOGY SECT, NCI",Erika P Ginsburg|Anita  Goldhar|Russell C Hovey|Kenichi  Satoh|Josephine F Trott,NULL,Tadeusz  Malewski  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13830
104,BC008281-18,"October 01, 1999 -  September 30, 2000",Mechanism of cAMP-growth regulatory function,"Yoon S Cho-Chung; MD, PhD",NULL,"CELLULAR BIOCHEMSTRY SECT, NCI",Catherine  Neary,NULL,Langzhu  Tan  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11023
105,BC008303-28,"October 01, 1999 -  September 30, 2000",Regulation of Membrane Fusion by Viral and Cellular Proteins and Lipids,Robert  Blumenthal; PhD|IRP Faculty Profile,NULL,"Membrane Structure and Function Section, NCI",Sherimay  Ablan|Antony  Dimitrov|Stephen A Gallo|Anu  Puri; PhD|Satinder  Rawat|Mathias  Viard,NULL,NULL,NULL,"1. Hoover DM, Rajashankar KR, Blumenthal R, Puri A, Oppenheim JJ, Chertov O, Lubkowski J   (2000) The structure of human beta-defensin-2 shows evidence of higher order oligomerization.  J Biol Chem 275:32911-8.|2. Hug P, Lin HM, Korte T, Xiao X, Dimitrov DS, Wang JM, Puri A, Blumenthal R   (2000) Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.  J Virol 74:6377-85.|3. Jernigan KM, Blumenthal R, Puri A   (2000) Varying effects of temperature, Ca(2+) and cytochalasin on fusion activity mediated by human immunodeficiency virus type 1 and type 2 glycoproteins.  FEBS Lett 474:246-51.|4. Kliger Y, Peisajovich SG, Blumenthal R, Shai Y   (2000) Membrane-induced conformational change during the activation of HIV-1 gp41.  J Mol Biol 301:905-14.|5. Puri A, Riley JL, Kim D, Ritchey DW, Hug P, Jernigan K, Rose P, Blumenthal R, Carroll RG   (2000) Influenza virus upregulates CXCR4 expression in CD4+ cells.  AIDS Res Hum Retroviruses 16:19-25.|6. Raviv Y, Puri A, Blumenthal R   (2000) P-glycoprotein-overexpressing multidrug-resistant cells are resistant to infection by enveloped viruses that enter via the plasma membrane.  FASEB J 14:511-5.",https://intramural.nih.gov/search/searchview.taf?ipid=11024
106,BC008363-18,"October 01, 1999 -  September 30, 2000",Membrane Protein Modeling,Homer Robert Guy; PhD,NULL,"Molecular Structure Section, NCI",Stewart  Durell,NULL,NULL,NULL,"1. Cho HC, Tsushima RG, Nguyen TT, Guy HR, Backx PH   (2000) Two critical cysteine residues implicated in disulfide bond formation and proper folding of Kir21.  Biochemistry 39:4649-57.|2. Durell SR, Bakker EP, Guy HR   (2000) Does the KdpA subunit from the high affinity K(+)-translocating P-type KDP-ATPase have a structure similar to that of K(+) channels?  Biophys J 78:188-99.",https://intramural.nih.gov/search/searchview.taf?ipid=11021
107,BC008370-17,"October 01, 1999 -  September 30, 2000",Developing Dynamic Mechanisms from Protein Structures and Analyzing Cell-line Sc,Robert L Jernigan; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,Stewart  Durell  (Molecular Structure Section)|Daniel T Flatow  (Molecular Structure Section)|Olga  Tcherkasskay  (Molecular Structure Section)|Kai Li H Ting  (Molecular Structure Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11022
108,BC008371-17,"October 01, 1999 -  September 30, 2000",DNA Deformations and Interactions in Complexes with Proteins,Robert L Jernigan; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,Stewart  Durell  (Molecular Structure Section)|Kai Li H Ting  (Molecular Structure Section)|Michael Ye Tolstorukov  (National Cancer Institute)|Victor  Zhurkin; PhD  (Molecular Structure Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11019
109,BC008380-16,"October 01, 1999 -  September 30, 2000",Molecular Structure of Animal Viruses and Cells by Computational Analysis,Jacob V. Maizel; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Shu Yun  Le|Buyong  Ma|John  Owens|Chung  Tsai,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11020
110,BC008381-17,"October 01, 1999 -  September 30, 2000",Computer Aided Two-Dimensional Electrophoretic Gel Analysis (GELLAB),Peter F Lemkin; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11017
111,BC008382-17,"October 01, 1999 -  September 30, 2000",Computer Analysis of Nucleic Acid Structure,Bruce Allen Shapiro; PhD|IRP Faculty Profile,NULL,"MEMBRANE BIOLOGY SECT, NCI",Kathleen  Currey,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11018
112,BC008396-12,"October 01, 1999 -  September 30, 2000",Molecular Information Theory,Thomas Dana Schneider; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",Ilya  Lyakhov,NULL,Marie A Lewis  (National Cancer Institute)|Xiaomei  Ma  (Office Of The Director)|Shu  Ouyang  (National Cancer Institute),NULL,"1. Kannan N, Schneider TD, Vishveshwara S   (2000) Logos for amino-acid preferences in different backbone packing density regions of protein structural classes.  Acta Crystallogr D Biol Crystallogr 56 ( Pt 9):1156-65.|2. Schneider TD   (2000) Evolution of biological information.  Nucleic Acids Res 28:2794-9.|3. Schneider TD   (2000) The bottle.  nature 406:351.|4. Svojanovsky SR, Schneider TD, Rogan PK   (2000) Redundant designations of BRCA1 intron 11 splicing mutation; c 4216-2A>G; IVS11-2A>G; L78833, 37698, A>G.  Hum Mutat 16:264.",https://intramural.nih.gov/search/searchview.taf?ipid=11015
113,BC008575-27,"October 01, 1999 -  September 30, 2000",Inflammation,Edward Joseph Leonard,NULL,"Immunopathology Section, NCI",Alla  Danilkovitch|Alison H Skeel,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11016
114,BC008577-15,"October 01, 1999 -  September 30, 2000",Genetic Basis of Human Kidney Cancer,Berton K Zbar; PhD,NULL,"Cellular Immunity Section, NCI",NULL,NULL,Wenbin  Ma  (Laboratory of Immunobiology),NULL,"1. Nickerson ML, Weirich G, Zbar B, Schmidt LS   (2000) Signature-based analysis of MET proto-oncogene mutations using DHPLC.  Hum Mutat 16:68-76.|2. Ornstein DK, Lubensky IA, Venzon D, Zbar B, Linehan WM, Walther MM   (2000) Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer.  J Urol 163:431-3.|3. Sgambati MT, Stolle C, Choyke PL, Walther MM, Zbar B, Linehan WM, Glenn GM   (2000) Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents.  Am J Hum Genet 66:84-91.|4. Zbar B   (2000) Inherited epithelial tumors of the kidney: old and new diseases.  Semin Cancer Biol 10:313-8.",https://intramural.nih.gov/search/searchview.taf?ipid=11012
115,BC008579-07,"October 01, 1999 -  September 30, 2000",Cloning tumor suppressor genes (TSG) from human chromosomes 3p and 8p,"Michael I Lerman; MD, PhD",NULL,"Laboratory of Immunobiology, NCI",Alla  Ivanova,NULL,Fuh-Mei  Duh  (Cancer Causing Genes Section)|Laura  Geil  (Cancer Causing Genes Section)|Sergey  Ivanov  (Cancer Causing Genes Section)|Berton K Zbar; PhD  (Cellular Immunity Section),NULL,"1. Angeloni D, Ivanov SV, Breathnach R, Johnson BE, Leonard EJ, Lerman MI   (2000) Gene structure of the human receptor tyrosine kinase RON and mutation analysis in lung cancer samples.  Genes Chromosomes Cancer 29:147-56.|2. Angeloni D, Wei MH, Duh FM, Johnson BE, Lerman MI   (2000) A G-to-A single nucleotide polymorphism in the human alpha 2 delta 2 calcium channel subunit gene that maps at chromosome 3p213.  Mol Cell Probes 14:53-4.|3. Cheng Y, Stanbridge EJ, Kong H, Bengtsson U, Lerman MI, Lung ML   (2000) A functional investigation of tumor suppressor gene activities in a nasopharyngeal carcinoma cell line HONE1 using a monochromosome transfer approach.  Genes Chromosomes Cancer 28:82-91.|4. Danilkovitch A, Angeloni D, Skeel A, Donley S, Lerman MI, Leonard E   (2000) Integrin-mediated RON growth factor receptor phosphorylation requires tyrosine kinase activity of both the receptor and c-Src.  J Biol Chem 275:14783-6.|5. Gao B, Sekido Y, Maximov A, Saad M, Forgacs E, Latif F, Wei MH, Lerman M, Lee JH, Perez-Reyes E, Bezprozvanny I, Minna JD   (2000) Functional properties of a new voltage-dependent calcium channel alpha(2)delta auxiliary subunit gene (CACNA2D2).  J Biol Chem 275:12237-42.|6. Lerman MI, Minna JD   (2000) The 630-kb lung cancer homozygous deletion region on human chromosome 3p213: identification and evaluation of the resident candidate tumor suppressor genes The International Lung Cancer Chromosome 3p213 Tumor Suppressor Gene Consortium.  Cancer Res 60:6116-33.|7. Matsuo K, Shintani S, Tsuji T, Nagata E, Lerman M, McBride J, Nakahara Y, Ohyama H, Todd R, Wong DT   (2000) p12(DOC-1), a growth suppressor, associates with DNA polymerase alpha/primase.  FASEB J 14:1318-24.|8. Pertsemlidis A, Pande A, Miller B, Schilling P, Wei MH, Lerman MI, Minna JD, Garner HR   (2000) PANORAMA: an integrated Web-based sequence analysis tool and its role in gene discovery.  Genomics 70:300-6.|9. Plisov SY, Ivanov SV, Yoshino K, Dove LF, Plisova TM, Higinbotham KG, Karavanova I, Lerman M, Perantoni AO   (2000) Mesenchymal-epithelial transition in the developing metanephric kidney: gene expression study by differential display.  Genesis 27:22-31.|10. Shintani S, Ohyama H, Zhang X, McBride J, Matsuo K, Tsuji T, Hu MG, Hu G, Kohno Y, Lerman M, Todd R, Wong DT   (2000) p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein.  Mol Cell Biol 20:6300-7.|11. Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L, Fondon JW, Garner HR, McKay B, Latif F, Lerman MI, Lam S, Gazdar AF, Minna JD   (2000) High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.  Cancer Res 60:1949-60.",https://intramural.nih.gov/search/searchview.taf?ipid=11013
116,BC008710-23,"October 01, 1999 -  September 30, 2000",Molecular Chaperones and DNA Replication,Sue H Wickner; PhD|IRP Faculty Profile,NULL,"DNA Molecular Biology Section, NCI",Joel R Hoskins,NULL,Soonyoung  Kim  (Molecular Biology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11010
117,BC008714-23,"October 01, 1999 -  September 30, 2000",Bacterial Functions Involved in Cell Growth Control,Susan  Gottesman; PhD|IRP Faculty Profile,NULL,"MOLECULAR CELL GENETICS SECT, NCI",NULL,NULL,Gabriella  Baliko; PhD  (Biochemical Genetics Section)|Nadim  Majdalani  (Biochemical Genetics Section)|Eric  Masse  (Biochemical Genetics Section)|Francis H Repoila  (Biochemical Genetics Section)|Yan Ning H Zhou  (Biochemical Genetics Section),NULL,"1. Booth CL, Pulaski L, Gottesman MM, Pastan I   (2000) Analysis of the properties of the N-terminal nucleotide-binding domain of human P-glycoprotein.  Biochemistry 39:5518-26.|2. Hafkemeyer P, Licht T, Pastan I, Gottesman MM   (2000) Chemoprotection of hematopoietic cells by a mutant P-glycoprotein resistant to a potent chemosensitizer of multidrug-resistant cancers.  Hum Gene Ther 11:555-65.|3. Lee CG, Ramachandra M, Jeang KT, Martin MA, Pastan I, Gottesman MM   (2000) Effect of ABC transporters on HIV-1 infection: inhibition of virus production by the MDR1 transporter.  FASEB J 14:516-522.|4. Licht T, Goldenberg SK, Vieira WD, Gottesman MM, Pastan I   (2000) Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in mice.  Gene Ther 7:348-58.",https://intramural.nih.gov/search/searchview.taf?ipid=11011
118,BC008727-22,"October 01, 1999 -  September 30, 2000",Structure and function of oncogenes and anti-oncogenes,J. Frederic Mushinski; MD,NULL,"Molecular Genetics Section, NCI",Kee-Oh  Chay|James D Owens|Walter A Schlapkohl|Lisa  Stevens,NULL,Ali M Saboori  (Laboratory of Genetics),NULL,"1. Dammeier S, Lovric J, Eulitz M, Kolch W, Mushinski JF, Mischak H   (2000) Identification of the smooth muscle-specific protein, sm22, as a novel protein kinase C substrate using two-dimensional gel electrophoresis and mass spectrometry.  Electrophoresis 21:2443-2453.|2. Kim JS, Pirnia F, Choi YH, Nguyen PM, Knepper B, Tsokos M, Schulte TW, Birrer MJ, Blagosklonny MV, Schaefer O, Mushinski JF, Trepel JB   (2000) Lovastatin induces apoptosis in a primitive neuroectodermal tumor cell line in association with RB down-regulation and loss of the G1 checkpoint.  Oncogene 19:6082-90.",https://intramural.nih.gov/search/searchview.taf?ipid=11009
119,BC008750-20,"October 01, 1999 -  September 30, 2000",Genetic Regulatory Mechanisms in Escherichia coli and its Bacteriophage,Susan  Garges; PhD,NULL,"Genetics Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11141
120,BC008751-20,"October 01, 1999 -  September 30, 2000",Regulation of Gene Transcription,Sankar  Adhya; PhD|IRP Faculty Profile,NULL,"Developmental Genetics Section, NCI",Mark  Geanacopoulos|Sudeshna  Kar|Dale  Lewis; PhD|Heon M Lim,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11007
121,BC008752-20,"October 01, 1999 -  September 30, 2000",Molecular Mechanisms of Thyroid Hormone Action,Sheueyann  Cheng; PhD|IRP Faculty Profile,NULL,"Gene Regulation Section, NCI",Yuji  Kamiya,NULL,Huei-Min  Lin  (Laboratory of Molecular Biology)|Yun  Park  (Laboratory of Molecular Biology),NULL,"1. Cheng S   (2000) Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors, in Reviews in Endrocrine and Metabolic Disorders. LeRoith D, ed., Kluwer Academic Publishers (Boston, MA), pp. 9-18.|2. Kaneshige M, Kaneshige K, Zhu Xg, Dace A, Garrett L, Carter TA, Kazlauskaite R, Pankratz DG, Wynshaw-Boris A, Refetoff S, Weintraub B, Willingham MC, Barlow C, Cheng Sy   (2000) Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone.  Proc Natl Acad Sci U S A 97:13209-14.|3. Puzianowska-Kuznicka M, Nauman A, Madej A, Tanski Z, Cheng S, Nauman J   (2000) Expression of thyroid hormone receptors is disturbed in human renal clear cell carcinoma.  Cancer Lett 155:145-52.",https://intramural.nih.gov/search/searchview.taf?ipid=11004
122,BC008753-18,"October 01, 1999 -  September 30, 2000",Immunotoxin Therapy of Solid and Hematopoietic Tumors:  Preclinical Studies,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Richard A Beers|Tapan K Bera|Verity L Fogg|Maria G Gallo|Juanita A Williams,NULL,Satoshi  Nagata; PhD  (Laboratory of Molecular Biology)|Masanori  Onda  (Laboratory of Molecular Biology)|Kenneth  Santora  (Laboratory of Molecular Biology)|Yasuo  Tsutsumi  (Laboratory of Molecular Biology)|James J Vincent  (Molecular Modeling Section)|Qing cheng F Wang  (Clinical Immunotherapy Section),NULL,"1. Pastan IH, Beers RH, Bigner DH, Chowdhury PH (submitted in 2000) Anti-egfrviii Scfvs With Improved Cytotoxicity And Yield, Immunotoxins Based Thereon, And Methods Of Use Thereof. Patent issued: 2,400,868 (CA in 2013). Patents pending: 106998 (BG application); PI0108646-4 (BR application); 01807175.9 (CN application); 2002-2796 (CZ application); 01914471.6 (DE application); 01914471.6 (EP application); 01914471.6 (FR application); 01914471.6 (GB application); 2001239857 (AU application); BAP021207A (BA application); 03105948.9 (HK application); P20020769A (cr application); P0204142 (HU application); 2001-562705 (JP application); 2002-7011187 (KR application); PA/A/2002/008178 (MX application); 2002 4034 (NO application); 520622 (NZ application); P357448 (PL application); 2002125514 (RU application); 1223-2002 (SK application); 2002086976M (UA application); 10/203,675 (US application); P-633/02 (YU application).",https://intramural.nih.gov/search/searchview.taf?ipid=11003
123,BC008754-17,"October 01, 1999 -  September 30, 2000",Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells (Ira Pasta,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",NULL,NULL,Catherine L Booth  (National Cancer Institute)|Carol O Cardarelli  (Multidrug Resistence Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11001
124,BC008756-13,"October 01, 1999 -  September 30, 2000",Genetically Engineered Mice as Models to Study Receptor Tyrosine Kinase Function,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Molecular Genetics Section, NCI",Chamelli  Jhappan; PhD|Shiquan  Liu|Richard D Sharp|Yanlin  Yu,NULL,NULL,NULL,"1. Jhappan C, Yusufzai TM, Anderson S, Anver MR, Merlino G   (2000) The p53 response to DNA damage in vivo is independent of DNA-dependent protein kinase.  Mol Cell Biol 20:4075-83.|2. Otsuka T, Jakubczak J, Vieira W, Bottaro DP, Breckenridge D, Larochelle WJ, Merlino G   (2000) Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis.  Mol Cell Biol 20:2055-65.",https://intramural.nih.gov/search/searchview.taf?ipid=11002
125,BC008757-13,"October 01, 1999 -  September 30, 2000",Bio-Therapies for the Treatment of Cancer and Infectious Disease,David J Fitzgerald; PhD|IRP Faculty Profile,NULL,"Biotherapy Section, NCI",Marc  Gwadz|Ralf  Hertle|Marian  Mckee|Maria L Virata,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10999
126,BC008758-09,"October 01, 1999 -  September 30, 2000",Transcription Machinery and Its Mechanism in Escherichia coli,Ding Jun Jin,NULL,"Developmental Genetics Section, NCI",Norman  Yeh|Huijun  Zhi,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=11000
127,BC008759-09,"October 01, 1999 -  September 30, 2000",Molecular Modeling and Bioinformatics,Byungkook  Lee; PhD|IRP Faculty Profile,NULL,"Molecular Modeling Section, NCI",Bartlett  Ailey|Bangalore K Sathyanarayana|Shrish  Tiwari|James J Vincent,NULL,Jong-Sun  Jung  (Laboratory of Molecular Biology)|Jae-Min  Shin  (National Cancer Institute),NULL,"1. Jung J, Lee B   (2000) Protein structure alignment using environmental profiles.  Protein Eng 13:535-43.|2. Jung J, Lee B   (2000) Use of residue pairs in protein sequence-sequence and sequence-structure alignments.  Protein Sci 9:1576-88.|3. Liu XF, Helman LJ, Yeung C, Bera TK, Lee B, Pastan I   (2000) XAGE-1, a new gene that is frequently expressed in Ewing's sarcoma.  Cancer Res 60:4752-5.|4. Tsutsumi Y, Onda M, Nagata S, Lee B, Kreitman RJ, Pastan I   (2000) Site-specific chemical modification with polyethylene glycol of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) improves antitumor activity and reduces animal toxicity and immunogenicity.  Proc Natl Acad Sci U S A 97:8548-53.|5. Wolfgang CD, Essand M, Vincent JJ, Lee B, Pastan I   (2000) TARP: a nuclear protein expressed in prostate and breast cancer cells derived from an alternate reading frame of the T cell receptor gamma chain locus.  Proc Natl Acad Sci U S A 97:9437-42.",https://intramural.nih.gov/search/searchview.taf?ipid=10996
128,BC008905-19,"October 01, 1999 -  September 30, 2000",Tumor gene expression in vitro and in vivo,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI","Xiaolan  Qian; MD, PhD",NULL,Alan  Sheppard  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10998
129,BC008950-18,"October 01, 1999 -  September 30, 2000",Molecular and biological basis of immune recognition,"Sandra  Smith-Gill; MS, PhD, BS",NULL,"Basic Research Laboratory, NCI",Claudia A Lipschultz|Neeti  Sinha,NULL,NULL,NULL,"1. Li Y, Li H, Smith-Gill SJ, Mariuzza RA   (2000) Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).  Biochemistry 39:6296-309.|2. Lipschultz CA, Li Y, Smith-Gill S   (2000) Experimental design for analysis of complex kinetics using surface plasmon resonance.  Methods 20:310-8.",https://intramural.nih.gov/search/searchview.taf?ipid=10995
130,BC008952-14,"October 01, 1999 -  September 30, 2000",Oncogenes in murine acute myeloid leukemia,Linda  Wolff; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Richard P Koller,NULL,Peter  Haviernik  (National Cancer Institute)|Wei  Liao  (National Cancer Institute)|Martina  Schmidt  (National Cancer Institute),Michael K Schmidt; PhD (NHLBI),"1. Bies J, Feikova S, Bottaro DP, Wolff L   (2000) Hyperphosphorylation and increased proteolytic breakdown of c-Myb induced by the inhibition of Ser/Thr protein phosphatases.  Oncogene 19:2846-54.|2. Feikova S, Wolff L, Bies J   (2000) Constitutive ubiquitination and degradation of c-myb by the 26S proteasome during proliferation and differentiation of myeloid cells.  Neoplasma 47:212-8.|3. Schmidt M, Nazarov V, Stevens L, Watson R, Wolff L   (2000) Regulation of the resident chromosomal copy of c-myc by c-Myb is involved in myeloid leukemogenesis.  Mol Cell Biol 20:1970-81.",https://intramural.nih.gov/search/searchview.taf?ipid=10944
131,BC009003-18,"October 01, 1999 -  September 30, 2000",The Role of Cripto in the Pathogenesis of Breast and Colon Cancer,David  Salomon; PhD,NULL,"TUMOR GROWTH FACTOR SECT, NCI",Caterina  Bianco; MD|Brenda W Jones|Nadia Iqbal Khan|Youping  Sun,NULL,NULL,NULL,"1. Casamassimi A, De Luca A, Agrawal S, Stromberg K, Salomon DS, Normanno N   (2000) EGF-related antisense oligonucleotides inhibit the proliferation of human ovarian carcinoma cells.  Ann Oncol 11:319-25.|2. De Luca A, Arra C, D'Antonio A, Casamassimi A, Losito S, Ferraro P, Ciardiello F, Salomon DS, Normanno N   (2000) Simultaneous blockage of different EGF-like growth factors results in efficient growth inhibition of human colon carcinoma xenografts.  Oncogene 19:5863-71.|3. De Santis ML, Martinez-Lacaci I, Bianco C, Seno M, Wallace-Jones B, Kim N, Ebert A, Wechselberger C, Salomon DS   (2000) Cripto-1 induces apoptosis in HC-11 mouse mammary epithelial cells.  Cell Death Differ 7:189-96.|4. Ebert AD, Wechselberger C, Martinez-Lacaci I, Bianco C, Weitzel HK, Salomon DS   (2000) Expression and function of EGF-related peptides and their receptors in gynecological cancer--from basic science to therapy.  J Recept Signal Transduct Res 20:1-46.|5. Ebert AD, Wechselberger C, Nees M, Clair T, Schaller G, Martinez-Lacaci I, Wallace-Jones B, Bianco C, Weitzel HK, Salomon DS   (2000) Cripto-1-induced increase in vimentin expression is associated with enhanced migration of human Caski cervical carcinoma cells.  Exp Cell Res 257:223-9.|6. Martinez-Lacaci I, Kannan S, De Santis M C, Bianco N, Kim B, Wallace-Jones AD, Ebert C, Wechselberger DS, Salomon D   (2000) RAS transformation causes sustained activation of epidermal growth factor receptor and elevation of mitogen-activated protein kinase in human mammary epithelial cells.  Int J Cancer 88:44-52.|7. Salomon DS   (2000) Cell-cell and cell-extracellular matrix adhesion molecules communicate with growth factor receptors: an interactive signaling Web.  Cancer Invest 18:591-3.|8. Bianco C, Salomon D (submitted in 2000) Detection And Quantification Of Cripto-1. Patent issued: 2,434,694 (CA in 2012). Patents pending: 02703238.2 (CH application); 02703238.2 (DE application); 02703238.2 (EP application); 02703238.2 (ES application); 02703238.2 (FR application); 02703238.2 (GB application); 02703238.2 (IE application); 02703238.2 (IT application); 559686/2002 (JP application); PCT/US02/02225 (PC application); 60/264,643 (US application); 10/470,322 (US application); 2002236871 (AU application).",https://intramural.nih.gov/search/searchview.taf?ipid=10945
132,BC009029-08,"October 01, 1999 -  September 30, 2000",Host Immune Responses to Tumor-Specific Antigens Induced by Peptide Vaccines,Scott  Abrams; PhD,NULL,"Experimental Oncology Section, NCI",Elwood W Mcduffie,NULL,Elke S Bergmann  (Laboratory of Tumor Immunology and Biology),NULL,"1. Schlom J, Abrams S   (2000) Tumor Immunology, in Cancer Medicine. Bast RC, Kufe DW, Pollack RE, Holland JF, Frei E, eds., B.C. Decker, Inc. (Hamilton, Ontario, Canada), pp. 153-167.|2. Abrams SI, Schlom J   (2000) Rational antigen modification as a strategy to upregulate or downregulate antigen recognition.  Curr Opin Immunol 12:85-91.|3. Bergmann-Leitner ES, Abrams SI   (2000) Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTL.  J Immunol 164:4941-54.|4. Bergmann-Leitner ES, Abrams SI   (2000) Influence of interferon gamma on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8+ cytotoxic T lymphocyte attack.  Cancer Immunol Immunother 49:193-207.|5. Bristol JA, Orsini C, Lindinger P, Thalhamer J, Abrams SI   (2000) Identification of a ras Oncogene Peptide That Contains Both CD4(+) and CD8(+) T Cell Epitopes in a Nested Configuration and Elicits Both T Cell Subset Responses by Peptide or DNA Immunization.  Cell Immunol 205:73-83.",https://intramural.nih.gov/search/searchview.taf?ipid=13840
133,BC009052-11,"October 01, 1999 -  September 30, 2000",Papillomavirus Virion Proteins and Vaccines,John  Schiller; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Patricia  Day; PhD|Joseph I Lee; MD|Yuk Ying S Pang|Cynthia D Thompson,NULL,F  Lenz  (National Cancer Institute)|Diana  Pastrana  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10938
134,BC009053-06,"October 01, 1999 -  September 30, 2000",Molecular analysis of growth regulation,Jeffrey  DeClue; PhD,NULL,"Laboratory of Cellular Oncology, NCI",Richard B Braverman,NULL,"Hongzhen  Li; MD, PhD  (National Cancer Institute)|Shaowei  Li  (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10939
135,BC009100-15,"October 01, 1999 -  September 30, 2000",Melanoma and Melanogenesis,Vincent J. Hearing; PhD,NULL,"Pigment Cell Biology Section, NCI",Tie Chi Lei|Kazutomo  Toyofuku,NULL,Wilfred D Vieira  (Multidrug Resistence Section),NULL,"1. Abdel-Malek Z, Scott MC, Suzuki I, Tada A, Im S, Lamoreux L, Ito S, Barsh G, Hearing VJ   (2000) The melanocortin-1 receptor is a key regulator of human cutaneous pigmentation.  Pigment Cell Res 13 Suppl 8:156-62.|2. Hearing VJ   (2000) The melanosome: the perfect model for cellular responses to the environment.  Pigment Cell Res 13 Suppl 8:23-34.|3. Matsunaga N, Virador V, Santis C, Vieira WD, Furumura M, Matsunaga J, Kobayashi N, Hearing VJ   (2000) In situ localization of agouti signal protein in murine skin using immunohistochemistry with an ASP-specific antibody.  Biochem Biophys Res Commun 270:176-82.|4. Virador VM, Santis C, Furumura M, Kalbacher H, Hearing VJ   (2000) Bioactive motifs of agouti signal protein.  Exp Cell Res 259:54-63.",https://intramural.nih.gov/search/searchview.taf?ipid=10891
136,BC009101-08,"October 01, 1999 -  September 30, 2000",Design of Antiviral Drugs Effective Against the HIV-1 Virus,Ettore  Appella; MD|IRP Faculty Profile,NULL,"Chemical Immunology Section, NCI",Atul  Goel; PhD|Yong Sheng  Song,NULL,NULL,NULL,"1. Basrur V, Song Y, Mazur SJ, Higashimoto Y, Turpin JA, Rice WG, Inman JK, Appella E   (2000) Inactivation of HIV-1 nucleocapsid protein P7 by pyridinioalkanoyl thioesters Characterization of reaction products and proposed mechanism of action.  J Biol Chem 275:14890-7.|2. Inman JK, Appella EK, Goel AK, Schito MK, Turpin JK (submitted in 2000) Acylthiols And Compositions Thereof As Anti-hiv And Anti-retroviral Agents. Patents issued: 2456083 (CA in 2012); 8,076,372 (US in 2012); 1425262 (EP in 2014). Patents pending: 60/310,133 (US application); 2002322721 (AU application); 10/485,165 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=10937
137,BC009247-20,"October 01, 1999 -  September 30, 2000",Natural Cell-Mediated Immunity Mechanism of Lysis,John R Ortaldo; PhD,NULL,"Laboratory of Experimental Immunology, NCI",NULL,NULL,Earl W Bere  (Cellular and Molecular Immunology Section)|Anna T Mason  (Leukocyte Cell Biology Section)|Llewellyn H Mason  (Leukocyte Cell Biology Section)|Jami D Willette brown  (Leukocyte Cell Biology Section)|John W Wine  (Experimental Therapeutics Section)|Robin T Winkler Pickett  (Leukocyte Cell Biology Section),NULL,"1. Bosco MC, Curiel RE, Zea AH, Malabarba MG, Ortaldo JR, Espinoza-Delgado I   (2000) IL-2 signaling in human monocytes involves the phosphorylation and activation of p59hck.  J Immunol 164:4575-85.|2. Makrigiannis AP, Etzler J, Winkler-Pickett R, Mason A, Ortaldo JR, Anderson SK   (2000) Identification of the Ly49L protein: evidence for activating counterparts to inhibitory Ly49 proteins.  J Leukoc Biol 68:765-71.|3. Mason LH, Willette-Brown J, Mason AT, McVicar D, Ortaldo JR   (2000) Interaction of Ly-49D+ NK cells with H-2Dd target cells leads to Dap-12 phosphorylation and IFN-gamma secretion.  J Immunol 164:603-11.|4. Ortaldo JR, Winkler-Pickett R, Wiegand G   (2000) Activating Ly-49D NK receptors: expression and function in relation to ontogeny and Ly-49 inhibitor receptors.  J Leukoc Biol 68:748-56.|5. Peacock CD, Lin MY, Ortaldo JR, Welsh RM   (2000) The virus-specific and allospecific cytotoxic T-lymphocyte response to lymphocytic choriomeningitis virus is modified in a subpopulation of CD8(+) T cells coexpressing the inhibitory major histocompatibility complex class I receptor Ly49G2.  J Virol 74:7032-8.|6. Raziuddin A, Bennett M, Winkler-Pickett R, Ortaldo JR, Longo DL, Murphy WJ   (2000) Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts.  Blood 95:3840-4.|7. Toimasello E, Desmoulins P, Chemin K, Guia S, Cremer H, Ortaldo J, Love P, Kaiserlian D, Vivier E   (2000) Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice.  J Leukoc Biol 68:748-756.",https://intramural.nih.gov/search/searchview.taf?ipid=10889
138,BC009251-30,"October 01, 1999 -  September 30, 2000",Target Cell Death by Cytotoxic Lymphocytes,Pierre A. Henkart; PhD,NULL,"Lymphocyte Cytotoxicity Section, NCI",Marta Liliana Catalfamo; PhD|Balaji  Kithiganahalli,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10890
139,BC009254-26,"October 01, 1999 -  September 30, 2000",Innate Immunity,David M Segal; PhD,NULL,"Immune Targeting Section, NCI",Alessandra  Mazzoni|Jessica H Spitzer,NULL,Alberto  Visintin  (Transplantation Immunology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10887
140,BC009255-26,"October 01, 1999 -  September 30, 2000",Application of Flow Cytometry to Cell Biology,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Anthony J Adams|Lawrence G Granger,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10888
141,BC009256-18,"October 01, 1999 -  September 30, 2000",Natural Cell-Mediated Immunity: Biology and Regulation of CD3- LGL,John R Ortaldo; PhD,NULL,"Laboratory of Experimental Immunology, NCI",NULL,NULL,Earl W Bere  (Cellular and Molecular Immunology Section)|Issac  Blanca-Pereira  (Leukocyte Cell Biology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10884
142,BC009257-25,"October 01, 1999 -  September 30, 2000",Mechanisms of Cellular Immune Responses,James Stephen Shaw; PhD|IRP Faculty Profile,NULL,"Human Immunology Section, NCI",Martin  Brown; PhD|Caroline E Graham|John A Hallam|Yin  Liu|Kakali  Sarkar; PhD,NULL,Koichi  Fujii  (Lymphocyte Development Section),J  Gretz (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10883
143,BC009263-18,"October 01, 1999 -  September 30, 2000",Apoptotic Death in T Lymphocytes,Pierre A. Henkart; PhD,NULL,"Lymphocyte Cytotoxicity Section, NCI",Kirsi  Allison,NULL,NULL,NULL,"1. Pinto LA, Williams MS, Dolan MJ, Henkart PA, Shearer GM   (2000) Beta-chemokines inhibit activation-induced death of lymphocytes from HIV-infected individuals.  Eur J Immunol 30:2048-55.",https://intramural.nih.gov/search/searchview.taf?ipid=10882
144,BC009264-17,"October 01, 1999 -  September 30, 2000",Cytokine Regulation of Normal and Neoplastic Hematopoietic Cell Growth,Francis W Ruscetti; PhD,NULL,"Laboratory of Leukocyte Biology, NCI",Daniel C Bertolette|Maria  Birchenall-Roberts|Tao  Fu|Yi  Huang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10879
145,BC009265-18,"October 01, 1999 -  September 30, 2000",Analysis of the T Cell Repertoire,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Immune Regulation Section, NCI",Melanie S Vacchio; PhD,NULL,Joy A Williams  (Transplantation Immunology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10880
146,BC009266-18,"October 01, 1999 -  September 30, 2000",T Cell Regulation of B Cell Activation,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Immune Regulation Section, NCI",NULL,NULL,Lisa K Petiniot  (National Cancer Institute),Xiang  Yu; PhD (NEI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10877
147,BC009267-18,"October 01, 1999 -  September 30, 2000",Immune Dysregulation in HIV/AIDS,Gene  Shearer; PhD|IRP Faculty Profile,NULL,"Cell Mediated Immunity Section, NCI",NULL,NULL,NULL,NULL,"1. Chougnet C, Kovacs A, Baker R, Mueller BU, Luban NL, Liewehr DJ, Steinberg SM, Thomas EK, Shearer GM   (2000) Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production.  J Infect Dis 181:1590-7.|2. Fowke KR, Kaul R, Rosenthal KL, Oyugi J, Kimani J, Rutherford WJ, Nagelkerke NJ, Ball TB, Bwayo JJ, Simonsen JN, Shearer GM, Plummer FA   (2000) HIV-1-specific cellular immune responses among HIV-1-resistant sex workers.  Immunol Cell Biol 78:586-95.|3. Margolis L, Glushakova S, Chougnet C, Shearer G, Markham P, Robert-Guroff M, Benveniste R, Miller CJ, Cranage M, Hirsch V, Franchini G   (2000) Replication of simian immunodeficiency virus (SIV) in ex vivo lymph nodes as a means to assess susceptibility of macaques in vivo.  Virology 275:391-397.|4. Olivero OA, Shearer GM, Chougnet CA, Kovacs AA, Baker R, Stek AM, Khoury MM, Poirier MC   (2000) Incorporation of zidovudine into cord blood DNA of infants and peripheral blood DNA of their HIV-1-positive mothers.  Ann N Y Acad Sci 918:262-8.|5. Tschetter JR, Mozes E, Shearer GM   (2000) Progression from acute to chronic disease in a murine parent-into-F(1) model of graft-versus-host disease.  J Immunol 165:5987-94.",https://intramural.nih.gov/search/searchview.taf?ipid=10878
148,BC009273-13,"October 01, 1999 -  September 30, 2000",T Cell Differentiation and Repertoire Selection,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,"Avinash  Bhandoola; MD, PhD  (Lymphocyte Development Section)|Remy J Bosselut; MD, PhD  (Laboratory of Immune Cell Biology)|Xuguang C Tai  (Lymphocyte Development Section)|Qing  Yu; MD, PhD  (Lymphocyte Development Section)",NULL,"1. Bhandoola A, Dolnick B, Fayad N, Nussenzweig A, Singer A   (2000) Immature thymocytes undergoing receptor rearrangements are resistant to an atm-dependent death pathway activated in mature T cells by double-stranded DNA breaks.  J Exp Med 192:891-8.|2. Bhandoola A, Kithiganahalli B, Granger L, Singer A   (2000) Programming for cytotoxic effector function occurs concomitantly with CD4 extinction during CD8(+) T cell differentiation in the thymus.  Int Immunol 12:1035-40.|3. Bosselut R, Kubo S, Guinter T, Kopacz JL, Altman JD, Feigenbaum L, Singer A   (2000) Role of CD8beta domains in CD8 coreceptor function: importance for MHC I binding, signaling, and positive selection of CD8+ T cells in the thymus.  Immunity 12:409-18.|4. Brugnera E, Bhandoola A, Cibotti R, Yu Q, Guinter TI, Yamashita Y, Sharrow SO, Singer A   (2000) Coreceptor reversal in the thymus: signaled CD4+8+ thymocytes initially terminate CD8 transcription even when differentiating into CD8+ T cells.  Immunity 13:59-71.|5. Cibotti R, Bhandoola A, Guinter TI, Sharrow SO, Singer A   (2000) CD8 coreceptor extinction in signaled CD4(+)CD8(+) thymocytes: coordinate roles for both transcriptional and posttranscriptional regulatory mechanisms in developing thymocytes.  Mol Cell Biol 20:3852-9.",https://intramural.nih.gov/search/searchview.taf?ipid=10875
149,BC009279-15,"October 01, 1999 -  September 30, 2000",Regulation of Expression of MHC Class I Genes,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Molecular Regulation Section, NCI",Aparna  Raval,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10876
150,BC009281-14,"October 01, 1999 -  September 30, 2000",Receptor Mediated T and B Cell Activation,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Immune Regulation Section, NCI",NULL,NULL,NULL,Xiang  Yu; PhD (NEI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10872
151,BC009282-14,"October 01, 1999 -  September 30, 2000",Immune Dysregulation in Autoimmune Disease,Gene  Shearer; PhD|IRP Faculty Profile,NULL,"Cell Mediated Immunity Section, NCI",Susan M Payne,NULL,NULL,NULL,"1. Dayan M, Segal R, Globerson A, Habut B, Shearer GM, Mozes E   (2000) Effect of aging on cytokine production in normal and experimental systemic lupus erythematosus-afflicted mice.  Exp Gerontol 35:225-36.|2. Zhu J, Quyyumi AA, Norman JE, Csako G, Waclawiw MA, Shearer GM, Epstein SE   (2000) Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels.  Am J Cardiol 85:140-6.|3. Zhu J, Shearer GM, Norman JE, Pinto LA, Marincola FM, Prasad A, Waclawiw MA, Csako G, Quyyumi AA, Epstein SE   (2000) Host response to cytomegalovirus infection as a determinant of susceptibility to coronary artery disease: sex-based differences in inflammation and type of immune response.  Circulation 102:2491-6.",https://intramural.nih.gov/search/searchview.taf?ipid=10873
152,BC009283-16,"October 01, 1999 -  September 30, 2000",Control of Cytokine Gene Expression in Lymphoid/Myeloid Cells,Howard A Young; PhD|IRP Faculty Profile,NULL,"Cellular and Molecular Immunology Section, NCI",Jay  Bream; PhD|Della A Reynolds|Osamu  Shimozato; PhD|Xia  Zhang; PhD,NULL,NULL,NULL,"1. Bream JH, Carrington M, O'Toole S, Dean M, Gerrard B, Shin HD, Kosack D, Modi W, Young HA, Smith MW   (2000) Polymorphisms of the human IFNG gene noncoding regions.  Immunogenetics 51:50-8.|2. Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA   (2000) Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation.  J Immunol 164:3596-9.",https://intramural.nih.gov/search/searchview.taf?ipid=10874
153,BC009285-14,"October 01, 1999 -  September 30, 2000",Responses of MHC Class I Genes to Exogeneous Stimuli,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Molecular Regulation Section, NCI",Aparna  Raval,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10870
154,BC009287-16,"October 01, 1999 -  September 30, 2000",Cytokines and T Cell Development,Scott K Durum; PhD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Amr  Khaled|Annette R Khaled,NULL,NULL,NULL,"1. Benbernou N, Muegge K, Durum SK   (2000) Interleukin (IL) 7 induces rapid activation of Pyk2 which is bound to Jak 1 and IL-7alpha.  J Biol Chem 275:7060-7065.|2. Nathan I, Dizdaroglu M, Bernstein L, Junker U, Lee CK, Muegge K, Durum SK   (2000) Induction of oxidative DNA damage in u937 cells by TNF or anti-Fas stimulation.  Cytokine 12:881-7.|3. Schlissel M, Durum SK, Muegge K   (2000) The interleukin 7 receptor is required for T cell receptor gamma locus accessibility to the V(D)J recombinase.  J Exp Med 191:1045-450.",https://intramural.nih.gov/search/searchview.taf?ipid=10871
155,BC009290-15,"October 01, 1999 -  September 30, 2000",T Cell Activation and Apoptosis,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Xiaoming  Li|Paul  Mittelstadt; PhD|Jodene K Moore|Yili D Yang,NULL,NULL,NULL,"1. Ashwell JD, Vacchio MS, Galon J   (2000) Do glucocorticoids participate in thymocyte development?  Immunol Today 21:644-6.|2. Lu FW, Yasutomo K, Goodman GB, McHeyzer-Williams LJ, McHeyzer-Williams MG, Germain RN, Ashwell JD   (2000) Thymocyte resistance to glucocorticoids leads to antigen-specific unresponsiveness due to holes in the T cell repertoire.  Immunity 12:183-92.|3. Rengarajan J, Mittelstadt PR, Mages HW, Gerth AJ, Kroczek RA, Ashwell JD, Glimcher LH   (2000) Sequential involvement of NFAT and Egr transcription factors in FasL regulation.  Immunity 12:293-300.|4. Vacchio MS, Ashwell JD   (2000) Glucocorticoids and thymocyte development.  Semin Immunol 12:475-85.|5. Yang Y, Fang S, Jensen JP, Weissman AM, Ashwell JD   (2000) Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli.  Science 288:874-7.|6. Yang Y, Jensen J, Weissman A (submitted in 2005) Inhibitors Of Ubiquitin E1. Patent issued: 8,242,160 (US in 2012). Patents pending: 13/547,417 (US application); PCT/US2006/045032 (PC application); 12/154,156 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=10868
156,BC009297-09,"October 01, 1999 -  September 30, 2000",Screening for genes essential for development of the mouse embryo,Michael Robert Kuehn; PhD,NULL,"Experimental Immunology Branch, NCI",Rodolfo  Murillas,NULL,NULL,NULL,"1. Lowe LA, Kuehn MR   (2000) Whole mount in situ hybridization to study gene expression during mouse development.  Methods Mol Biol 137:125-37.",https://intramural.nih.gov/search/searchview.taf?ipid=10869
157,BC009304-06,"October 01, 1999 -  September 30, 2000",Structural Studies and 3D Structure Determination of Recombinant,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,Boopathy  Ramakrishna  (Structural Glycobiology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10867
158,BC009349-12,"October 01, 1999 -  September 30, 2000",Cloning and Characterization of Protein Tyrosine Kinases Involved in Leukocyte A,Daniel  McVicar; PhD|IRP Faculty Profile,NULL,"Leukocyte Cell Biology Section, NCI",Lynn S Taylor,NULL,NULL,NULL,"1. Taylor LS, Paul SP, McVicar DW   (2000) Paired inhibitory and activating receptor signals.  Rev Immunogenet 2:204-19.",https://intramural.nih.gov/search/searchview.taf?ipid=10866
159,BC009369-10,"October 01, 1999 -  September 30, 2000",Consequences of Chemokine-Receptor Interactions: Immune Activation and Angiogene,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Xin  Chen|Ruth  Neta|Rosalba  Salcedo|De  Yang,NULL,Venugopal  Gangur  (National Cancer Institute),Aiko  Shirakawa; PhD (NIAID) |Ken  Wasserman (NIAID),"1. Chen X, Yang D, Shen W, Dong HF, Wang JM, Oppenheim JJ, Howard MZ   (2000) Characterization of chenodeoxycholic acid as an endogenous antagonist of the G-coupled formyl peptide receptors.  Inflamm Res 49:744-55.|2. Chertov O, Yang D, Howard OM, Oppenheim JJ   (2000) Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses.  Immunol Rev 177:68-78.|3. De Yang Q, Chen AP, Schmidt GM, Anderson JM, Wang J, Wooters JJ, Oppenheim O, Chertov    (2000) LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.  J Exp Med 192:1069-74.|4. Gangur V, Oppenheim JJ   (2000) Are chemokines essential or secondary participants in allergic responses?  Ann Allergy Asthma Immunol 84:569-79; quiz 579-81.|5. Hoover DM, Rajashankar KR, Blumenthal R, Puri A, Oppenheim JJ, Chertov O, Lubkowski J   (2000) The structure of human beta-defensin-2 shows evidence of higher order oligomerization.  J Biol Chem 275:32911-8.|6. Howard OM, Dong HF, Shirakawa AK, Oppenheim JJ   (2000) LEC induces chemotaxis and adhesion by interacting with CCR1 and CCR8.  Blood 96:840-5.|7. Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, Oppenheim JJ, Murphy WJ   (2000) Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.  Blood 96:34-40.|8. Salcedo R, Resau JH, Halverson D, Hudson EA, Dambach M, Powell D, Wasserman K, Oppenheim JJ   (2000) Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells.  FASEB J 14:2055-64.|9. Tani K, Murphy WJ, Chertov O, Salcedo R, Koh CY, Utsunomiya I, Funakoshi S, Asai O, Herrmann SH, Wang JM, Kwak LW, Oppenheim JJ   (2000) Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens.  Int Immunol 12:691-700.|10. Yang D, Chen Q, Chertov O, Oppenheim JJ   (2000) Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells.  J Leukoc Biol 68:9-14.|11. Yang D, Chen Q, Stoll S, Chen X, Howard OM, Oppenheim JJ   (2000) Differential regulation of responsiveness to fMLP and C5a upon dendritic cell maturation: correlation with receptor expression.  J Immunol 165:2694-702.",https://intramural.nih.gov/search/searchview.taf?ipid=10858
160,BC009371-09,"October 01, 1999 -  September 30, 2000",Mice with deficiences in the TNF/LT locus generated with Cre-loxP technology,"Sergei A. Nedospasov; PhD, DSc",NULL,"Laboratory of Molecular Immunoregulation, NCI",Koichiro  Abe,NULL,NULL,NULL,"1. Eskdale J, Turestkaya RL, Armstrong C, Kuprash DV, Nedospasov SA, Gallagher GA   (2000) A polymorphic microsatellite marker in the human p55 TNF receptor, CD120a.  Genes Immun 1:228-230.|2. Shakhov AN, Lyakhov IG, Tumanov AV, Rubstov AV, Drutskaya LN, Marino MJ, Nedospasov SA   (2000) Gene profiling approach in the analysis of lymphotoxin and TNF deficiencies.  J Leukoc Biol 68:151-157.|3. Shakhov AN, Rubtsov AV, Tumanov AV, Lyakhov IG, Nedospasov SA   (2000) SPLASH, a novel member of phospholipase A2, family is associated with lymphotoxin deficiency.  Genes Immun 1:191-199.",https://intramural.nih.gov/search/searchview.taf?ipid=10855
161,BC009392-08,"October 01, 1999 -  September 30, 2000",Determining the Fate of Transmembrane Proteins,Allan M Weissman; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Kevin L Lorick; PhD|Alessandra  Magnifico|Swati  Tiwari; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10856
162,BC009400-08,"October 01, 1999 -  September 30, 2000",Role of MHC Class I in the Generation of Autoimmune Diseases,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Molecular Regulation Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10857
163,BC009401-08,"October 01, 1999 -  September 30, 2000",HIV Tat-Mediated Repression of MHC Class I Gene Expression,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Molecular Regulation Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10852
164,BC009402-08,"October 01, 1999 -  September 30, 2000",Immune Dysregulation in Cancer,Gene  Shearer; PhD|IRP Faculty Profile,NULL,"Cell Mediated Immunity Section, NCI",Jian-ping  Zou,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10853
165,BC009404-06,"October 01, 1999 -  September 30, 2000",Protein Trafficking in Lymphocytes,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Elizabeth W Hiltbold|Niti  Puri,NULL,NULL,NULL,"1. Anderson HA, Hiltbold EM, Roche PA (2000) Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat Immunol 1:156-62|2. Vaidyanathan VV, Roche PA   (2000) Structure and chromosomal localization of the mouse SNAP-23 gene.  Gene 247:181-9.",https://intramural.nih.gov/search/searchview.taf?ipid=10854
166,BC009405-06,"October 01, 1999 -  September 30, 2000",Regulation of Lymphocyte Proliferation and Replicative Capacity,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Immune Regulation Section, NCI",NULL,NULL,Lisa K Petiniot  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10851
167,BC010001-05,"October 01, 1999 -  September 30, 2000",Molecular/Cellular Regulation of Hematopoiesis - Gene Therapy Applications,Jonathan  Keller; PhD,NULL,"Laboratory of Molecular Immunoregulation, NCI",NULL,NULL,NULL,Jeffrey C Smith; PhD (NINDS),"1. Keller J, Linnekin D   (2000) Stem Cell Factor, in The Cytokine Reference: A Compendium of Cytokines and Other Mediators of Host Defense. Oppenheim JJ, Feldmann M, Durum SK, Hirano T, Vilcek J, Nicola N, eds., Academic Press (London, England), pp. 877-897.|2. Linnekin D, Keller J   (2000) The stem cell factor receptor, in The Cytokine Reference: A Compendium of Cytokines and other Mediators of Host Defense. Oppenheim JJ, Feldmann M, Durum SK, Hirano T, Vilcek J, Nicola N, eds., Academic Press (London, England), pp. 1913-1934.|3. Du Y, Tsai S, Keller JR, Williams SC   (2000) Identification of an interleukin-3-regulated aldoketo reductase gene in myeloid cells which may function in autocrine regulation of myelopoiesis.  J Biol Chem 275:6724-32.|4. Welniak LA, Tian ZG, Sun R, Keller JR, Richards S, Ruscetti FW, Murphy WJ   (2000) Effects of growth hormone and prolactin on hematopoiesis.  Leuk Lymphoma 38:435-45.",https://intramural.nih.gov/search/searchview.taf?ipid=10846
168,BC010002-05,"October 01, 1999 -  September 30, 2000",Immunobiology of Bone Marrow Transplantation,William J. Murphy,NULL,"Genetics Section, NCI",NULL,NULL,Julie  Hixon  (Laboratory of Leukocyte Biology)|Crystal Y Koh  (Laboratory of Molecular Immunoregulation)|Arati  Raziuddin  (Laboratory of Leukocyte Biology)|Steven  Stull  (Laboratory of Leukocyte Biology)|Lisbeth A Welniak  (Laboratory of Molecular Immunoregulation),NULL,"1. Huang-Lee S, Huang P, Sun Y, Chen H, Kung H, Huang P, Murphy WJ   (2000) Inhibition of MDA-MB231 human breast tumor xenografts and HER2 expression by anti-tumor agents GAP31 and MAP30.  Anticancer Res 20:653-660.|2. Murphy WJ   (2000) Revisiting graft-versus-host disease models of autoimmunity: new insights in immune regulatory processes.  J Clin Invest 106:745-7.|3. Panoskaltsis-Mortai A, Streiter R, Hermanson J, Fegeding K, Farrell C, Lacey D, Murphy WJ, Blazer B   (2000) Induction of moncyte and T-cell attracting chemokines in the lunch during the generation of idiopathic pnemonia syndrome (IPS) following allogeneic bone marrow transplantation.  Blood 96:834-839.|4. Raziuddin A, Bennett M, Winkler-Pickett R, Ortaldo JR, Longo DL, Murphy WJ   (2000) Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts.  Blood 95:3840-4.|5. Richards S, Murphy WJ   (2000) Use of human prolactin as a therapeutic protein to potentiate immunohematopoietic function.  J Neuroimmunol 109:56-62.|6. Welniak LA, Tian ZG, Sun R, Keller JR, Richards S, Ruscetti FW, Murphy WJ   (2000) Effects of growth hormone and prolactin on hematopoiesis.  Leuk Lymphoma 38:435-45.",https://intramural.nih.gov/search/searchview.taf?ipid=10847
169,BC010003-05,"October 01, 1999 -  September 30, 2000",Retrovirus-Gene Regulation,David  Derse; PhD,NULL,"Basic Research Laboratory, NCI",Hye-Kyung  Chung|Shawn A Hill|Barry A Morse,NULL,Maureen  Shuh  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10845
170,BC010004-05,"October 01, 1999 -  January 01, 1900",Signal Transduction Pathways of Stem Cell Factor in Hematopoietic Cells,Diana M Linnekin; PhD,NULL,"Basic Research Laboratory, NCI",Nina  Radosevic,NULL,Bridget E O'Laughlin  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13841
171,BC010005-05,"October 01, 1999 -  September 30, 2000",The Role of Apc and beta-Catenin in Cell Regulation and Carcinogenesis,James Ming Phang; MD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,NULL,Steven  Donald  (Metabolism and Cancer Susceptibility Section)|Jay M Mei  (Metabolism and Cancer Susceptibility Section),Sandra D White (NIAID),"1. Mei JM, Hord NG, Winterstein DF, Donald SP, Phang JM   (2000) Differential formation of beta-catenin/lymphoid enhancer factor-1 DNA binding complex induced by nitric oxide in mouse colonic epithelial cells differing in adenomatous polyposis coli (Apc) genotype.  Cancer Res 60:3379-83.|2. Mei JM, Hord NG, Winterstein DF, Donald SP, Phang JM   (2000) Expression of prostaglandin endoperoxide H synthase-2 induced by nitric oxide in conditionally immortalized murine colonic epithelial cells.  FASEB J 14:1188-201.",https://intramural.nih.gov/search/searchview.taf?ipid=10842
172,BC010006-05,"October 01, 1999 -  September 30, 2000",Developmental Signal Transduction in Xenopus Oocytes and Embryos,Ira  Daar; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,NULL,Ryu  Maeda  (Developmental Signal Transduction Section)|Eui Kyun Park  (Regulation of Cell Growth Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10840
173,BC010007-05,"October 01, 1999 -  September 30, 2000",Cloning and Characterization of Novel Cell Cycle Regulated Protein Kinases,Douglas K Ferris; PhD,NULL,"Laboratory of Leukocyte Biology, NCI",Sharon  Maloid,NULL,NULL,Yang  Feng (NIA),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10841
174,BC010008-05,"October 01, 1999 -  September 30, 2000",The Genetics of Susceptibility to Mouse Plasma Cell Tumors,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Genetics, NCI","Valery  Bliskovsky; PhD|Christine E Meek|Edward S Ramsay|Shuling  Zhang; MD, PhD",NULL,Rebecca Liddell Huppi  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10838
175,BC010011-05,"October 01, 1999 -  September 30, 2000",Cellular and Molecular Mechanisms of Preclinical Cancer Immunotherapy,Kristin L Komschlies McConville; PhD,NULL,"Laboratory of Experimental Immunology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10839
176,BC010012-05,"October 01, 1999 -  September 30, 2000",Mechanisms of Immune-mediated Tumor Cell Destruction,Thomas Joseph Sayers; PhD,NULL,"Laboratory of Experimental Immunology, NCI",NULL,NULL,Alan  Brooks  (Leukocyte Cell Biology Section),NULL,"1. Lee JK, Sayers TJ, Brooks AD, Back TC, Young HA, Komschlies KL, Wigginton JM, Wiltrout RH   (2000) IFN-gamma-dependent delay of in vivo tumor progression by Fas overexpression on murine renal cancer cells.  J Immunol 164:231-9.|2. Sayers TJ, Brooks AD, Seki N, Smyth MJ, Yagita H, Blazar BR, Malyguine AM   (2000) T cell lysis of murine renal cancer: multiple signaling pathways for cell death via Fas.  J Leukoc Biol 68:81-6.",https://intramural.nih.gov/search/searchview.taf?ipid=10835
177,BC010013-05,"October 01, 1999 -  September 30, 2000",Molecular Studies of Cellular Cytotoxicity,Stephen K Anderson; PhD,NULL,"Laboratory of Experimental Immunology, NCI",NULL,NULL,Andrew  Makrigiannis  (Leukocyte Cell Biology Section)|Paul  Wright  (Leukocyte Cell Biology Section),NULL,"1. Gosselin P, Makrigiannis AP, Nalewaik R, Anderson SK   (2000) Characterization of the Ly49I promoter.  Immunogenetics 51:326-31.|2. Makrigiannis AP, Anderson SK   (2000) Ly49 gene expression in different inbred mouse strains.  Immunol Res 21:39-47.|3. Makrigiannis AP, Etzler J, Winkler-Pickett R, Mason A, Ortaldo JR, Anderson SK   (2000) Identification of the Ly49L protein: evidence for activating counterparts to inhibitory Ly49 proteins.  J Leukoc Biol 68:765-71.",https://intramural.nih.gov/search/searchview.taf?ipid=10836
178,BC010014-05,"October 01, 1999 -  September 30, 2000",Gene Rearrangement and Chromatin Accessibility,Kathrin  Muegge; MD,NULL,"Laboratory of Molecular Immunoregulation, NCI",Kathleen E Dennis|Tao  Fan|Jiaqiang  Huang|Qingsheng  Yan,NULL,NULL,NULL,"1. Geiman TM, Muegge K   (2000) Lsh, an SNF2/helicase family member, is required for proliferation of mature T lymphocytes.  Proc Natl Acad Sci U S A 97:4772-7.|2. Schlissel M, Durum SK, Muegge K   (2000) The interleukin 7 receptor is required for T cell receptor gamma locus accessibility to the V(D)J recombinase.  J Exp Med 191:1045-450.",https://intramural.nih.gov/search/searchview.taf?ipid=10837
179,BC010015-05,"October 01, 1999 -  September 30, 2000","Identification of Cellular Receptors Involved in HIV Infection, Tumor Metastasis","Ji Ming  Wang; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI",Nancy M Dunlop|Ying-Ying  Le,NULL,NULL,NULL,"1. Le Y, Hu J, Gong W, Shen W, Li B, Dunlop N, Halverson D, Blair D, Wang JM   (2000) Expression of functional chemotractic peptide receptors by human astrocytoma cell lines.  J Neuroimmunol 111:102-108.|2. Le Y, Jiang S, Hu J, Gong W, Su S, Dunlop N, Shen W, Li BQ, Wang JM   (2000) N36, a synthetic N-terminal heptad repeat domain of the HIV-1 envelope gp41, is an activator of human phagocytes.  Clin Immunol 96:236-242.|3. Le Y, Li B, Gong W, Shen W, Hu J, Dunlop NM, Oppenheim JJ, Wang JM   (2000) Novel pathophysiological role of classical chemotactic peptide receptors and their communications with chemokine receptors.  Immunol Rev 177:185-94.|4. Shen W, Li B, Wetzel MA, Rogers TJ, Henderson EE, Su SB, Gong W, Le Y, Sargeant R, Dimitrov DS, Oppenheim JJ, Wang JM   (2000) Down-regulation of the chemokine receptor CCR5 by activation of chemotactic formyl peptide receptor in human monocytes.  Blood 96:2887-94.|5. Shen W, Proost P, Li B, Gong W, Le Y, Sargeant R, Murphy P, VanDamme J, Wang JM   (2000) Activation of the chemotactic peptide receptor FPRL1 monocytes phosphorylates and chemokine receptor CCR5 and attenuates cell responses to selected chemokines.  Biochem Biophys Res Commun 272:276-293.",https://intramural.nih.gov/search/searchview.taf?ipid=10834
180,BC010017-05,"October 01, 1999 -  September 30, 2000","The Use of Bacteriophage in the Prevention, Diagnosis, and Treatment of Human Di",Sankar  Adhya; PhD|IRP Faculty Profile,NULL,"Developmental Genetics Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10831
181,BC010019-05,"October 01, 1999 -  September 30, 2000",Regulation of Cancer Cell Growth and Behavior,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10832
182,BC010020-05,"October 01, 1999 -  September 30, 2000",Clinical Trials with Immunotoxins,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Richard A Beers|Verity L Fogg|Juanita A Williams,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10833
183,BC010021-05,"October 01, 1999 -  September 30, 2000",Biology of Mammary Gland Development and Tumorigenesis,Gilbert  Smith; PhD|IRP Faculty Profile,NULL,"ONCOGENETICS SECT, NCI",Corinne A Boulanger-Espeut,NULL,Susan B Rasmussen  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10829
184,BC010022-05,"October 01, 1999 -  September 30, 2000",Genetics of Renal Disease in African Americans,Cheryl Ann Winkler,NULL,"Laboratory of Genomic Diversity, NCI",NULL,NULL,"Michael J Smith; PhD, BS  (Office of Management)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10830
185,BC010023-05,"October 01, 1999 -  September 30, 2000",The Structure and Expression of the c-MYC/PVT Megagene Locus,"Konrad  Huppi; MD, PhD",NULL,"Molecular Genetics Section, NCI",Lena  Diaw|David F Siwarski,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10827
186,BC010024-05,"October 01, 1999 -  September 30, 2000",Chromosomal translocations deregulating c-myc,"Konrad  Huppi; MD, PhD",NULL,"Molecular Genetics Section, NCI",Lena  Diaw|David F Siwarski,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10828
187,BC010025-05,"October 01, 1999 -  September 30, 2000",The Role of AP-1 and Other Transcription Factors in Cancer Cause and Prevention,Nancy H Colburn; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,NULL,Glenn  Hegamyer  (Gene Regulation Section)|Rajalakshmi  Nair  (National Cancer Institute)|Matthew R Young; PhD  (Gene Regulation Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10825
188,BC010026-05,"October 01, 1999 -  September 30, 2000",Genes Differentially Expressed During Tumor Promotion and Progression,Nancy H Colburn; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,NULL,Glenn  Hegamyer  (Gene Regulation Section)|Hsin-Sheng  Yang  (Gene Regulation Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10826
189,BC010027-06,"October 01, 1999 -  September 30, 2000",Function of Steroid Receptors in Subcellular Compartments,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,NULL,Matthias  Becker; PhD  (Hormone Action and Oncogenesis Section)|Cem C Elbi  (Hormone Action and Oncogenesis Section),NULL,"1. Hager GL, Fletcher TM, Xiao N, Baumann CT, Muller WG, McNally JG   (2000) Dynamics of gene targeting and chromatin remodelling by nuclear receptors.  Biochem Soc Trans 28:405-10.|2. Hager GL, Lim CS, Elbi C, Baumann CT   (2000) Trafficking of nuclear receptors in living cells.  J Steroid Biochem Mol Biol 74:249-54.|3. McNally JG, Muller WG, Walker D, Wolford R, Hager GL   (2000) The glucocorticoid receptor: rapid exchange with regulatory sites in living cells.  Science 287:1262-5.",https://intramural.nih.gov/search/searchview.taf?ipid=10823
190,BC010029-05,"October 01, 1999 -  September 30, 2000",Involvement of Valosin-Containing Protein in Ubiquitin-Proteasome Mediated Degra,Chou-Chi  Li; PhD,NULL,"Laboratory of Leukocyte Biology, NCI",Qing  Wang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10824
191,BC010030-05,"October 01, 1999 -  September 30, 2000",Biochemical Analysis of Multidrug Resistance-linked Transport Proteins,Suresh V Ambudkar; PhD|IRP Faculty Profile,NULL,"Transport Biochemistry Section, NCI",Zuben  Sauna; PhD|Melissa M Smith,NULL,Michael Marc Gottesman; MD (Laboratory of Cell Biology)|Michelle  Yong  (National Cancer Institute),NULL,"1. Ambudkar SV, Rosen BP, Gottesman MM   (2000) Workshop on ABC Transporters and Human Diseases.  Drug Resist Updat 3:51-54.|2. Andrus MB, Turner TM, Sauna ZE, Ambudkar SV   (2000) The synthesis and evaluation of a solution phase indexed combinatorial library of non-natural polyenes for reversal of P-glycoprotein mediated multidrug resistance.  J Org Chem 65:4973-83.|3. Gribar JJ, Ramachandra M, Hrycyna CA, Dey S, Ambudkar SV   (2000) Functional characterization of glycosylation-deficient human P-glycoprotein using a vaccinia virus expression system.  J Membr Biol 173:203-14.|4. Sauna ZE, Ambudkar SV   (2000) Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein.  Proc Natl Acad Sci U S A 97:2515-20.",https://intramural.nih.gov/search/searchview.taf?ipid=10822
192,BC010033-05,"October 01, 1999 -  September 30, 2000",The Role of Tobacco-Related Chemical Carcinogens and Oxyradicals in Human Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",NULL,NULL,Lorne J Hofseth  (Molecular Genetics and Carcinogenesis Section)|Mark D Sawyer  (National Cancer Institute)|Zhipeng  Yu  (Molecular Genetics and Carcinogenesis Section)|Xiaoling  Zhou  (Molecular Cytogenetics Section),NULL,"1. Galateau-Salle FB, Luna RE, Horiba K, Sheppard MN, Hayashi T, Fleming MV, Colby TV, Bennett W, Harris CC, Stetler-Stevenson WG, Liotta L, Ferrans VJ, Travis WD   (2000) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions.  Hum Pathol 31:296-305.|2. Gemma A, Seike M, Seike Y, Uematsu K, Hibino S, Kurimoto F, Yoshimura A, Shibuya M, Harris CC, Kudoh S   (2000) Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer.  Genes Chromosomes Cancer 29:213-8.|3. Marrogi AJ, Travis WD, Welsh JA, Khan MA, Rahim H, Tazelaar H, Pairolero P, Trastek V, Jett J, Caporaso NE, Liotta LA, Harris CC   (2000) Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma.  Clin Cancer Res 6:4739-44.|4. Zhou X, Espey MG, Chen JX, Hofseth LJ, Miranda KM, Hussain SP, Wink DA, Harris CC   (2000) Inhibitory effects of nitric oxide and nitrosative stress on dopamine-beta-hydroxylase.  J Biol Chem 275:21241-6.",https://intramural.nih.gov/search/searchview.taf?ipid=10820
193,BC010036-05,"October 01, 1999 -  September 30, 2000",Vitamin E Reduces Chromosomal Damage and Inhibits Hepatic Tumor Formation in a T,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI",NULL,NULL,Valentina  Factor  (Cellular and Molecular Biology Section),NULL,"1. Factor VM, Laskowska D, Jensen MR, Woitach JT, Popescu NC, Thorgeirsson SS   (2000) Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model.  Proc Natl Acad Sci U S A 97:2196-201.",https://intramural.nih.gov/search/searchview.taf?ipid=10821
194,BC010037-05,"October 01, 1999 -  September 30, 2000",Carcinogenic and Toxicologic Effects of PhIP on the Mammary Gland,Elizabeth  Snyderwine; PhD,NULL,"Chemical Carcinogenesis Section, NCI",Liang  Shan|Minshu R Yu,NULL,NULL,NULL,"1. Snyderwine E, Turteltaub K   (2000) Interactions with Cellular Macromolecules, in Food Borne Carcinogens Heterocyclic Amines. Nagao M, Sugimura T, eds., John Wiley & Sons, LTD (New York), pp. 131-161.",https://intramural.nih.gov/search/searchview.taf?ipid=10817
195,BC010038-05,"October 01, 1999 -  September 30, 2000",Molecular Cytogenetics of Solid Tumors,Nicolae C Popescu; PhD,NULL,"Molecular Cytogenetics Section, NCI",Marian E Durkin|Zhihong  Shan,NULL,"Snorri S. Thorgeirsson; MD, PhD  (Laboratory of Experimental Carcinogenesis)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13842
196,BC010041-05,"October 01, 1999 -  September 30, 2000",Oligosaccharide Conformations and Their Interactions with Proteins,Pradman  Qasba; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,NULL,NULL,1. Qasba P   (2000) Involvement of Sugars in Protein-Protein Interactions.  Carbohydrate Polymers 41 (2000):293-309.,https://intramural.nih.gov/search/searchview.taf?ipid=13843
197,BC010042-05,"October 01, 1999 -  September 30, 2000",Cell Dynamics in Cancer and AIDS,Dimiter Stanchev Dimitrov; PhD,NULL,"Membrane Structure and Function Section, NCI",NULL,NULL,Igor A Sidorov  (National Cancer Institute),NULL,"1. Endo Y, Igarashi T, Nishimura Y, Buckler C, Buckler-White A, Plishka R, Dimitrov DS, Martin MA   (2000) Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus.  J Virol 74:6935-6945.|2. Lempicki RA, Kovacs JA, Baseler MW, Adelsberger JW, Dewar RL, Natarajan V, Bosche MC, Metcalf JA, Stevens RA, Lambert LA, Alvord WG, Polis MA, Davey RT, Dimitrov DS, Lane HC   (2000) Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients.  Proc Natl Acad Sci U S A 97:13778-13783.",https://intramural.nih.gov/search/searchview.taf?ipid=10813
198,BC010043-05,"October 01, 1999 -  September 30, 2000",Publishing Protein Databases on the Web Using dbEngine,Peter F Lemkin; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10814
199,BC010044-05,"October 01, 1999 -  September 30, 2000",Interactive Biomedical Image Flicker-Comparison Across the Internet,Peter F Lemkin; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,Gregory  Thornwall  (MEMBRANE BIOLOGY SECT),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10810
200,BC010045-05,"October 01, 1999 -  September 30, 2000",Pattern Discovery for Combinatorial Databases,Bruce Allen Shapiro; PhD|IRP Faculty Profile,NULL,"MEMBRANE BIOLOGY SECT, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10811
201,BC010046-05,"October 01, 1999 -  September 30, 2000",Stabilization of Three Stranded Nucleic Acid Structures in Solution and in Trans,Robert L Jernigan; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,Kai Li H Ting  (Molecular Structure Section)|Victor  Zhurkin; PhD  (Molecular Structure Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10812
202,BC010049-05,"October 01, 1999 -  September 30, 2000",TGF-beta1 in Hematopoietic and Immune Cell Differentiation and Function,John J Letterio; MD,NULL,"Laboratory of Cell Regulation and Carcinogenesis, NCI",Mario A Anzano|Shellyann K Sharpe|Lawrence A Wolfraim,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10808
203,BC010050-05,"October 01, 1999 -  September 30, 2000",Molecular mechanisms of resistance to TGF-beta-mediated apoptosis,Seong-Jin  Kim; PhD,NULL,"Laboratory of Cell Regulation and Carcinogenesis, NCI",Byung-Chul  Kim,NULL,Byoung Ick Lee  (National Cancer Institute)|Cecile  Lee  (National Cancer Institute),NULL,"1. Larisch S, Yi Y, Lotan R, Kerner H, Eimerl S, Parks W, De caestecker M, Danielpour D, Book-Melamed N, Timberg R, Lechleider R, Orly J, Kim S, Roberts A   (2000) A novel mitochondrial septin, ARTS, mediates TGF-beta-induced apoptosis via its P-loop motif.  Nat Cell Biol 2:915-921.",https://intramural.nih.gov/search/searchview.taf?ipid=10809
204,BC010251-05,"October 01, 1999 -  September 30, 2000",Biological Activity and Structural Analysis of Secreted Frizzled-Related Protein,"Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Carole K Lengel|Kanae  Muraiso|William G Taylor|Vladimir  Wolf,NULL,Jennifer  Ellis  (National Cancer Institute)|Lilian L Soon  (Laboratory of Cell Regulation and Carcinogenesis),NULL,"1. Panoskaltsis-Mortari A, Taylor PA, Rubin JS, Uren A, Welniak LA, Murphy WJ, Farrell CL, Lacey DL, Blazar BR   (2000) Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury.  Blood 96:4350-4356.|2. Sakata H, Rubin JS, Taylor WG, Miki T   (2000) A Rho-specific exchange factor Ect2 is induced from S to M phases in regenerating mouse liver.  Hepatology 32:193-9.|3. Slayden OD, Rubin JS, Lacey DL, Brenner RM   (2000) Effects of keratinocyte growth factor in the endometrium of rhesus macaques during the luteal-follicular transition.  J Clin Endocrinol Metab 85:275-85.|4. Uren A, Reichsman F, Anest V, Taylor WG, Muraiso K, Bottaro DP, Cumberledge S, Rubin JS   (2000) Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling.  J Biol Chem 275:4374-82.|5. Rubin JS, Cumberledge SS, Reichsman FS, Uren AS (submitted in 2000) Methods Of Use Of Fragments Of Secreted Frizzled Related Protein, Sfrp. Patents issued: 7,947,651 (US in 2011); 8,158,603 (US in 2012); 8,735,355 (US in 2014). Patents pending: 09/546,043 (US application); 10/425,586 (US application).|6. Rubin JS, Gillespie MS, Horwood NS, Kay BS, Uren AS, Weisblum BS (submitted in 2000) Sfrp And Peptide Motifs That Interact With Sfrp And Methods Of Their Use. Patents issued: 1387854 (AT in 2012); 1387854 (BE in 2012); 1387854 (CH in 2012); 1387854 (CY in 2012); 1387854 (DE in 2012); 1387854 (DK in 2012); 1387854 (EP in 2012); 1387854 (ES in 2012); 1387854 (FI in 2012); 1387854 (FR in 2012); 1387854 (GB in 2012); 1387854 (GR in 2012); 1387854 (IE in 2012); 1387854 (IT in 2012); 1387854 (LI in 2012); 1387854 (LU in 2012); 1387854 (MC in 2012); 1387854 (NL in 2012); 1387854 (PT in 2012); 1387854 (SE in 2012); TR201206809 (TR in 2012); 8,334,260 (US in 2013); 2,434,672 (CA in 2014). Patents pending: 2002241859 (AU application); 2002-556615 (JP application); 2007-120533 (JP application); 2008-169716 (JP application); PCT/US02/00869 (PC application); 10/466,136 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=10806
205,BC010252-05,"October 01, 1999 -  September 30, 2000",Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.,Francis W Ruscetti; PhD,NULL,"Laboratory of Leukocyte Biology, NCI",Rachel  Beyer|Kathryn  Jones; PhD|Manisha D Nath,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10807
206,BC010253-05,"October 01, 1999 -  September 30, 2000",Molecular Mechanisms of Growth Factor Modulated Proliferation,William  Farrar,NULL,"Cytokine Molecular Mechanisms Section, NCI",Lihua  Wang,NULL,NULL,NULL,"1. Chen T, Wang LH, Farrar WL   (2000) Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.  Cancer Res 60:2132-5.|2. Wang LH, Kirken RA, Yang XY, Erwin RA, DaSilva L, Yu CR, Farrar WL   (2000) Selective disruption of interleukin 4 autocrine-regulated loop by a tyrosine kinase inhibitor restricts activity of T-helper 2 cells.  Blood 95:3816-22.|3. Wang LH, Yang XY, Kirken RA, Resau JH, Farrar WL   (2000) Targeted disruption of stat6 DNA binding activity by an oligonucleotide decoy blocks IL-4-driven T(H)2 cell response.  Blood 95:1249-57.|4. Yang XY, Wang LH, Chen T, Hodge DR, Resau JH, DaSilva L, Farrar WL   (2000) Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists PPARgamma co-association with transcription factor NFAT.  J Biol Chem 275:4541-4.",https://intramural.nih.gov/search/searchview.taf?ipid=10804
207,BC010254-05,"October 01, 1999 -  September 30, 2000",Cellular and Cytokine Regulation of TransplantationResponses,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Transplantation Immunology Section, NCI",NULL,NULL,Josef  Bodor  (National Cancer Institute),NULL,"1. Bishop MR, Dean RM, Steinberg SM, Odom J, Pollack SM, Pavletic SZ, Sportes C, Gress RE, Fowler DH (2010). Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma. Cancer  116, 852-62.   https://doi.org/10.1002/cncr.24845|2. Lucas PJ, Kim SJ, Melby SJ, Gress RE   (2000) Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor.  J Exp Med 191:1187-96.",https://intramural.nih.gov/search/searchview.taf?ipid=10805
208,BC010255-05,"October 01, 1999 -  September 30, 2000",T Cell Regeneration and Function Following T Cell Depletion,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Transplantation Immunology Section, NCI",Catherine Virginia Bare,NULL,NULL,NULL,"1. Lucas PJ, Kim SJ, Melby SJ, Gress RE   (2000) Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor.  J Exp Med 191:1187-96.",https://intramural.nih.gov/search/searchview.taf?ipid=10802
209,BC010256-05,"October 01, 1999 -  September 30, 2000",Analysis of the function of the nodal gene during embryonic development,Michael Robert Kuehn; PhD,NULL,"Experimental Immunology Branch, NCI",Linda A Lowe,NULL,NULL,Amit  Kumar; PhD (NIDDK),"1. Fujinaga M, Lowe LA, Kuehn MR   (2000) alpha(1)-Adrenergic stimulation perturbs the left-right asymmetric expression pattern of nodal during rat embryogenesis.  Teratology 62:317-24.|2. Lowe LA, Yamada S, Kuehn MR   (2000) HoxB6-Cre transgenic mice express Cre recombinase in extra-embryonic mesoderm, in lateral plate and limb mesoderm and at the midbrain/hindbrain junction.  Genesis 26:118-20.|3. Pfendler KC, Yoon J, Taborn GU, Kuehn MR, Iannaccone PM   (2000) Nodal and bone morphogenetic protein 5 interact in murine mesoderm formation and implantation.  Genesis 28:1-14.",https://intramural.nih.gov/search/searchview.taf?ipid=10803
210,BC010257-05,"October 01, 1999 -  September 30, 2000",HIV-1 Entry,Dimiter Stanchev Dimitrov; PhD,NULL,"Membrane Structure and Function Section, NCI",Yen-Hung  Chow|Xiaodong  Xiao,NULL,NULL,NULL,"1. Chabot DJ, Chen H, Dimitrov DS, Broder CC   (2000) N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates.  J Virol 74:4404-13.|2. Dimitrov DS   (2000) Cell biology of virus entry.  Cell 101:697-702.|3. Hug P, Lin HM, Korte T, Xiao X, Dimitrov DS, Wang JM, Puri A, Blumenthal R   (2000) Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.  J Virol 74:6377-85.|4. Shen W, Li B, Wetzel MA, Rogers TJ, Henderson EE, Su SB, Gong W, Le Y, Sargeant R, Dimitrov DS, Oppenheim JJ, Wang JM   (2000) Down-regulation of the chemokine receptor CCR5 by activation of chemotactic formyl peptide receptor in human monocytes.  Blood 96:2887-94.|5. Xiao X, Kinter A, Broder CC, Dimitrov DS   (2000) Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.  Exp Mol Pathol 68:133-8.|6. Xiao X, Norwood D, Feng YR, Moriuchi M, Jones-Trower A, Stantchev TS, Moriuchi H, Broder CC, Dimitrov DS   (2000) Inefficient formation of a complex among CXCR4, CD4 and gp120 in U937 clones resistant to X4 gp120-gp41-mediated fusion.  Exp Mol Pathol 68:139-46.",https://intramural.nih.gov/search/searchview.taf?ipid=10800
211,BC010258-04,"October 01, 1999 -  September 30, 2000",Molecular mechanisms regulating the transition from acute to chronic inflammatio,Teizo  Yoshimura; PhD,NULL,"Immunopathology Section, NCI",NULL,NULL,Carole Lynn Galligan  (Laboratory of Molecular Immunoregulation)|Hidenobu  Kamohara  (Laboratory of Molecular Immunoregulation),NULL,"1. Inadera H, Sekiya T, Yoshimura T, Matsushima K   (2000) Molecular analysis of the inhibition of monocyte chemoattractant protein-1 gene expression by estrogens and xenoestrogens in MCF-7 cells.  Endocrinology 141:50-9.|2. Usui M, Egashira K, Tomita H, Koyanagi M, Katoh M, Shimokawa H, Takeya M, Yoshimura T, Matsushima K, Takeshita A   (2000) Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats.  Circulation 101:305-10.|3. Yamashiro S, Kamohara H, Yoshimura T   (2000) Alteration in the responsiveness to tumour necrosis factor-alpha is crucial for maximal expression of monocyte chemoattractant protein-1 in human neutrophils.  Immunology 101:97-103.|4. Yamashiro S, Wang JM, Yang D, Gong WH, Kamohara H, Yoshimura T   (2000) Expression of CCR6 and CD83 by cytokine-activated human neutrophils.  Blood 96:3958-63.",https://intramural.nih.gov/search/searchview.taf?ipid=10801
212,BC010259-04,"October 01, 1999 -  September 30, 2000",Exploratory Data Analysis of Web Quantitative Gel Databases,Peter F Lemkin; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,Gregory  Thornwall  (MEMBRANE BIOLOGY SECT),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10797
213,BC010262-04,"October 01, 1999 -  September 30, 2000",Characterization of Recombination and Linkage Disequilibrium in the Human MHC,"Mary  Carrington; MS, PhD",NULL,"Laboratory of Genomic Diversity, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10795
214,BC010263-04,"October 01, 1999 -  September 30, 2000",Comparative Feline Genomics:  High-Throughput BAC/PAC Contig Mapping,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10796
215,BC010264-04,"October 01, 1999 -  September 30, 2000",SDF-1 3  UTR Mutation Delays Progression to AIDS,Cheryl Ann Winkler,NULL,"Laboratory of Genomic Diversity, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10793
216,BC010265-04,"October 01, 1999 -  September 30, 2000",Developing the Feline Radiation Hybrid Map,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",NULL,NULL,Naoya  Yuhki; MD  (Genetics Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10794
217,BC010269-04,"October 01, 1999 -  September 30, 2000",Genetic Effects on Infectious Disease,"Mary  Carrington; MS, PhD",NULL,"Laboratory of Genomic Diversity, NCI",Stephen J O'Brien; PhD,NULL,Michael  Dean; PhD (Human Genetics Section)|Arman A Bashirova  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10787
218,BC010270-04,"October 01, 1999 -  September 30, 2000",High-Throughput Genotyping for MALD and Candidate Gene Analysis,"Michael J Smith; PhD, BS",NULL,"Office of Management, NCI",NULL,NULL,Kyu-Woan  Cho  (National Cancer Institute)|Stephen J O'Brien; PhD  (Laboratory of Genomic Diversity)|Cheryl Ann Winkler  (Laboratory of Genomic Diversity),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10785
219,BC010271-04,"October 01, 1999 -  September 30, 2000",Identification of Genes Involved in HIV-1/AIDS: An Important IL-10 Promoter Vari,"Michael J Smith; PhD, BS",NULL,"Office of Management, NCI",NULL,NULL,"Michael  Dean; PhD (Human Genetics Section)|Mary  Carrington; MS, PhD  (Laboratory of Genomic Diversity)|Kyu-Woan  Cho  (National Cancer Institute)|Stephen J O'Brien; PhD  (Laboratory of Genomic Diversity)|Cheryl Ann Winkler  (Laboratory of Genomic Diversity)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10786
220,BC010272-04,"October 01, 1999 -  September 30, 2000",Protein Reviews on the Web (PROW),James Stephen Shaw; PhD|IRP Faculty Profile,NULL,"Human Immunology Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10782
221,BC010275-03,"October 01, 1999 -  September 30, 2000",Neuronal Cell Death Regulation in Drosophila,"Florence M Davidson; MS, PhD, BA",NULL,"Biochemistry of Gene Expression Section, NCI",NULL,NULL,Nicola M Marsden-Haug  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10784
222,BC010276-03,"October 01, 1999 -  September 30, 2000",Protein Folding and Protein Design,Yawen  Bai; PhD|IRP Faculty Profile,NULL,"Protein Biochemistry Section, NCI",NULL,NULL,Rui-Ai  Chu  (National Cancer Institute)|Jiro  Takei  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10779
223,BC010277-03,"October 01, 1999 -  September 30, 2000",Control of DNA Replication,Dhruba K Chattoraj; PhD|IRP Faculty Profile,NULL,"Center for Cancer Research, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10778
224,BC010278-03,"October 01, 1999 -  September 30, 2000",Atomic Resolution Biological Electron Microscopy,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Biochemistry, NCI",NULL,NULL,Peijun  Zhang; PhD  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10776
225,BC010279-03,"October 01, 1999 -  September 30, 2000",Interaction of Progesterone Receptor with Chromatin,Catharine L Smith; PhD,NULL,"Hormone Action and Oncogenesis Section, NCI",Jennifer J Botos,NULL,NULL,NULL,"1. List HJ, Smith CL, Martinez E, Harris VK, Danielsen M, Riegel AT   (2000) Effects of antiandrogens on chromatin remodeling and transcription of the integrated mouse mammary tumor virus promoter.  Exp Cell Res 260:160-5.|2. Smith CL, Wolford RG, O'Neill TB, Hager GL   (2000) Characterization of transiently and constitutively expressed progesterone receptors: evidence for two functional states.  Mol Endocrinol 14:956-71.",https://intramural.nih.gov/search/searchview.taf?ipid=10777
226,BC010280-03,"October 01, 1999 -  September 30, 2000",Cell motility within a cell mass,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Waltraud  Mueller,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10774
227,BC010281-03,"October 01, 2000 -  September 30, 2001",Tools for Drug Discovery: Examinations of Genome-Wide Biological Databases and M,David  Covell,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10775
228,BC010282-03,"October 01, 1999 -  September 30, 2000",B-cell  mutagenesis in vivo,"Siegfried  Janz; MD, DSc",NULL,"Laboratory of Genetics, NCI",Klaus M Felix,NULL,Ming  Qian  (Surgy Br),NULL,"1. Kovalchuk AL, Qi CF, Torrey TA, Taddesse-Heath L, Feigenbaum L, Park SS, Gerbitz A, Klobeck G, Hoertnagel K, Polack A, Bornkamm GW, Janz S, Morse HC   (2000) Burkitt lymphoma in the mouse.  J Exp Med 192:1183-90.",https://intramural.nih.gov/search/searchview.taf?ipid=10772
229,BC010283-03,"October 01, 1999 -  September 30, 2000",DNA Repair,Andre A Nussenzweig; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Simone  Difilippantonio,NULL,NULL,NULL,"1. Arrington ED, Caldwell MC, Kumaravel TS, Lohani A, Joshi A, Evans MK, Chen HT, Nussenzweig A, Holbrook NJ, Gorospe M.    (2000) Enhanced sensitivity and long-term G2 arrest in hydrogen peroxide-treated Ku80-null cells are unrelated to DNA repair defects. Free Radic Biol Med. 29:1166-76.",https://intramural.nih.gov/search/searchview.taf?ipid=10773
230,BC010284-03,"October 01, 1999 -  September 30, 2000",Mechanisms of Tumor Suppression by Transforming Growth Factor-beta,Adam  Glick; PhD,NULL,"In Vitro Pathogenesis Section, NCI",NULL,NULL,Ervind S Bhogte  (Laboratory of Cellular Carcinogenesis and Tumor Promotion),NULL,"1. Tremain R, Marko M, Kinnimulki V, Ueno H, Bottinger E, Glick A   (2000) Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras.  Oncogene 19:1698-709.",https://intramural.nih.gov/search/searchview.taf?ipid=10769
231,BC010285-03,"October 01, 1999 -  September 30, 2000",Development and Utilization of Models for Inducible Gene Expression in the Epide,Adam  Glick; PhD,NULL,"In Vitro Pathogenesis Section, NCI",NULL,NULL,Xin  Liu  (National Cancer Institute),NULL,"1. Diamond I, Owolabi T, Marco M, Lam C, Glick A   (2000) Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter.  J Invest Dermatol 115:788-94.",https://intramural.nih.gov/search/searchview.taf?ipid=10770
232,BC010286-03,"October 01, 1999 -  September 30, 2000",Dissection of Jun-mediated Signal Transduction Pathway in Drosophila,Steven X Hou|IRP Faculty Profile,NULL,"Cancer Causing Genes Section, NCI",Su-Wan  Oh|Tracy Marie Ulderich,NULL,Huachun  Chen  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10771
233,BC010288-03,"October 01, 1999 -  September 30, 2000",Genetics of Susceptibility to Development of Skin Tumors:  Mechanisms of Action,Henry  Hennings; PhD,NULL,"In Vitro Pathogenesis Section, NCI",Rana A Abdel-Fattah|Alesia J Holly,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10768
234,BC010289-03,"October 01, 1999 -  September 30, 2000",Chromatin-specific repression of transcription by cAMP signaling,Catharine L Smith; PhD,NULL,"Hormone Action and Oncogenesis Section, NCI",Edlyn  Soeth,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10763
235,BC010290-03,"October 01, 1999 -  September 30, 2000","The role of the polo-box of polo kinases, Plk and Cdc5, in cytokinesis.",Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Suk Gil  Song,NULL,Hyeon-Su  Ro; PhD  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10764
236,BC010291-03,"October 01, 1999 -  September 30, 2000",Raiolabelled Therapy of Solid Tumors,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Juanita A Williams,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10765
237,BC010292-03,"October 01, 1999 -  September 30, 2000",Enzymes and substrates of the ubiquitin conjugating system,Allan M Weissman; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Shengyun  Fang|Marco  Ferrone|Jane P Jensen|Kevin L Lorick; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10760
238,BC010296-03,"October 01, 1999 -  September 30, 2000",Pathology of Animal Models of Human Cancers and Related Diseases,"Jerrold M Ward; DVM, PhD",NULL,"VET and TUMOR PATHOLOGY SECT, NCI",Deborah E Devor henneman,NULL,NULL,NULL,"1. Boorman GA, McCormick DL, Ward JM, Haseman JK, Sills RC   (2000) Magnetic fields and mammary cancer in rodents: a critical review and evaluation of published literature.  Radiat Res 153:617-26.|2. Qian X, Esteban L, Vass WC, Upadhyaya C, Papageorge AG, Yienger K, Ward JM, Lowy DR, Santos E   (2000) The Sos1 and Sos2 Ras-specific exchange factors: differences in placental expression and signaling properties.  EMBO J 19:642-54.",https://intramural.nih.gov/search/searchview.taf?ipid=10761
239,BC010297-03,"October 01, 1999 -  September 30, 2000",Identification of Candidate Gene Polymorphisms Associated with Infectious Diseas,Cheryl Ann Winkler,NULL,"Laboratory of Genomic Diversity, NCI",NULL,NULL,"Michael J Smith; PhD, BS  (Office of Management)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10762
240,BC010298-03,"October 01, 1999 -  September 30, 2000",Gene Discovery,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Verity L Fogg,NULL,Kristi A Egland  (Laboratory of Molecular Biology)|Carlo  Iavarone  (Laboratory of Molecular Biology)|James J Vincent  (Molecular Modeling Section)|Curt Douglas Wolfgang  (Laboratory of Molecular Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10757
241,BC010299-03,"October 01, 1999 -  September 30, 2000",Transport of glucocorticoid receptor,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,NULL,NULL,Robert G Ryan (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10758
242,BC010300-03,"October 01, 1999 -  September 30, 2000",Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages,Daniel  McVicar; PhD|IRP Faculty Profile,NULL,"Leukocyte Cell Biology Section, NCI",Lynn S Taylor,NULL,Sujatha  Paul  (National Cancer Institute),NULL,"1. Mason LH, Willette-Brown J, Mason AT, McVicar D, Ortaldo JR   (2000) Interaction of Ly-49D+ NK cells with H-2Dd target cells leads to Dap-12 phosphorylation and IFN-gamma secretion.  J Immunol 164:603-11.|2. Paul SP, Taylor LS, Stansbury EK, McVicar DW   (2000) Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2.  Blood 96:483-90.|3. Taylor LS, Paul SP, McVicar DW   (2000) Paired inhibitory and activating receptor signals.  Rev Immunogenet 2:204-19.",https://intramural.nih.gov/search/searchview.taf?ipid=10759
243,BC010301-03,"October 01, 1999 -  September 30, 2000",Development of Recombinant Toxins for Treatment of Patients with Hematologic Mal,"Robert J Kreitman; MD, PhD|IRP Faculty Profile",NULL,"Clinical Immunotherapy Section, NCI",NULL,NULL,Inger M Margulies  (Molecular Biology Section),Diana J O hagan (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10754
244,BC010302-03,"October 01, 1999 -  September 30, 2000","Population Dynamics, Genetics, and Evolution of Retroviruses",John Miller Coffin; PhD,NULL,"HIV Drug Resistance Program, NCI",Susan Beth C Jordan|Connie L Kinna,NULL,Frank  Maldarelli  (In Vivo Section),NULL,"1. Stoye JP, Coffin JM   (2000) A provirus put to work.  nature 403:715, 717.|2. Weidhaas JB, Angelichio EL, Fenner S, Coffin JM   (2000) Relationship between retroviral DNA integration and gene expression.  J Virol 74:8382-9.",https://intramural.nih.gov/search/searchview.taf?ipid=10755
245,BC010303-02,"October 01, 1999 -  September 30, 2000",MicroArray Explorer for the data mining of expression profiles of cDNA microarra,Peter F Lemkin; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,Gregory  Thornwall  (MEMBRANE BIOLOGY SECT),NULL,"1. Lemkin PF, Thornwall GC, Walton KD, Hennighausen L   (2000) The microarray explorer tool for data mining of cDNA microarrays: application for the mammary gland.  Nucleic Acids Res 28:4452-9.",https://intramural.nih.gov/search/searchview.taf?ipid=10756
246,BC010304-02,"October 01, 1999 -  September 30, 2000",Biochemical Basis of T Cell Activation,Lawrence Elliot Samelson; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Stephen C Bunnell|Claudette L Fuller|Veena N Kapoor|Shin-Ichiroh  Saitoh|Connie  Sommers; PhD|Lihong  Yang,NULL,NULL,NULL,"1. Sloan-lancaster J, Samelson LE   (2000) Proximal Events in T-Cell Activation, in Signaling Networks and Cell Cycle Control: The Molecular Basis of Cancer and Other Diseases. Gutkind JS, ed., Humana Press Inc. (Totowa, NJ, USA) Volume 6,  pp. 99-111.|2. Martelli MP, Lin H, Zhang W, Samelson LE, Bierer BE   (2000) Signaling via LAT (linker for T-cell activation) and Syk/ZAP70 is required for ERK activation and NFAT transcriptional activation following CD2 stimulation.  Blood 96:2181-90.|3. Saitoh S, Arudchandran R, Manetz TS, Zhang W, Sommers CL, Love PE, Rivera J, Samelson LE   (2000) LAT is essential for Fc(epsilon)RI-mediated mast cell activation.  Immunity 12:525-35.|4. Zhang W, Samelson LE   (2000) The role of membrane-associated adaptors in T cell receptor signalling.  Semin Immunol 12:35-41.|5. Zhang W, Trible RP, Zhu M, Liu SK, McGlade CJ, Samelson LE   (2000) Association of Grb2, Gads, and phospholipase C-gamma 1 with phosphorylated LAT tyrosine residues Effect of LAT tyrosine mutations on T cell angigen receptor-mediated signaling.  J Biol Chem 275:23355-61.",https://intramural.nih.gov/search/searchview.taf?ipid=13844
247,BC010305-02,"October 01, 1999 -  September 30, 2000",Role of Killer Inhibitory Receptor Genes in Autoimmune and Infectious Diseases,"Mary  Carrington; MS, PhD",NULL,"Laboratory of Genomic Diversity, NCI",NULL,NULL,Arman A Bashirova  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10753
248,BC010306-02,"October 01, 1999 -  September 30, 2000",Identification of Needle Sharing: A Risk Factor for Viral Infection,"Michael J Smith; PhD, BS",NULL,"Office of Management, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10751
249,BC010307-02,"October 01, 1999 -  September 30, 2000",Cell Growth Control In Vivo by C/EBPbeta and C/EBPdelta,Gisela Esta Sterneck; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Shikha  Sharan,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10752
250,BC010308-02,"October 01, 1999 -  September 30, 2000",In vivo Imaging Analysis of Steroid/Nuclear Receptor Function,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Waltraud  Mueller,NULL,NULL,Robert G Ryan (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10749
251,BC010309-02,"October 01, 1999 -  September 30, 2000",Nuclear architecture and gene expression,Thomas A Misteli; PhD|IRP Faculty Profile,NULL,"Hormone Action and Oncogenesis Section, NCI",Miroslav  Dundr|Stephen A Mabon|Luis F Parada,NULL,Bernd  Kalbfuss  (National Cancer Institute),NULL,"1. Phair RD, Misteli T   (2000) High mobility of proteins in the mammalian cell nucleus.  nature 404:604-9.",https://intramural.nih.gov/search/searchview.taf?ipid=10750
252,BC010310-02,"October 01, 1999 -  September 30, 2000",Single-Molecule Approaches to Chromatin Structure and Dynamics,Sanford H Leuba; PhD,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,NULL,Mikhail  Karymov; PhD  (Hormone Action and Oncogenesis Section),NULL,"1. Leuba SH, Zlatanova J, Karymov M, Bash R, Liu YZ, Lohr DE, Harrington RE, Lindsay SM   (2000) The mechanical properties of single chromatin fibers under tension.  Single Molecules 1:185-192.|2. Zlatanova J, Lindsay SM, Leuba SH   (2000) Single molecule force spectroscopy in biology using the atomic force microscope.  Prog Biophys Mol Biol 74:37-61.",https://intramural.nih.gov/search/searchview.taf?ipid=13891
253,BC010311-02,"October 01, 1999 -  September 30, 2000",IGV expression and absence of VL allelic exclusion in malignant and pre-malignan,"Konrad  Huppi; MD, PhD",NULL,"Molecular Genetics Section, NCI",Lena  Diaw|David F Siwarski,NULL,NULL,NULL,"1. Diaw L, Siwarski D, DuBois W, Jones G, Huppi K   (2000) Double producers of kappa and lambda define a subset of B cells in mouse plasmacytomas.  Mol Immunol 37:775-81.",https://intramural.nih.gov/search/searchview.taf?ipid=10748
254,BC010312-02,"October 01, 1999 -  September 30, 2000",Analysis of gene expression in cervical cancer,"Carl C Baker; MD, PhD",NULL,"Cellular Regulation and Transformation Section, NCI",Janet M Dipasquale|Jesse F Quintero,NULL,Fang  Yuan  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10698
255,BC010313-02,"October 01, 1999 -  September 30, 2000",Molecular profiling of hepatocellular carcinoma,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Chuan-Ging  Wu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10699
256,BC010314-02,"October 01, 1999 -  September 30, 2000",Protein/Nucleic Acid Interactions Controlling Retroviral Replication,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Resistance Mechanisms Laboratory, NCI",Susan N Toms,NULL,Daniela  Lener  (National Cancer Institute)|Jennifer T Miller  (Reverse Transcriptase Biochemistry Section)|Jason William Rausch  (Reverse Transcriptase Biochemistry Section),Scott R Budihas; PhD (NIMH),"1. Brule F, Bec G, Keith G, Le Grice SF, Roques BP, Ehresmann B, Ehresmann C, Marquet R   (2000) In vitro evidence for the interaction of tRNA(3)(Lys) with U3 during the first strand transfer of HIV-1 reverse transcription.  Nucleic Acids Res 28:634-640.|2. Cowan JA, Ohyama T, Howard K, Rausch JW, Cowan SM, Le Grice SF   (2000) Metal ion stoichiometry of the HIV-1 RT ribonuclease H domain: evidence for two mutually exclusive sites leads to new mechanistic insights on metal-mediated hydrolysis in nucleic acid biochemistry.  J Biol Inorg Chem 5:67-74.|3. Lanchy JM, Isel C, Keith G, Le Grice SF, Ehresmann C, Ehresmann B, Marquet R   (2000) Dynamics of the HIV-1 reverse transcription complex during initiation of DNA synthesis.  J Biol Chem 275:12306-12312.|4. Rausch JW, Bona-Le Grice MK, Nymark-McMahon MH, Miller JT, Le Grice SF   (2000) Interaction of p55 reverse transcriptase from the Saccharomyces cerevisiae retrotransposon Ty3 with conformationally distinct nucleic acid duplexes.  J Biol Chem 275:13879-13887.|5. Rausch JW, Sathyanarayana BK, Bona MK, Le Grice SF   (2000) Probing contacts between the ribonuclease H domain of HIV-1 reverse transcriptase and nucleic acid by site-specific photocross-linking.  J Biol Chem 275:16015-22.|6. Rigourd M, Lanchy JM, Le Grice SF, Ehresmann B, Ehresmann C, Marquet R   (2000) Inhibition of the initiation of HIV-1 reverse transcription by 3'-azido-3'-deoxythymidine Comparison with elongation.  J Biol Chem 275:26944-26951.",https://intramural.nih.gov/search/searchview.taf?ipid=10695
257,BC010315-02,"October 01, 1999 -  September 30, 2000",The DNA Sequencing Minicore Facility,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI",Kathleen D Hartman,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10696
258,BC010316-02,"October 01, 1999 -  September 30, 2000",Insights into Mammalian Genome Organization and Evolution by Molecular Cytogenet,Johannes C Wienberg; PhD,NULL,"Hormone Action and Oncogenesis Section, NCI",NULL,NULL,Lisa  Adams; MSc  (Basic Research Laboratory)|Lutz  Froenicke  (Molecular Cytogenetics Section)|Gary A Stone; BA  (Molecular Cytogenetics Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10697
259,BC010317-02,"October 01, 1999 -  September 30, 2000",Automation of AIDS Candidate Gene Analysis,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",NULL,NULL,"Michael J Smith; PhD, BS  (Office of Management)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10693
260,BC010318-02,"October 01, 1999 -  September 30, 2000",Interactions Between HIV and HCV in Coinfected Hemophiliacs,Cheryl Ann Winkler,NULL,"Laboratory of Genomic Diversity, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10694
261,BC010319-02,"October 01, 1999 -  September 30, 2000",Structural Analysis of Biological Membrane Proteins,"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Aarti H Bhatia|Xiu-Gong  Gao,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13831
262,BC010320-01,"October 01, 1999 -  September 30, 2000",Recombination and Genetic Interaction Between Distinct and Similar Retroviruses,Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Viral Recombination Section, NCI",Benjamin E Beasley|William W Fu|Timur O Kabdulov|Dexter T Poon|Terence  Rhodes,NULL,Hong Que Thi Dang  (National Cancer Institute),NULL,"1. Anderson JA, Pathak VK, Hu WS   (2000) Effect of the murine leukemia virus extended packaging signal on the rates and locations of retroviral recombination.  J Virol 74:6953-63.|2. Cheslock SR, Anderson JA, Hwang CK, Pathak VK, Hu WS   (2000) Utilization of nonviral sequences for minus-strand DNA transfer and gene reconstitution during retroviral replication.  J Virol 74:9571-9.|3. Hu WS, Pathak VK   (2000) Design of retroviral vectors and helper cells for gene therapy.  Pharmacol Rev 52:493-511.",https://intramural.nih.gov/search/searchview.taf?ipid=13832
263,BC010321-01,"October 01, 1999 -  September 30, 2000","HIV-1 Reverse Transcriptase, Retroviral Vector Design, and Molecular Mechanisms",Stephen H Hughes; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Hilda L Marusiodis,NULL,Paul L Boyer  (Vector Design and Replicaton Section)|Mark D Driscoll  (Vector Design and Replicaton Section)|Andrea L Ferris  (Vector Design and Replicaton Section)|Marie-Pierre  Golinelli  (Vector Design and Replicaton Section)|John G Julias  (Vector Design and Replicaton Section)|Mary J McWilliams  (Vector Design and Replicaton Section)|Show all 8.,NULL,"1. Boyer PL, Hughes SH   (2000) Effects of amino acid substitutions at position 115 on the fidelity of human immunodeficiency virus type 1 reverse transcriptase.  J Virol 74:6494-500.|2. Boyer PL, Sarafianos SG, Arnold E, Hughes SH   (2000) Analysis of mutations at positions 115 and 116 in the dNTP binding site of HIV-1 reverse transcriptase.  Proc Natl Acad Sci U S A 97:3056-61.|3. Driscoll MD, Hughes SH   (2000) Human immunodeficiency virus type 1 nucleocapsid protein can prevent self-priming of minus-strand strong stop DNA by promoting the annealing of short oligonucleotides to hairpin sequences.  J Virol 74:8785-92.|4. Gao HQ, Boyer PL, Sarafianos SG, Arnold E, Hughes SH   (2000) The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase.  J Mol Biol 300:403-18.|5. Pinto VB, Prasad S, Yewdell J, Bennink J, Hughes SH   (2000) Restricting expression prolongs expression of foreign genes introduced into animals by retroviruses.  J Virol 74:10202-6.|6. Sutrave P, Leferovich JM, Kelly AM, Hughes SH   (2000) The induction of skeletal muscle hypertrophy by a ski transgene is promoter-dependent.  Gene 241:107-16.",https://intramural.nih.gov/search/searchview.taf?ipid=13833
264,BC010322-01,"October 01, 1999 -  September 30, 2000",Understanding Host-Virus Interactions in HIV Infection to Develop New Animal Mod,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Model Development Section, NCI",Andrei  Chertov|Tom  Martin|Li  Wu,NULL,NULL,NULL,"1. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, Figdor CG, van Kooyk Y   (2000) DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells.  Cell 100:587-97.",https://intramural.nih.gov/search/searchview.taf?ipid=13834
265,BC010323-01,"October 01, 1999 -  September 30, 2000","Mechanisms of Retroviral Mutation, Reverse Transcription, and Replication",Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Viral Mutation Section, NCI",Krista A Delviks-Frankenberry|Carey  Hwang|Evguenia  Svarovskaia|Rebekah A Thorick|Wen-Hui  Zhang,NULL,NULL,NULL,"1. Halvas EK, Svarovskaia ES, Freed EO, Pathak VK   (2000) Wild-type and YMDD mutant murine leukemia virus reverse transcriptases are resistant to 2',3'-dideoxy-3'-thiacytidine.  J Virol 74:6669-6674.|2. Halvas EK, Svarovskaia ES, Pathak VK   (2000) Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelity.  J Virol 74:312-9.|3. Halvas EK, Svarovskaia ES, Pathak VK   (2000) Role of murine leukemia virus reverse transcriptase deoxyribonucleoside triphosphate-binding site in retroviral replication and in vivo fidelity.  J Virol 74:10349-58.|4. Svarovskaia ES, Delviks KA, Hwang CK, Pathak VK   (2000) Structural determinants of murine leukemia virus reverse transcriptase that affect the frequency of template switching.  J Virol 74:7171-8.",https://intramural.nih.gov/search/searchview.taf?ipid=13835
266,BC010324-01,"October 01, 1999 -  September 30, 2000",Mechanisms in Retroviral Replication and Pathogenesis,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retrovirus Assembly Section, NCI",Stephen J Campbell|Ya-Xiong  Feng|Demetria P Harvin|Jane  Mirro|Delphine  Muriaux,NULL,Catherine S Hibbert  (HIV Drug Resistance Program),Masamichi  Oshima (NIAID),"1. Feng YX, Moore SP, Garfinkel DJ, Rein A   (2000) The genomic RNA in Ty1 virus-like particles is dimeric.  J Virol 74:10819-21.|2. Yuan B, Campbell S, Bacharach E, Rein A, Goff SP   (2000) Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses.  J Virol 74:7250-60.",https://intramural.nih.gov/search/searchview.taf?ipid=13836
267,BC010325-01,"October 01, 1999 -  September 30, 2000",The 2DWG Meta-Database of 2-D Electrophoretic Gel Images on the Internet,Peter F Lemkin; PhD,NULL,"Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13837
268,BC010326-01,"October 01, 1999 -  September 30, 2000",Structural Chemistry of Biomolecular Systems by X-ray Diffraction,Xinhua  Ji; PhD|IRP Faculty Profile,NULL,"Biomolecular Structure Section, NCI",Yijun  Gu|John R Knowlton,NULL,NULL,NULL,"1. Blaszczyk J, Coillie EV, Proost P, Damme JV, Opdenakker G, Bujacz GD, Wang JM, Ji X   (2000) Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors(,).  Biochemistry 39:14075-81.|2. Blaszczyk J, Shi G, Yan H, Ji X   (2000) Catalytic center assembly of HPPK as revealed by the crystal structure of a ternary complex at 125 A resolution.  Structure Fold Des 8:1049-58.|3. Gu Y, Singh SV, Ji X   (2000) Residue R216 and catalytic efficiency of a murine class alpha glutathione S-transferase toward benzo[a]pyrene 7(R),8(S)-diol 9(S), 10(R)-epoxide.  Biochemistry 39:12552-7.|4. Shi G, Gong Y, Savchenko A, Zeikus JG, Xiao B, Ji X, Yan H   (2000) Dissecting the nucleotide binding properties of Escherichia coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase with fluorescent 3'(2)'-o-anthraniloyladenosine 5'-triphosphate.  Biochim Biophys Acta 1478:289-99.",https://intramural.nih.gov/search/searchview.taf?ipid=13838
269,BC010327-01,"October 01, 1999 -  September 30, 2000",Regulation and Function of the p53 Tumor Suppressor Protein,Karen H Vousden,NULL,"Regulation of Cell Growth Laboratory, NCI",Robert L Ludwig,NULL,Eva  Balint  (Molecular Carcinogenesis Section)|Carlton J Briggs  (Molecular Carcinogenesis Section)|Marion A Lohrum  (Molecular Carcinogenesis Section)|Katsunori  Nakano  (Molecular Carcinogenesis Section)|Andrew C Phillips  (Molecular Carcinogenesis Section)|Kevin W Ryan  (Molecular Carcinogenesis Section)|Show all 7.,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13892
270,BC010328-01,"October 01, 1999 -  September 30, 2000",Function and regulation of C/EBP proteins,Peter F Johnson; PhD|IRP Faculty Profile,NULL,"Eukaryotic Transcriptional Regulation Section, NCI",Mark E Baer|Carrie A Cantwell|Victoria J Heath|Sara E Parkin|Jennifer L Wessells; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13893
271,BC010329-01,"October 01, 1999 -  September 30, 2000",Regulation of Ras-Dependent Signal Transduction Pathways,Deborah K Morrison|IRP Faculty Profile,NULL,"Cellular Growth Mechanisms Section, NCI",Carolyn B McGill|Jurgen  Muller|Daniel A Ritt,NULL,Ming  Zhou  (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10780
272,BC010330-01,"October 01, 1999 -  September 30, 2000",Regulation of Rel/NFkB-Family Transcription Factors,Nancy R Rice,NULL,"Transcriptional Controls Mechanisms Section, NCI",Marina A Dobrovolskaia|Linda L Dunn|Mary K Ernst|Lyudmila A Lyakh,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10781
273,BC010331-01,"October 01, 1999 -  September 30, 2000",Phospholipid and Sphingolipid Signaling in Drosophila,"Jairaj K Acharya; MBBS, PhD|IRP Faculty Profile",NULL,"Phospholipid Signaling Section, NCI",Usha R Acharya,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10766
274,BC010332-01,"October 01, 1999 -  September 30, 2000",Oncogene-dependent caspase activation,Howard O Fearnhead,NULL,"Apoptosis Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10767
275,BC010333-01,"October 01, 1999 -  September 30, 2000",The Segregation of Bacterial Chromosomes to Daughter Cells,Stuart J Austin|IRP Faculty Profile,NULL,"Cell Cycle Regulation Section, NCI","Therese G Brendler; BS, PhD|Yongfang  Li|Lucretia D Reaves|Kirill V Sergueev|Brenda L Youngren",NULL,James A Sawitzke  (Molecular Control and Genetics Section),NULL,"1. Brendler T, Sawitzke J, Sergueev K, Austin S   (2000) A case for sliding SeqA tracts at anchored replication forks during Escherichia coli chromosome replication and segregation.  EMBO J 19:6249-58.|2. Sawitzke JA, Austin S   (2000) Suppression of chromosome segregation defects of Escherichia coli muk mutants by mutations in topoisomerase I.  Proc Natl Acad Sci U S A 97:1671-6.|3. Sayeed S, Reaves L, Radnedge L, Austin S   (2000) The stability region of the large virulence plasmid of Shigella flexneri encodes an efficient postsegregational killing system.  J Bacteriol 182:2416-21.|4. Youngren B, Radnedge L, Hu P, Garcia E, Austin S   (2000) A plasmid partition system of the P1-P7par family from the pMT1 virulence plasmid of Yersinia pestis.  J Bacteriol 182:3924-8.",https://intramural.nih.gov/search/searchview.taf?ipid=13894
276,BC010334-01,"October 01, 1999 -  September 30, 2000",Study of the mechanisms of posttranscriptional mRNA regulation,Barbara K Felber|IRP Faculty Profile,NULL,"Human Retrovirus Pathogenesis Section, NCI",Jenifer L Bear|Daniel  Michalowski|Sergey V Smulevitch|Wei  Tan|Andrei S Zolotukhin,NULL,NULL,NULL,"1. Tan W, Zolotukhin AS, Bear J, Patenaude DJ, Felber BK   (2000) The mRNA export in Caenorhabditis elegans is mediated by Ce-NXF-1, an ortholog of human TAP/NXF and Saccharomyces cerevisiae Mex67p.  RNA 6:1762-72.",https://intramural.nih.gov/search/searchview.taf?ipid=13895
277,BC010335-01,"October 01, 1999 -  September 30, 2000",Control of Gene Expression and the Cell Cycle,Donald L Court; PhD|IRP Faculty Profile,NULL,"Molecular Control and Genetics Section, NCI",Howard K Peters|Helen R Wilson,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13896
278,BC010336-01,"October 01, 1999 -  September 30, 2000",An Efficient Recombination System for Chromosome Engineering in E. coli,Donald L Court; PhD|IRP Faculty Profile,NULL,"Molecular Control and Genetics Section, NCI",Teresa L Baker,NULL,NULL,NULL,"1. Court DL, Copeland NL, Ellis HL, Jenkins-Copeland NL, Lee EL, Liu PL, Sharan SL, Swaminathan SL, Yu DL (submitted in 2000) Enhanced Homologous Recombination Mediated By Lambda Recombination Proteins. Patents issued: 60147197.0 (DE in 2012); 1311661 (CH in 2013); 1311661 (DK in 2013); 1311661 (EP in 2013); 1311661 (ES in 2013); 1311661 (FR in 2013); 1311661 (GB in 2013); 1311661 (IT in 2013); 2419322 (CA in 2013); 1311661 (SE in 2013). Patents pending: 10184430.6 (EP application); PCT/US01/25507 (PC application); 2001283377 (AU application).",https://intramural.nih.gov/search/searchview.taf?ipid=13897
279,BC010337-01,"October 01, 1999 -  September 30, 2000",Mechanism of Transcription Elongation by RNA Polymerase II from S. cerevisiae,Mikhail V Kashlev|IRP Faculty Profile,NULL,"Molecular Mechanisms of Transcription Section, NCI",Jodi L Becker|Maria L Kireeva|Natalia  Komissarova,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13898
280,BC010338-01,"October 01, 1999 -  September 30, 2000",The Role of Fgf Signaling in Vertebrate Development,Mark B Lewandoski|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,Catherine P Wilson  (Cancer and Developmental Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13899
281,BC010339-01,"October 01, 1999 -  September 30, 2000",The Role of Rx in the Adult Retina,Mark B Lewandoski|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13900
282,BC010340-01,"October 01, 1999 -  September 30, 2000",Ty Element Retrotransposition in Saccharomyces cerevisiae,David J. Garfinkel; PhD,NULL,"Movable Genetic Elements Section, NCI",Carol L Burck|Sharon P Moore|Anuradha  Sundararajan,NULL,NULL,NULL,"1. Feng YX, Moore SP, Garfinkel DJ, Rein A   (2000) The genomic RNA in Ty1 virus-like particles is dimeric.  J Virol 74:10819-21.|2. Lee BS, Bi L, Garfinkel DJ, Bailis AM   (2000) Nucleotide excision repair/TFIIH helicases RAD3 and SSL2 inhibit short-sequence recombination and Ty1 retrotransposition by similar mechanisms.  Mol Cell Biol 20:2436-45.|3. Moore SP, Garfinkel DJ   (2000) Correct integration of model substrates by Ty1 integrase.  J Virol 74:11522-30.|4. Rattray A, Shafer B, Garfinkel DJ   (2000) The Saccharomyces cerevisiae DNA recombination and repair functions of the RAD52 epistasis group inhibit Ty1 transposition.  Genetics 154:543-556.",https://intramural.nih.gov/search/searchview.taf?ipid=13901
283,BC010341-01,"October 01, 1999 -  September 30, 2000",Protein Expression and Purification in the Fast Lane,David S Waugh; PhD|IRP Faculty Profile,NULL,"Protein Engineering Section, NCI",Jeffrey D Fox|Rachel B Kapust,NULL,NULL,NULL,"1. Eisenmesser EZ, Kapust RB, Nawrocki JP, Mazzulla MJ, Pannell LK, Waugh DS, Byrd RA   (2000) Expression, purification, refolding, and characterization of recombinant human interleukin-13: utilization of intracellular processing.  Protein Expr Purif 20:186-95.|2. Kapust RB, Waugh DS   (1999) Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused.  Protein Sci 8:1668-74.|3. Kapust RB, Waugh DS   (2000) Controlled intracellular processing of fusion proteins by TEV protease.  Protein Expr Purif 19:312-8.|4. Kireeva M, Komissarova N, Waugh DS, Kashlev M   (2000) The 8-Nucleotide-long RNA:DNA Hybrid Is a Primary Stability Determinant of the RNA Polymerase II Elongation Complex.  J Biol Chem 275:65306536.",https://intramural.nih.gov/search/searchview.taf?ipid=13902
284,BC010342-01,"October 01, 1999 -  September 30, 2000",Structural Biology of Virulence Mechanisms in Potential Agents of Bioterrorism,David S Waugh; PhD|IRP Faculty Profile,NULL,"Protein Engineering Section, NCI",Artem G Evdokimov,NULL,NULL,NULL,"1. Evdokimov AG, Anderson DE, Routzahn KM, Waugh DS   (2000) Overproduction, purification, crystallization and preliminary X-ray diffraction analysis of YopM, an essential virulence factor extruded by the plague bacterium Yersinia pestis.  Acta Crystallogr D Biol Crystallogr 56:1676-1679.",https://intramural.nih.gov/search/searchview.taf?ipid=13903
285,BC010343-01,"October 01, 1999 -  September 30, 2000",Transcription Through Nucleosomes by RNA Polymerase II (Pol II) from the Yeast <,Mikhail V Kashlev|IRP Faculty Profile,NULL,"Molecular Mechanisms of Transcription Section, NCI",Jodi L Becker|Maria L Kireeva|Natalia  Komissarova,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13904
286,BC010344-01,"October 01, 1999 -  September 30, 2000",Mechanism of Intrinsic Transcription Termination by E. coli RNA Polymerase,Mikhail V Kashlev|IRP Faculty Profile,NULL,"Molecular Mechanisms of Transcription Section, NCI",Jodi L Becker|Maria L Kireeva|Natalia  Komissarova,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13905
287,BC010345-01,"October 01, 1999 -  September 30, 2000",The Role of Wnt Genes in Vertebrate Development,Terence P Yamaguchi; PhD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13906
288,BC010346-01,"October 01, 1999 -  September 30, 2000",Structural Biology of Proteins Involved in Signal Transduction and Regulation of,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Uknown organization, NCI",NULL,NULL,Amanda S Altieri; PhD  (Macromolecular NMR Section)|R Heath Coats  (Macromolecular NMR Section)|David A Horita  (Macromolecular NMR Section)|Frederick Y Luh  (Macromolecular NMR Section)|Steven W Sparks  (Structural Biophysics Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13907
289,BC010347-01,"October 01, 1999 -  September 30, 2000",Design of Drugs Against Cancer and Viral Diseases,Christopher J Michejda; PhD,NULL,"Molecular Aspects of Drug Design Section, NCI",David W Farnsworth|Weiying  Pan; PhD|Nadya I Tarasova; PhD,NULL,Sergey G Tarasov  (Structural Biophysics Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13908
290,BC010348-01,"October 01, 1999 -  September 30, 2000",Protein Structure,Alexander  Wlodawer; PhD|IRP Faculty Profile,NULL,"Program in Structural Biology, NCI",NULL,NULL,Ingrid  Ponten; PhD (National Cancer Institute)|Istvan  Botos; PhD  (Protein Structure Section)|Changsoo  Chang  (Protein Structure Section)|David M Hoover  (Protein Structure Section)|Alexander S Zdanov  (Protein Structure Section),Maria E Miller (CIT),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13909
291,BC010349-01,"October 01, 1999 -  September 30, 2000",Genomic Imprinting in Development and Disease,Colin L Stewart; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI",NULL,NULL,Aboubaker  Elkharroubi  (Mammalian Developmental Biology Section)|John P Hagan  (Mammalian Developmental Biology Section)|Shoichi  Sunahara  (Mammalian Developmental Biology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13910
292,BC010350-01,"October 01, 1999 -  September 30, 2000",Study of pathogenicity and immunogenicity of attenuated Rev-independent HIV and,Barbara K Felber|IRP Faculty Profile,NULL,"Human Retrovirus Pathogenesis Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13911
293,BC010376-01,"October 01, 1999 -  September 30, 2000",Leukemia Inhibitory Factor and Embryo Development,Colin L Stewart; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI",NULL,NULL,Jr Gang  Cheng  (Mammalian Developmental Biology Section)|Diana M Escalante Alcade  (Mammalian Developmental Biology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13912
294,BC010377-01,"October 01, 1999 -  September 30, 2000",The Nuclear Envelope in Development and Disease,Colin L Stewart; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI",NULL,NULL,Diana M Escalante Alcade  (Mammalian Developmental Biology Section)|Teresa L Sullivan  (Mammalian Developmental Biology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13913
295,BC010378-01,"October 01, 1999 -  September 30, 2000",Macromolecular Crystallography Activity at Beamline X9B of the National Synchrot,Zbigniew  Dauter|IRP Faculty Profile,NULL,"Synchrotron Radiation Research Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13914
296,BC010379-01,"October 01, 1999 -  September 30, 2000",Search for the Structural Basis of Biomacromolecular Function and Activity,Yun  Wang,NULL,"Nucleic Acid NMR Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13915
297,BC010380-01,"October 01, 1999 -  September 30, 2000",Recombination and Regulation,Jeffrey N Strathern,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,NULL,Deanna R Gotte  (Genome Recombination and Regulation Section)|Dwight V Nissley  (Genome Recombination and Regulation Section)|Alison J Rattray  (Genome Recombination and Regulation Section)|Brenda K Shafer  (Genome Recombination and Regulation Section),Edward H Davis (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13916
298,BC010381-01,"October 01, 1999 -  September 30, 2000",Studies on Silencing,Amar J S Klar; PhD,NULL,"Developmental Genetics Section, NCI",Michael J Bonaduce|Gurjeet  Singh,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13917
299,BC010382-01,"October 01, 1999 -  September 30, 2000",Chemotherapy Adjuvants,Robert C Moschel; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI",NULL,NULL,Monica D Cooper  (Carcinogen Modified Nucleic Acid Chemistry Section)|David E Mire  (Carcinogen Modified Nucleic Acid Chemistry Section)|Gary T Pauly  (Carcinogen Modified Nucleic Acid Chemistry Section),NULL,"1. Friedman H, Pluda J, Quinn J, Ewesuedo R, Long L, Friedman A, Cokgor I, Colvin O, Haglund M, Ashley D, Rich J, Sampson J, Pegg A, Moschel RC, McLendon R, Provenzale J, Stewart E, Tourt-Uhlig S, Garcia-Turner A, Herndon II J, Bigner D, Dolan M   (2000) Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.  J Clin Oncol 18:3522-3528.|2. Long LM, Berg SL, Roy S, McCully CL, Song-Yoo HW, Moschel RC, Balis FM, Dolan MF   (2000) Plasma and cerebrospinal fluid pharmacokinetics of O6-benzylguanine and analogs in non-human primates.  Clin Cancer Res 6:3662-9.",https://intramural.nih.gov/search/searchview.taf?ipid=13918
300,BC010383-01,"October 01, 1999 -  September 30, 2000",Chemistry and Mutagenicity of Site-Specific Carcinogen-DNA Damage,Robert C Moschel; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI",NULL,NULL,Gary T Pauly  (Carcinogen Modified Nucleic Acid Chemistry Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13919
301,BC010384-01,"October 01, 1999 -  September 30, 2000",Mechanisms of Chemical Carcinogenesis,Robert C Moschel; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI",NULL,NULL,Leilani A Ramos  (Molecular Aspects of Chemical Carcinogenesis Section),NULL,"1. Friedman H, Pluda J, Quinn J, Ewesuedo R, Long L, Friedman A, Cokgor I, Colvin O, Haglund M, Ashley D, Rich J, Sampson J, Pegg A, Moschel RC, McLendon R, Provenzale J, Stewart E, Tourt-Uhlig S, Garcia-Turner A, Herndon II J, Bigner D, Dolan M   (2000) Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.  J Clin Oncol 18:3522-3528.|2. Kokkinakis D, Moschel RC, Pegg A, Schold S   (2000) Potentiation of BCNU antitumor efficacy by 9-substituted O6-benzylguanines Effect of metabolism.  Cancer Chemother Pharmacol 45:69-77.",https://intramural.nih.gov/search/searchview.taf?ipid=13920
302,BC010385-01,"October 01, 1999 -  September 30, 2000",Studies on mat1 Imprinting,Amar J S Klar; PhD,NULL,"Developmental Genetics Section, NCI",Michael J Bonaduce,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13921
303,BC010386-01,"October 01, 1999 -  September 30, 2000",Human Handedness Studies,Amar J S Klar; PhD,NULL,"Developmental Genetics Section, NCI",Joy F Sabl,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13922
304,BC010387-01,"October 01, 1999 -  September 30, 2000",Functional Analysis of Breast Cancer Susceptibility Genes in Mice,Shyam K Sharan|IRP Faculty Profile,NULL,"Genetics of Cancer Susceptibility Section, NCI",NULL,NULL,Yong-Tae  Ahn  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13923
305,BC010388-01,"October 01, 1999 -  September 30, 2000",Computer-Aided Drug Design (CADD) MiniCore Facility Project: HIV Integrase Model,Victor  Marquez; PhD,NULL,"ORGANIC CHEMSTRY SECT, NCI",Yun  Tang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13924
306,BC010389-01,"October 01, 1999 -  September 30, 2000",Computer-Aided Drug Design (CADD) MiniCore Facility Project: The Open NCI Databa,Victor  Marquez; PhD,NULL,"ORGANIC CHEMSTRY SECT, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13925
307,BC010390-01,"October 01, 1999 -  September 30, 2000",Role of Neurotrophins and Their Receptors in the Development of the Mammalian Ne,Lino  Tessarollo|IRP Faculty Profile,NULL,"Neural Development Section, NCI",Vincenzo  Coppola|Pedro F Esteban|Mary Ellen  Palko,NULL,NULL,Javier  Martinez De Velasco (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13926
308,BC010391-01,"October 01, 1999 -  September 30, 2000",Role of Neurotrophins and Their Receptors in Nonneuronal Organ Development,Lino  Tessarollo|IRP Faculty Profile,NULL,"Neural Development Section, NCI",Mary Ellen  Palko,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13927
309,BC010392-01,"October 01, 1999 -  September 30, 2000",Myeloid Leukemia: Disease Gene Identification and Mouse Model Development,Neal G Copeland; PhD,NULL,"Mouse Cancer Genetics Program, NCI",Deborah A Swing,NULL,Linda S Cleveland  (Molecular Genetics of Oncogenesis Section)|Debra J Gilbert  (Molecular Genetics of Development Section)|Tomoyuki  Hisa  (Molecular Genetics of Oncogenesis Section)|Pentao  Liu  (Molecular Genetics of Oncogenesis Section)|Sally E Spence  (Molecular Genetics of Development Section)|Naoyuki  Yahata  (Molecular Genetics of Development Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13928
310,BC010393-01,"October 01, 1999 -  September 30, 2000",Interspecific Backcross Mapping and the Development of New Genetic Tools,Neal G Copeland; PhD,NULL,"Mouse Cancer Genetics Program, NCI",Deborah A Swing,NULL,Linda S Cleveland  (Molecular Genetics of Oncogenesis Section)|Debra J Gilbert  (Molecular Genetics of Development Section)|Deborah B Householder  (Molecular Genetics of Oncogenesis Section)|Pentao  Liu  (Molecular Genetics of Oncogenesis Section),Andree  Reuss; MA (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13929
311,BC010394-01,"October 01, 1999 -  September 30, 2000",A Genetic Approach to the Study of Pigment Granule Transport,Nancy  Jenkins-Copeland; PhD,NULL,"Molecular Genetics of Development Section, NCI",Scott M Wilson,NULL,Linda S Cleveland  (Molecular Genetics of Oncogenesis Section)|Deborah A Swing  (Mouse Cancer Genetics Program),Andree  Reuss; MA (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13930
312,BC010395-01,"October 01, 1999 -  September 30, 2000",Molecular Genetic Characterization of the Mitf-Tfe Family of bHLH-Zip Transcript,Nancy  Jenkins-Copeland; PhD,NULL,"Molecular Genetics of Development Section, NCI",NULL,NULL,Linda S Cleveland  (Molecular Genetics of Oncogenesis Section)|Deborah A Swing  (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13931
313,BC010396-01,"October 01, 1999 -  September 30, 2000",Understanding Neural Development Through the Use of Classical and Induced Mouse,Nancy  Jenkins-Copeland; PhD,NULL,"Molecular Genetics of Development Section, NCI",Scott M Wilson,NULL,Linda S Cleveland  (Molecular Genetics of Oncogenesis Section)|Deborah B Householder  (Molecular Genetics of Oncogenesis Section)|Deborah A Swing  (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13932
314,BC010397-01,"October 01, 1999 -  September 30, 2000",Pathogenic Mechanisms of HIV,"George N Pavlakis; MD, PhD|IRP Faculty Profile",NULL,"Human Retrovirus Section, NCI",Patricia A Eyler|Margherita  Rosati|Olga R Slobodskaya|Antonio L Valentin,NULL,Maria  Tsopanomichalou  (National Cancer Institute),NULL,"1. Valentin A, Trivedi H, Lu W, Kostrikis LG, Pavlakis GN   (2000) CXCR4 mediates entry and productive infection of syncytia-inducing (X4) HIV-1 strains in primary macrophages.  Virology 269:294-304.|2. Franchini G, Hel Z, Pavlakis G, Tartaglia J (submitted in 2000) Immunogenicity Using A Combination Of Dna And Vaccinia Virus Vector Vaccines. Patent issued: 7,771,729 (US in 2010). Patents pending: 01932792.3 (EP application); 2001-579837 (JP application); 60/200,444 (US application); 10/258,570 (US application); 12/845,350 (US application); 2001259291 (AU application); 2407303 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=13933
315,BC010399-01,"October 01, 1999 -  September 30, 2000",NMR Core Facility Project: Structural Analysis of Conformationally Biased Nuclei,Victor  Marquez; PhD,NULL,"ORGANIC CHEMSTRY SECT, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13934
316,BC010401-01,"October 01, 1999 -  September 30, 2000",Inhibition of TNF-alpha gene transcription in macrophages,Peter F Johnson; PhD|IRP Faculty Profile,NULL,"Eukaryotic Transcriptional Regulation Section, NCI",Mark E Baer|Jennifer L Wessells; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13935
317,BC010411-01,"October 01, 1999 -  September 30, 2000",Initiation of DNA replication in Mammalian Cells,Mirit I Aladjem; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Ajay K Sharma,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13936
318,BC010412-01,"October 01, 1999 -  September 30, 2000",Structural Analysis of Macromolecular Complexes by High Resolution Electron Micr,Jacqueline L Milne,NULL,"Laboratory of Cell Biology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13937
319,BC010413-01,"October 01, 1999 -  September 30, 2000",Organization and Function of Chromosomal Regions that are Required for Stability,"Vladimir L Larionov; PhD, DSc|IRP Faculty Profile",NULL,"Office of the Director, NCI",NULL,NULL,Maxim  Koryabin  (Genome Structure and Function Section)|Natalay  Kouprina  (Genome Structure and Function Section)|Vladimir  Noskov; PhD  (Genome Structure and Function Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13938
320,BC010414-01,"October 01, 1999 -  September 30, 2000",Signal transduction during T-lymphocyte differentiation,"Remy J Bosselut; MD, PhD|IRP Faculty Profile",NULL,"Lymphocyte Development Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13939
321,BC010415-01,"October 01, 1999 -  September 30, 2000",GDNF/c-RET signaling during mammalian development and diseases,Liya  Shen; PhD,NULL,"Laboratory of Cellular Carcinogenesis and Tumor Promotion, NCI",Yang  Chang,NULL,NULL,NULL,"1. Granholm AC, Reyland M, Albeck D, Sanders L, Gerhardt G, Hoernig G, Shen L, Westphal H, Hoffer B   (2000) Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons.  J Neurosci 20:3182-90.|2. Messer CJ, Eisch AJ, Carlezon WA, Whisler K, Shen L, Wolf DH, Westphal H, Collins F, Russell DS, Nestler EJ   (2000) Role for GDNF in biochemical and behavioral adaptations to drugs of abuse.  Neuron 26:247-57.|3. Oppenheim RW, Houenou LJ, Parsadanian AS, Prevette D, Snider WD, Shen L   (2000) Glial cell line-derived neurotrophic factor and developing mammalian motoneurons: regulation of programmed cell death among motoneuron subtypes.  J Neurosci 20:5001-11.",https://intramural.nih.gov/search/searchview.taf?ipid=13940
322,BC010416-01,"October 01, 1999 -  September 30, 2000",Regulation of Secretory and Membrane Protein Biogenesis,"Ramanujan S Hegde; MD, PhD",NULL,"Laboratory of Cellular Oncology, NCI",Brigette  Bogert|Soo J Kim,NULL,NULL,NULL,"1. Wilhelm JE, Vale RD, Hegde RS   (2000) Coordinate control of translation and localization of Vg1 mRNA in Xenopus oocytes.  Proc Natl Acad Sci U S A 97:13132-7.",https://intramural.nih.gov/search/searchview.taf?ipid=13941
323,BC010417-01,"October 01, 1999 -  September 30, 2000","Cell Senescence, Carcinogenesis, and Aging",James Carl Barrett; PhD,NULL,"Office of the Director, NCI",NULL,NULL,Natalay  Kouprina  (Genome Structure and Function Section),NULL,"1. Tsutsui T, Tamura Y, Suzuki A, Hirose Y, Kobayashi M, Nishimura H, Metzler M, Barrett JC   (2000) Mammalian cell transformation and aneuploidy induced by five bisphenols.  Int J Cancer 86:151-4.|2. Barrett JC   (2000) Genetic basis for replicative cellular senescence of human cells Gerontological Approaches to Care for the Aged in the 21st Century.  Proceedings of the 6th Asia/Oceania Regional congress of Geroontology. 2000:3-9.",https://intramural.nih.gov/search/searchview.taf?ipid=13942
324,BC010418-01,"October 01, 1999 -  September 30, 2000",Signal Transduction and Cell Migration,Carole A Parent; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,Paul W Kriebel  (CELLULAR FUNCTION SECT),NULL,"1. Parent CA   (2000) Dictystelium cell dynamics, in Current Protocols in Cell Biology. Bonifacino JS, Dasso M, LippincottSchwartz J, Hartford JB, Yamada KM, eds., John Wiley & Sons Press (New York) Volume 1,  pp. Unit12.5.|2. Weiner O, Servant G, Parent CA, Devreotes P, Bourne H   (2000) Cell polarity in response to chemoattractants in Cell polarity, in Frontiers in Molecular Biology. Drubin DG, Hames BD, Glover DM, eds., Oxford University Press (New York), pp. 201-239.|3. Jin T, Zhang N, Long Y, Parent CA, Devreotes PN   (2000) Localization of the G protein betagamma complex in living cells during chemotaxis.  Science 287:1034-6.|4. Patel H, Guo K, Parent C, Gross J, Devreotes PN, Weijer CJ   (2000) A temperature-sensitive adenylyl cyclase mutant of Dictyostelium.  EMBO J 19:2247-56.",https://intramural.nih.gov/search/searchview.taf?ipid=13943
325,BC010419-01,"October 01, 1999 -  September 30, 2000",Molecular mechanisms of TGF-beta signaling pathway,Ying  Zhang|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Zareena  Hussain,NULL,NULL,NULL,"1. Qing J, Zhang Y, Derynck R   (2000) Structural and functional characterization of the transforming growth factor-beta -induced Smad3/c-Jun transcriptional cooperativity.  J Biol Chem 275:38802-12.|2. Zhang Y, Derynck R   (2000) Transcriptional regulation of the transforming growth factor-beta -inducible mouse germ line Ig alpha constant region gene by functional cooperation of Smad, CREB, and AML family members.  J Biol Chem 275:16979-85.",https://intramural.nih.gov/search/searchview.taf?ipid=13944
326,BC010420-01,"October 01, 1999 -  September 30, 2000",De Novo Methylation and Cancer,Keith D Robertson; PhD,NULL,"Hormone Action and Oncogenesis Section, NCI",NULL,NULL,NULL,NULL,"1. Liang G, Robertson KD, Talmadge C, Sumegi J, Jones PA   (2000) The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells.  Cancer Res 60:4907-12.|2. Robertson KD   (2000) The role of DNA methylation in modulating Epstein-Barr virus gene expression.  Curr Top Microbiol Immunol 249:21-34.|3. Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones PL, Wolffe AP   (2000) DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters.  Nat Genet 25:338-42.|4. Robertson KD, Jones PA   (2000) DNA methylation: past, present and future directions.  Carcinogenesis 21:461-7.|5. Robertson KD, Keyomarsi K, Gonzales FA, Velicescu M, Jones PA   (2000) Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G(0)/G(1) to S phase transition in normal and tumor cells.  Nucleic Acids Res 28:2108-13.|6. Robertson KD, Wolffe AP   (2000) DNA methylation in health and disease.  Nat Rev Genet 1:11-9.",https://intramural.nih.gov/search/searchview.taf?ipid=13945
327,BC010421-01,"October 01, 1999 -  September 30, 2000",Mechanisms of G2/M cell cycle checkpoint controls,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",NULL,NULL,NULL,NULL,"1. Yang Q, Manicone A, Coursen JD, Linke SP, Nagashima M, Forgues M, Wang XW   (2000) Identification of a functional domain in a GADD45-mediated G2/M checkpoint.  J Biol Chem 275:36892-8.|2. Yoo JY, Wang XW, Rishi AK, Lessor T, Xia XM, Gustafson TA, Hamburger AW   (2000) Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin.  Br J Cancer 82:683-90.",https://intramural.nih.gov/search/searchview.taf?ipid=13946
328,BC010422-01,"October 01, 1999 -  September 30, 2000",Immune-based Therapy in HIV Disease,Gene  Shearer; PhD|IRP Faculty Profile,NULL,"Cell Mediated Immunity Section, NCI",Edith  Grene|Ligia  Pinto|Naomi I Torres,NULL,Vesna  Blazevic  (National Cancer Institute),NULL,"1. Blazevic V, Mac Trubey C GM, Shearer G   (2000) Comparison of in vitro immunostimulatory potential of live and inactivated influenza viruses.  Hum Immunol 61:845-9.|2. Blazevic V, Pinto LA, Trubey CM, Shearer GM   (2000) Alloantigenic stimulation bypasses CD28-B7 costimulatory blockade by an interleukin-2-dependent mechanism.  J Leukoc Biol 67:817-24.|3. Blazevic V, Sahgal N, Kessler HA, Landay AL, Shearer GM   (2000) T cell responses to recall antigens, alloantigen, and mitogen of HIV-infected patients receiving long-term combined antiretroviral therapy.  AIDS Res Hum Retroviruses 16:1887-93.|4. Grene E, Newton DA, Brown EA, Berzofsky JA, Gattoni-Celli S, Shearer GM   (2000) Semi-allogeneic cell hybrids stimulate HIV-1 envelope-specific cytotoxic T lymphocytes.  AIDS 14:1497-506.|5. Grene E, Pinto LA, Kwak-Kim JY, Giorgi JV, Landay AL, Kessler HA, Beer AE, Shearer GM   (2000) Increased levels of anti-CCR5 antibodies in sera from individuals immunized with allogeneic lymphocytes.  AIDS 14:2627-8.|6. Hel Z, Venzon D, Poudyal M, Tsai WP, Giuliani L, Woodward R, Chougnet C, Shearer G, Altman JD, Watkins D, Bischofberger N, Abimiku A, Markham P, Tartaglia J, Franchini G   (2000) Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques.  Nat Med 6:1140-6.|7. Lehner T, Shearer GM, Hackett CJ, Schultz A, Sharma OK   (2000) Alloimmunization as a strategy for vaccine design against HIV/AIDS.  AIDS Res Hum Retroviruses 16:309-13.|8. Pinto LA, Blazevic V, Patterson BK, Mac Trubey C MJ, Dolan GM, Shearer G   (2000) Inhibition of human immunodeficiency virus type 1 replication prior to reverse transcription by influenza virus stimulation.  J Virol 74:4505-11.|9. Pinto LA, Blazevic V, Shearer GM, Patterson BK, Dolan MJ   (2000) Alloantigen-induced anti-HIV activity occurs prior to reverse transcription and can be generated by leukocytes from HIV-infected individuals.  Blood 95:1875-6.|10. Pinto LA, Shearer GM, Blazevic V   (2000) Immune-based approaches for control of HIV infection and viral-induced immunopathogenesis.  Clin Immunol 97:1-8.",https://intramural.nih.gov/search/searchview.taf?ipid=13947
329,BC010423-01,"October 01, 1999 -  September 30, 2000",Roles of Akt/PKB and IKK Complex in Constitutive Induction of NF-,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI",NULL,NULL,Valentina  Factor  (Cellular and Molecular Biology Section)|Tanya N Hoang  (Cellular and Molecular Biology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13948
330,BC010424-01,"October 01, 1999 -  September 30, 2000",Hypoxia and Tumorigenesis,Eric  Huang; MD,NULL,"Laboratory of Human Carcinogenesis, NCI",NULL,NULL,Jie  Gu  (Molecular Genetics and Carcinogenesis Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13949
331,BC010425-01,"October 01, 1999 -  September 30, 2000",Development of Vaccines and Vaccine Strategies for Human Cancer,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",NULL,NULL,"Philip M Arlen; MD  (Experimental Oncology Section)|John  Greiner; PhD  (Experimental Oncology Section)|Douglas  Grosenbach  (Experimental Oncology Section)|James W Hodge; PhD  (Experimental Oncology Section)|Kwong Yok Tsang  (Experimental Oncology Section)|Mingzhu  Zhu; MD, PhD  (Experimental Oncology Section)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13950
332,BC010426-01,"October 01, 1999 -  September 30, 2000",T-Cell Costimulation in the Design of Cancer Vaccines,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",NULL,NULL,John  Greiner; PhD  (Experimental Oncology Section)|Douglas  Grosenbach  (Experimental Oncology Section)|James W Hodge; PhD  (Experimental Oncology Section)|Helen B Sabzevari  (Experimental Oncology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13951
333,BC010427-01,"October 01, 1999 -  September 30, 2000",Mechanism of Human T-Cell Activation,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",NULL,NULL,Douglas  Grosenbach  (Experimental Oncology Section)|James W Hodge; PhD  (Experimental Oncology Section)|Helen B Sabzevari  (Experimental Oncology Section)|Kwong Yok Tsang  (Experimental Oncology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13952
334,BC010428-01,"October 01, 1999 -  September 30, 2000",Cytokines as Biologic Adjuvants,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",NULL,NULL,John  Greiner; PhD  (Experimental Oncology Section)|James W Hodge; PhD  (Experimental Oncology Section)|Eva  Reali  (Experimental Oncology Section),NULL,"1. Schlom J, Greiner J, Kass E, Panicali D (submitted in 2000) A Recombinant Non-replicating Virus Expressing Gm-csf And Uses Thereof To Enhance Immune Responses. Patent issued: 2412050 (CA in 2011). Patents pending: 01946395.9 (EP application); 03105975.5 (HK application); 2002-510097 (JP application); PCT/US01/19201 (PC application); 60/211,717 (US application); 10/297,168 (US application); 2001268452 (AU application).",https://intramural.nih.gov/search/searchview.taf?ipid=13953
335,BC010429-01,"October 01, 1999 -  September 30, 2000",Novel Recombinant Immunoglobulin Forms for Cancer Therapy and Diagnosis,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",NULL,NULL,Philip M Arlen; MD  (Experimental Oncology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13954
336,BC010430-01,"October 01, 1999 -  September 30, 2000","Bni5, a novel cytokinetic component important for the stability of septin ring s",Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13955
337,BC010431-01,"October 01, 1999 -  September 30, 2000",A Metastasis Suppressor Gene For Prostatic Cancer,James Carl Barrett; PhD,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,"1. Dunn SE, Torres JV, Nihei N, Barrett JC   (2000) The insulin-like growth factor-1 elevates urokinase-type plasminogen activator-1 in human breast cancer cells: a new avenue for breast cancer therapy.  Mol Carcinog 27:10-7.",https://intramural.nih.gov/search/searchview.taf?ipid=13956
338,CP004410-24,"October 01, 1999 -  September 30, 2000",Family Studies,Margaret Anne Tucker|IRP Faculty Profile,NULL,"Genetic Epidemiology Branch, NCI",Lynn Rachel Goldin; PhD|Mary C Fraser|Naoko  Ishibe; ScD|Mary Louise McMaster; MD|Dawn E McNeil; MD|Maria T Sgambati,NULL,"Neil Edward Caporaso; MS, MD  (Pharmacogenetics Sect)|Gladys M. Glenn; MD, PhD  (Family Studies Sect)|Alisa  Goldstein; PhD  (Population And Statistical Genetics Sect)|Dilys  Parry; PhD  (Family Studies Sect)",NULL,"1. Bai Y, Goldin L, Goldstein A   (2000) Gene-Environment Interaction from Case-Control and Case-Case Approaches.  Genet Epidemiol, in press.|2. Ciotti P, Struewing JP, Mantelli M, Chompret A, Avril MF, Santi PL, Tucker MA, Bianchi-Scarra G   (2000) A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families.  Am J Hum Genet 67:311-9.|3. Goldstein AM, Martinez M, Tucker MA, Demenais F   (2000) Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families.  Cancer Epidemiol Biomarkers Prev 9:889-94.|4. Goldstein AM, Struewing JP, Chidambaram A, Fraser MC, Tucker MA   (2000) Genotype-phenotype relationships in US melanoma-prone families with CDKN2A and CDK4 mutations.  J Natl Cancer Inst 92:1006-10.|5. Harland M, Holland EA, Ghiorzo P, Mantelli M, Bianchi-Scarra G, Goldstein AM, Tucker MA, Ponder BA, Mann GJ, Bishop DT, Newton Bishop J   (2000) Mutation screening of the CDKN2A promoter in melanoma families.  Genes Chromosomes Cancer 28:45-57.|6. Kluwe L, Mautner V, Parry DM, Jacoby LB, Baser M, Gusella J, Davis K, Stavrou D, MacCollin M   (2000) The parental origin of new mutations in neurofibromatosis 2.  Neurogenetics 3:17-24.|7. Libutti SK, Choyke PL, Alexander HR, Glenn G, Bartlett DL, Zbar B, Lubensky I, McKee SA, Maher ER, Linehan WM, Walther MM   (2000) Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease.  Surgery 128:1022-7;discussion 1027-8.|8. Lim DJ, Rubenstein AE, Evans DG, Jacks T, Seizinger BG, Baser ME, Beebe D, Brackmann DE, Chiocca EA, Fehon RG, Giovannini M, Glazer R, Gusella JF, Gutmann DH, Korf B, Lieberman F, Martuza R, McClatchey AI, Parry DM, Pulst SM, Ramesh V, Ramsey WJ, Ratner N, Rutkowski JL, Ruttledge M, et al. [1 more author]   (2000) Advances in neurofibromatosis 2 (NF2): a workshop report.  J Neurogenet 14:63-106.|9. Sgambati MT, Stolle C, Choyke PL, Walther MM, Zbar B, Linehan WM, Glenn GM   (2000) Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents.  Am J Hum Genet 66:84-91.|10. Shennan MG, Badin AC, Walsh S, Summers A, From L, McKenzie M, Goldstein AM, Tucker MA, Hogg D, Lassam N   (2000) Lack of germline CDK6 mutations in familial melanoma.  Oncogene 19:1849-52.|11. Tucker M   (2000) Major cancer susceptibility genes and radiation: what do we know?  Radiat Res 154:740-1.",https://intramural.nih.gov/search/searchview.taf?ipid=10425
339,CP005779-06,"October 01, 1999 -  September 30, 2000",Epidemiology and Natural History of Human Immunodeficiency Viruses,"Thomas R O'Brien; BA, MPH, MD|IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Cleghorn FR, Jack N, Carr JK, Edwards J, Mahabir B, Sill A, McDanal CB, Connolly SM, Goodman D, Bennetts RQ, O'Brien TR, Weinhold KJ, Bartholomew C, Blattner WA, Greenberg ML   (2000) A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago.  Proc Natl Acad Sci U S A 97:10532-7.|2. Hisada M, O'Brien TR, Rosenberg PS, Goedert JJ   (2000) Virus load and risk of heterosexual transmission of human immunodeficiency virus and hepatitis C virus by men with hemophilia The Multicenter Hemophilia Cohort Study.  J Infect Dis 181:1475-8.|3. Masel J, Arnaout RA, O'Brien TR, Goedert JJ, Lloyd AL   (2000) Fluctuations in HIV-1 viral load are correlated to CD4+ T-lymphocyte count during the natural course of infection.  J Acquir Immune Defic Syndr 23:375-9.|4. McDermott DH, Colla JS, Kleeberger CA, Plankey M, Rosenberg PS, Smith ED, Zimmerman PA, Combadiere C, Leitman SF, Kaslow RA, Goedert JJ, Berger EA, O'Brien TR, Murphy PM   (2000) Genetic polymorphism in CX3CR1 and risk of HIV disease.  Science 290:2031.|5. O'Brien TR, McDermott DH, Ioannidis JP, Carrington M, Murphy PM, Havlir DV, Richman DD   (2000) Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy.  AIDS 14:821-6.|6. Yeo AE, Matsumoto A, Hisada M, Shih JW, Alter HJ, Goedert JJ   (2000) Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia Multicenter Hemophilia Cohort Study.  Ann Intern Med 132:959-63.",https://intramural.nih.gov/search/searchview.taf?ipid=10423
340,CP005780-06,"October 01, 1999 -  September 30, 2000",Epidemiology and Natural History of Human T-cell Lymphotropic Viruses,James Jerome Goedert; MD,NULL,"Infection & Immunoepidemiology Branch, NCI","Robert  Biggar; MD|Michie  Hisada; MD, MPH, ScD|Elizabeth M Maloney",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10424
341,CP005781-06,"October 01, 1999 -  September 30, 2000",HIV and AIDS-Associated Cancers,Charles  Rabkin|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",NULL,NULL,"Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)|Robert  Biggar; MD  (Infection & Immunoepidemiology Branch)|James Jerome Goedert; MD  (Infection & Immunoepidemiology Branch)|Thomas R O'Brien; BA, MPH, MD  (Infection & Immunoepidemiology Branch)",NULL,"1. Biggar RJ, Frisch M   (2000) Estimating the Risk of Cancer in Children With AIDS.  JAMA 284:2593-2594.|2. Biggar RJ, Frisch M, Goedert JJ   (2000) Risk of cancer in children with AIDS AIDS-Cancer Match Registry Study Group.  JAMA 284:205-9.|3. Engels EA, Frisch M, Biggar RJ, Goedert JJ   (2000) AIDS-Related opportunistic illness and potent antiretroviral therapy.  JAMA 283:2653-4.|4. Frisch M, Biggar RJ, Goedert JJ   (2000) Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome.  J Natl Cancer Inst 92:1500-10.|5. Rabkin CS   (2000) AIDS and cancer in the era of highly active antiretroviral therapy (HAART).  Eur J Cancer 37:1316-9.|6. Rabkin CS   (2000) The need for investigations of prophylactic regimens to prevent AIDS-associated non-Hodgkin's lymphoma.  Clin Infect Dis 30:762-3.|7. Zhang YJ, Deng JH, Rabkin C, Gao SJ   (2000) Hot-spot variations of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen and application in genotyping by PCR-RFLP.  J Gen Virol 81 Pt 8:2049-58.",https://intramural.nih.gov/search/searchview.taf?ipid=10422
342,CP005782-06,"October 01, 1999 -  September 30, 2000",Epidemiology of Oncogenic Viruses,James Jerome Goedert; MD,NULL,"Infection & Immunoepidemiology Branch, NCI","Eric Andrew Engels; PhD|Robert  Biggar; MD|Michie  Hisada; MD, MPH, ScD|Elizabeth M Maloney|Thomas R O'Brien; BA, MPH, MD",NULL,Charles  Rabkin  (Clinical Genetics Branch),NULL,"1. Frisch M, Hjalgrim H, Jaeger AB, Biggar RJ   (2000) Changing patterns of tonsillar squamous cell carcinoma in the United States.  Cancer Causes Control 11:489-95.|2. Hayes RB, Pottern LM, Strickler H, Rabkin C, Pope V, Swanson GM, Greenberg RS, Schoenberg JB, Liff J, Schwartz AG, Hoover RN, Fraumeni JF   (2000) Sexual behaviour, STDs and risks for prostate cancer.  Br J Cancer 82:718-25.|3. Hisada M, Rabkin CS, Strickler HD, Wright WE, Christianson RE, van den Berg BJ   (2000) Human papillomavirus antibody and risk of prostate cancer.  JAMA 283:340-1.|4. Maloney EM, Hisada M, Palmer P, Brooks K, Pate E, Wiktor SZ, Lagrenade L, Manns A   (2000) Human T cell lymphotropic virus type I-associated infective dermatitis in Jamaica: a case report of clinical and biologic correlates.  Pediatr Infect Dis J 19:560-5.|5. Seeff LB, Miller RN, Rabkin CS, Buskell-Bales Z, Straley-Eason KD, Smoak BL, Johnson LD, Lee SR, Kaplan EL   (2000) 45-year follow-up of hepatitis C virus infection in healthy young adults.  Ann Intern Med 132:105-11.",https://intramural.nih.gov/search/searchview.taf?ipid=10420
343,CP005803-06,"October 01, 1999 -  September 30, 2000",Genetic Epidemiology,Alisa  Goldstein; PhD|IRP Faculty Profile,NULL,"Population And Statistical Genetics Sect, NCI",NULL,NULL,"Christina M Bromley  (National Cancer Institute)|Mary C Fraser  (Genetic Epidemiology Branch)|Gladys M. Glenn; MD, PhD  (Family Studies Sect)|Naoko  Ishibe; ScD  (Genetic Epidemiology Branch)|Dilys  Parry; PhD  (Family Studies Sect)|Margaret Anne Tucker  (Genetic Epidemiology Branch)",NULL,"1. Cope JU, Tsokos M, Helman LJ, Gridley G, Tucker MA   (2000) Inguinal hernia in patients with Ewing sarcoma: a clue to etiology.  Med Pediatr Oncol 34:195-9.|2. Hu N, Roth MJ, Polymeropolous M, Tang ZZ, Emmert-Buck MR, Wang QH, Goldstein AM, Feng SS, Dawsey SM, Ding T, Zhuang ZP, Han XY, Ried T, Giffen C, Taylor PR   (2000) Identification of novel regions of allelic loss from a genomewide scan of esophageal squamous-cell carcinoma in a high-risk Chinese population.  Genes Chromosomes Cancer 27:217-28.|3. Huang J, Hu N, Goldstein AM, Emmert-Buck MR, Tang ZZ, Roth MJ, Wang QH, Dawsey SM, Han XY, Ding T, Li G, Giffen C, Taylor PR   (2000) High frequency allelic loss on chromosome 17p133-p111 in esophageal squamous cell carcinomas from a high incidence area in northern china.  Carcinogenesis 21:2019-26.|4. Laake K, Jansen L, Hahnemann JM, Brondum-Nielsen K, Lonnqvist T, Kaariainen H, Sankila R, Lahdesmaki A, Hammarstrom L, Yuen J, Tretli S, Heiberg A, Olsen JH, Tucker M, Kleinerman R, B?rresen-Dale AL   (2000) Characterization of ATM mutations in 41 Nordic families with ataxia telangiectasia.  Hum Mutat 16:232-46.|5. Stavrou T, Dubovsky EC, Reaman GH, Goldstein AM, Vezina G   (2000) Intracranial calcifications in childhood medulloblastoma: relation to nevoid basal cell carcinoma syndrome.  AJNR Am J Neuroradiol 21:790-4.|6. Tucker M, Goldstein A, Dean M, Knudson A   (2000) National Cancer Institute Workshop Report: the phakomatoses revisited.  J Natl Cancer Inst 92:530-3.",https://intramural.nih.gov/search/searchview.taf?ipid=10421
344,CP005804-06,"October 01, 1999 -  September 30, 2000",Pharmacogenetic Studies,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile",NULL,"Pharmacogenetics Sect, NCI","Maria Teresa Pia Landi; MD, PhD",NULL,Lynn Rachel Goldin; PhD (Genetic Epidemiology Branch)|Alisa  Goldstein; PhD  (Population And Statistical Genetics Sect)|Naoko  Ishibe; ScD  (Genetic Epidemiology Branch)|Margaret Anne Tucker  (Genetic Epidemiology Branch),NULL,"1. Harty LC, Garcia-Closas M, Rothman N, Reid YA, Tucker MA, Hartge P   (2000) Collection of buccal cell DNA using treated cards.  Cancer Epidemiol Biomarkers Prev 9:501-6.",https://intramural.nih.gov/search/searchview.taf?ipid=10419
345,CP005805-06,"October 01, 1999 -  September 30, 2000",Late Effects of Cancer Treatment,Margaret Anne Tucker|IRP Faculty Profile,NULL,"Genetic Epidemiology Branch, NCI",Mary C Fraser,NULL,Robert R Miller (RADIATION PHYSICS and COMPUTER AUTOMATION SECT)|Dilys  Parry; PhD  (Family Studies Sect),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10417
346,CP010101-05,"October 01, 1999 -  September 30, 2000",Gastroenterological Cancer Studies,Wei Cheng R You,NULL,"Biostatistics Branch, NCI","Mitchell Henry Gail; PhD, MD|Linda M Brown; MPH, DPhil",NULL,"Gloria L Gridley  (Epidemiologic Methods Sect)|Steven  Mark; MD, ScD  (Epidemiologic Methods Sect)",NULL,"1. Brown LM   (2000) Helicobacter pylori: epidemiology and routes of transmission.  Epidemiol Rev 22:283-97.|2. Mark SD, Qiao YL, Dawsey SM, Wu YP, Katki H, Gunter EW, Fraumeni JF, Blot WJ, Dong ZW, Taylor PR   (2000) Prospective study of serum selenium levels and incident esophageal and gastric cancers.  J Natl Cancer Inst 92:1753-63.|3. You WC, Ma JL, Liu W, Gail MH, Chang YS, Zhang L, Hu YR, Fraumeni JF, Xu GW   (2000) Blood type and family cancer history in relation to precancerous gastric lesions.  Int J Epidemiol 29:405-7.|4. You Wc, Zhang L, Gail MH, Chang Ys, Liu Wd, Ma Jl, Li Jy, Jin Ml, Hu Yr, Yang Cs, Blaser MJ, Correa P, Blot WJ, Fraumeni JF, Xu Gw   (2000) Gastric dysplasia and gastric cancer: helicobacter pylori, serum vitamin C, and other risk factors.  J Natl Cancer Inst 92:1607-12.",https://intramural.nih.gov/search/searchview.taf?ipid=10416
347,CP010105-05,"October 01, 1999 -  September 30, 2000",Record-Linkage Studies of Cancer,Gloria L Gridley,NULL,"Epidemiologic Methods Sect, NCI",NULL,NULL,"Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)|Robert  Biggar; MD  (Infection & Immunoepidemiology Branch)|Aaron E Blair; PhD, MPH  (Occupational and Environmental Epidemiology Branch)|Louise  Brinton; PhD  (Hormonal and Reproductive Epidemiology Branch)|Wong H Chow  (Occupational and Environmental Epidemiology Branch)|Mustafa  Dosemeci; PhD  (Occupational and Environmental Epidemiology Branch)|Show all 9.",NULL,"1. Boffetta P, Gridley G, Gustavsson P, Brennan P, Blair A, Ekstrom AM, Fraumeni JF   (2000) Employment as butcher and cancer risk in a record-linkage study from Sweden.  Cancer Causes Control 11:627-33.|2. Mellemkjaer L, Johansen C, Gridley G, Linet MS, Kjaer SK, Olsen JH   (2000) Crohn's disease and cancer risk (Denmark).  Cancer Causes Control 11:145-50.",https://intramural.nih.gov/search/searchview.taf?ipid=10418
348,CP010108-05,"October 01, 1999 -  September 30, 2000",Descriptive Studies,Susan Shaw Devesa,NULL,"Descriptive Studies Sect, NCI",Betty Jane Stone; PhD,NULL,"Mitchell Henry Gail; PhD, MD (Biostatistics Branch)|Linda M Brown; MPH, DPhil  (Biostatistics Branch)|Wong H Chow  (Occupational and Environmental Epidemiology Branch)|Mustafa  Dosemeci; PhD  (Occupational and Environmental Epidemiology Branch)|Thomas  Fears; PhD  (Epidemiologic Methods Sect)|James Jerome Goedert; MD  (Infection & Immunoepidemiology Branch)|Show all 19.",NULL,"1. Groves FD, Linet MS, Travis LB, Devesa SS   (2000) Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995.  J Natl Cancer Inst 92:1240-51.|2. Hsing AW, Tsao L, Devesa SS   (2000) International trends and patterns of prostate cancer incidence and mortality.  Int J Cancer 85:60-7.",https://intramural.nih.gov/search/searchview.taf?ipid=10412
349,CP010110-05,"October 01, 1999 -  September 30, 2000",Methods for Designing and Analyzing Epidemiologic Studies,"Mitchell Henry Gail; PhD, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI",Nilanjan  Chatterjee|Philip Samuel Rosenberg; PhD,NULL,"Dalsu  Baris  (Occupational and Environmental Epidemiology Branch)|Neil Edward Caporaso; MS, MD  (Pharmacogenetics Sect)|Susan Shaw Devesa  (Descriptive Studies Sect)|Michael  Hauptmann; PhD  (National Cancer Institute)|Hormuzdiar Aspandiar Katki; MS  (Epidemiologic Methods Sect)|Elaine  Ron; PhD  (Office of the Director)|Show all 9.",NULL,"1. Carroll RJ, Gail MH, Benichou J, Pee D   (2000) Score tests for familial correlation in genotyped-proband designs.  Genet Epidemiol 18:293-306.|2. Engels EA, Sinclair MD, Biggar RJ, Whitby D, Ebbesen P, Goedert JJ, Gastwirth JL   (2000) Latent class analysis of human herpesvirus 8 assay performance and infection prevalence in sub-saharan Africa and Malta.  Int J Cancer 88:1003-8.|3. Fears TR, Gail MH   (2000) Analysis of a two-stage case-control study with cluster sampling of controls: application to nonmelanoma skin cancer.  Biometrics 56:190-8.|4. Freidlin B, Gastwirth J   (2000) Should the Median Test be Retired from General Use?  Am Stat 54:161-164.|5. Gail MH, JL G   (2000) Properties of the Hui and Walter and Related Methods for Estimating Prevalence Rates and Error Rates of Diagonstic Testing Procedures.  Drug Inf J 2000:605-615.|6. Gail MH, Pfeiffer R, van Houwelingen HC, Carroll RJ   (2000) On meta-analytic assessment of surrogate outcomes.  Biostatistics 1:231-246.|7. Gail MH, Sinclair M   (2000) Properties of the Hui and Walter and Related Methods for Estimating Prevalence Rates and Error Rates of Diagnostic Testing Procedures.  Drug Inf J 2000:605-615.|8. Gastwirth JL   (2000) The efficiency of pooling in the detection of rare mutations.  Am J Hum Genet 67:1036-9.|9. Gastwirth JL, Freidlin B   (2000) On power and efficiency robust linkage tests for affected sibs.  Ann Hum Genet 64:443-53.|10. Grauman DJ, Tarone RE, Devesa SS, Fraumeni JF   (2000) Alternate ranging methods for cancer mortality maps.  J Natl Cancer Inst 92:534-43.|11. Hauptmann M, Lubin JH, Rosenberg P, Wellmann J, Kreienbrock L   (2000) The use of sliding time windows for the exploratory analysis of temporal effects of smoking histories on lung cancer risk.  Stat Med 19:2185-94.|12. Hauptmann M, Wellmann J, Lubin JH, Rosenberg PS, Kreienbrock L   (2000) Analysis of exposure-time-response relationships using a spline weight function.  Biometrics 56:1105-8.|13. Pfeiffer RM, Gail MH, Brown LM   (2000) Probability of helicobacter pylori infection based on IgG levels and other covariates using a mixture model.  J Epidemiol Biostat 5:267-75.|14. Sinclair M, Gastwirth J   (2000) Properties of the Hui and Walter and Related Methods for Estimating Prevalence Rates and Error Rates of Diagnositic Testing Procedures.  Drug Inf J 2000:605-615.|15. Sinclair MD, Gastwirth JL   (2000) Properties of the Hui and Walter and Related Methods for Estimating Prevalence Rates and Error Rates of Diagnostic Testing Procedures.  Drug Inf J 2000:605-615.|16. Wacholder S, Rothman N, Caporaso N   (2000) Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias.  J Natl Cancer Inst 92:1151-8.|17. Zheng G, Gastwirth J   (2000) Where is the Fisher Information in an Ordered Sample?  Statistics Sinica 10:1267-1280.",https://intramural.nih.gov/search/searchview.taf?ipid=13958
350,CP010111-05,"October 01, 1999 -  September 30, 2000",Risk Assessment,"Mitchell Henry Gail; PhD, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI",Nilanjan  Chatterjee,NULL,"Hormuzdiar Aspandiar Katki; MS  (Epidemiologic Methods Sect)|Steven  Mark; MD, ScD  (Epidemiologic Methods Sect)|Sholom  Wacholder; PhD  (Epidemiologic Methods Sect)",NULL,"1. Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V   (2000) Re: Risk/benefit assessment of tamoxifen to prevent breast cancer-still a work in progress?  J Natl Cancer Inst 92:574-5.|2. Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V   (2000) RESPONSE: re: weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.  J Natl Cancer Inst 92:758.",https://intramural.nih.gov/search/searchview.taf?ipid=10410
351,CP010112-05,"October 01, 1999 -  September 30, 2000",Intervention Trials and Related Studies,"Steven  Mark; MD, ScD",NULL,"Epidemiologic Methods Sect, NCI",Hormuzdiar Aspandiar Katki; MS,NULL,"Mitchell Henry Gail; PhD, MD (Biostatistics Branch)|Linda M Brown; MPH, DPhil  (Biostatistics Branch)|Wei Cheng R You  (Biostatistics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10409
352,CP010113-05,"October 01, 1999 -  September 30, 2000",Studies of Environmental and Occupational Exposures,Jay  Lubin; PhD,NULL,"Epidemiologic Methods Sect, NCI",Thomas  Fears; PhD|Sholom  Wacholder; PhD,NULL,"Dalsu  Baris  (Occupational and Environmental Epidemiology Branch)|Aaron E Blair; PhD, MPH  (Occupational and Environmental Epidemiology Branch)|Louise  Brinton; PhD  (Hormonal and Reproductive Epidemiology Branch)|Linda M Brown; MPH, DPhil  (Biostatistics Branch)|Susan Shaw Devesa  (Descriptive Studies Sect)|Mustafa  Dosemeci; PhD  (Occupational and Environmental Epidemiology Branch)|Show all 12.",NULL,"1. Alavanja MC, Lubin JH, Mahaffey JA, Brownson RC   (2000) Re: Residential radon gas exposure and lung cancer: the Iowa Radon Lung Cancer Study.  Am J Epidemiol 152:895-6.|2. Auvinen A, Linet MS, Hatch EE, Kleinerman RA, Robison LL, Kaune WT, Misakian M, Niwa S, Wacholder S, Tarone RE   (2000) Extremely low-frequency magnetic fields and childhood acute lymphoblastic leukemia: an exploratory analysis of alternative exposure metrics.  Am J Epidemiol 152:20-31.|3. Baris D, Brown LM, Silverman DT, Hayes R, Hoover RN, Swanson GM, Dosemeci M, Schwartz AG, Liff JM, Schoenberg JB, Pottern LM, Lubin J, Greenberg RS, Fraumeni, Jr JF   (2000) Socioeconomic status and multiple myeloma among US blacks and whites.  Am J Public Health 90:1277-81.|4. Brinton LA, Brown SL, Colton T, Burich MC, Lubin J   (2000) Characteristics of a population of women with breast implants compared with women seeking other types of plastic surgery.  Plast Reconstr Surg 105:919-27; discussion 928-9.|5. Brinton LA, Lubin JH, Burich MC, Colton T, Brown SL, Hoover RN   (2000) Breast cancer following augmentation mammoplasty (United States).  Cancer Causes Control 11:819-27.|6. Brown LM   (2000) The role of race/ethnicity in the epidemiology of esophageal cancer.  J Assoc Acad Minor Phys 11:32-7.|7. Carroll RJ, Schafer DW, Lubin JH, Ron E, Stovall M   (2000) Thyroid cancer after scalp irradiation: a reanalysis accounting for uncertainty in dosimetry.  Radiat Res 154:721-2;discussion 723-4.|8. Freedman DM, Dosemeci M, Alavanja MC   (2000) Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates.  Occup Environ Med 57:418-21.|9. Hatch EE, Kleinerman RA, Linet MS, Tarone RE, Kaune WT, Auvinen A, Baris D, Robison LL, Wacholder S   (2000) Do confounding or selection factors of residential wiring codes and magnetic fields distort findings of electromagnetic fields studies?  Epidemiology 11:189-98.|10. Kaune WT, Miller MC, Linet MS, Hatch EE, Kleinerman RA, Wacholder S, Mohr AH, Tarone RE, Haines C   (2000) Children's exposure to magnetic fields produced by US television sets used for viewing programs and playing video games.  Bioelectromagnetics 21:214-27.|11. Kleinerman R, Wang Z, Lubin J, Zhang S, Metayer C, Brenner A   (2000) Lung cancer and indoor air pollution in rural china.  Ann Epidemiol 10:469.|12. Kleinerman RA, Kaune WT, Hatch EE, Wacholder S, Linet MS, Robison LL, Niwa S, Tarone RE   (2000) Are children living near high-voltage power lines at increased risk of acute lymphoblastic leukemia?  Am J Epidemiol 151:512-5.|13. Morin Doody M, Mandel JS, Linet MS, Ron E, Lubin JH, Boice JD, Fraumeni JF   (2000) Mortality among Catholic nuns certified as radiologic technologists.  Am J Ind Med 37:339-48.|14. Pfeiffer RM, Gail MH, Brown LM   (2000) Probability of helicobacter pylori infection based on IgG levels and other covariates using a mixture model.  J Epidemiol Biostat 5:267-75.|15. Rubinow D, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R   (2000) Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.  JAMA 283:485-91.|16. Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R   (2000) Estrogen-progestin replacement and risk of breast cancer.  JAMA 284:691-4.|17. Wang L, Lubin JH, Zhang SR, Metayer C, Xia Y, Brenner A, Shang B, Wang Z, Kleinerman RA   (2000) Lung cancer and environmental tobacco smoke in a non-industrial area of China.  Int J Cancer 88:139-45.",https://intramural.nih.gov/search/searchview.taf?ipid=10408
353,CP010114-05,"October 01, 1999 -  September 30, 2000",Studies of Genetic and Molecular Epidemiology,Sholom  Wacholder; PhD|IRP Faculty Profile,NULL,"Epidemiologic Methods Sect, NCI",Thomas  Fears; PhD,NULL,"Mitchell Henry Gail; PhD, MD (Biostatistics Branch)|Louise  Brinton; PhD  (Hormonal and Reproductive Epidemiology Branch)|Nilanjan  Chatterjee  (Biostatistics Branch)|Jennifer L Donaldson  (Radiation Epidemiology Branch)|Roni T Falk  (Hormonal Studies Sect)|Capri-mara  Fillmore  (Hormonal and Reproductive Epidemiology Branch)|Show all 15.",NULL,"1. Allikmets R, Gail MH   (2000) Further evidence for an association of the ABCR alleles with age-related macular degeneration.  Am J Hum Genet 67:487-491.|2. Falk RT, Rossi SC, Fears TR, Sepkovic DW, Migella A, Adlercreutz H, Donaldson J, Bradlow HL, Ziegler RG   (2000) A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid.  Cancer Epidemiol Biomarkers Prev 9:81-7.|3. Fears TR, Ziegler RG, Donaldson JL, Falk RT, Hoover RN, Stanczyk FZ, Vaught JB, Gail MH   (2000) Reproducibility studies and interlaboratory concordance for androgen assays in female plasma.  Cancer Epidemiol Biomarkers Prev 9:403-12.",https://intramural.nih.gov/search/searchview.taf?ipid=10407
354,CP010115-05,"October 01, 1999 -  September 30, 2000",Studies of HIV/AIDS,Philip Samuel Rosenberg; PhD|IRP Faculty Profile,NULL,"BIOSTATISTICS BR, NCI",NULL,NULL,"Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)|Mitchell Henry Gail; PhD, MD (Biostatistics Branch)|Robert  Biggar; MD  (Infection & Immunoepidemiology Branch)|James Jerome Goedert; MD  (Infection & Immunoepidemiology Branch)|Michie  Hisada; MD, MPH, ScD  (Infection & Immunoepidemiology Branch)|Hormuzdiar Aspandiar Katki; MS  (Epidemiologic Methods Sect)|Show all 7.",NULL,"1. Taha TE, Kumwenda NI, Hoover DR, Biggar RJ, Broadhead RL, Cassol S, van der Hoven L, Markakis D, Liomba GN, Chiphangwi JD, Miotti PG   (2000) Association of HIV-1 load and CD4 lymphocyte count with mortality among untreated African children over one year of age.  AIDS 14:453-9.|2. Yeo AE, Matsumoto A, Hisada M, Shih JW, Alter HJ, Goedert JJ   (2000) Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia Multicenter Hemophilia Cohort Study.  Ann Intern Med 132:959-63.",https://intramural.nih.gov/search/searchview.taf?ipid=10406
355,CP010117-05,"October 01, 1999 -  September 30, 2000",Research on Statistical Methods,Robert  Tarone; PhD,NULL,"Statistical Resch And Biological Applications Sect, NCI",NULL,NULL,NULL,NULL,"1. Tarone RE, Chu KC   (2000) Age-period-cohort analyses of breast-, ovarian-, endometrial- and cervical-cancer mortality rates for Caucasian women in the USA.  J Epidemiol Biostat 5:221-31.|2. Tarone RE, Chu KC   (2000) Nonparametric evaluation of birth cohort trends in disease rates.  J Epidemiol Biostat 5:177-91.",https://intramural.nih.gov/search/searchview.taf?ipid=10405
356,CP010118-05,"October 01, 1999 -  September 30, 2000",Consulting and Collaboration on Epidemiologic Studies,Robert  Tarone; PhD,NULL,"Statistical Resch And Biological Applications Sect, NCI",NULL,NULL,"Michael  Alavanja; PhD  (Occupational and Environmental Epidemiology Branch)|Aaron E Blair; PhD, MPH  (Occupational and Environmental Epidemiology Branch)|Barry Ira Graubard; PhD  (Biostatistics Branch)|Elizabeth  Hatch; PhD  (Radiation Epidemiology Branch)|Ruth Anne Kleinerman; MPH  (Risk Analysis Section)|Martha S Linet; PhD  (Risk Analysis Section)|Show all 9.",NULL,"1. Auvinen A, Linet MS, Hatch EE, Kleinerman RA, Robison LL, Kaune WT, Misakian M, Niwa S, Wacholder S, Tarone RE   (2000) Extremely low-frequency magnetic fields and childhood acute lymphoblastic leukemia: an exploratory analysis of alternative exposure metrics.  Am J Epidemiol 152:20-31.|2. Baris D, Kwak LW, Rothman N, Wilson W, Manns A, Tarone RE, Hartge P   (2000) Blood levels of organochlorines before and after chemotherapy among non-Hodgkin's lymphoma patients.  Cancer Epidemiol Biomarkers Prev 9:193-7.|3. Breslow RA, Graubard BI, Sinha R, Subar AF   (2000) Diet and lung cancer mortality: a 1987 National Health Interview Survey cohort study.  Cancer Causes Control 11:419-31.|4. Freedman D, Linet M, Doody M, Mohan A, Alexander B, Boice J, Mandel J, Tarone R   (2000) Trends in reproductive, smoking, and other chronic disease risk factors by birth cohort in a large occupational study.  Ann Epidemiol 10:457-458.|5. Hatch EE, Kleinerman RA, Linet MS, Tarone RE, Kaune WT, Auvinen A, Baris D, Robison LL, Wacholder S   (2000) Do confounding or selection factors of residential wiring codes and magnetic fields distort findings of electromagnetic fields studies?  Epidemiology 11:189-98.|6. Hawk E, Breslow RA, Graubard BI   (2000) Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey.  Cancer Epidemiol Biomarkers Prev 9:523-7.|7. Kant AK, Schatzkin A, Graubard BI, Schairer C   (2000) A prospective study of diet quality and mortality in women.  JAMA 283:2109-15.|8. Karlson BM, Ekbom A, Wacholder S, McLaughlin JK, Hsing AW   (2000) Cancer of the upper gastrointestinal tract among patients with pernicious anemia: a case-cohort study.  Scand J Gastroenterol 35:847-51.|9. Kaune WT, Miller MC, Linet MS, Hatch EE, Kleinerman RA, Wacholder S, Mohr AH, Tarone RE, Haines C   (2000) Children's exposure to magnetic fields produced by US television sets used for viewing programs and playing video games.  Bioelectromagnetics 21:214-27.|10. Kleinerman RA, Kaune WT, Hatch EE, Wacholder S, Linet MS, Robison LL, Niwa S, Tarone RE   (2000) Are children living near high-voltage power lines at increased risk of acute lymphoblastic leukemia?  Am J Epidemiol 151:512-5.|11. Krebs-Smith SM, Graubard BI, Kahle LL, Subar AF, Cleveland LE, Ballard-Barbash R   (2000) Low energy reporters vs others: a comparison of reported food intakes.  Eur J Clin Nutr 54:281-7.|12. Tarone RE, Chu KC, Brawley OW   (2000) Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates.  Epidemiology 11:167-70.|13. Tziraki C, Graubard BI, Manley M, Kosary C, Moler JE, Edwards BK   (2000) Effect of training on adoption of cancer prevention nutrition-related activities by primary care practices: results of a randomized, controlled study.  J Gen Intern Med 15:155-62.",https://intramural.nih.gov/search/searchview.taf?ipid=10404
357,CP010119-05,"October 01, 1999 -  September 30, 2000",Studies of Occupational Cancer (Pesticides),Michael  Alavanja; PhD,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Aaron E Blair; PhD, MPH|Kenneth  Cantor; PhD|Joanne S Colt|Mustafa  Dosemeci; PhD|Debra  Silverman; ScD, ScM|Show all 7",NULL,"Patricia  Hartge; ScD  (Epidemiology and Biostatistics Program)|Jay  Lubin; PhD  (Epidemiologic Methods Sect)|Robert  Tarone; PhD  (Statistical Resch And Biological Applications Sect)|Shelia K Zahm; ScM, ScD  (Office of the Director)",NULL,"1. Baris D, Zahm SH   (2000) Epidemiology of lymphomas.  Curr Opin Oncol 12:383-94.|2. Cocco P, Kazerouni N, Zahm SH   (2000) Cancer mortality and environmental exposure to DDE in the United States.  Environ Health Perspect 108:1-4.|3. Figgs LW, Holland NT, Rothmann N, Zahm SH, Tarone RE, Hill R, Vogt RF, Smith MT, Boysen CD, Holmes FF, VanDyck K, Blair A   (2000) Increased lymphocyte replicative index following 2,4-dichlorophenoxyacetic acid herbicide exposure.  Cancer Causes Control 11:373-80.|4. Holford TR, Zheng T, Mayne ST, Zahm SH, Tessari JD, Boyle P   (2000) Joint effects of nine polychlorinated biphenyl (PCB) congeners on breast cancer risk.  Int J Epidemiol 29:975-82.|5. Mage DT, Alavanja MC, Sandler DP, McDonnell CJ, Kross B, Rowland A, Blair A   (2000) A model for predicting the frequency of high pesticide exposure events in the Agricultural Health Study.  Environ Res 83:67-71.|6. Stewart PA, Carel R, Schairer C, Blair A   (2000) Comparison of industrial hygienists' exposure evaluations for an epidemiologic study.  Scand J Work Environ Health 26:44-51.|7. Zheng T, Holford TR, Mayne ST, Tessari J, Ward B, Carter D, Owens PH, Boyle P, Dubrow R, Archibeque-Engle S, Dawood O, Zahm SH   (2000) Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2'-bis(p-chlorophenyl)ethylene.  Cancer Epidemiol Biomarkers Prev 9:167-74.|8. Zheng T, Holford TR, Tessari J, Mayne ST, Zahm SH, Owens PH, Zhang B, Ward B, Carter D, Zhang Y, Zhang W, Dubrow R, Boyle P   (2000) Oxychlordane and trans-nonachlor in breast adipose tissue and risk of female breast cancer.  J Epidemiol Biostat 5:153-60.",https://intramural.nih.gov/search/searchview.taf?ipid=13959
358,CP010120-05,"October 01, 1999 -  September 30, 2000",Studies of Occupational Cancer,"Aaron E Blair; PhD, MPH",NULL,"Occupational and Environmental Epidemiology Branch, NCI",Michael  Alavanja; PhD|Dalsu  Baris|Kenneth  Cantor; PhD|Wong H Chow|Joseph B Coble|Joanne S Colt|Show all 11,NULL,Omur C Elci  (National Cancer Institute)|Qing  Lan  (National Cancer Institute)|Jay  Lubin; PhD  (Epidemiologic Methods Sect)|Barry  Miller  (Cancer Statistics Branch)|Roel  Vermeulen  (National Cancer Institute),NULL,"1. Boffetta P, Gridley G, Gustavsson P, Brennan P, Blair A, Ekstrom AM, Fraumeni JF   (2000) Employment as butcher and cancer risk in a record-linkage study from Sweden.  Cancer Causes Control 11:627-33.|2. Hauptmann M, Lubin JH, Rosenberg P, Wellmann J, Kreienbrock L   (2000) The use of sliding time windows for the exploratory analysis of temporal effects of smoking histories on lung cancer risk.  Stat Med 19:2185-94.|3. Hauptmann M, Wellmann J, Lubin JH, Rosenberg PS, Kreienbrock L   (2000) Analysis of exposure-time-response relationships using a spline weight function.  Biometrics 56:1105-8.|4. Hayes RB, Zhang L, Yin S, Swenberg JA, Xi L, Wiencke J, Bechtold WE, Yao M, Rothman N, Haas R, O'Neill JP, Zhang D, Wiemels J, Dosemeci M, Li G, Smith MT   (2000) Genotoxic markers among butadiene polymer workers in China.  Carcinogenesis 21:55-62.|5. Lubin JH, Fraumeni JF   (2000) Re: Does arsenic exposure increase the risk for circulatory disease?  Am J Epidemiol 152:290-3.|6. Lubin JH, Pottern LM, Stone BJ, Fraumeni JF   (2000) Respiratory cancer in a cohort of copper smelter workers: results from more than 50 years of follow-up.  Am J Epidemiol 151:554-65.|7. Sharma-Wagner S, Chokkalingam AP, Malker HS, Stone BJ, McLaughlin JK, Hsing AW   (2000) Occupation and prostate cancer risk in Sweden.  J Occup Environ Med 42:517-25.",https://intramural.nih.gov/search/searchview.taf?ipid=10402
359,CP010121-05,"October 01, 1999 -  September 30, 2000",Molecular Epidemiology Studies of Occupational and Environmental Exposures,Nathaniel C Rothman; MD|IRP Faculty Profile,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Michael  Alavanja; PhD|Dalsu  Baris|Aaron E Blair; PhD, MPH|Kenneth  Cantor; PhD|Wong H Chow|Mustafa  Dosemeci; PhD|Show all 7",NULL,"Qing  Lan  (National Cancer Institute)|Shelia K Zahm; ScM, ScD  (Office of the Director)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10403
360,CP010122-05,"October 01, 1999 -  September 30, 2000",Occupational Exposure Assessment,Patricia S Stewart; PhD,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Michael  Alavanja; PhD|Dalsu  Baris|Aaron E Blair; PhD, MPH|Kenneth  Cantor; PhD|Wong H Chow|Joseph B Coble|Show all 10",NULL,"Mitchell Henry Gail; PhD, MD (Biostatistics Branch)|Louise  Brinton; PhD  (Hormonal and Reproductive Epidemiology Branch)|Linda M Brown; MPH, DPhil  (Biostatistics Branch)|Omur C Elci  (National Cancer Institute)|Roni T Falk  (Hormonal Studies Sect)|Barry Ira Graubard; PhD  (Biostatistics Branch)|Show all 16.",NULL,"1. Kamel F, Boyes WK, Gladen BC, Rowland AS, Alavanja MC, Blair A, Sandler DP   (2000) Retinal degeneration in licensed pesticide applicators.  Am J Ind Med 37:618-28.|2. Mage DT, Alavanja MC, Sandler DP, McDonnell CJ, Kross B, Rowland A, Blair A   (2000) A model for predicting the frequency of high pesticide exposure events in the Agricultural Health Study.  Environ Res 83:67-71.|3. Stewart PA, Carel R, Schairer C, Blair A   (2000) Comparison of industrial hygienists' exposure evaluations for an epidemiologic study.  Scand J Work Environ Health 26:44-51.",https://intramural.nih.gov/search/searchview.taf?ipid=10401
361,CP010123-05,"October 01, 1999 -  September 30, 2000",Studies of Occupational Cancer among Women and Minorities,Wong H Chow,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Michael  Alavanja; PhD|Dalsu  Baris|Aaron E Blair; PhD, MPH|Kenneth  Cantor; PhD|Mustafa  Dosemeci; PhD|Bu Tian  Ji|Show all 8",NULL,"Linda M Brown; MPH, DPhil  (Biostatistics Branch)|Gloria L Gridley  (Epidemiologic Methods Sect)|Patricia  Hartge; ScD  (Epidemiology and Biostatistics Program)|Robert  Hoover; MD, ScD  (Epidemiology and Biostatistics Program)|Martha S Linet; PhD  (Risk Analysis Section)|Shelia K Zahm; ScM, ScD  (Office of the Director)",NULL,"1. Zahm SK, Ward M, Silverman D   (1999) Occupation and Cancer, in Women and Health. Goldman MB, Hatch MC, eds., Academic Press (San Diego, CA), pp. 493-502.",https://intramural.nih.gov/search/searchview.taf?ipid=10400
362,CP010124-05,"October 01, 1999 -  September 30, 2000",Cervical cancer and human papillomavirus (HPV) infection,Mark  Schiffman; MD|IRP Faculty Profile,NULL,"Interdisciplinary Studies Sect, NCI",Allan  Hildesheim; PhD,NULL,Patti E Gravitt  (National Cancer Institute)|Tammy S Shields  (National Cancer Institute)|Sholom  Wacholder; PhD  (Epidemiologic Methods Sect),NULL,"1. Cox JT, Koutsky L, Schiffman M, Solomon D   (2000) Re: Emerging technologies and cervical cancer.  J Natl Cancer Inst 92:1014.|2. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ   (2000) Improved amplification of genital human papillomaviruses.  J Clin Microbiol 38:357-61.|3. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, Schiffman M   (2000) Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica.  J Natl Cancer Inst 92:464-74.|4. Hutchinson ML, Schiffman M   (2000) Author reply.  Cancer 90:67-9.|5. Schiffman M, Adrianza ME   (2000) ASCUS-LSIL Triage Study Design, methods and characteristics of trial participants.  Acta Cytol 44:726-42.|6. Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S, Alfaro M, Hutchinson M, Morales J, Greenberg MD, Lorincz AT   (2000) HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.  JAMA 283:87-93.|7. Schiffman M, Hildesheim A, Herrero R, Bratti C   (2000) Human papillomavirus testing as a screening tool for cervical cancer.  JAMA 283:2525-6.|8. Smith AE, Sherman ME, Scott DR, Tabbara SO, Dworkin L, Olson J, Thompson J, Faser C, Snell J, Schiffman M   (2000) Review of the Bethesda System atlas does not improve reproducibility or accuracy in the classification of atypical squamous cells of undetermined significance smears.  Cancer 90:201-6.",https://intramural.nih.gov/search/searchview.taf?ipid=10399
363,CP010125-05,"October 01, 1999 -  September 30, 2000",Cancer Risk and Exposures to Drinking Water Contaminants and Other Environmental,Kenneth  Cantor; PhD,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Michael  Alavanja; PhD|Dalsu  Baris|Aaron E Blair; PhD, MPH|Wong H Chow|Joanne S Colt|Mustafa  Dosemeci; PhD|Show all 8",NULL,"Allan  Hildesheim; PhD  (Interdisciplinary Studies Sect)|Peter D Inskip; ScD  (Risk Analysis Section)|Jay  Lubin; PhD  (Epidemiologic Methods Sect)|Rashmi P Sinha; PhD  (Nutritional Epidemiology Branch)|Shelia K Zahm; ScM, ScD  (Office of the Director)",NULL,"1. Alavanja MC, Lubin JH, Mahaffey JA, Brownson RC   (2000) Re: Residential radon gas exposure and lung cancer: the Iowa Radon Lung Cancer Study.  Am J Epidemiol 152:895-6.|2. Freedman DM, Cantor KP, Ward MH, Helzlsouer KJ   (2000) A comparison of recent and long-term average measurements of nitrate in drinking water.  J Expo Anal Environ Epidemiol 10:206-9.|3. Ward MH, Mark SD, Cantor KP, Weisenburger D, Correa-Villasenor A   (2000) Non-Hodgkin's lymphoma and nitrate in drinking water.  J Epidemiol Community Health 54:772-3.",https://intramural.nih.gov/search/searchview.taf?ipid=10398
364,CP010126-05,"October 01, 1999 -  September 30, 2000",Hormone-Related Cancers,Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",NULL,NULL,"Aaron E Blair; PhD, MPH  (Occupational and Environmental Epidemiology Branch)|Roni T Falk  (Hormonal Studies Sect)|Ann  Hsing; PhD  (Hormonal Studies Sect)|James V Lacey; MPH, PhD  (National Cancer Institute)|Patricia  Madigan  (Hormonal Studies Sect)|Tammy S Shields  (National Cancer Institute)",NULL,"1. Lacey JV, Brinton LA, Barnes WA, Gravitt PE, Greenberg MD, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Kurman RJ, Hildesheim A   (2000) Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix.  Gynecol Oncol 77:149-54.|2. Lacey JV, Brinton LA, Mortel R, Berman ML, Wilbanks GD, Twiggs LB, Barrett RJ   (2000) Tubal sterilization and risk of cancer of the endometrium.  Gynecol Oncol 79:482-4.",https://intramural.nih.gov/search/searchview.taf?ipid=10397
365,CP010127-05,"October 01, 1999 -  September 30, 2000",Etiologic Studies of Diet and Cancer,Arthur  Schatzkin; PhD,NULL,"Nutritional Epidemiology Branch, NCI",Rashmi P Sinha; PhD,NULL,"Michael  Alavanja; PhD  (Occupational and Environmental Epidemiology Branch)|Louise  Brinton; PhD  (Hormonal and Reproductive Epidemiology Branch)|Neil Edward Caporaso; MS, MD  (Pharmacogenetics Sect)|Wong H Chow  (Occupational and Environmental Epidemiology Branch)|Jennifer L Donaldson  (Radiation Epidemiology Branch)|Andrew P Flood  (National Cancer Institute)|Show all 14.",NULL,"1. Lopez-Carrillo L, Lopez-Cervantes M, Ward MH, Bravo-Alvarado J, Ramirez-Espitia A   (1999) Nutrient intake and gastric cancer in Mexico.  Int J Cancer 83:601-5.|2. Poirier LA, Wise CK, Delongchamp RR, Sinha R (2001) Blood determinations of S-adenosylmethionine, S-adenosylhomocysteine, and homocysteine: correlations with diet. Cancer Epidemiol Biomarkers Prev 10:649-55|3. Sinha R, Gustafson DR, Kulldorff M, Wen WQ, Cerhan JR, Zheng W (2000) 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a carcinogen in high-temperature-cooked meat, and breast cancer risk. J Natl Cancer Inst 92:1352-4|4. Sinha R, Kulldorff M, Chow WH, Denobile J, Rothman N (2001) Dietary intake of heterocyclic amines, meat-derived mutagenic activity, and risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 10:559-62|5. Sinha R, Kulldorff M, Swanson CA, Curtin J, Brownson RC, Alavanja MC   (2000) Dietary heterocyclic amines and the risk of lung cancer among Missouri women.  Cancer Res 60:3753-6.|6. Ward MH, Pan WH, Cheng YJ, Li FH, Brinton LA, Chen CJ, Hsu MM, Chen IH, Levine PH, Yang CS, Hildesheim A   (2000) Dietary exposure to nitrite and nitrosamines and risk of nasopharyngeal carcinoma in Taiwan.  Int J Cancer 86:603-9.",https://intramural.nih.gov/search/searchview.taf?ipid=10396
366,CP010128-05,"October 01, 1999 -  September 30, 2000",Therapeutic and Diagnostic Factors as Related to Cancer Risk,Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",NULL,NULL,"Allan  Hildesheim; PhD  (Interdisciplinary Studies Sect)|James V Lacey; MPH, PhD  (National Cancer Institute)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10395
367,CP010130-05,"October 01, 1999 -  September 30, 2000",Consulting and Collaboration on Laboratory Studies,Robert  Tarone; PhD,NULL,"Statistical Resch And Biological Applications Sect, NCI",NULL,NULL,NULL,NULL,"1. Behrens C, Travis LB, Wistuba II, Davis S, Maitra A, Clarke EA, Lynch CF, Glimelius B, Wiklund T, Tarone R, Gazdar AF   (2000) Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease.  Cancer Epidemiol Biomarkers Prev 9:1027-35.|2. Metter EJ, Tarone RE, Bohr VA, Grossman L, Hedayati M, Bale SJ, Emmert S, Kraemer KH   (2000) A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism.  Carcinogenesis 21:1821-5.|3. Tawn EJ, Whitehouse CA, Holdsworth D, Morris S, Tarone RE   (2000) Chromosome analysis of workers occupationally exposed to radiation at the Sellafield nuclear facility.  Int J Radiat Biol 76:355-65.",https://intramural.nih.gov/search/searchview.taf?ipid=10394
368,CP010131-05,"October 01, 1999 -  September 30, 2000",Studies of Medical Radiation and Other Therapeutic Agents,Elaine  Ron; PhD,NULL,"Radiation Epidemiology Branch, NCI",Rochelle E Curtis|Deirdre A Hill|Charles E. Land; PhD|Catherine  Metayer; MD|Lois B Travis; PhD,NULL,Zhanat  Abylkassimov  (National Cancer Institute)|Alina V Brenner  (National Cancer Institute)|Ethel  Gilbert  (Population Studies Section)|Peter D Inskip; ScD  (Risk Analysis Section)|Ruth Anne Kleinerman; MPH  (Risk Analysis Section)|Margaret Anne Tucker  (Genetic Epidemiology Branch),NULL,"1. Kleinerman RA, Tarone RE, Abramson DH, Seddon JM, Li FP, Tucker MA   (2000) Hereditary retinoblastoma and risk of lung cancer.  J Natl Cancer Inst 92:2037-9.|2. Littlefield L, McFee A, Sayer A, O'Neil J, Kleinerman RA, Maor M   (2000) Induction and persistence of chromosome aberrations in human lymphocytes exposed to neutrons in vitro or in vivo: Implications of findings in retrospective biological dosimetry.  Radiat Prot Dosimetry 88:9.|3. Morin Doody M, Lonstein JE, Stovall M, Hacker DG, Luckyanov N, Land CE   (2000) Breast cancer mortality after diagnostic radiography: findings from the US Scoliosis Cohort Study.  Spine 25:2052-63.|4. Travis LB, Andersson M, Gospodarowicz M, van Leeuwen FE, Bergfeldt K, Lynch CF, Curtis RE, Kohler BA, Wiklund T, Storm H, Holowaty E, Hall P, Pukkala E, Sleijfer DT, Clarke EA, Boice JD, Stovall M, Gilbert E   (2000) Treatment-associated leukemia following testicular cancer.  J Natl Cancer Inst 92:1165-71.|5. Travis LB, Land CE, Andersson M, Nyberg U, Goldman MB, Knudson Gaul L, Berger E, Storm HH, Hall P, Auvinen A, Janower ML, Holm LE, Monson RR, Schottenfeld D, Boice JD (2001) Mortality after cerebral angiography with or without radioactive Thorotrast: an international cohort of 3,143 two-year survivors. Radiat Res 156:136-50",https://intramural.nih.gov/search/searchview.taf?ipid=10393
369,CP010132-05,"October 01, 1999 -  September 30, 2000",Studies of Populations Exposed to Enviromental Sources of Radiation,Gilbert  Beebe; PhD,NULL,"Radiation Epidemiology Branch, NCI",Charles E. Land; PhD|Nickolas  Luckyanov|Ihor  Masnyk,NULL,Zhanat  Abylkassimov  (National Cancer Institute)|Alina V Brenner  (National Cancer Institute)|Ethel  Gilbert  (Population Studies Section)|Elaine  Ron; PhD  (Office of the Director),NULL,"1. Burkhart W, Kellerer A, Bauer S, Harrison J, Land CE, Shoiket Y, Kiselev V, Simon S, Tsukani T, de Vathaire F   (2000) Health Effects, in Scope 59: Test Explosions: Environmental and Health Impacts. Warner F, Kirchmann R, eds., John Wiley & Sons (Chichester, United Kingdom) Volume 59,  pp. 179-228.",https://intramural.nih.gov/search/searchview.taf?ipid=10392
370,CP010133-05,"October 01, 1999 -  September 30, 2000",Studies of Populations Exposed to Occupational Sources of Radiation,Elaine  Ron; PhD,NULL,"Radiation Epidemiology Branch, NCI","Deirdre A Hill|Nickolas  Luckyanov|Kiyohiko  Mabuchi; MD, DPhil|Ihor  Masnyk|Terry L Thomas",NULL,"Alina V Brenner  (National Cancer Institute)|Ethel  Gilbert  (Population Studies Section)|Peter D Inskip; ScD  (Risk Analysis Section)|Martha S Linet; PhD  (Risk Analysis Section)|Jeffery P Struewing; MS, MD  (Lab Of Population Genetics)|Robert  Tarone; PhD  (Statistical Resch And Biological Applications Sect)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10391
371,CP010134-05,"October 01, 1999 -  September 30, 2000",Studies of Atomic Bomb Survivors,Charles E. Land; PhD,NULL,"Radiation Epidemiology Branch, NCI","Nickolas  Luckyanov|Kiyohiko  Mabuchi; MD, DPhil",NULL,Zhanat  Abylkassimov  (National Cancer Institute)|Kenneth  Buetow; PhD  (Lab Of Population Genetics)|Capri-mara  Fillmore  (Hormonal and Reproductive Epidemiology Branch)|Ethel  Gilbert  (Population Studies Section)|Elaine  Ron; PhD  (Office of the Director)|Margaret Anne Tucker  (Genetic Epidemiology Branch),NULL,"1. Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE   (2000) A prospective study of estradiol and breast cancer in Japanese women.  Cancer Epidemiol Biomarkers Prev 9:575-9.",https://intramural.nih.gov/search/searchview.taf?ipid=10390
372,CP010135-05,"October 01, 1999 -  September 30, 2000",Studies of Non-Ionizing Radiation-Related Cancer,Martha S Linet; PhD|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",NULL,NULL,Mustafa  Dosemeci; PhD  (Occupational and Environmental Epidemiology Branch)|Gloria L Gridley  (Epidemiologic Methods Sect)|Ruth Anne Kleinerman; MPH  (Risk Analysis Section)|Robert  Tarone; PhD  (Statistical Resch And Biological Applications Sect)|Sholom  Wacholder; PhD  (Epidemiologic Methods Sect),NULL,"1. Auvinen A, Linet MS, Hatch EE, Kleinerman RA, Robison LL, Kaune WT, Misakian M, Niwa S, Wacholder S, Tarone RE   (2000) Extremely low-frequency magnetic fields and childhood acute lymphoblastic leukemia: an exploratory analysis of alternative exposure metrics.  Am J Epidemiol 152:20-31.|2. Hatch EE, Kleinerman RA, Linet MS, Tarone RE, Kaune WT, Auvinen A, Baris D, Robison LL, Wacholder S   (2000) Do confounding or selection factors of residential wiring codes and magnetic fields distort findings of electromagnetic fields studies?  Epidemiology 11:189-98.|3. Kaune WT, Miller MC, Linet MS, Hatch EE, Kleinerman RA, Wacholder S, Mohr AH, Tarone RE, Haines C   (2000) Children's exposure to magnetic fields produced by US television sets used for viewing programs and playing video games.  Bioelectromagnetics 21:214-27.|4. Kleinerman RA, Kaune WT, Hatch EE, Wacholder S, Linet MS, Robison LL, Niwa S, Tarone RE   (2000) Are children living near high-voltage power lines at increased risk of acute lymphoblastic leukemia?  Am J Epidemiol 151:512-5.|5. Neglia JP, Linet MS, Shu XO, Severson RK, Potter JD, Mertens AC, Wen W, Kersey JH, Robison LL (2000) Patterns of infection and day care utilization and risk of childhood acute lymphoblastic leukaemia. Br J Cancer 82:234-40",https://intramural.nih.gov/search/searchview.taf?ipid=10389
373,CP010136-05,"October 01, 1999 -  September 30, 2000",Cancer Risk in Human Populations,"Debra  Silverman; ScD, ScM|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Michael  Alavanja; PhD|Dalsu  Baris|Aaron E Blair; PhD, MPH|Kenneth  Cantor; PhD|Wong H Chow|Joseph B Coble|Show all 10",NULL,"Linda M Brown; MPH, DPhil  (Biostatistics Branch)",NULL,"1. Bennett WP, Alavanja MC, Harris CC   (2000) RESPONSE: re: environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women.  J Natl Cancer Inst 92:760-1.|2. Brownson RC, Alavanja MC   (2000) Previous lung disease and lung cancer risk among women (United States).  Cancer Causes Control 11:853-8.|3. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF, Rabkin CS   (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer.  nature 404:398-402.",https://intramural.nih.gov/search/searchview.taf?ipid=10388
374,CP010137-03,"October 01, 1999 -  September 30, 2000",Research on Statistical Methods for Analyzing Complex Surveys,Barry Ira Graubard; PhD|IRP Faculty Profile,NULL,"Biostatistics Branch, NCI",NULL,NULL,Thomas  Fears; PhD  (Epidemiologic Methods Sect),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10386
375,CP010138-03,"October 01, 1999 -  September 30, 2000",BRCA1/2 and Breast and Ovarian Cancer,"Jeffery P Struewing; MS, MD",NULL,"Family Studies Sect, NCI",NULL,NULL,Michael R Davila  (Lab Of Population Genetics)|Joni L Rutter  (Lab Of Population Genetics)|Amelia  Smith  (Lab Of Population Genetics),NULL,"1. Biesecker BB, Ishibe N, Hadley DW, Giambarresi TR, Kase RG, Lerman C, Struewing JP   (2000) Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families.  Am J Med Genet 93:257-63.",https://intramural.nih.gov/search/searchview.taf?ipid=10385
376,CP010139-03,"October 01, 1999 -  September 30, 2000",Molecular Genetic Epidemiology of Primary Hepatocellular Carcinoma,Kenneth  Buetow; PhD,NULL,"Lab Of Population Genetics, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10384
377,CP010140-03,"October 01, 1999 -  September 30, 2000",Molecular Genetic Epidemiology of leading  U.S. Cancers,Kenneth  Buetow; PhD,NULL,"Lab Of Population Genetics, NCI",NULL,NULL,"Shelia K Zahm; ScM, ScD  (Office of the Director)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10383
378,CP010141-03,"October 01, 1999 -  September 30, 2000",The Cancer Genome Anatomy Project s Genetic Annotation Initiative,Kenneth  Buetow; PhD,NULL,"Lab Of Population Genetics, NCI",NULL,NULL,Carol  Dahl  (Office Of Science Planning and Assessment)|Robert  Strausberg  (Office Of Science Planning and Assessment),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10380
379,CP010142-02,"October 01, 1999 -  September 30, 2000",Genetic Polymorphisms as Determinants of Outcomes Following Treatment for Cancer,Mark H Greene; MD|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",NULL,NULL,"Mitchell Henry Gail; PhD, MD (Biostatistics Branch)|Kenneth  Buetow; PhD  (Lab Of Population Genetics)|Neil Edward Caporaso; MS, MD  (Pharmacogenetics Sect)|Rochelle E Curtis  (Radiation Epidemiology Branch)|Barbara  Dunn  (Basic Prevention Science Research Group)|Patricia  Hartge; ScD  (Epidemiology and Biostatistics Program)|Show all 9.",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13960
380,CP010143-02,"October 01, 1999 -  September 30, 2000",Genetic Epidemiology Technology Development,Kenneth  Buetow; PhD,NULL,"Lab Of Population Genetics, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10381
381,CP010144-02,"October 01, 1999 -  September 30, 2000",Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,Mark H Greene; MD|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",NULL,NULL,"Robert R Miller (National Cancer Institute)|Mitchell Henry Gail; PhD, MD (Biostatistics Branch)|Christina M Bromley  (National Cancer Institute)|Roni T Falk  (Hormonal Studies Sect)|Thomas  Fears; PhD  (Epidemiologic Methods Sect)|Mary C Fraser  (Genetic Epidemiology Branch)|Show all 16.",NULL,"1. Frost M, Walsh-Vockley C, Suman VJ, Greene MH, Zahasky K, Hartmann L   (2000) Perceived familial risk of cancer - Health concerns and pysychosocial adjustment.  Journal of Psychosocial Oncology 18:63-82.|2. Gail MH, Greene MH   (2000) Gail model and breast cancer.  Lancet 355:1017.",https://intramural.nih.gov/search/searchview.taf?ipid=13961
382,CP010145-01,"October 01, 1999 -  September 30, 2000",Intervention Trials in Persons at Increased Genetic Risk of Cancer,Mark H Greene; MD|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",NULL,NULL,Alisa  Goldstein; PhD  (Population And Statistical Genetics Sect)|June  Peters  (Office of the Director)|Arthur  Schatzkin; PhD  (Nutritional Epidemiology Branch)|Margaret Anne Tucker  (Genetic Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13962
383,CP010146-01,"October 01, 1999 -  September 30, 2000",Genetic Modifiers of Intitiation and Progression of Mammary Cancer,Kent W Hunter; PhD|IRP Faculty Profile,NULL,"Lab Of Population Genetics, NCI",Jessica A Rouse,NULL,NULL,NULL,"1. Le Voyer T, Lu Z, Babb J, Lifsted T, Williams M, Hunter K   (2000) An epistatic interaction controls the latency of a transgene-induced mammary tumor.  Mamm Genome 11:883-9.",https://intramural.nih.gov/search/searchview.taf?ipid=10411
384,CP010147-01,"October 01, 1999 -  September 30, 2000",Genetic Predisposition to Aflatoxin-Induced Hepatocellular Carcinoma,Kent W Hunter; PhD|IRP Faculty Profile,NULL,"Lab Of Population Genetics, NCI",Jessica A Rouse|Phillip D Wise,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10387
385,CP010148-01,"October 01, 1999 -  September 30, 2000",Chromosomal transmission of HHV6 in Japanese with acute lymphocyte leukemia,"Michie  Hisada; MD, MPH, ScD",NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13963
386,CP010149-01,"October 01, 1999 -  September 30, 2000",Natural History of HTLV-I: A prospective follow-up of a cohort blood donors in J,"Michie  Hisada; MD, MPH, ScD",NULL,"Infection & Immunoepidemiology Branch, NCI",Robert  Biggar; MD|James Jerome Goedert; MD|Elizabeth M Maloney,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13964
387,CP010150-01,"October 01, 1999 -  September 30, 2000","HIV, human herpesvirus 8, and cancer",Eric Andrew Engels; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI","Robert  Biggar; MD|James Jerome Goedert; MD|Thomas R O'Brien; BA, MPH, MD",NULL,Philip Samuel Rosenberg; PhD  (Biostatistics Branch),NULL,"1. Biggar RJ, Black F, Whitby D   (2000) Reply.  J Infect Dis 182:1574-5.|2. Biggar RJ, Whitby D, Marshall V, Linhares AC, Black F   (2000) Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype.  J Infect Dis 181:1562-8.|3. Engels EA, Eastman H, Ablashi DV, Wilks RJ, Braham J, Manns A   (2000) Persistent human herpesvirus 8 viremia associated with coinfection with human T-cell lymphotropic virus type I and myelofibrosis.  J Acquir Immune Defic Syndr 23:283-6.|4. Engels EA, Whitby D, Goebel PB, Stossel A, Waters D, Pintus A, Contu L, Biggar RJ, Goedert JJ   (2000) Identifying human herpesvirus 8 infection: performance characteristics of serologic assays.  J Acquir Immune Defic Syndr 23:346-54.",https://intramural.nih.gov/search/searchview.taf?ipid=13965
388,CP010151-01,"October 01, 1999 -  September 30, 2000",KSHV and other oncogenic viruses,Denise  Whitby,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Whitby D, Luppi M, Sabin C, Barozzi P, Di Biase AR, Balli F, Cucci F, Weiss RA, Boshoff C, Torelli G (2000) Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission. Br J Cancer 82:702-4",https://intramural.nih.gov/search/searchview.taf?ipid=13966
389,CP010152-01,"October 01, 1999 -  September 30, 2000",Etiology of Colorectal Tumors in the PLCO Trial,Richard  Hayes; PhD,NULL,"Occupational and Environmental Epidemiology Branch, NCI",Bu Tian  Ji,NULL,Jimmie B Vaught  (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13967
390,CP010153-01,"October 01, 1999 -  September 30, 2000",Cancer Risk and Environmental Exposures to Nitrate and Pesticides,"Mary Helen Ward; MS, PhD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Michael  Alavanja; PhD|Dalsu  Baris|Kenneth  Cantor; PhD|Joanne S Colt|Mustafa  Dosemeci; PhD|Debra  Silverman; ScD, ScM",NULL,"Omur C Elci  (National Cancer Institute)|Barry Ira Graubard; PhD  (Biostatistics Branch)|Patricia  Hartge; ScD  (Epidemiology and Biostatistics Program)|Allan  Hildesheim; PhD  (Interdisciplinary Studies Sect)|Steven  Mark; MD, ScD  (Epidemiologic Methods Sect)|Rashmi P Sinha; PhD  (Nutritional Epidemiology Branch)|Show all 7.",NULL,"1. Freedman DM, Cantor KP, Ward MH, Helzlsouer KJ   (2000) A case-control study of nitrate in drinking water and non-Hodgkin's lymphoma in Minnesota.  Arch Environ Health 55:326-9.|2. Ward M, Nuckols J, Weigel S, Maxwell S, Cantor KP, Miller R   (2000) Geographic information systems A new tool in environmental epidemiology.  Ann Epidemiol 10:477.|3. Ward MH, Mark SD, Cantor KP, Weisenburger D, Correa-Villasenor A   (2000) Non-Hodgkin's lymphoma and nitrate in drinking water.  J Epidemiol Community Health 54:772-3.|4. Ward MH, Nuckols JR, Weigel SJ, Maxwell SK, Cantor KP, Miller RS   (2000) Identifying populations potentially exposed to agricultural pesticides using remote sensing and a Geographic Information System.  Environ Health Perspect 108:5-12.",https://intramural.nih.gov/search/searchview.taf?ipid=13968
391,CP010154-01,"October 01, 1999 -  September 30, 2000",Genetics and Epigenetics of Cancer,Maxwell P Lee; PhD,NULL,"Lab Of Population Genetics, NCI",Kenneth  Buetow; PhD|Myung Soo  Lyu,NULL,Alisa  Goldstein; PhD  (Population And Statistical Genetics Sect)|Hanson Shuen Lo  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13969
392,CP010155-01,"October 01, 1999 -  September 30, 2000",Informatics Solutions to Biomedical Research,Maxwell P Lee; PhD,NULL,"Lab Of Population Genetics, NCI",Kenneth  Buetow; PhD|Ying  Hu; PhD|Carl F Schaefer,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13970
393,SC000100-17,"October 01, 1999 -  September 30, 2000","Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study and Cohort Follow-up",Demetrius  Albanes; MD|IRP Faculty Profile,NULL,"Cancer Prevention Studies Br, NCI","Joseph A Tangrea|Philip  Taylor; MD, ScD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10379
394,SC000154-10,"October 01, 1999 -  September 30, 2000","Fels Early Nutrition, Growth, and Breast Cancer Risk Factors Study",Demetrius  Albanes; MD|IRP Faculty Profile,NULL,"Cancer Prevention Studies Br, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13971
395,SC000164-09,"October 01, 1999 -  September 30, 2000",The Molecular Mechanisms of Oncogene Action,Michael  Birrer,NULL,"Experimental Intervention Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10378
396,SC000165-09,"October 01, 1999 -  September 30, 2000",The Use of Transcriptional Factors as Targets and Agents in Carcinogenesis,Michael  Birrer,NULL,"Experimental Intervention Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10377
397,SC000166-09,"October 01, 1999 -  September 30, 2000",Transforming Growth Factor-beta in Lung Cancer,Sonia B Jakowlew; PhD,NULL,"Experimental Biochemistry Sect, NCI",Jerry J Angdisen|Pavan E Aujla|Yang  Kang|Jennifer B Mariano|Laurent L Ozbun,NULL,NULL,NULL,"1. Farley J, Gray K, Nycum L, Prentice M, Birrer MJ, Jakowlew SB   (2000) Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).  Gynecol Oncol 78:113-22.|2. Jakowlew SB, Zakowicz H, Moody TW   (2000) Retinoic acid down-regulates VPAC(1) receptors and TGF-beta 3 but up-regulates TGF-beta 2 in lung cancer cells.  Peptides 21:1831-7.|3. Kang Y, Mariano JM, Angdisen J, Moody TW, Diwan BA, Wakefield LM, Jakowlew SB   (2000) Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1.  Mol Carcinog 29:112-26.|4. Kang Y, Prentice MA, Mariano JM, Davarya S, Linnoila RI, Moody TW, Wakefield LM, Jakowlew SB   (2000) Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis.  Exp Lung Res 26:685-707.",https://intramural.nih.gov/search/searchview.taf?ipid=10376
398,SC000167-09,"October 01, 1999 -  September 30, 2000",Molecular Pathology of Pulmonary Carcinogenesis,Ilona  Linnoila; MD,NULL,"Experimental Pathology Sect, NCI",Xu  Naizhen|Margaret A Prentice,NULL,Noriaki  Miyoshi  (National Cancer Institute)|Yongping  Yang; PhD  (Genetics of Cancer Susceptibility Section),NULL,"1. Castro CM, Yang Y, Zhang Z, Linnoila RI   (2000) Attenuation of pulmonary neuroendocrine differentiation in mice lacking Clara cell secretory protein.  Lab Invest 80:1533-40.|2. Devouassoux-Shisheboran M, Hayashi T, Linnoila RI, Koss MN, Travis WD   (2000) A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium.  Am J Surg Pathol 24:906-16.|3. Linnoila RI, Sahu A, Miki M, Ball DW, DeMayo FJ   (2000) Morphometric analysis of CC10-hASH1 transgenic mouse lung a model for bronchiolization of alveoli and neuroendocrine carcinoma.  Exp Lung Res 26:595-615.|4. Linnoila RI, Szabo E, DeMayo F, Witschi H, Sabourin C, Malkinson A   (2000) The role of CC10 in pulmonary carcinogenesis from a marker to tumor suppression.  Ann N Y Acad Sci 923:249-67.|5. Linnoila RI, Zhao B, DeMayo JL, Nelkin BD, Baylin SB, DeMayo FJ, Ball DW   (2000) Constitutive achaete-scute homologue-1 promotes airway dysplasia and lung neuroendocrine tumors in transgenic mice.  Cancer Res 60:4005-9.",https://intramural.nih.gov/search/searchview.taf?ipid=10375
399,SC000170-09,"October 01, 1999 -  September 30, 2000",Clinical Evaluation of New Intervention Agents,Christian Arthur Combs; PhD,NULL,"Experimental Intervention Sect, NCI",Ingalill R Avis,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10374
400,SC000171-09,"October 01, 1999 -  September 30, 2000",Biological Regulation of Lung Cancer Growth,Christian Arthur Combs; PhD,NULL,"Experimental Intervention Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10373
401,SC000172-09,"October 01, 1999 -  September 30, 2000",Immunocytomorphic Test for Early Lung Cancer,Christian Arthur Combs; PhD,NULL,"Experimental Intervention Sect, NCI",Alfredo  Martinez; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10372
402,SC000173-09,"October 01, 1999 -  September 30, 2000",Identification of Peptide Growth Factors That Regulate Human Tumor Proliferation,Frank  Cuttitta; PhD,NULL,"Experimental Intervention Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10371
403,SC000181-08,"October 01, 1999 -  September 30, 2000",The Molecular Genetics of Gynecologic Cancers,Michael  Birrer,NULL,"Experimental Intervention Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10370
404,SC000192-07,"October 01, 1999 -  September 30, 2000",Growth of Human Tumor Cell Lines in Protein-free/Hormone-Free Media,Frank  Cuttitta; PhD,NULL,"Experimental Intervention Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10369
405,SC000200-06,"October 01, 1999 -  September 30, 2000",Arachidonic Acid Metabolites and Lung Cancer,Terry  Moody; PhD,NULL,"Experimental Biochemistry Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10365
406,SC000201-06,"October 01, 1999 -  September 30, 2000",Peptide and Growth Factor Receptors in Epithelial Cancers,Terry  Moody; PhD,NULL,"Experimental Biochemistry Sect, NCI",NULL,NULL,NULL,Julius  Leyton; PhD (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10364
407,SC000550-20,"October 01, 1999 -  September 30, 2000",Immunologic Characterization of Malignant Lymphomas,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Hematopathlgy Sect, NCI",Stefania  Pittaluga|Mark  Raffeld; MD|Lynn Rose Sorbara,NULL,Peijie  Cong  (Surgl Pathlgy Sect),NULL,"1. Jaffe ES, Sander CA, Flaig MJ   (2000) Cutaneous lymphomas: a proposal for a unified approach to classification using the REAL/WHO Classification.  Ann Oncol 11 Suppl 1:17-21.|2. Longo DL, Duffey PL, Gribben JG, Jaffe ES, Curti BD, Gause BL, Janik JE, Braman VM, Esseltine D, Wilson WH, Kaufman D, Wittes RE, Nadler LM, Urba WJ   (2000) Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.  Cancer J 6:146-50.|3. Quintanilla-Martinez L, Jaffe ES   (2000) Commentary: aggressive NK cell lymphomas: insights into the spectrum of NK cell derived malignancies.  Histopathology 37:372-4.|4. Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma DW, Sorbara L, Raffeld M, Straus SE, Jaffe ES   (2000) Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome.  Blood 96:443-51.|5. Toro JR, Beaty M, Sorbara L, Turner ML, White J, Kingma DW, Raffeld M, Jaffe ES   (2000) gamma delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study.  Arch Dermatol 136:1024-32.|6. Wellmann A, Thieblemont C, Pittaluga S, Sakai A, Jaffe ES, Siebert P, Raffeld M   (2000) Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas.  Blood 96:398-404.|7. Yao L, Pike SE, Setsuda J, Parekh J, Gupta G, Raffeld M, Jaffe ES, Tosato G   (2000) Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12.  Blood 96:1900-5.",https://intramural.nih.gov/search/searchview.taf?ipid=10361
408,SC000852-47,"October 01, 1999 -  September 30, 2000",Cytology Applied to Human Diagnostic Problems and Research Problems,"Lance A Liotta; MD, PhD",NULL,"Lab Pathlgy, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10362
409,SC000853-47,"October 01, 1999 -  September 30, 2000",Surgical Pathology,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Surgl Pathlgy Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10363
410,SC000891-17,"October 01, 1999 -  September 30, 2000",Stimulated Motility in Tumor Cells,"Lance A Liotta; MD, PhD",NULL,"Lab Pathlgy, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10359
411,SC000892-17,"October 01, 1999 -  September 30, 2000",Molecular Biology of the Metastatic Phenotype,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Women's Cancer Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10358
412,SC003638-31,"October 01, 1999 -  September 30, 2000",Studies of DNA Repair in Human Degenerative Diseases,Jay H Robbins; MD,NULL,"Dermatology Br, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10357
413,SC003657-26,"October 01, 1999 -  September 30, 2000",Immunopathologic Mechanisms Involved in Inflammatory Skin Diseases,"Stephen I Katz; PhD, MD",NULL,"Div Clncl Scncs, NCI",NULL,NULL,Jay T Linton  (Dermatology Br)|Edit  Olasz  (National Cancer Institute)|Akihiko  Shibaki  (National Cancer Institute)|Nobuo  Yamada  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10356
414,SC003669-11,"October 01, 1999 -  September 30, 2000",Regulation of Cutaneous Accessory Cell Activity in Health and Disease,Mark  Udey; MD,NULL,"Dermatology Br, NCI",Bai V Nguyen|Mark A Wilson,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10355
415,SC003670-08,"October 01, 1999 -  September 30, 2000",Ex vivo and in vivo manipulations of keratinocyte gene expression,Jonathan  Vogel; MD,NULL,"Dermatology Br, NCI",Michael R Albert|Ruth A Foster|Wolfgang  Pfutzner,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10354
416,SC003671-07,"October 01, 1999 -  September 30, 2000",Mechanisms of keratinocyte adhesion to epidermal basement membrane,"Kim  Yancey; MD, PhD",NULL,"Dermatology Br, NCI",Conleth A Egan|Jooyoung E Roh|Carole L Yee,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10353
417,SC003800-30,"October 01, 1999 -  September 30, 2000",Surgical Consultants and Collaborative Research Involving Surgical Services at N,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgy Br, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10352
418,SC003811-26,"October 01, 1999 -  September 30, 2000",The Immunotherapy of Animal and Human Cancer,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgy Br, NCI",NULL,NULL,NULL,NULL,"1. Hwu P, Kershaw M, Rosenberg S (submitted in 2000) Activated Dual Specificity T Lymphocytes And Their Methods Of Use. Patent issued: 7,723,111 (US in 2010). Patents pending: 02721335.4 (FR application); 02721335.4 (GB application); PCT/US02/07249 (PC application); 12/715,829 (US application); 02721335.4 (DE application); 02721335.4 (EP application).|2. Wang R, Rosenberg S, Zeng G (submitted in 2000) Novel Mhc Class Ii Restricted T Cell Epitopes From The Cancer Antigen Ny Eso-1. Patents issued: 7,619,057 (US in 2010); 4776852 (JP in 2011); 5588363 (JP in 2014); 8,754,046 (US in 2014); 2398743 (CA in 2015); 9,447,144 (US in 2016); 2333065 (EP in 2017); 2333065 (GB in 2017). Patents pending: 01905152.3 (EP application); 10010353.0 (EP application); 10010389.4 (EP application); 15/241,996 (US application); 33062/01 (AU application).",https://intramural.nih.gov/search/searchview.taf?ipid=10351
419,SC004002-31,"October 01, 1999 -  September 30, 2000",Defects in Immunoregulatory Cell Receptors in Patients with Leukemia/Lymphoma,"Thomas Alexander Waldmann; MD, PhD|IRP Faculty Profile",NULL,"Metabolism Br, NCI","Nazli  Azimi|Sigrid Priscilla Dubois|Carolyn  Goldman|Michael N Petrus|Yutaka  Tagaya; MD, PhD|Latresia A Wilson|Show all 7",NULL,Jennifer  Mariner  (DISCOVERY SECT)|Marc S Rickford  (National Cancer Institute),Bonnie  Quearry (NIMH),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10303
420,SC004016-27,"October 01, 1999 -  September 30, 2000",Mechanism of Action of Insulin-like Growth Factors,Peter  Nissley; PhD,NULL,"Endocrinology Sect, NCI",Susan L Spence,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10304
421,SC004017-22,"October 01, 1999 -  September 30, 2000",Biology of the Immune Response,"David  Nelson; MD, PhD",NULL,"Immunophysiology Sect, NCI",Cynthia H Schoonover|Donn M Stewart; MD,NULL,Lan  Tian  (Metabolism Br),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10302
422,SC004020-23,"October 01, 1999 -  September 30, 2000","Antigen-specific T-cell activation, application to vaccines for Cancer and AIDS","Jay Arthur Berzofsky; MD, PhD|IRP Faculty Profile",NULL,"Molecular Immunogenetics and Vaccine Research Section, NCI","Jeffrey D Ahlers|Igor M. Belyakov; MD, PhD|David Francis Contois; BS|Sangkon  Oh|James T Snyder; PhD|Masaki  Terabe|Show all 7",NULL,Michael  Derby  (Metabolism Br),NULL,"1. Terabe M, Matsui S, Noben-Trauth N, Chen H, Watson C, Donaldson DD, Carbone DP, Paul WE, Berzofsky JA   (2000) NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway.  Nat Immunol 1:515-20.",https://intramural.nih.gov/search/searchview.taf?ipid=10298
423,SC004024-13,"October 01, 1999 -  September 30, 2000",Regulation of Gene Expression in Normal and Malignant Human Lymphocytes,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Metabolism Br, NCI",Lauren M Averett|Jena M Giltnane|Yunsheng  He|Lloyd T Lam|Oxana K Pickeral; PhD|Xin H Yu,NULL,Andreas  Rosenwald  (National Cancer Institute),"Liming  Yang; PhD, MD (CIT)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10296
424,SC006310-21,"October 01, 1999 -  September 30, 2000",Surgery versus Radiation Therapy in Treatment of Primary Breast Cancer,"Rosemary  Altemus; MD, PhD",NULL,"RADIATION THERAPY SECT, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10293
425,SC006321-21,"October 01, 1999 -  September 30, 2000",Modulation of Therapeutic Response,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radlgy Biology Br, NCI",NULL,NULL,"Angelo  Russo; MD, PhD  (MOLECULAR MECHANISMS SECT)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10291
426,SC006329-20,"October 01, 1999 -  September 30, 2000",Clinical Radiation Physics Service,Robert R Miller,NULL,"RADIATION PHYSICS and COMPUTER AUTOMATION SECT, NCI",Frank S Harrington,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10292
427,SC006330-20,"October 01, 1999 -  September 30, 2000",Radiation Field Modeling and Computerized Treatment Planning,Robert R Miller,NULL,"RADIATION PHYSICS and COMPUTER AUTOMATION SECT, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10290
428,SC006353-18,"October 01, 1999 -  September 30, 2000",Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,Martin W Brechbiel; PhD|IRP Faculty Profile,NULL,"INORGANIC and RADIOIMMUNE CHEMSTRY SECT, NCI",Alexander  Yordanov; PhD,NULL,NULL,NULL,"1. Adams GP, Shaller CC, Chappell LL, Wu C, Horak EM, Simmons HH, Litwin S, Marks JD, Weiner LM, Brechbiel MW   (2000) Delivery of the alpha-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules.  Nucl Med Biol 27:339-46.|2. Brechbiel M, Waldmann T    (2000) Anti-HER2 Radioimmunotherapy. Breast Disease. 11:125-132.|3. Chappell LL, Dadachova E, Milenic DE, Garmestani K, Wu C, Brechbiel MW   (2000) Synthesis, characterization, and evaluation of a novel bifunctional chelating agent for the lead isotopes 203Pb and 212Pb.  Nucl Med Biol 27:93-100.|4. Chappell LL, Deal KA, Dadachova E, Brechbiel MW   (2000) Synthesis, conjugation, and radiolabeling of a novel bifunctional chelating agent for (225)Ac radioimmunotherapy applications.  Bioconjug Chem 11:510-9.|5. Clarke K, Lee FT, Brechbiel MW, Smyth FE, Old LJ, Scott AM   (2000) In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice.  Cancer Res 60:4804-11.|6. Clarke K, Lee FT, Brechbiel MW, Smyth FE, Old LJ, Scott AM   (2000) Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.  Clin Cancer Res 6:3621-8.|7. Govindan SV, Goldenberg DM, Elsamra SE, Griffiths GL, Ong GL, Brechbiel MW, Burton J, Sgouros G, Mattes MJ   (2000) Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with beta-particle emitters.  J Nucl Med 41:2089-97.|8. Kennel SJ, Chappell LL, Dadachova K, Brechbiel MW, Lankford TK, Davis IA, Stabin M, Mirzadeh S   (2000) Evaluation of 225Ac for vascular targeted radioimmunotherapy of lung tumors.  Cancer Biother Radiopharm 15:235-44.|9. Kennel SJ, Mirzadeh S, Hurst GB, Foote LJ, Lankford TK, Glowienka KA, Chappell LL, Kelso JR, Davern SM, Safavy A, Brechbiel MW   (2000) Labeling and distribution of linear peptides identified using in vivo phage display selection for tumors.  Nucl Med Biol 27:815-25.|10. Kobayashi H, Kao CH, Kreitman RJ, Le N, Kim MK, Brechbiel MW, Paik CH, Pastan I, Carrasquillo JA   (2000) Pharmacokinetics of 111In- and 125I-labeled antiTac single-chain Fv recombinant immunotoxin.  J Nucl Med 41:755-62.|11. Kobayashi H, Sato N, Saga T, Nakamoto Y, Ishimori T, Toyama S, Togashi K, Konishi J, Brechbiel MW   (2000) Monoclonal antibody-dendrimer conjugates enable radiolabeling of antibody with markedly high specific activity with minimal loss of immunoreactivity.  Eur J Nucl Med 27:1334-9.|12. McDevitt MR, Barendswaard E, Ma D, Lai L, Curcio MJ, Sgouros G, Ballangrud AM, Yang WH, Finn RD, Pellegrini V, Geerlings MW, Lee M, Brechbiel MW, Bander NH, Cordon-Cardo C, Scheinberg DA   (2000) An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.  Cancer Res 60:6095-100.|13. Pai-Scherf LH, Carrasquillo JA, Paik C, Gansow O, Whatley M, Pearson D, Webber K, Hamilton M, Allegra C, Brechbiel M, Willingham MC, Pastan I   (2000) Imaging and phase I study of 111In- and 90Y-labeled anti-LewisY monoclonal antibody B3.  Clin Cancer Res 6:1720-30.|14. Yordanov A, Deal K, Garmestani K, Kobayashi H, Herring B, Waldmann T, Brechbiel M    (2000) Synthesis and Biodistribution Study of a New 211At-Calix[4]arene Complex. J Labelled Comp Radiopharm. 43:1219-1225.",https://intramural.nih.gov/search/searchview.taf?ipid=10288
429,SC006358-17,"October 01, 1999 -  September 30, 2000","Radiolysis, Photolysis and Sonolysis of Cells and their Constituents",Peter  Riesz; PhD,NULL,"BIOPHYSICAL SPECTROSCOPY SECT, NCI",NULL,NULL,NULL,NULL,"1. Kondo T, Umemura S, Tanabe K, Ogawa R, Adachi I, Riesz P   (2000) Novel therapeutic applications of ultrasound Utilization of thermal and cavitational effects.  Japanese Journal of Hyperthermic Oncology 16, No.4:203-216.",https://intramural.nih.gov/search/searchview.taf?ipid=10289
430,SC006378-15,"October 01, 1999 -  September 30, 2000",QA of Treatment Delivery by means of Overlaid Digitized Simulator Port Films,Robert R Miller,NULL,"RADIATION PHYSICS and COMPUTER AUTOMATION SECT, NCI",Frank S Harrington,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10287
431,SC006387-13,"October 01, 1999 -  September 30, 2000",Nitroxides as Protectors Against Oxidative Stress,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radlgy Biology Br, NCI",NULL,NULL,"Angelo  Russo; MD, PhD  (MOLECULAR MECHANISMS SECT)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10286
432,SC006390-12,"October 01, 1999 -  September 30, 2000",Bifunctional Chelating Agents for Gallium (III),Martin W Brechbiel; PhD|IRP Faculty Profile,NULL,"INORGANIC and RADIOIMMUNE CHEMSTRY SECT, NCI",NULL,NULL,NULL,NULL,"1. Park G, Ye N, Rogers R, Brechbiel M, Planalp R   (2000) Dicationic Metal Complexes ([MIIL][ClO4]2, M = Zn, Cd, and Hg) of N,N',N'?-tris(2-methylenepyridyl)-cis-1,3,5-triaminocyclohexane: Preparation, Characterization, and Structures.  Polyhedron 19:1155-1161.",https://intramural.nih.gov/search/searchview.taf?ipid=10285
433,SC006536-07,"October 01, 1999 -  September 30, 2000",Development of Analytical Methods for New Anticancer and Antiviral Agents,William D Figg; PharmD|IRP Faculty Profile,NULL,"PHARMACOKINETICS SECT, NCI",NULL,NULL,Yuichi  Ando  (Cellular And Clinical Pharmacology Sect)|Siiri  Forbes  (National Cancer Institute)|Michelle A Rudek  (Cellular And Clinical Pharmacology Sect)|Suoping  Zhai  (National Cancer Institute),NULL,"1. Bauer KS, Lush RM, Rudek MA, Shih C, Sausville E, Figg WD   (2000) A high-performance liquid chromatography method using ultraviolet and fluorescence detection for the quantitation of UCN-01, 7-hydroxystaurosporine, from human plasma and saliva.  Biomed Chromatogr 14:338-43.|2. Rudek MA, March CL, Bauer KS, Pluda JM, Figg WD   (2000) High-performance liquid chromatography with mass spectrometry detection for quantitating COL-3, a chemically modified tetracycline, in human plasma.  J Pharm Biomed Anal 22:1003-14.",https://intramural.nih.gov/search/searchview.taf?ipid=10283
434,SC006537-07,"October 01, 1999 -  September 30, 2000",Development of Pharmacokinetic Models to Characterize the Disposition of New Ant,William D Figg; PharmD|IRP Faculty Profile,NULL,"PHARMACOKINETICS SECT, NCI",NULL,NULL,Yuichi  Ando  (Cellular And Clinical Pharmacology Sect)|Siiri  Forbes  (National Cancer Institute)|Michelle A Rudek  (Cellular And Clinical Pharmacology Sect)|Suoping  Zhai  (National Cancer Institute),NULL,"1. Gutierrez M, Chabner BA, Pearson D, Steinberg SM, Jaffe ES, Cheson BD, Fojo A, Wilson WH   (2000) Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: An 8-year follow-Up study of EPOCH.  J Clin Oncol 18:3633-42.|2. Kreitman RJ, Wilson WH, White JD, Stetler-Stevenson M, Jaffe ES, Giardina S, Waldmann TA, Pastan I   (2000) Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies.  J Clin Oncol 18:1622-36.|3. Little RF, Wyvill KM, Pluda JM, Welles L, Marshall V, Figg WD, Newcomb FM, Tosato G, Feigal E, Steinberg SM, Whitby D, Goedert JJ, Yarchoan R   (2000) Activity of thalidomide in AIDS-related Kaposi's sarcoma.  J Clin Oncol 18:2593-602.|4. Messmann RA, Vitetta ES, Headlee D, Senderowicz AM, Figg WD, Schindler J, Michiel DF, Creekmore S, Steinberg SM, Kohler D, Jaffe ES, Stetler-Stevenson M, Chen H, Ghetie V, Sausville EA   (2000) A phase I study of combination therapy with immunotoxins IgG-HD37-deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma.  Clin Cancer Res 6:1302-13.|5. Thrasher JB, Deeths J, Bennett C, Iyer P, Dineen MK, Zhai S, Figg WD, McLeod DG   (2000) Comparative study of the clinical efficacy of two dosing regimens of flutamide.  Mol Urol 4:259-63;discussion 265.",https://intramural.nih.gov/search/searchview.taf?ipid=10281
435,SC006538-07,"October 01, 1999 -  September 30, 2000",Development of Angiogenesis Inhibitors using Prostate Cancer as a Tumor Model,William D Figg; PharmD|IRP Faculty Profile,NULL,"PHARMACOKINETICS SECT, NCI",NULL,NULL,Yuichi  Ando  (Cellular And Clinical Pharmacology Sect)|Shannon  Dixon  (Cellular And Clinical Pharmacology Sect)|Erwin A Kruger  (National Cancer Institute)|Douglas K Price  (Cellular And Clinical Pharmacology Sect)|Michelle A Rudek  (Cellular And Clinical Pharmacology Sect),NULL,"1. Bauer KS, Cude KJ, Dixon SC, Kruger EA, Figg WD   (2000) Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathway.  J Pharmacol Exp Ther 292:31-7.|2. Berger AC, Alexander HR, Tang G, Wu PS, Hewitt SM, Turner E, Kruger E, Figg WD, Grove A, Kohn E, Stern D, Libutti SK   (2000) Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis.  Microvasc Res 60:70-80.|3. Berger AC, Feldman AL, Gnant MF, Kruger EA, Sim BK, Hewitt S, Figg WD, Alexander HR, Libutti SK   (2000) The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing.  J Surg Res 91:26-31.|4. Figg WD, Kruger EA   (2000) TNP-470: an angiogenesis inhibitor in clinical development for cancer.  Expert Opin Investig Drugs 9:1383-96.|5. Kruger EA, Duray PH, Tsokos MG, Venzon DJ, Libutti SK, Dixon SC, Rudek MA, Pluda J, Allegra C, Figg WD   (2000) Endostatin inhibits microvessel formation in the ex vivo rat aortic ring angiogenesis assay.  Biochem Biophys Res Commun 268:183-91.|6. Figg WD, Eger KD, Guetshow MD, Hauschildt SD, Hecker TD, Teubert UD, Weiss MD (submitted in 2000) Analogs Of Thalidomide As Potential Angiogenesis Inhibitors. Patent issued: 1389203 (LI in 2010). Patents pending: PCT/US02/05868 (PC application); 2009-143087 (JP application).",https://intramural.nih.gov/search/searchview.taf?ipid=13974
436,SC006539-06,"October 01, 1999 -  September 30, 2000",The Human Biology of DNA Damage and Repair,Eddie  Reed,NULL,"Clncl Pharmclgy Br, NCI",NULL,NULL,Cheryl L Cross  (National Cancer Institute)|Manasses K Yunmbam  (Medical Ovarian Cancer Sect),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10280
437,SC006540-06,"October 01, 1999 -  September 30, 2000",Clinical Treatment of Ovarian Cancer,Eddie  Reed,NULL,"Clncl Pharmclgy Br, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10279
438,SC006579-17,"October 01, 1999 -  September 30, 2000",Genes Involved in Cellular Differentiation and Proliferation,Ilan  Kirsch; MD,NULL,"Acquired Gene Rearrangements Sect, NCI",NULL,NULL,Stefano  Campaner  (National Cancer Institute)|Petra  Delgado  (National Cancer Institute)|Shai  Izraeli; MD  (Medcn Br),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10278
439,SC006581-17,"October 01, 1999 -  September 30, 2000",Molecular Pathogenesis of Multiple Myeloma,"Walter M Kuehl; MD, PhD",NULL,"Molecular Biology Of Differentiation Sect, NCI",Leslie Ann Brents|Theresa K Chen|Constance M Cultraro,NULL,Amel  Dib  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10277
440,SC006587-16,"October 01, 1999 -  September 30, 2000",Gene Rearrangements as Tumor Specific Markers,Ilan  Kirsch; MD,NULL,"Acquired Gene Rearrangements Sect, NCI",Kenneth E Nakahara,NULL,NULL,NULL,"1. Kirsch IR, Green ED, Yonescu R, Strausberg R, Carter N, Bentley D, Leversha MA, Dunham I, Braden VV, Hilgenfeld E, Schuler G, Lash AE, Shen GL, Martelli M, Kuehl WM, Klausner RD, Ried T   (2000) A systematic, high-resolution linkage of the cytogenetic and physical maps of the human genome.  Nat Genet 24:339-40.|2. Kirsch IR, Ried T   (2000) Integration of cytogenetic data with genome maps and available probes: present status and future promise.  Semin Hematol 37:420-8.|3. Shou Y, Martelli ML, Gabrea A, Qi Y, Brents LA, Roschke A, Dewald G, Kirsch IR, Bergsagel PL, Kuehl WM   (2000) Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma.  Proc Natl Acad Sci U S A 97:228-33.|4. Tonon G, Roschke A, Stover K, Shou Y, Kuehl WM, Kirsch IR   (2000) Spectral karyotyping combined with locus-specific FISH simultaneously defines genes and chromosomes involved in chromosomal translocations.  Genes Chromosomes Cancer 27:418-23.|5. Wang J, Jani-Sait E, Escalon E, Carroll A, deJong P, Kirsch I, Aplan P   (2000) The t(14;21)(q112;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene.  Proc Natl Acad Sci U S A 97:3497-3502.",https://intramural.nih.gov/search/searchview.taf?ipid=10276
441,SC006657-18,"October 01, 1999 -  September 30, 2000",Development of New Cancer Treatments and Imaging Techniques Using Regional or Is,"H Richard Alexander; MD, PhD",NULL,"Surgl Metabolism Sect, NCI",David  Bartlett; MD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10275
442,SC006659-18,"October 01, 1999 -  September 30, 2000",Molecular Genetics of Kidney Cancer,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Br, NCI",John L Phillips; MD|James R Vasselli|Shubo  Zhou; MD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10274
443,SC006660-17,"October 01, 1999 -  September 30, 2000",Study of Interleukin-2 Based Immunotherapy,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Tumor Immunology Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10273
444,SC006663-11,"October 01, 1999 -  September 30, 2000",Tamoxifen and Retinoid Regulation of Breast Epithelial Cell Growth and Metabolis,David  Danforth,NULL,"Surgy Br, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10272
445,SC006664-11,"October 01, 1999 -  September 30, 2000",Specific Immune Recognition of Tumor-Associated Antigens by Human T cells,Suzanne L. Topalian; MD,NULL,"Tumor Immunology Sect, NCI",Monica I Gonzales|Franck  Housseau,NULL,Kimberly R Lindsey  (Surgy Br),Anitha K Moorthy (NIAID),"1. Ornstein DK, Gillespie JW, Paweletz CP, Duray PH, Herring J, Vocke CD, Topalian SL, Bostwick DG, Linehan WM, Petricoin EF, Emmert-Buck MR   (2000) Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines.  Electrophoresis 21:2235-42.",https://intramural.nih.gov/search/searchview.taf?ipid=10271
446,SC006670-08,"October 01, 1999 -  September 30, 2000",Recombinant and Synthetic Anti-Cancer Vaccines,Nicholas Phillip Restifo; MD|IRP Faculty Profile,NULL,"Tumor Immunology Sect, NCI",Kari  Irvine,NULL,Christophe E Touloukian  (Surgy Br),NULL,"1. Garcia-sastre A, Palese P, Restifo N (submitted in 2000) Recombinant Influenza Viruses Expressing Tumor-associated Antigens As Antitumor Agents. Patent issued: 8,012,490 (US in 2011). Patents pending: 09/070,629 (US application); 10/848,620 (US application); PCT/US98/08929 (PC application); 60/045,176 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=10270
447,SC006672-07,"October 01, 1999 -  September 30, 2000",The Genetic Modification of Hematopoietic Cells for Cancer Therapy,Patrick  Hwu; MD,NULL,"Tumor Immunology Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10269
448,SC006675-06,"October 01, 1999 -  September 30, 2000",Variables Affecting the Immunobiology of Melanoma,Francesco M. Marincola; MD,NULL,"Tumor Immunology Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=29506
449,SC006731-12,"October 01, 1999 -  September 30, 2000",Laboratory and Clinical Studies in Drug Resistance Reversal,Susan  Bates; MD,NULL,"Experimental Therapeutics Sect, NCI",Susan  Mertins,NULL,Robert W Robey  (Molecular Therapeutics Sect),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10205
450,SC006732-12,"October 01, 1999 -  September 30, 2000",Laboratory and Clinical Translational Studies of Drug Resistance,"Antonio  Fojo; MD, PhD",NULL,"Experimental Therapeutics Sect, NCI","Lyn Ann J Mickley|Vemulkonda Koneti Rao; MD, FRCPA",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10204
451,SC006737-09,"October 01, 1999 -  September 30, 2000",Development of Novel Therapies for HIV Infection and Related Malignancies,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Br, NCI",David A Davis; MD|Kathleen M Wyvill,NULL,Elisabeth L Read-Connole  (National Cancer Institute)|Andrea  Rinderknecht  (National Cancer Institute),NULL,"1. Little R, Yarchoan R   (2000) Considerations in the management of HIV infection in patients undergoing antineoplastic chemotherapy, in AIDS-Related Cancers and their Treatment. Feigal EG, Levine AM, Bigger RJ, eds., Marcel Dekker, Inc. (New York, NY), pp. 281-330.|2. Aoki Y, Tosato G, Nambu Y, Iwamoto A, Yarchoan R   (2000) Detection of vascular endothelial growth factor in AIDS-related primary effusion lymphomas.  Blood 95:1109-10.|3. Aoki Y, Yarchoan R, Braun J, Iwamoto A, Tosato G   (2000) Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions.  Blood 96:1599-601.|4. Cocchi F, DeVico AL, Yarchoan R, Redfield R, Cleghorn F, Blattner WA, Garzino-Demo A, Colombini-Hatch S, Margolis D, Gallo RC   (2000) Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection.  Proc Natl Acad Sci U S A 97:13812-13817.|5. Foster CB, Lehrnbecher T, Samuels S, Stein S, Mol F, Metcalf JA, Wyvill K, Steinberg SM, Kovacs J, Blauvelt A, Yarchoan R, Chanock SJ   (2000) An IL6 promoter polymorphism is associated with a lifetime risk of development of kaposi sarcoma in men infected with human immunodeficiency virus.  Blood 96:2562-7.|6. Lehrnbecher TL, Foster CB, Zhu S, Venzon D, Steinberg SM, Wyvill K, Metcalf JA, Cohen SS, Kovacs J, Yarchoan R, Blauvelt A, Chanock SJ   (2000) Variant genotypes of FcgammaRIIIA influence the development of Kaposi's sarcoma in HIV-infected men.  Blood 95:2386-90.|7. Little RF, Wyvill KM, Pluda JM, Welles L, Marshall V, Figg WD, Newcomb FM, Tosato G, Feigal E, Steinberg SM, Whitby D, Goedert JJ, Yarchoan R   (2000) Activity of thalidomide in AIDS-related Kaposi's sarcoma.  J Clin Oncol 18:2593-602.|8. Little RF, Yarchoan R, Wilson WH   (2000) Systemic chemotherapy for HIV-associated lymphoma in the era of highly active antiretroviral therapy.  Curr Opin Oncol 12:438-44.|9. Sgadari C, Toschi E, Palladino C, Barillari G, Carlei D, Cereseto A, Ciccolella C, Yarchoan R, Monini P, Sturzl M, Ensoli B   (2000) Mechanism of paclitaxel activity in Kaposi's sarcoma.  J Immunol 165:509-17.|10. Walther MM, Rehak NN, Venzon D, Myers CE, Linehan WM, Figg WD   (2000) Suramin administration is associated with a decrease in serum calcium levels.  World J Urol 18:388-91.|11. Wilson WH, Sorbara L, Figg WD, Mont EK, Sausville E, Warren KE, Balis FM, Bauer K, Raffeld M, Senderowicz AM, Monks A   (2000) Modulation of clinical drug resistance in a B cell lymphoma patient by the protein kinase inhibitor 7-hydroxystaurosporine: presentation of a novel therapeutic paradigm.  Clin Cancer Res 6:415-21.",https://intramural.nih.gov/search/searchview.taf?ipid=10203
452,SC006738-09,"October 01, 1999 -  September 30, 2000",Antiviral Therapy of HIV-1 Infection,Hiroaki  Mitsuya,NULL,"Medcn Br, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10202
453,SC006741-08,"October 01, 1999 -  September 30, 2000",Lymphoma Studies,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Medcn Br, NCI",NULL,NULL,NULL,NULL,"1. Lucas PJ, Kim SJ, Melby SJ, Gress RE   (2000) Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor.  J Exp Med 191:1187-96.",https://intramural.nih.gov/search/searchview.taf?ipid=13839
454,SC006743-07,"October 01, 1999 -  September 30, 2000",Signal Transduction Events and the Regulation of Cell Growth,Jane Beth Trepel,NULL,"Cell Signaling And Oncogenesis Sect, NCI",Eunjoo Serena Chung|Jin Woo Kim|Jung-Sik  Kim|Sunmin T Lee,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10200
455,SC006744-06,"October 01, 1999 -  September 30, 2000",Immunotoxin Protocols Under the Medicine Branch: Targeted Therapy of Lymphoid Ne,Edward A Sausville,NULL,"Developmental Therapeutics Program, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10199
456,SC006745-07,"October 01, 1999 -  September 30, 2000",Cellular Function and Immune Therapy in the Treatment of Cancer,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Transplantation Immunology Section, NCI",NULL,NULL,Frances  Hakim; PhD  (Experimental Transplantation And Immunology Sect)|Patricia H Harley  (Experimental Transplantation And Immunology Sect)|Gretchen  Schwartz; PhD  (Experimental Transplantation And Immunology Sect)|Xiao Y Yan  (Experimental Transplantation And Immunology Sect),NULL,"1. Lucas PJ, Kim SJ, Melby SJ, Gress RE   (2000) Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor.  J Exp Med 191:1187-96.",https://intramural.nih.gov/search/searchview.taf?ipid=10198
457,SC006747-06,"October 01, 1999 -  September 30, 2000",Immunotoxin Therapy for Solid Tumors: Clinical studies,"Robert J Kreitman; MD, PhD|IRP Faculty Profile",NULL,"Clinical Immunotherapy Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10197
458,SC006813-18,"October 01, 1999 -  September 30, 2000",Cell and Molecular Genetic Analysis of Pediatric Tumors,Carol J Thiele|IRP Faculty Profile,NULL,"Cell And Molecular Biology Sect, NCI",NULL,NULL,Habib R Hamidi  (National Cancer Institute)|Arvind  Ingle  (National Cancer Institute)|Jerry  Jaboin  (National Cancer Institute)|Mitsunari  Nakamura  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10196
459,SC006830-30,"October 01, 1999 -  September 30, 2000",Treatment of Infections in Immunocompromised Children with Cancer and HIV,Thomas J. Walsh; MD,NULL,"Immunocompromised Host Section, NCI",Andrea A Francesconi|Joanne S Peter|Vidamantas  Petraitis|Robert L Schaufele,NULL,Andreas  Groll; MD  (Pediatric Oncology Br)|Ruta  Petraitiene  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10195
460,SC006880-23,"October 01, 1999 -  September 30, 2000",Drug Development and Clinical Pharmacology of Anticancer and Antiretroviral Drug,"Frank M Balis; MD, PhD",NULL,"Pharmclgy And Experimental Therapeutics Sect, NCI",Diane  Cole|Nalini M Jayaprakash|Cynthia M Lester mccully|Robert F Murphy,NULL,Elizabeth  Fox; MD (Pediatric Oncology Br),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10193
461,SC006891-12,"October 01, 1999 -  September 30, 2000",Solid Tumors,Lee Jay Helman; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Br, NCI",Crystal L. Mackall; MD,NULL,Lauren M Long (Immunocompromised Host Section),NULL,"1. Navid F, Helman LJ   (1999) Childhood cancers, in Molecular Pathology of Early Cancer. Srivastava S, Henson DE, Gazdar A, eds., IOS Press (Amsterdam, Netherlands), pp. 123-134.|2. Wexler L, Helman LJ   (2000) Soft tissue sarcomas of childhood, in Cancer Medicine. BC Decker (New York, NY), pp. 2198-2203.",https://intramural.nih.gov/search/searchview.taf?ipid=10188
462,SC006892-12,"October 01, 1999 -  September 30, 2000",Molecular Biology of Pediatric Tumors,Lee Jay Helman; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Br, NCI",Chand  Khanna; MD|Fariba  Navid; MD,NULL,NULL,NULL,"1. Berzofsky J, Helman LJ, Carbone D   (2000) Cancer Vaccines: Cancer Antigens: Oncogenes and Mutations, in Biologic Therapy of Cancer: Principles and Practice. DHR Publishers (New Haven, CT), pp. 526-541.|2. Navid F, Letterio JJ, Yeung CL, Pegtel M, Helman LJ   (2000) Autocrine transforming growth factor-beta growth pathway in murine osteosarcoma cell lines associated with inability to affect phosphorylation of retinoblastoma protein.  Sarcoma 4:93-102.",https://intramural.nih.gov/search/searchview.taf?ipid=10187
463,SC007202-17,"October 01, 1999 -  September 30, 2000",Biostatistics and Data Management Section,Seth M Steinberg; PhD|IRP Faculty Profile,NULL,"Biostat and Data Mgmt Sect, NCI",Janet Sue Doernberg|David J Venzon; PhD,NULL,NULL,NULL,"1. Breathnach OS, Georgiadis MS, Schuler BS, Pizzella P, Llorens V, Kasturi V, Steinberg SM, O'Neil K, Takimoto CH, Johnson BE   (2000) Phase II trial of paclitaxel by 96-hour continuous infusion in combination with cisplatin for patients with advanced non-small cell lung cancer.  Clin Cancer Res 6:2670-6.|2. Chougnet C, Kovacs A, Baker R, Mueller BU, Luban NL, Liewehr DJ, Steinberg SM, Thomas EK, Shearer GM   (2000) Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production.  J Infect Dis 181:1590-7.|3. Foster CB, Lehrnbecher T, Samuels S, Stein S, Mol F, Metcalf JA, Wyvill K, Steinberg SM, Kovacs J, Blauvelt A, Yarchoan R, Chanock SJ   (2000) An IL6 promoter polymorphism is associated with a lifetime risk of development of kaposi sarcoma in men infected with human immunodeficiency virus.  Blood 96:2562-7.|4. Gutierrez M, Chabner BA, Pearson D, Steinberg SM, Jaffe ES, Cheson BD, Fojo A, Wilson WH   (2000) Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: An 8-year follow-Up study of EPOCH.  J Clin Oncol 18:3633-42.|5. Kurdziel K, Bacharach S, Carrasquillo J, Huebsch S, Whatley M, Sellers D, Steinberg S, Libutti S, Pluda J, Reed E, Dahut W, Figg W   (2000) 8:45-9:00 Using PET 18F-FDG, 11CO, and 15O-water for Monitoring Prostate Cancer During a Phase II Anti-angiogenic Drug Trial with Thalidomide.  Clin Positron Imaging 3:144.|6. Lehrnbecher TL, Foster CB, Zhu S, Venzon D, Steinberg SM, Wyvill K, Metcalf JA, Cohen SS, Kovacs J, Yarchoan R, Blauvelt A, Chanock SJ   (2000) Variant genotypes of FcgammaRIIIA influence the development of Kaposi's sarcoma in HIV-infected men.  Blood 95:2386-90.|7. Little RF, Wyvill KM, Pluda JM, Welles L, Marshall V, Figg WD, Newcomb FM, Tosato G, Feigal E, Steinberg SM, Whitby D, Goedert JJ, Yarchoan R   (2000) Activity of thalidomide in AIDS-related Kaposi's sarcoma.  J Clin Oncol 18:2593-602.|8. Messmann RA, Vitetta ES, Headlee D, Senderowicz AM, Figg WD, Schindler J, Michiel DF, Creekmore S, Steinberg SM, Kohler D, Jaffe ES, Stetler-Stevenson M, Chen H, Ghetie V, Sausville EA   (2000) A phase I study of combination therapy with immunotoxins IgG-HD37-deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma.  Clin Cancer Res 6:1302-13.|9. Moretti S, Marcellini S, Boschini A, Famularo G, Santini G, Alesse E, Steinberg SM, Cifone MG, Kroemer G, De Simone C   (2000) Apoptosis and apoptosis-associated perturbations of peripheral blood lymphocytes during HIV infection: comparison between AIDS patients and asymptomatic long-term non-progressors.  Clin Exp Immunol 122:364-73.|10. Petiniot LK, Weaver Z, Barlow C, Shen R, Eckhaus M, Steinberg SM, Ried T, Wynshaw-Boris A, Hodes RJ   (2000) Recombinase-activating gene (RAG) 2-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice.  Proc Natl Acad Sci U S A 97:6664-9.|11. Reed E, Zerbe CS, Brawley OW, Bicher A, Steinberg SM   (2000) Analysis of autopsy evaluations of ovarian cancer patients treated at the National Cancer Institute, 1972-1988.  Am J Clin Oncol 23:107-16.|12. Riker AI, Kammula US, Panelli MC, Wang E, Ohnmacht GA, Steinberg SM, Rosenberg SA, Marincola FM   (2000) Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes.  Int J Cancer 86:818-26.|13. Sanz-Ortega J, Steinberg SM, Moro E, Saez M, Lopez JA, Sierra E, Sanz-Esponera J, Merino MJ   (2000) Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer.  Histol Histopathol 15:455-62.|14. Sparber A, Bauer L, Curt G, Eisenberg D, Levin T, Parks S, Steinberg SM, Wootton J   (2000) Use of complementary medicine by adult patients participating in cancer clinical trials.  Oncol Nurs Forum 27:623-30.|15. Sparber A, Wootton JC, Bauer L, Curt G, Eisenberg D, Levin T, Steinberg SM   (2000) Use of complementary medicine by adult patients participating in HIV/AIDS clinical trials.  J Altern Complement Med 6:415-22.",https://intramural.nih.gov/search/searchview.taf?ipid=10186
464,SC007224-09,"October 01, 1999 -  September 30, 2000",Functional  Magnetic Resonance Imaging for Tumors in small animals using  Electr,Murali  Krishna; PhD|IRP Faculty Profile,NULL,"BIOPHYSICAL SPECTROSCOPY SECT, NCI",Sankaran  Subramanian; MD,NULL,"James B Mitchell; PhD  (Radlgy Biology Br)|Angelo  Russo; MD, PhD  (MOLECULAR MECHANISMS SECT)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10185
465,SC007233-06,"October 01, 1999 -  September 30, 2000",Pentoxifylline for Radiation Induced Advanced Regional Fibrosis,"Rosemary  Altemus; MD, PhD",NULL,"RADIATION THERAPY SECT, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10184
466,SC007234-06,"October 01, 1999 -  September 30, 2001",A Phase I Study of Hydroxyurea and Pentoxifylline For Treatment of Glioblastoma,Brian  Fuller; MD,NULL,"RADIATION THERAPY SECT, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10182
467,SC007256-12,"October 01, 1999 -  September 30, 2000",Mechanisms of Oncogene Action in Tumorigenesis,Frederic  Kaye; MD,NULL,"Acquired Gene Rearrangements Sect, NCI",Sanjay R Modi,NULL,Akihoto  Kubo  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10183
468,SC007257-12,"October 01, 1999 -  September 30, 2000",Myc Network Proteins Regulate Cell Growth and Differentiation,Shoshana  Segal,NULL,"Medcn Br, NCI",NULL,NULL,Alexandra G Dace  (National Cancer Institute)|Yaffa  Rubinstein  (Cellular And Clinical Pharmacology Sect),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10181
469,SC007260-09,"October 01, 1999 -  September 30, 2000",Preclinical and Clinical Pharmacology and Therapeutics for Adenocarcinomas Arisi,Jean  Grem; MD,NULL,"Cellular And Clinical Pharmacology Sect, NCI",Vivien F Kao|Diana A Nguyen,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10180
470,SC007263-08,"October 01, 1999 -  September 30, 2000","Molecular Control of Growth, Differentiation, and Death in Breast Cancer Cells","Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Acquired Gene Rearrangements Sect, NCI",Marion M Nau,NULL,Mauricio A Cuello  (National Cancer Institute)|Seth A Ettenberg  (National Cancer Institute),NULL,"1. Bachmaier K, Krawczyk C, Kozieradzki I, Kong YY, Sasaki T, Oliveira-dos-Santos A, Mariathasan S, Bouchard D, Wakeham A, Itie A, Le J, Ohashi PS, Sarosi I, Nishina H, Lipkowitz S, Penninger JM   (2000) Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b.  nature 403:211-6.|2. Borinstein SC, Hyatt MA, Sykes VW, Straub RE, Lipkowitz S, Boulter J, Bogler O   (2000) SETA is a multifunctional adapter protein with three SH3 domains that binds Grb2, Cbl, and the novel SB1 proteins.  Cell Signal 12:769-79.|3. Keane M, Rubenstein Y, Cuello M, Ettenberg S, Banerjee P, Nau M, Lipkowitz S   (2000) Inhibition of NF-kB enhances TRAIL mediated apoptosis in breast cancer cell lines.  Breast Cancer Res Treat 64:211-219.",https://intramural.nih.gov/search/searchview.taf?ipid=10179
471,SC007264-07,"October 01, 1999 -  September 30, 2000",Clinical Investigation Section,J Michael Hamilton,NULL,"Clinical Investigations Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10176
472,SC007265-06,"October 01, 1999 -  September 30, 2000",Cancer Genetics,Ilan  Kirsch; MD,NULL,"Acquired Gene Rearrangements Sect, NCI",Pamela  Klein,NULL,George  Kim; MD  (Medcn Br)|Kristen G Stover  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10177
473,SC007281-07,"October 01, 1999 -  September 30, 2000",Nitric Oxide as a Modifier of Oxidative Stress,David Anderson Wink|IRP Faculty Profile,NULL,"TUMOR BIOLOGY SECT, NCI","Michael G Espey; MT, PhD|Katrina M Miranda",NULL,"James B Mitchell; PhD  (Radlgy Biology Br)|Angelo  Russo; MD, PhD  (MOLECULAR MECHANISMS SECT)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10178
474,SC007283-07,"October 01, 1999 -  September 30, 2000",Intracellular Modulation of Specific Intracellular Proteins,"Angelo  Russo; MD, PhD",NULL,"MOLECULAR MECHANISMS SECT, NCI",NULL,NULL,James B Mitchell; PhD  (Radlgy Biology Br),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10175
475,SC007311-09,"October 01, 1999 -  September 30, 2000",Protein Kinase Antagonists: Preclinical and Clinical,Edward A Sausville,NULL,"Developmental Therapeutics Program, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10174
476,SC009131-16,"October 01, 1999 -  September 30, 2000",Regulation of the RPSA gene in human cancers,"Mark  Sobel; MD, PhD",NULL,"Molecular Pathlgy Sect, NCI",Jing  Han|Phuoc  Le|Linda S Wrathall,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10173
477,SC009144-16,"October 01, 1999 -  September 30, 2000",Identification of Proteins Binding to c-myc Regulatory Sequences,David  Levens; PhD|IRP Faculty Profile,NULL,"Gene Regln Sect, NCI",Hye-Jung  Chung|Irene  Collins; PhD|Juhong  Liu|Suzanne Laurie Sanford,NULL,NULL,Liusheng  He; PhD (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10172
478,SC009163-13,"October 01, 1999 -  September 30, 2000",Signal Transduction Therapy--Basic Science,Elise C Kohn; MD,NULL,"Tumor Invasion And Metastases Sect, NCI",NULL,NULL,NULL,NULL,"1. Brown MR, Kohn EC, Hutter RV   (2000) The new millennium: applying novel technology to the study of the cancer cell in situ.  Cancer 88:2-5.|2. Brown MR, Kohn EC, Hutter RV   (2000) The new millennium: applying novel technology to the study of the cancer cell in situ.  Eur J Nucl Med 27:S27-30.",https://intramural.nih.gov/search/searchview.taf?ipid=10171
479,SC009170-13,"October 01, 1999 -  September 30, 2000",Genes regulating pattern formation during embryonic development,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Lab Pathlgy, NCI",Eiichiro  Nakamura,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10166
480,SC009172-12,"October 01, 1999 -  September 30, 2000",Cellular Interactions with Thrombospondin,David D Roberts; PhD|IRP Faculty Profile,NULL,"Biochemical Pathlgy Sect, NCI",John M Sipes,NULL,Chao-Zhen  He  (National Cancer Institute),NULL,"1. Albo D, Rothman VL, Roberts DD, Tuszynski GP   (2000) Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor.  Br J Cancer 83:298-306.|2. Chandrasekaran L, He CZ, Al-Barazi H, Krutzsch HC, Iruela-Arispe ML, Roberts DD   (2000) Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1.  Mol Biol Cell 11:2885-900.|3. Guo N, Templeton NS, Al-Barazi H, Cashel JA, Sipes JM, Krutzsch HC, Roberts DD   (2000) Thrombospondin-1 promotes alpha3beta1 integrin-mediated adhesion and neurite-like outgrowth and inhibits proliferation of small cell lung carcinoma cells.  Cancer Res 60:457-66.|4. Shafiee A, Penn JS, Krutzsch HC, Inman JK, Roberts DD, Blake DA   (2000) Inhibition of retinal angiogenesis by peptides derived from thrombospondin-1.  Invest Ophthalmol Vis Sci 41:2378-88.|5. Yu H, Tyrrell D, Cashel J, Guo NH, Vogel T, Sipes JM, Lam L, Fillit HM, Hartman J, Mendelovitz S, Panel A, Roberts DD   (2000) Specificities of heparin-binding sites from the amino-terminus and type 1 repeats of thrombospondin-1.  Arch Biochem Biophys 374:13-23.",https://intramural.nih.gov/search/searchview.taf?ipid=10165
481,SC009173-12,"October 01, 1999 -  September 30, 2000",Host Receptors for Human Pathogens,David D Roberts; PhD|IRP Faculty Profile,NULL,"Biochemical Pathlgy Sect, NCI",Michael L Pendrak,NULL,NULL,NULL,"1. Pendrak ML, Krutzsch HC, Roberts DD   (2000) Structural requirements for hemoglobin to induce fibronectin receptor expression in Candida albicans.  Biochemistry 39:16110-8.",https://intramural.nih.gov/search/searchview.taf?ipid=13979
482,SC009174-12,"October 01, 1999 -  September 30, 2000",Role of Glycoconjugates in Tumor Cell Adhesion,David D Roberts; PhD|IRP Faculty Profile,NULL,"Biochemical Pathlgy Sect, NCI",NULL,NULL,NULL,NULL,"1. Yu H, Tyrrell D, Cashel J, Guo NH, Vogel T, Sipes JM, Lam L, Fillit HM, Hartman J, Mendelovitz S, Panel A, Roberts DD   (2000) Specificities of heparin-binding sites from the amino-terminus and type 1 repeats of thrombospondin-1.  Arch Biochem Biophys 374:13-23.",https://intramural.nih.gov/search/searchview.taf?ipid=10167
483,SC009179-12,"October 01, 1999 -  September 30, 2000","Novel Metalloproteinase Inhibitors: Role in Tumor Invasion, Metastasis and Angio","William G Stetler-Stevenson; MD, PhD|IRP Faculty Profile",NULL,"Lab Pathlgy, NCI",NULL,NULL,Bente  Birkedal hansen  (Extracellular Matrix Pathlgy Sect),NULL,"1. Birkedal-Hansen B, Pavelic ZP, Gluckman JL, Stambrook P, Li YQ, Stetler-Stevenson WG   (2000) MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.  Oral Dis 6:376-82.|2. Hewitt RE, Brown KE, Corcoran M, Stetler-Stevenson WG   (2000) Increased expression of tissue inhibitor of metalloproteinases type 1 (TIMP-1) in a more tumourigenic colon cancer cell line.  J Pathol 192:455-9.|3. Hewitt RE, McMarlin A, Kleiner D, Wersto R, Martin P, Tsoskas M, Stamp GW, Stetler-Stevenson WG   (2000) Validation of a model of colon cancer progression.  J Pathol 192:446-54.|4. Hoegy SE, Oh HR, Corcoran ML, Stetler-Stevenson WG   (2000) Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition.  J Biol Chem, in press.|5. Holten-Andersen MN, Stephens RW, Nielsen HJ, Murphy G, Christensen IJ, Stetler-Stevenson W, Brunner N   (2000) High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer.  Clin Cancer Res 6:4292-9.",https://intramural.nih.gov/search/searchview.taf?ipid=10164
484,SC009182-12,"October 01, 1999 -  September 30, 2000",Molecular Biology of Lymphoproliferative Diseases,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Hematopathlgy Sect, NCI",Stefania  Pittaluga|Mark  Raffeld; MD|Lynn Rose Sorbara,NULL,Peijie  Cong  (Surgl Pathlgy Sect),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10163
485,SC009185-11,"October 01, 1999 -  September 30, 2000",Laser Capture Microdissection applied to human pathophysiology,"Lance A Liotta; MD, PhD",NULL,"Lab Pathlgy, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10162
486,SC009357-10,"October 01, 1999 -  September 30, 2000",GEM: A Mitogen-Inducible RAS-Related Protein,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"MOLECULAR IMMUNE ACTIVATION SECT, NCI",NULL,NULL,Beth A Spinelli  (Transduction Sect)|Seow Fong Yap  (Medcn Br),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10157
487,SC009358-10,"October 01, 1999 -  September 30, 2000",ERK-Dependent Growth and Differentiation Pathways,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"MOLECULAR IMMUNE ACTIVATION SECT, NCI",NULL,NULL,Warner  Wang  (National Cancer Institute)|Yvona  Ward; PhD  (Medcn Br),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10158
488,SC009361-10,"October 01, 1999 -  September 30, 2000","Determination of p53, c-erb-B2, BRCA1, and TIMP 2 alterations in infiltrating, c",Maria  Merino; PhD|IRP Faculty Profile,NULL,"Surgl Pathlgy Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10155
489,SC009364-09,"October 01, 1999 -  September 30, 2000",Postmortem Pathology,"Lance A Liotta; MD, PhD",NULL,"Lab Pathlgy, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10153
490,SC009372-09,"October 01, 1999 -  September 30, 2000",Flow Cytometric Analysis of Benign and Malignant Tumors,"Maryalice  Stetler-Stevenson; MD, PhD",NULL,"Hematopathlgy Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10154
491,SC009373-09,"October 01, 1999 -  September 30, 2000",TIMP-1 Expression by Normal Lymphocytes and in Lymphoid Neoplasms,"Maryalice  Stetler-Stevenson; MD, PhD",NULL,"Hematopathlgy Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10156
492,SC009374-09,"October 01, 1999 -  September 30, 2000",Calcium Regulation of Signaling Pathways,Elise C Kohn; MD,NULL,"Tumor Invasion And Metastases Sect, NCI",NULL,NULL,NULL,NULL,"1. Berger AC, Alexander HR, Tang G, Wu PS, Hewitt SM, Turner E, Kruger E, Figg WD, Grove A, Kohn E, Stern D, Libutti SK   (2000) Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis.  Microvasc Res 60:70-80.",https://intramural.nih.gov/search/searchview.taf?ipid=10152
493,SC009375-08,"October 01, 1999 -  September 30, 2000",Signal Transduction Therapy--Clinical,Elise C Kohn; MD,NULL,"Tumor Invasion And Metastases Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10150
494,SC009377-08,"October 01, 1999 -  September 30, 2000",Molecular Alterations in Premalignant and In-Situ Breast Lesions,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Women's Cancer Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10151
495,SC009387-07,"October 01, 1999 -  September 30, 2000",Kinetic Characterization of the Activation of Gelatinase A,"William G Stetler-Stevenson; MD, PhD|IRP Faculty Profile",NULL,"Lab Pathlgy, NCI",NULL,NULL,NULL,NULL,"1. Taraboletti G, Sonzogni L, Vergani V, Hosseini G, Ceruti R, Ghilardi C, Bastone A, Toschi E, Borsotti P, Scanziani E, Giavazzi R, Pepper MS, Stetler-Stevenson WG, Bani MR   (2000) Posttranscriptional stimulation of endothelial cell matrix metalloproteinases 2 and 1 by endothelioma cells.  Exp Cell Res 258:384-94.",https://intramural.nih.gov/search/searchview.taf?ipid=10147
496,SC009389-07,"October 01, 1999 -  September 30, 2000",A Mitogen-induced G Protein-coupled Receptor,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"MOLECULAR IMMUNE ACTIVATION SECT, NCI","Makoto  Haino; MD, PhD",NULL,Weihua  Luo  (Transduction Sect),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10148
497,SC009392-07,"October 01, 1999 -  September 30, 2000",Determination of Genetic alterations and prognostic markers in benign and cancer,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Surgl Pathlgy Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10149
498,SC009394-07,"October 01, 1999 -  September 30, 2000",Diagnostic Electron Microscopy  (EM),Maria  Tsokos; MD,NULL,"Ultrastructural Pathlgy Sect, NCI",NULL,NULL,NULL,NULL,"1. Bornstein SR, Abu-Asab M, Glasow A, Path G, Hauner H, Tsokos M, Chrousos GP, Scherbaum WA   (2000) Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture.  Diabetes 49:532-8.|2. Caffrey M, Braddock DT, Louis JM, Abu-Asab MA, Kingma D, Liotta L, Tsokos M, Tresser N, Pannell LK, Watts N, Steven AC, Simon MN, Stahl SJ, Wingfield PT, Clore GM   (2000) Biophysical characterization of gp41 aggregates suggests a model for the molecular mechanism of HIV-associated neurological damage and dementia.  J Biol Chem 275:19877-82.|3. Kruger EA, Duray PH, Tsokos MG, Venzon DJ, Libutti SK, Dixon SC, Rudek MA, Pluda J, Allegra C, Figg WD   (2000) Endostatin inhibits microvessel formation in the ex vivo rat aortic ring angiogenesis assay.  Biochem Biophys Res Commun 268:183-91.",https://intramural.nih.gov/search/searchview.taf?ipid=10146
499,SC009397-06,"October 01, 1999 -  September 30, 2000",Immunization of Stem Cell Transplant Donors with Myeloma Antigen Vaccines,Larry  Kwak,NULL,"Experimental Transplantation And Immunology Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13980
500,SC009431-06,"October 01, 1999 -  September 30, 2000",Histologic and Molecular Characterization of Solid Pediatric Tumors,Maria  Tsokos; MD,NULL,"Ultrastructural Pathlgy Sect, NCI",NULL,NULL,NULL,NULL,"1. Kumar S, Perlman E, Harris CA, Raffeld M, Tsokos M   (2000) Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues.  Mod Pathol 13:988-93.|2. Wexler LH, Meyer WH, Parham DM, Tsokos M   (2000) Neural differentiation and prognosis in peripheral primitive neuroectodermal tumor.  J Clin Oncol 18:2187-8.",https://intramural.nih.gov/search/searchview.taf?ipid=10145
501,SC010051-05,"October 01, 1999 -  September 30, 2000",Metal Chelate Conjugated Dendrimer Constructs for Diagnosis and Therapy,Martin W Brechbiel; PhD|IRP Faculty Profile,NULL,"INORGANIC and RADIOIMMUNE CHEMSTRY SECT, NCI",Alexander  Yordanov; PhD,NULL,NULL,NULL,"1. Bryant Jr, Yordanov AT, Linnoila JJ, Brechbiel MW, Frank JA   (2000) First Noncovalently Bound Calix.  Angew Chem Int Ed Engl 39:1641-1643.|2. Kobayashi H, Sato N, Saga T, Nakamoto Y, Ishimori T, Toyama S, Togashi K, Konishi J, Brechbiel MW   (2000) Monoclonal antibody-dendrimer conjugates enable radiolabeling of antibody with markedly high specific activity with minimal loss of immunoreactivity.  Eur J Nucl Med 27:1334-9.|3. Konda SD, Aref M, Brechbiel M, Wiener EC   (2000) Development of a tumor-targeting MR contrast agent using the high-affinity folate receptor: work in progress.  Invest Radiol 35:50-7.",https://intramural.nih.gov/search/searchview.taf?ipid=10144
502,SC010052-05,"October 01, 1999 -  September 30, 2000",Drosophila Model for the Identification of Proteins Involved in Tumor Cell Motil,"Lance A Liotta; MD, PhD",NULL,"Lab Pathlgy, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10143
503,SC010053-05,"October 01, 1999 -  September 30, 2000",Development of tumor selective viral vectors and development of surgical procedu,David  Bartlett; MD,NULL,"Surgl Metabolism Sect, NCI","H Richard Alexander; MD, PhD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10142
504,SC010056-05,"October 01, 1999 -  September 30, 2000",The Role of p300-mediated CREB/Rel transcription factor cross-talk in regulating,"Kevin  Gardner; MD, PhD",NULL,"Gene Regln Sect, NCI",Wendy J Freebern|Cynthia  Haggerty,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10141
505,SC010058-05,"October 01, 1999 -  September 30, 2000",Regulation of the Fas Receptor and its Ligand in Pediatric Tumors,Maria  Tsokos; MD,NULL,"Ultrastructural Pathlgy Sect, NCI",Betty Lay Hua Lee,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10139
506,SC010062-05,"October 01, 1999 -  September 30, 2000",The Role of Human Herpesvirus 8 in the Pathogenesis of Kaposi s Sarcoma,Andrew  Blauvelt; MD,NULL,"Dermatology Br, NCI",Debra L Borris,NULL,Tatsuyoshi  Kawamura  (National Cancer Institute)|Takahiro  Watanabe  (National Cancer Institute)|Jean P Zoeteweij  (National Cancer Institute),NULL,"1. Blauvelt A, Cobb MW, Turner ML   (2000) Widespread cutaneous vascular papules associated with peripheral blood eosinophilia and prominent inguinal lymphadenopathy.  J Am Acad Dermatol 43:698-700.|2. Foster CB, Lehrnbecher T, Samuels S, Stein S, Mol F, Metcalf JA, Wyvill K, Steinberg SM, Kovacs J, Blauvelt A, Yarchoan R, Chanock SJ   (2000) An IL6 promoter polymorphism is associated with a lifetime risk of development of kaposi sarcoma in men infected with human immunodeficiency virus.  Blood 96:2562-7.|3. Lehrnbecher TL, Foster CB, Zhu S, Venzon D, Steinberg SM, Wyvill K, Metcalf JA, Cohen SS, Kovacs J, Yarchoan R, Blauvelt A, Chanock SJ   (2000) Variant genotypes of FcgammaRIIIA influence the development of Kaposi's sarcoma in HIV-infected men.  Blood 95:2386-90.|4. Orenstein JM, Ciufo DM, Zoeteweij JP, Blauvelt A, Hayward GS   (2000) Morphogenesis of HHV8 in primary human dermal microvascular endothelium and primary effusion lymphomas.  Ultrastruct Pathol 24:291-300.",https://intramural.nih.gov/search/searchview.taf?ipid=10137
507,SC010065-05,"October 01, 1999 -  September 30, 2001",A Phase I Study of 2-Chlorodeoxyadenosine and Radiation for the Treatment of Hig,Brian  Fuller; MD,NULL,"RADIATION THERAPY SECT, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10138
508,SC010068-05,"October 01, 1999 -  September 30, 2000",Clinical New Drug Development,Eddie  Reed,NULL,"Clncl Pharmclgy Br, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10136
509,SC010069-05,"October 01, 1999 -  September 30, 2000",Bioinorganic Interactions Between Heavy Metals and Human Cells,Eddie  Reed,NULL,"Clncl Pharmclgy Br, NCI",NULL,NULL,Manasses K Yunmbam  (Medical Ovarian Cancer Sect),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10134
510,SC010074-05,"October 01, 1999 -  September 30, 2000",Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Tumor Cell Biology Sect, NCI",Yun-Jin J Jung|Monica G Marcu|Ivo A Wortman|Wanping  Xu,NULL,Nathan B McGovern  (National Cancer Institute),NULL,"1. An WG, Schulte TW, Neckers LM   (2000) The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome.  Cell Growth Differ 11:355-60.|2. Bonvini P, Hwang SG, El-Gamil M, Robbins P, Kim JS, Trepel J, Neckers L   (2000) Nuclear beta-catenin displays GSK-3beta- and APC-independent proteasome sensitivity in melanoma cells.  Biochim Biophys Acta 1495:308-18.|3. Garayoa M, Martinez A, Lee S, Pio R, An WG, Neckers L, Trepel J, Montuenga LM, Ryan H, Johnson R, Gassmann M, Cuttitta F   (2000) Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis.  Mol Endocrinol 14:848-62.|4. Marcu MG, Chadli A, Bouhouche I, Catelli M, Neckers LM   (2000) The heat shock protein 90 antagonist novobiocin interacts with a previously unrecognized ATP-binding domain in the carboxyl terminus of the chaperone.  J Biol Chem 275:37181-6.|5. Marcu MG, Schulte TW, Neckers L   (2000) Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins.  J Natl Cancer Inst 92:242-8.|6. Mimnaugh EG, Yunmbam MK, Li Q, Bonvini P, Hwang S, Trepel J, Reed E, Neckers L   (2000) Prevention of cisplatin-DNA adduct repair and potentiation of cisplatin-induced apoptosis in ovarian carcinoma cells by proteasome inhibitors.  Biochem Pharmacol 60:1343-54.|7. Shiotsu Y, Neckers LM, Wortman I, An WG, Schulte TW, Soga S, Murakata C, Tamaoki T, Akinaga S   (2000) Novel oxime derivatives of radicicol induce erythroid differentiation associated with preferential G(1) phase accumulation against chronic myelogenous leukemia cells through destabilization of Bcr-Abl with Hsp90 complex.  Blood 96:2284-91.|8. Xu W, Mimnaugh E, Rosser MF, Nicchitta C, Marcu M, Yarden Y, Neckers L   (2001) Sensitivity of mature ErbB2 to geldanamycin is conferred by its kinase domain and is mediated by chaperone protein Hsp90.  J Biol Chem 276:3702-3708.",https://intramural.nih.gov/search/searchview.taf?ipid=10135
511,SC010075-05,"October 01, 1999 -  September 30, 2000",A Phase I/II Study of a Vaccinia-HPV Recombinant,Samir N. Khleif; MD,NULL,"Acquired Gene Rearrangements Sect, NCI",NULL,NULL,NULL,NULL,"1. Khleif SN, Berzofsky JN (submitted in 2001) Human Papilloma Virus Immunoreactive Peptides. Patent issued: 2441947 (CA in 2014). Patents pending: 02728570.9 (EP application); 60/278,520 (US application); 10/472,661 (US application); 11/685,632 (US application); 2002258614 (AU application).",https://intramural.nih.gov/search/searchview.taf?ipid=10133
512,SC010078-05,"October 01, 1999 -  September 30, 2000",Evaluation of Cellular and Humoral Immunity Against Myeloma Idiotype,Larry  Kwak,NULL,"Experimental Transplantation And Immunology Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10131
513,SC010081-05,"October 01, 1999 -  September 30, 2000",Cancer Vaccines for Lymphomas,Larry  Kwak,NULL,"Experimental Transplantation And Immunology Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10132
514,SC010083-04,"October 01, 1999 -  September 30, 2000",Molecular basis for augmentation of host response and understanding genetic risk,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Immunocompromised Host Section, NCI",Renee A Chen|Eunhwa  Choi,NULL,Charles  Foster; MD  (Pediatric Oncology Br)|James G Taylor; MD  (Pediatric Oncology Br),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10130
515,SC010084-29,"October 01, 1999 -  September 30, 2000",Pediatric HIV/AIDS Clinical Research,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Br, NCI","Lori  Wiener; PhD, LCSW-C|Haven  Battles; PhD|Perdita P Taylor|Lauren V Wood; MD",NULL,NULL,Shirley  Jankelevich (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10129
516,SC010086-04,"October 01, 1999 -  September 30, 2000",Molecular signaling in human cancer,Edison  Liu; MD,NULL,"Ofc Dir, NCI",NULL,NULL,Olga  Aprelikova; PhD  (Molecular Signaling and Oncogenesis Section)|Carole  Carter  (Molecular Signaling and Oncogenesis Section)|Bruno S Fang  (Medcn Br)|Yih woei  Fridell  (Molecular Signaling and Oncogenesis Section)|Qingbin  Guo  (Molecular Signaling and Oncogenesis Section)|Mei  He  (Molecular Signaling and Oncogenesis Section)|Show all 8.,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10128
517,SC010087-04,"October 01, 1999 -  September 30, 2000",HIV Molecular Virology and Pathogenesis,"Steven Leonard Zeichner; MD, PhD",NULL,"HIV and AIDS Malignancy Br, NCI",NULL,NULL,Patrick Wei Pern Ng  (National Cancer Institute)|Mini  Paulose-Murphy  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10127
518,SC010088-04,"October 01, 1999 -  September 30, 2000",Analysis of p53 regulation in neuroblastoma cell lines,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Tumor Cell Biology Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10125
519,SC010090-04,"October 01, 1999 -  September 30, 2000",Fluorescent Pteridine Nucleoside Analogs,"Frank M Balis; MD, PhD",NULL,"Pharmclgy And Experimental Therapeutics Sect, NCI",Mary  Hawkins,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10126
520,SC010093-04,"October 01, 1999 -  September 30, 2000",Molecular Intervention in Thoracic Malignancies,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic Onclgy Sect, NCI","Dao M Nguyen; MD, MS|Jean A Tretler",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10122
521,SC010094-04,"October 01, 1999 -  September 30, 2000",The Role of Langerhans Cells in the Immunopathogenesis of HIV Disease,Andrew  Blauvelt; MD,NULL,"Dermatology Br, NCI",Debra L Borris,NULL,Tatsuyoshi  Kawamura  (National Cancer Institute)|Takahiro  Watanabe  (National Cancer Institute)|Jean P Zoeteweij  (National Cancer Institute),NULL,"1. Blauvelt A, Glushakova S, Margolis LB   (2000) HIV-infected human Langerhans cells transmit infection to human lymphoid tissue ex vivo.  AIDS 14:647-51.|2. Grivel JC, Malkevitch N, Margolis L   (2000) Human immunodeficiency virus type 1 induces apoptosis in CD4(+) but not in CD8(+) T cells in ex vivo-infected human lymphoid tissue.  J Virol 74:8077-84.|3. Grivel JC, Penn ML, Eckstein DA, Schramm B, Speck RF, Abbey NW, Herndier B, Margolis L, Goldsmith MA   (2000) Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue.  J Virol 74:5347-51.|4. Kawamura T, Cohen SS, Borris DL, Aquilino EA, Glushakova S, Margolis LB, Orenstein JM, Offord RE, Neurath AR, Blauvelt A   (2000) Candidate microbicides block HIV-1 infection of human immature langerhans cells within epithelial tissue explants.  J Exp Med 192:1491-500.|5. Wu SJ, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, Putvatana R, Louder MK, Filgueira L, Marovich MA, Wong HK, Blauvelt A, Murphy GS, Robb ML, Innes BL, Birx DL, Hayes CG, Frankel SS   (2000) Human skin Langerhans cells are targets of dengue virus infection.  Nat Med 6:816-20.",https://intramural.nih.gov/search/searchview.taf?ipid=10121
522,SC010095-04,"October 01, 1999 -  September 30, 2000",Molecular Genetics of Prostate Cancer,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Br, NCI",Cathy  Vocke; PhD|Jonathan T Walker; MD|Youfeng  Yang,NULL,Donald M Ayers  (National Cancer Institute)|Byron O Whyte  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10120
523,SC010097-01,"October 01, 1999 -  September 30, 2000",Inflammatory Breast Cancer,Sandra M Swain; MD,NULL,"Medcn Br, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13981
524,SC010098-01,"October 01, 1999 -  September 30, 2000",The Evaluation of Novel Therapeutics for Genitourinary Malignancies,William Laurence Dahut; MD|IRP Faculty Profile,NULL,"Medcn Br, NCI",NULL,NULL,William D Figg; PharmD  (PHARMACOKINETICS SECT),NULL,"1. Blagosklonny MV, Dixon SC, Figg WD   (2000) Efficacy of microtubule-active drugs followed by ketoconazole in human metastatic prostate cancer cell lines.  J Urol 163:1022-6.|2. Mueller E, Smith M, Sarraf P, Kroll T, Aiyer A, Kaufman DS, Oh W, Demetri G, Figg WD, Zhou XP, Eng C, Spiegelman BM, Kantoff PW   (2000) Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer.  Proc Natl Acad Sci U S A 97:10990-5.|3. Salnikow K, Costa M, Figg WD, Blagosklonny MV   (2000) Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.  Cancer Res 60:5630-4.",https://intramural.nih.gov/search/searchview.taf?ipid=10169
525,SC010099-01,"October 01, 1999 -  September 30, 2000",Epithelial Cancer Proteomics,Terry  Moody; PhD,NULL,"Experimental Biochemistry Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10168
526,SC010100-01,"October 01, 1999 -  September 30, 2000",Developmental Therapeutics for Improved Treatment of Tumors of the Central Nervo,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI",NULL,NULL,Katherine Elizabeth Warren; MD  (Pediatric Oncology Br),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13982
527,SC010276-03,"October 01, 1999 -  September 30, 2000",Molecular Mechanisms of TNF signaling and apoptosis,Zhenggang  Liu; PhD|IRP Faculty Profile,NULL,"Div Clncl Scncs, NCI",NULL,NULL,Anne  Devin; PhD  (Molecular Signaling and Oncogenesis Section)|Joseph  Lewis  (Molecular Signaling and Oncogenesis Section)|Yong  Lin  (Molecular Signaling and Oncogenesis Section)|Yolanda M Rodriguez  (National Cancer Institute),NULL,"1. Devin A, Cook A, Lin Y, Rodriguez Y, Kelliher M, Liu Z   (2000) The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation.  Immunity 12:419-29.|2. Lewis J, Devin A, Miller A, Lin Y, Rodriguez Y, Neckers L, Liu ZG   (2000) Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation.  J Biol Chem 275:10519-26.|3. Lin Y, Devin A, Cook A, Keane MM, Kelliher M, Lipkowitz S, Liu ZG   (2000) The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase.  Mol Cell Biol 20:6638-45.",https://intramural.nih.gov/search/searchview.taf?ipid=10118
528,SC010277-03,"October 01, 1999 -  September 30, 2000",Chemokines in Skin Immune Cell Trafficking and Function,"Sam  Hwang; MD, PhD",NULL,"Dermatology Br, NCI",NULL,NULL,NULL,NULL,"1. Fitzhugh DJ, Naik S, Caughman SW, Hwang ST   (2000) Cutting edge: C-C chemokine receptor 6 is essential for arrest of a subset of memory T cells on activated dermal microvascular endothelial cells under physiologic flow conditions in vitro.  J Immunol 165:6677-81.|2. Papadopoulos EJ, Fitzhugh DJ, Tkaczyk C, Gilfillan AM, Sassetti C, Metcalfe DD, Hwang ST   (2000) Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin.  Eur J Immunol 30:2355-61.|3. Saeki H, Wu MT, Olasz E, Hwang ST   (2000) A migratory population of skin-derived dendritic cells expresses CXCR5, responds to B lymphocyte chemoattractant in vitro, and co-localizes to B cell zones in lymph nodes in vivo.  Eur J Immunol 30:2808-14.",https://intramural.nih.gov/search/searchview.taf?ipid=10117
529,SC010278-03,"October 01, 1999 -  September 30, 2000",Waldenstrom s Macroglobulinemia,"Walter M Kuehl; MD, PhD",NULL,"Molecular Biology Of Differentiation Sect, NCI",NULL,NULL,Ying  Qi  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10115
530,SC010279-03,"October 01, 1999 -  September 30, 2001",Mechanisms of effector activation by the RAS oncogene,Geoffrey J Clark; PhD,NULL,"Medcn Br, NCI",NULL,NULL,Chad  Ellis  (Molecular Signaling and Oncogenesis Section)|Michele D Vos  (Molecular Signaling and Oncogenesis Section),NULL,"1. Drugan JK, Rogers-Graham K, Gilmer T, Campbell S, Clark GJ   (2000) The Ras/p120 GTPase-activating protein (GAP) interaction is regulated by the p120 GAP pleckstrin homology domain.  J Biol Chem 275:35021-7.|2. Reuther GW, Buss JE, Quilliam LA, Clark GJ, Der CJ   (2000) Analysis of function and regulation of proteins that mediate signal transduction by use of lipid-modified plasma membrane-targeting sequences.  Methods Enzymol 327:331-50.|3. Williams JG, Drugan JK, Yi GS, Clark GJ, Der CJ, Campbell SL   (2000) Elucidation of binding determinants and functional consequences of Ras/Raf-cysteine-rich domain interactions.  J Biol Chem 275:22172-9.",https://intramural.nih.gov/search/searchview.taf?ipid=10116
531,SC010280-03,"October 01, 1999 -  September 30, 2000",The role of Ras-related proteins in transformation,Geoffrey J Clark; PhD,NULL,"Medcn Br, NCI",NULL,NULL,NULL,NULL,"1. Ellis CA, Clark G   (2000) The importance of being K-Ras.  Cell Signal 12:425-34.|2. Reuther GW, Buss JE, Quilliam LA, Clark GJ, Der CJ   (2000) Analysis of function and regulation of proteins that mediate signal transduction by use of lipid-modified plasma membrane-targeting sequences.  Methods Enzymol 327:331-50.",https://intramural.nih.gov/search/searchview.taf?ipid=10114
532,SC010281-03,"October 01, 1999 -  September 30, 2000",Directing T Cell Responses during Immune Reconstitution,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Br, NCI",NULL,NULL,Terry J Fry  (Molecular Onclgy Sect),NULL,"1. Mackall CL   (2000) T-cell immunodeficiency following cytotoxic antineoplastic therapy: a review.  Stem Cells 18:10-8.|2. Mackall CL, Stein D, Fleisher TA, Brown MR, Hakim FT, Bare CV, Leitman SF, Read EJ, Carter CS, Wexler LH, Gress RE   (2000) Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults.  Blood 96:754-62.",https://intramural.nih.gov/search/searchview.taf?ipid=10113
533,SC010282-03,"October 01, 1999 -  September 30, 2000",Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL),Diane Carol Arthur; MD,NULL,"Lab Pathlgy, NCI",NULL,NULL,Lisa A Krueger  (Clinical Cytogenetics Sect),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10112
534,SC010283-03,"October 01, 1999 -  September 30, 2000",Possible Role of the Dihydrofolate Reductase (DHFR) Gene in the 5q- Syndrome,Diane Carol Arthur; MD,NULL,"Lab Pathlgy, NCI",NULL,NULL,Lisa A Krueger  (Clinical Cytogenetics Sect),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10111
535,SC010284-03,"October 01, 1999 -  September 30, 2000",Sentinel Node Detection,"Angelo  Russo; MD, PhD",NULL,"MOLECULAR MECHANISMS SECT, NCI",NULL,NULL,James B Mitchell; PhD  (Radlgy Biology Br),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10110
536,SC010287-03,"October 01, 1999 -  September 30, 2000",Induction of Apoptosis in Lymphoma Cells by Activation of CD30,"Colin  Duckett; MD, PhD",NULL,"Metabolism Br, NCI",Bettina W M Richter,NULL,Samy S Mir  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10106
537,SC010288-03,"October 01, 1999 -  September 30, 2000",Autologous and Allogeneic T Cell Strategies for the Treatment of Hematologic Mal,Daniel H Fowler,NULL,"Medcn Br, NCI",J  Foley,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10107
538,SC010289-02,"October 01, 1999 -  September 30, 2000",Clinical Trials of Immune Reconstitution/Tumor Vaccination in Pediatric Sarcomas,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Br, NCI",Donna B Bernstein,NULL,Lauren M Long (Immunocompromised Host Section),NULL,"1. Mackall CL, Goletz T, Berzofsky J, Helman L   (2000) Toward New Approaches: Targeting Tumor Specific Molecular Alterations with Immune Based Therapy, in Translocations in Solid Tumors. Cooper C, ed., Landes Biosciences (Georgetown, Texas, U.S.A.), pp. 182-197.|2. Mackall C, Berzofsky J, Helman LJ   (2000) Targeting tumor specific translocations in sarcomas in pediatric patients for immunotherapy.  Clin Orthop  25-31 pp.",https://intramural.nih.gov/search/searchview.taf?ipid=10105
539,SC010290-02,"October 01, 1999 -  September 30, 2000",Development of an Approach for Purging Pediatric Sarcoma Cells from Lymphocyte a,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Br, NCI",NULL,NULL,Margret Emborsky Merino  (Molecular Onclgy Sect),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10104
540,SC010291-02,"October 01, 1999 -  September 30, 2000",Identification of Tumor Antigens in Pediatric Sarcomas,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Br, NCI",NULL,NULL,Hua  Zhang  (National Cancer Institute),NULL,"1. Mackall CL, Helman LJ   (2000) Targeting pediatric malignancies for T cell-mediated immune responses.  Curr Oncol Rep 2:539-46.",https://intramural.nih.gov/search/searchview.taf?ipid=10103
541,SC010292-02,"October 01, 1999 -  September 30, 2000",Identification and regulation of signal transduction pathways that promote survi,"Phillip A Dennis; MD, PhD",NULL,"Lung Cancer Biology Sect, NCI",John Fickes Brognard; MS,NULL,Yucheng  Ni  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10102
542,SC010294-02,"October 01, 1999 -  September 30, 2000",A RETROVIRAL VECTOR ENCODING A REVERSE TRANSCRIPTION-ACTIVATED TRANSGENE.,John Charles Morris; MD,NULL,"Metabolism Br, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13983
543,SC010295-02,"October 01, 1999 -  September 30, 2000",Clinical and laboratory studies on angiogenesis inRenal Cancer,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Tumor Immunology Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10101
544,SC010296-02,"October 01, 1999 -  September 30, 2000",Molecular Genetics of Bladder Cancer,"Fredrick S Leach; MD, PhD, BS, BA",NULL,"Urologic Oncology Br, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10098
545,SC010297-02,"October 01, 1999 -  September 30, 2001",A Pilot study of Stereotaxic Radiosurgery for Intracranial Neoplasms,Brian  Fuller; MD,NULL,"RADIATION THERAPY SECT, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10099
546,SC010298-02,"October 01, 1999 -  September 30, 2000",Identification of chromosomal aberrations in human epithelial cancers and hemato,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Acquired Gene Rearrangements Sect, NCI",Michael John Difilippantonio; PhD|Hesed M Padilla Nash,NULL,Michael  Djavidan  (National Cancer Institute)|Jens  Habermann  (National Cancer Institute)|Madhvi B Upender  (National Cancer Institute)|Zoe  Weaver  (National Cancer Institute),Eva  Hilgenfeld (NHGRI),"1. Chen HT, Bhandoola A, Difilippantonio MJ, Zhu J, Brown MJ, Tai X, Rogakou EP, Brotz TM, Bonner WM, Ried T, Nussenzweig A   (2000) Response to RAG-Mediated V(D)J Cleavage by NBS1 and gamma-H2AX.  Science 290:1962-1965.|2. Difilippantonio MJ, Zhu J, Chen HT, Meffre E, Nussenzweig MC, Max EE, Ried T, Nussenzweig A   (2000) DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation.  nature 404:510-4.",https://intramural.nih.gov/search/searchview.taf?ipid=10100
547,SC010299-02,"October 01, 1999 -  September 30, 2000",Identification of mechanisms and consequences of chromosomal aneuploidy and chro,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Acquired Gene Rearrangements Sect, NCI",Michael John Difilippantonio; PhD|Hesed M Padilla Nash,NULL,Madhvi B Upender  (National Cancer Institute),Eva  Hilgenfeld (NHGRI),"1. Chen HT, Bhandoola A, Difilippantonio MJ, Zhu J, Brown MJ, Tai X, Rogakou EP, Brotz TM, Bonner WM, Ried T, Nussenzweig A   (2000) Response to RAG-Mediated V(D)J Cleavage by NBS1 and gamma-H2AX.  Science 290:1962-1965.|2. Difilippantonio MJ, Zhu J, Chen HT, Meffre E, Nussenzweig MC, Max EE, Ried T, Nussenzweig A   (2000) DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation.  nature 404:510-4.|3. Ghadimi BM, Sackett DL, Difilippantonio MJ, Schrock E, Neumann T, Jauho A, Auer G, Ried T   (2000) Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations.  Genes Chromosomes Cancer 27:183-90.",https://intramural.nih.gov/search/searchview.taf?ipid=10097
548,SC010300-02,"October 01, 1999 -  September 30, 2000",Development of diagnostic tools to visualize chromosomal and genetic markers of,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Acquired Gene Rearrangements Sect, NCI",Nicole E Mcneil|Linda I Stapleton,NULL,Michael  Djavidan  (National Cancer Institute)|Kerstin  Heselmeyer  (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10095
549,SC010352-02,"October 01, 1999 -  September 30, 2000",Prospective Study of Factors Affecting Weight Gain Among Breast Cancer Patients,Noreen M Aziz,NULL,"PREVENTIVE ONCLGY BR, NCI",NULL,NULL,Demetrius  Albanes; MD  (Office of the Director)|Jennifer A Klein  (Cancer Prevention Studies Br),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10096
550,SC010353-01,"October 01, 1999 -  September 30, 2000",Experimental therapeutics of pediatric hematopoietic malignancies,Alan S Wayne; MD,NULL,"Pediatric Oncology Br, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13985
551,SC010354-01,"October 01, 1999 -  September 30, 2000",Clinical development of novel drugs for children with cancer and neurofibromatos,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Pharmclgy And Experimental Therapeutics Sect, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13986
552,SC010355-01,"October 01, 1999 -  September 30, 2000",Angiogenesis and Tumor Growth,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Molecular and Cell Biology Section, NCI","Dong  Jiang; MD, PhD",NULL,"David D Ho  (National Cancer Institute)|Gang  Wang; MD, PhD  (Tumor Immunology Sect)|Lei  Yao  (Experimental Transplantation And Immunology Sect)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13987
553,SC010356-01,"October 01, 1999 -  September 30, 2000",A Role for KSHV (Kaposi s Sarcoma-associated Herpesvirus) in the Pathogenesis of,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Molecular and Cell Biology Section, NCI",NULL,NULL,Yoshiyasu  Aoki  (Experimental Transplantation And Immunology Sect),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13988
554,SC010357-01,"October 01, 1999 -  September 30, 2000",Viral RNA splicing and tumorigenesis,"Zhi Ming  Zheng; MD, PhD|IRP Faculty Profile",NULL,"Cellular Regulation and Transformation Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13989
555,SC010358-01,"October 01, 1999 -  September 30, 2000",Characterization of the Inhibitor of Apoptosis (IAP) Gene Family,"Colin  Duckett; MD, PhD",NULL,"Metabolism Br, NCI",Lisa J Eiben|Stephanie B Reffey,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13990
556,SC010359-02,"October 01, 1999 -  September 30, 2000",The Role of Nore1 Class Effectors in Ras Mediated Transformation,Geoffrey J Clark; PhD,NULL,"Medcn Br, NCI",NULL,NULL,NULL,NULL,"1. Vos MD, Ellis CA, Bell A, Birrer MJ, Clark GJ   (2000) Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis.  J Biol Chem 275:35669-72.",https://intramural.nih.gov/search/searchview.taf?ipid=13991
557,SC010360-02,"October 01, 1999 -  September 30, 2000",Molecular Determinants of Faithful Chromosome Transmission and Cell Cycle Regula,Munira A Basrai; PhD|IRP Faculty Profile,NULL,"Medcn Br, NCI",NULL,NULL,Oliver  Kerscher  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13995
558,SC010361-01,"October 01, 1999 -  September 30, 2000",Genetic Cancer Vaccines,Larry  Kwak,NULL,"Experimental Transplantation And Immunology Sect, NCI",NULL,NULL,NULL,NULL,"1. Biragyn A, Kwak L (submitted in 2000) Defensin-antigen Fusion Proteins. Patents issued: 7,754,676 (US in 2010); 7,915,040 (US in 2011); 8,084,250 (US in 2012); 8,551,936 (US in 2014); 8,754,030 (US in 2014). Patents pending: 14/268,949 (US application); PCT/US01/29074 (PC application).|2. Biragyn A, Kwak L (submitted in 2000) Viral Chemokine-antigen Fusion Proteins. Patents issued: 7,897,152 (US in 2011); 8,318,177 (US in 2013); 8,460,675 (US in 2013). Patents pending: 13/890,502 (US application); PCT/US01/29075 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=13996
559,SC010362-01,"October 01, 1999 -  September 30, 2000",Maternal cohort study of the Nurses  Health Studies,Michele  Forman; PhD,NULL,"Cancer Prevention Studies Br, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13997
560,SC010364-01,"October 01, 1999 -  September 30, 2000",Tissue Microarray Design and Development for Novel Gene and Gene Product Screeni,"David Erwin Kleiner; MD, PhD",NULL,"Women's Cancer Sect, NCI",NULL,NULL,"Stephen M Hewitt; MD, PhD (Pulmonary Pathlgy Sect)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13998
561,SC010365-01,"October 01, 1999 -  September 30, 2000",Investigation of Graft Versus Tumor Effects in Non-hematologic Malignancies,Michael R Bishop; MD,NULL,"Medcn Br, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=13999
562,SC020293-02,"October 01, 1999 -  September 30, 2000",Kinase activation and control of apoptosis in breast cancer cells,"Phillip A Dennis; MD, PhD",NULL,"Lung Cancer Biology Sect, NCI",NULL,NULL,Amy S Clark  (National Cancer Institute),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=10094
